{
    "(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase inhibitor": 0,
    "(R)-3-amino-2-methylpropionate-pyruvate transaminase inhibitor": 1,
    "(R)-6-hydroxynicotine oxidase inhibitor": 2,
    "(R)-Pantolactone dehydrogenase (flavin) inhibitor": 3,
    "(R)-aminopropanol dehydrogenase inhibitor": 4,
    "(R)-limonene 6-monooxygenase inhibitor": 5,
    "(R,R)-butanediol dehydrogenase inhibitor": 6,
    "(S)-2-Methylmalate dehydratase inhibitor": 7,
    "(S)-2-hydroxy-acid oxidase inhibitor": 8,
    "(S)-3-amino-2-methylpropionate transaminase inhibitor": 9,
    "(S)-3-hydroxyacid ester dehydrogenase inhibitor": 10,
    "(S)-6-hydroxynicotine oxidase inhibitor": 11,
    "(S)-carnitine 3-dehydrogenase inhibitor": 12,
    "(S)-methylmalonyl-CoA hydrolase inhibitor": 13,
    "1,2-alpha-L-fucosidase inhibitor": 14,
    "1,3-Beta-glucan synthase inhibitor": 15,
    "1,4-Alpha-glucan branching enzyme inhibitor": 16,
    "1,4-Dihydroxy-2-naphthoyl-CoA synthase inhibitor": 17,
    "1,4-Lactonase inhibitor": 18,
    "1,5-Anhydro-D-fructose reductase inhibitor": 19,
    "1-Acylglycerol-3-phosphate O-acyltransferase ABHD5 inhibitor": 20,
    "1-Acylglycerol-3-phosphate O-acyltransferase beta inhibitor": 21,
    "1-Acylglycerol-3-phosphate O-acyltransferase inhibitor": 22,
    "1-Alkyl-2-acetylglycerol O-acyltransferase inhibitor": 23,
    "1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor": 24,
    "1-Alkylglycerophosphocholine O-acetyltransferase inhibitor": 25,
    "1-Aminocyclopropane-1-carboxylate deaminase inhibitor": 26,
    "1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor": 27,
    "1-Phosphatidylinositol-4-phosphate 5-kinase inhibitor": 28,
    "1-Phosphofructokinase inhibitor": 29,
    "1-Pyrroline-5-carboxylate dehydrogenase inhibitor": 30,
    "11-Beta-hydroxysteroid dehydrogenase 1 inhibitor": 31,
    "11-Beta-hydroxysteroid dehydrogenase 2 inhibitor": 32,
    "11-Beta-hydroxysteroid dehydrogenase inhibitor": 33,
    "11-Cis-retinyl-palmitate hydrolase inhibitor": 34,
    "12-Lipoxygenase inhibitor": 35,
    "15-Hydroxyprostaglandin dehydrogenase (NADP+) inhibitor": 36,
    "15-Hydroxyprostaglandin-D dehydrogenase (NADP+) inhibitor": 37,
    "15-Lipoxygenase 2 inhibitor": 38,
    "15-Lipoxygenase inhibitor": 39,
    "15-Lipoxygenase stimulant": 40,
    "15-Oxoprostaglandin 13-reductase inhibitor": 41,
    "17-Beta-hydroxysteroid dehydrogenase 1 inhibitor": 42,
    "17-Beta-hydroxysteroid dehydrogenase 5 inhibitor": 43,
    "2,2-Dialkylglycine decarboxylase (pyruvate) inhibitor": 44,
    "2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase inhibitor": 45,
    "2,3-Oxidosqualene-lanosterol cyclase inhibitor": 46,
    "2,3-dihydroxybenzoate-AMP ligase inhibitor": 47,
    "2,4-Diaminopentanoate dehydrogenase inhibitor": 48,
    "2,4-Dichlorophenol 6-monooxygenase inhibitor": 49,
    "2,5-Dihydroxypyridine 5,6-dioxygenase inhibitor": 50,
    "2,6-Dihydroxypyridine 3-monooxygenase inhibitor": 51,
    "2-(acetamidomethylene)succinate hydrolase inhibitor": 52,
    "2-Acylglycerol O-acyltransferase 2 inhibitor": 53,
    "2-Acylglycerol O-acyltransferase inhibitor": 54,
    "2-Amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase inhibitor": 55,
    "2-Aminoadipate transaminase inhibitor": 56,
    "2-Aminoethylphosphonate-pyruvate transaminase inhibitor": 57,
    "2-Aminohexano-6-lactam racemase inhibitor": 58,
    "2-Aminohexanoate transaminase inhibitor": 59,
    "2-Chlorobenzoate 1,2-dioxygenase inhibitor": 60,
    "2-Dehydro-3-deoxy-L-arabinonate dehydratase inhibitor": 61,
    "2-Dehydro-3-deoxy-phosphogluconate aldolase inhibitor": 62,
    "2-Dehydropantoate 2-reductase inhibitor": 63,
    "2-Dehydropantoate aldolase inhibitor": 64,
    "2-Dehydropantolactone reductase (A-specific) inhibitor": 65,
    "2-Enoate reductase inhibitor": 66,
    "2-Ethylmalate synthase inhibitor": 67,
    "2-Haloacid dehalogenase (configuration-inverting) inhibitor": 68,
    "2-Haloacid dehalogenase inhibitor": 69,
    "2-Hydroxy-3-oxoadipate synthase inhibitor": 70,
    "2-Hydroxy-3-oxopropionate reductase inhibitor": 71,
    "2-Hydroxyacylsphingosine 1-beta-galactosyltransferase inhibitor": 72,
    "2-Hydroxymuconate-semialdehyde hydrolase inhibitor": 73,
    "2-Hydroxyquinoline 5,6-dioxygenase inhibitor": 74,
    "2-Hydroxyquinoline 8-monooxygenase inhibitor": 75,
    "2-Isopropylmalate synthase inhibitor": 76,
    "2-Methyl-branched-chain-enoyl-CoA reductase inhibitor": 77,
    "2-Methylacyl-CoA dehydrogenase inhibitor": 78,
    "2-Methylcitrate dehydratase inhibitor": 79,
    "2-Methylcitrate synthase inhibitor": 80,
    "2-Methyleneglutarate mutase inhibitor": 81,
    "2-Nitrophenol 2-monooxygenase inhibitor": 82,
    "2-Nitropropane dioxygenase inhibitor": 83,
    "2-Oxoaldehyde dehydrogenase (NAD+) inhibitor": 84,
    "2-Oxoaldehyde dehydrogenase (NADP+) inhibitor": 85,
    "2-Oxoglutarate decarboxylase inhibitor": 86,
    "2-Oxoisovalerate dehydrogenase (acylating) inhibitor": 87,
    "2-Pyrocatechuate decarboxylase inhibitor": 88,
    "20-Alpha-hydroxysteroid dehydrogenase inhibitor": 89,
    "24-sterol C-methyltransferase inhibitor": 90,
    "27-Hydroxycholesterol 7alpha-monooxygenase inhibitor": 91,
    "3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor": 92,
    "3'(2'),5'-Bisphosphate nucleotidase inhibitor": 93,
    "3'-Demethylstaurosporine O-methyltransferase inhibitor": 94,
    "3'-Nucleotidase inhibitor": 95,
    "3(or 17)alpha-hydroxysteroid dehydrogenase inhibitor": 96,
    "3(or 17)beta-hydroxysteroid dehydrogenase inhibitor": 97,
    "3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase inhibitor": 98,
    "3,4-Dihydroxyphenylacetate 2,3-dioxygenase inhibitor": 99,
    "3-Alpha-hydroxysteroid dehydrogenase (B-specific) inhibitor": 100,
    "3-Alpha-hydroxysteroid dehydrogenase type II inhibitor": 101,
    "3-Aminobutyryl-CoA ammonia-lyase inhibitor": 102,
    "3-Carboxyethylcatechol 2,3-dioxygenase inhibitor": 103,
    "3-Chloro-D-alanine dehydrochlorinase inhibitor": 104,
    "3-Cyanoalanine hydratase inhibitor": 105,
    "3-Dehydroquinate dehydratase inhibitor": 106,
    "3-Dehydroquinate synthase inhibitor": 107,
    "3-Demethylubiquinone-9 3-O-methyltransferase inhibitor": 108,
    "3-Deoxy-7-phosphoheptulonate synthase inhibitor": 109,
    "3-Deoxy-8-phosphooctulonate synthase inhibitor": 110,
    "3-Galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase inhibitor": 111,
    "3-Hydroxy-4-oxoquinoline 2,4-dioxygenase inhibitor": 112,
    "3-Hydroxyacyl-CoA dehydrogenase 2 inhibitor": 113,
    "3-Hydroxyacyl-CoA dehydrogenase inhibitor": 114,
    "3-Hydroxyanthranilate 3,4-dioxygenase inhibitor": 115,
    "3-Hydroxyanthranilate oxidase inhibitor": 116,
    "3-Hydroxybenzoate 4-monooxygenase inhibitor": 117,
    "3-Hydroxybenzoate 6-monooxygenase inhibitor": 118,
    "3-Hydroxybutyrate dehydrogenase inhibitor": 119,
    "3-Hydroxybutyryl-CoA dehydrogenase inhibitor": 120,
    "3-Hydroxydecanoyl-[acyl-carrier-protein] dehydratase inhibitor": 121,
    "3-Hydroxyisobutyryl-CoA hydrolase inhibitor": 122,
    "3-Hydroxyphenylacetate 6-hydroxylase inhibitor": 123,
    "3-Isopropylmalate dehydratase inhibitor": 124,
    "3-Isopropylmalate dehydrogenase inhibitor": 125,
    "3-Keto-steroid reductase inhibitor": 126,
    "3-Ketovalidoxylamine C-N-lyase inhibitor": 127,
    "3-Mercaptopyruvate sulfurtransferase inhibitor": 128,
    "3-Methyl-2-oxobutanoate dehydrogenase (lipoamide) inhibitor": 129,
    "3-Methyl-2-oxobutanoate hydroxymethyltransferase inhibitor": 130,
    "3-Methylbutanal reductase inhibitor": 131,
    "3-Oxoacid CoA-transferase inhibitor": 132,
    "3-Oxoacyl-[acyl-carrier-protein] reductase inhibitor": 133,
    "3-Oxoacyl-[acyl-carrier-protein] synthase II inhibitor": 134,
    "3-Oxoacyl-[acyl-carrier-protein] synthase III inhibitor": 135,
    "3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor": 136,
    "3-Oxoadipate enol-lactonase inhibitor": 137,
    "3-Oxosteroid 1-dehydrogenase inhibitor": 138,
    "3-Phosphoshikimate 1-carboxyvinyltransferase inhibitor": 139,
    "3-Phytase inhibitor": 140,
    "3C-like protease (Human coronavirus) inhibitor": 141,
    "4,5-Dihydroxyphthalate decarboxylase inhibitor": 142,
    "4-Alpha-glucanotransferase inhibitor": 143,
    "4-Carboxymethyl-4-methylbutenolide mutase inhibitor": 144,
    "4-Chlorobenzoyl-CoA dehalogenase inhibitor": 145,
    "4-Chlorophenylacetate 3,4-dioxygenase inhibitor": 146,
    "4-Coumarate-CoA ligase inhibitor": 147,
    "4-Hydroxy-2-oxoglutarate aldolase inhibitor": 148,
    "4-Hydroxy-4-methyl-2-oxoglutarate aldolase inhibitor": 149,
    "4-Hydroxybenzoate 1-hydroxylase inhibitor": 150,
    "4-Hydroxybenzoate 3-monooxygenase [NAD(P)H] inhibitor": 151,
    "4-Hydroxybenzoate 3-monooxygenase inhibitor": 152,
    "4-Hydroxybenzoate decarboxylase inhibitor": 153,
    "4-Hydroxybenzoate nonaprenyltransferase inhibitor": 154,
    "4-Hydroxybenzoate-CoA ligase inhibitor": 155,
    "4-Hydroxyglutamate transaminase inhibitor": 156,
    "4-Hydroxymandelate oxidase inhibitor": 157,
    "4-Hydroxyphenylacetate 1-monooxygenase inhibitor": 158,
    "4-Hydroxyphenylacetate 3-monooxygenase inhibitor": 159,
    "4-Hydroxyphenylpyruvate dioxygenase inhibitor": 160,
    "4-Hydroxyproline epimerase inhibitor": 161,
    "4-Methoxybenzoate monooxygenase (O-demethylating) inhibitor": 162,
    "4-Nitrophenol 2-monooxygenase inhibitor": 163,
    "4-Nitrophenylphosphatase inhibitor": 164,
    "4-Phytase inhibitor": 165,
    "4-Pyridoxolactonase inhibitor": 166,
    "40S ribosomal protein S27 inhibitor": 167,
    "4a-Hydroxytetrahydrobiopterin dehydratase inhibitor": 168,
    "5 Hydroxytryptamine 1 agonist": 169,
    "5 Hydroxytryptamine 1 antagonist": 170,
    "5 Hydroxytryptamine 1A agonist": 171,
    "5 Hydroxytryptamine 1A antagonist": 172,
    "5 Hydroxytryptamine 1B agonist": 173,
    "5 Hydroxytryptamine 1B antagonist": 174,
    "5 Hydroxytryptamine 1D agonist": 175,
    "5 Hydroxytryptamine 1D antagonist": 176,
    "5 Hydroxytryptamine 1E antagonist": 177,
    "5 Hydroxytryptamine 1F agonist": 178,
    "5 Hydroxytryptamine 1F antagonist": 179,
    "5 Hydroxytryptamine 2 agonist": 180,
    "5 Hydroxytryptamine 2 antagonist": 181,
    "5 Hydroxytryptamine 2A agonist": 182,
    "5 Hydroxytryptamine 2A antagonist": 183,
    "5 Hydroxytryptamine 2B agonist": 184,
    "5 Hydroxytryptamine 2B antagonist": 185,
    "5 Hydroxytryptamine 2C agonist": 186,
    "5 Hydroxytryptamine 2C antagonist": 187,
    "5 Hydroxytryptamine 3 agonist": 188,
    "5 Hydroxytryptamine 3 antagonist": 189,
    "5 Hydroxytryptamine 3A agonist": 190,
    "5 Hydroxytryptamine 3A antagonist": 191,
    "5 Hydroxytryptamine 3B antagonist": 192,
    "5 Hydroxytryptamine 3E antagonist": 193,
    "5 Hydroxytryptamine 4 agonist": 194,
    "5 Hydroxytryptamine 4 antagonist": 195,
    "5 Hydroxytryptamine 4A antagonist": 196,
    "5 Hydroxytryptamine 4B antagonist": 197,
    "5 Hydroxytryptamine 4C antagonist": 198,
    "5 Hydroxytryptamine 4D antagonist": 199,
    "5 Hydroxytryptamine 4E antagonist": 200,
    "5 Hydroxytryptamine 5 antagonist": 201,
    "5 Hydroxytryptamine 5A antagonist": 202,
    "5 Hydroxytryptamine 5B antagonist": 203,
    "5 Hydroxytryptamine 6 agonist": 204,
    "5 Hydroxytryptamine 6 antagonist": 205,
    "5 Hydroxytryptamine 7 agonist": 206,
    "5 Hydroxytryptamine 7 antagonist": 207,
    "5 Hydroxytryptamine 7B antagonist": 208,
    "5 Hydroxytryptamine 7L antagonist": 209,
    "5 Hydroxytryptamine 7S antagonist": 210,
    "5 Hydroxytryptamine agonist": 211,
    "5 Hydroxytryptamine antagonist": 212,
    "5 Hydroxytryptamine release inhibitor": 213,
    "5 Hydroxytryptamine release stimulant": 214,
    "5 Hydroxytryptamine uptake inhibitor": 215,
    "5 Hydroxytryptamine uptake stimulant": 216,
    "5 Lipoxygenase activating protein inhibitor": 217,
    "5'-Nucleotidase inhibitor": 218,
    "5-Alpha-reductase 1 inhibitor": 219,
    "5-Alpha-reductase 2 inhibitor": 220,
    "5-Alpha-reductase inhibitor": 221,
    "5-Aminolevulinate synthase inhibitor": 222,
    "5-Aminovalerate transaminase inhibitor": 223,
    "5-Formyltetrahydrofolate cyclo-ligase inhibitor": 224,
    "5-Guanidino-2-oxopentanoate decarboxylase inhibitor": 225,
    "5-Hydroxypentanoate CoA-transferase inhibitor": 226,
    "5-Lipoxygenase inhibitor": 227,
    "5-Methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase inhibitor": 228,
    "5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase inhibitor": 229,
    "5-Oxoprolinase (ATP-hydrolysing) inhibitor": 230,
    "6,7-Dihydropteridine reductase inhibitor": 231,
    "6-Carboxyhexanoate-CoA ligase inhibitor": 232,
    "6-Methylsalicylate decarboxylase inhibitor": 233,
    "6-Phospho-1-fructokinase inhibitor": 234,
    "6-Phospho-beta-glucosidase inhibitor": 235,
    "6-Phosphofructo-2-kinase inhibitor": 236,
    "6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitor": 237,
    "6-Phosphogluconate dehydrogenase, decarboxylating, putative inhibitor": 238,
    "6-Pyruvoyltetrahydropterin synthase inhibitor": 239,
    "7-Dehydrocholesterol reductase inhibitor": 240,
    "8-Amino-7-oxononanoate synthase inhibitor": 241,
    "8-oxodGTPase stimulant": 242,
    "AASS expression inhibitor": 243,
    "AATK expression enhancer": 244,
    "ABCA1 expression enhancer": 245,
    "ABCA1 expression inhibitor": 246,
    "ABCB1 expression enhancer": 247,
    "ABCB1 expression inhibitor": 248,
    "ABCB10 expression inhibitor": 249,
    "ABCB11 expression enhancer": 250,
    "ABCB4 expression enhancer": 251,
    "ABCC1 expression enhancer": 252,
    "ABCC13 expression enhancer": 253,
    "ABCC2 expression enhancer": 254,
    "ABCC3 expression enhancer": 255,
    "ABCC3 expression inhibitor": 256,
    "ABCC4 expression enhancer": 257,
    "ABCC5 expression enhancer": 258,
    "ABCC5 expression inhibitor": 259,
    "ABCC6 expression inhibitor": 260,
    "ABCD3 expression inhibitor": 261,
    "ABCG1 expression enhancer": 262,
    "ABCG1 expression inhibitor": 263,
    "ABCG2 expression enhancer": 264,
    "ABCG2 expression inhibitor": 265,
    "ABCG5 expression enhancer": 266,
    "ABHD2 expression enhancer": 267,
    "ABHD3 expression enhancer": 268,
    "ABL1 expression inhibitor": 269,
    "ABLIM1 expression enhancer": 270,
    "ACADVL expression enhancer": 271,
    "ACAN expression enhancer": 272,
    "ACK1 kinase inhibitor": 273,
    "ACPP expression enhancer": 274,
    "ACPP expression inhibitor": 275,
    "ACSL1 expression enhancer": 276,
    "ACSL3 expression enhancer": 277,
    "ACSL3 expression inhibitor": 278,
    "ACTA2 expression inhibitor": 279,
    "ADAM inhibitor": 280,
    "ADAM10 endopeptidase inhibitor": 281,
    "ADAM12 inhibitor": 282,
    "ADAM15 expression inhibitor": 283,
    "ADAM17 expression inhibitor": 284,
    "ADAM22 expression inhibitor": 285,
    "ADAM33 inhibitor": 286,
    "ADAM9 inhibitor": 287,
    "ADAMTS1 expression enhancer": 288,
    "ADAMTS9 expression enhancer": 289,
    "ADARB1 expression inhibitor": 290,
    "ADCY9 expression inhibitor": 291,
    "ADD3 expression enhancer": 292,
    "ADD3 expression inhibitor": 293,
    "ADIPOR2 expression inhibitor": 294,
    "ADM expression enhancer": 295,
    "ADORA2B expression enhancer": 296,
    "ADP-ribose diphosphatase inhibitor": 297,
    "ADP-ribosylarginine hydrolase inhibitor": 298,
    "ADP-thymidine kinase inhibitor": 299,
    "ADRA1B expression enhancer": 300,
    "ADRB2 expression inhibitor": 301,
    "ADSL expression inhibitor": 302,
    "AFP expression enhancer": 303,
    "AGER expression enhancer": 304,
    "AHNAK expression inhibitor": 305,
    "AHR expression enhancer": 306,
    "AHR expression inhibitor": 307,
    "AHRR expression enhancer": 308,
    "AHSA1 expression enhancer": 309,
    "AICAR transformylase inhibitor": 310,
    "AIP expression inhibitor": 311,
    "AKAP12 expression enhancer": 312,
    "AKIRIN1 expression inhibitor": 313,
    "AKR1A1 expression enhancer": 314,
    "AKR1B1 expression inhibitor": 315,
    "AKR1B10 expression enhancer": 316,
    "AKR1C1 expression enhancer": 317,
    "AKR1C2 expression enhancer": 318,
    "AKR1C3 expression enhancer": 319,
    "AKT1 expression enhancer": 320,
    "ALAS1 expression enhancer": 321,
    "ALCAM expression inhibitor": 322,
    "ALDH1A1 expression enhancer": 323,
    "ALDH1A3 expression enhancer": 324,
    "ALDH1A3 expression inhibitor": 325,
    "ALDH4A1 expression inhibitor": 326,
    "ALDOA expression enhancer": 327,
    "ALDOB expression inhibitor": 328,
    "ALDOC expression enhancer": 329,
    "ALK inhibitor": 330,
    "ALOX5 expression enhancer": 331,
    "ALPL expression enhancer": 332,
    "ALPP expression enhancer": 333,
    "ALPPL2 expression enhancer": 334,
    "AMH expression inhibitor": 335,
    "AMHR2 expression inhibitor": 336,
    "AMP deaminase 1 inhibitor": 337,
    "AMP deaminase 2 inhibitor": 338,
    "AMP deaminase 3 inhibitor": 339,
    "AMP deaminase inhibitor": 340,
    "AMP nucleosidase inhibitor": 341,
    "AMP-activated protein kinase inhibitor": 342,
    "AMP-activated protein kinase stimulant": 343,
    "AMP-activated protein kinase, alpha-1 subunit inhibitor": 344,
    "AMP-activated protein kinase, alpha-2 subunit inhibitor": 345,
    "AMP-activated protein kinase, beta-1 subunit inhibitor": 346,
    "AMP-activated protein kinase, gamma-1 subunit inhibitor": 347,
    "AMPA 1 receptor agonist": 348,
    "AMPA 1 receptor antagonist": 349,
    "AMPA 2 receptor agonist": 350,
    "AMPA 2 receptor antagonist": 351,
    "AMPA 3 receptor antagonist": 352,
    "AMPA 4 receptor antagonist": 353,
    "AMPA 5 receptor antagonist": 354,
    "AMPA receptor agonist": 355,
    "AMPA receptor antagonist": 356,
    "AMPH expression inhibitor": 357,
    "ANAPC1 expression enhancer": 358,
    "ANG expression enhancer": 359,
    "ANGPT1 expression inhibitor": 360,
    "ANKRD1 expression inhibitor": 361,
    "ANKRD11 expression inhibitor": 362,
    "ANLN expression inhibitor": 363,
    "ANP32A expression inhibitor": 364,
    "ANXA1 expression enhancer": 365,
    "ANXA1 expression inhibitor": 366,
    "AOX1 expression enhancer": 367,
    "AP1S1 expression inhibitor": 368,
    "AP1S2 expression enhancer": 369,
    "APAF1 expression enhancer": 370,
    "APAF1 expression inhibitor": 371,
    "APBB2 expression inhibitor": 372,
    "APLP2 expression inhibitor": 373,
    "APOA1 expression enhancer": 374,
    "APOA1 expression inhibitor": 375,
    "APOB expression inhibitor": 376,
    "APOBEC-3G inhibitor": 377,
    "APOBEC3B expression enhancer": 378,
    "APOBEC3C expression enhancer": 379,
    "APOBEC3F expression enhancer": 380,
    "APOC3 expression inhibitor": 381,
    "APOD expression enhancer": 382,
    "APOE expression enhancer": 383,
    "APOM expression enhancer": 384,
    "APP expression inhibitor": 385,
    "APTX expression inhibitor": 386,
    "AQR expression inhibitor": 387,
    "AR expression enhancer": 388,
    "AR expression inhibitor": 389,
    "AREG expression enhancer": 390,
    "ARF3 expression enhancer": 391,
    "ARHGAP10 expression enhancer": 392,
    "ARHGDIA expression enhancer": 393,
    "ARHGDIA expression inhibitor": 394,
    "ARHGEF2 expression enhancer": 395,
    "ARL3 expression enhancer": 396,
    "ARL6IP1 expression enhancer": 397,
    "ARL6IP5 expression enhancer": 398,
    "ARNTL2 expression inhibitor": 399,
    "ARPC2 expression inhibitor": 400,
    "ARPC3 expression inhibitor": 401,
    "ASAH1 expression enhancer": 402,
    "ASAH1 expression inhibitor": 403,
    "ASB1 expression enhancer": 404,
    "ASCL1 expression enhancer": 405,
    "ASNS expression enhancer": 406,
    "ASNS expression inhibitor": 407,
    "ASPM expression enhancer": 408,
    "ASRGL1 expression enhancer": 409,
    "ASTN2 expression enhancer": 410,
    "ASXL1 expression inhibitor": 411,
    "ATAD2 expression enhancer": 412,
    "ATAD2B expression inhibitor": 413,
    "ATF3 expression enhancer": 414,
    "ATF3 expression inhibitor": 415,
    "ATG5 expression enhancer": 416,
    "ATG5 expression inhibitor": 417,
    "ATM expression enhancer": 418,
    "ATM kinase inhibitor": 419,
    "ATP adenylyltransferase inhibitor": 420,
    "ATP citrate lysase inhibitor": 421,
    "ATP citrate synthase inhibitor": 422,
    "ATP deaminase inhibitor": 423,
    "ATP diphosphatase inhibitor": 424,
    "ATP phosphoribosyltransferase inhibitor": 425,
    "ATP-binding cassette A1 stimulant": 426,
    "ATP-binding cassette G2 inhibitor": 427,
    "ATP-dependent RNA helicase inhibitor": 428,
    "ATP-dependent molecular chaperone HSP82 inhibitor": 429,
    "ATP1A1 expression enhancer": 430,
    "ATP1B1 expression inhibitor": 431,
    "ATP1B3 expression inhibitor": 432,
    "ATP2B1 expression inhibitor": 433,
    "ATP5B expression enhancer": 434,
    "ATP6V1A expression inhibitor": 435,
    "ATPase (Mitochondrial F1F0) inhibitor": 436,
    "ATPase (Vacuolar H+) inhibitor": 437,
    "ATPase inhibitor": 438,
    "ATPase stimulant": 439,
    "ATR expression inhibitor": 440,
    "ATR kinase inhibitor": 441,
    "ATXN1 expression enhancer": 442,
    "ATXN1 expression inhibitor": 443,
    "ATXN3 expression enhancer": 444,
    "ATXN3 expression inhibitor": 445,
    "ATXN7 expression inhibitor": 446,
    "AURKA expression enhancer": 447,
    "AURKA expression inhibitor": 448,
    "AURKB expression enhancer": 449,
    "AUTS2 expression inhibitor": 450,
    "AXL receptor tyrosine kinase inhibitor": 451,
    "Abdominal distension": 452,
    "Abdominal pain": 453,
    "Abl kinase inhibitor": 454,
    "Abortion inducer": 455,
    "Acaricide": 456,
    "Acetate kinase inhibitor": 457,
    "Acetate-CoA ligase inhibitor": 458,
    "Acetoacetate decarboxylase inhibitor": 459,
    "Acetoacetyl-CoA reductase inhibitor": 460,
    "Acetoin dehydrogenase inhibitor": 461,
    "Acetolactate decarboxylase inhibitor": 462,
    "Acetolactate synthase inhibitor": 463,
    "Acetyl CoA thiolase inhibitor": 464,
    "Acetyl-CoA C-acyltransferase inhibitor": 465,
    "Acetyl-CoA carboxylase 1 inhibitor": 466,
    "Acetyl-CoA carboxylase 2 inhibitor": 467,
    "Acetyl-CoA carboxylase inhibitor": 468,
    "Acetyl-CoA transferase 1 inhibitor": 469,
    "Acetyl-CoA transferase 2 inhibitor": 470,
    "Acetyl-CoA transferase inhibitor": 471,
    "Acetylcholine M1 receptor agonist": 472,
    "Acetylcholine M1 receptor antagonist": 473,
    "Acetylcholine M2 receptor agonist": 474,
    "Acetylcholine M2 receptor antagonist": 475,
    "Acetylcholine M3 receptor agonist": 476,
    "Acetylcholine M3 receptor antagonist": 477,
    "Acetylcholine M4 receptor agonist": 478,
    "Acetylcholine M4 receptor antagonist": 479,
    "Acetylcholine M5 receptor agonist": 480,
    "Acetylcholine M5 receptor antagonist": 481,
    "Acetylcholine agonist": 482,
    "Acetylcholine antagonist": 483,
    "Acetylcholine muscarinic agonist": 484,
    "Acetylcholine muscarinic antagonist": 485,
    "Acetylcholine neuromuscular blocking agent": 486,
    "Acetylcholine nicotinic agonist": 487,
    "Acetylcholine nicotinic antagonist": 488,
    "Acetylcholine release stimulant": 489,
    "Acetylcholinesterase inhibitor": 490,
    "Acetylcholinesterase stimulant": 491,
    "Acetylenecarboxylate hydratase inhibitor": 492,
    "Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase inhibitor": 493,
    "Acetylglutamate kinase inhibitor": 494,
    "Acetylornithine deacetylase inhibitor": 495,
    "Acetylserotonin O-methyltransferase inhibitor": 496,
    "Acetylspermidine deacetylase inhibitor": 497,
    "Acid ceramidase inhibitor": 498,
    "Acid phosphatase 1 inhibitor": 499,
    "Acid phosphatase inhibitor": 500,
    "Acid-sensing ion channel blocker": 501,
    "Acidifying agent gastric": 502,
    "Acidifying agent non gastric": 503,
    "Acidosis": 504,
    "Acidosis, lactic": 505,
    "Acidosis, metabolic": 506,
    "Acne": 507,
    "Acneiform eruption": 508,
    "Aconitate decarboxylase inhibitor": 509,
    "Aconitate hydratase inhibitor": 510,
    "Acrocylindropepsin inhibitor": 511,
    "Acrosin inhibitor": 512,
    "Actin depolymerization inhibitor": 513,
    "Actin depolymerization stimulant": 514,
    "Actin polymerization inhibitor": 515,
    "Actinic keratosis treatment": 516,
    "Activating transcription factor 1 inhibitor": 517,
    "Activating transcription factor inhibitor": 518,
    "Activin receptor-like kinase 2 inhibitor": 519,
    "Activin receptor-like kinase 4 inhibitor": 520,
    "Acute neurologic disorders treatment": 521,
    "Acute respiratory distress syndrome (ARDS)": 522,
    "Acute respiratory distress syndrome (ARDS) treatment": 523,
    "Acyl-CoA dehydrogenase (NADP+) inhibitor": 524,
    "Acyl-CoA dehydrogenase inhibitor": 525,
    "Acyl-CoA hydrolase inhibitor": 526,
    "Acyl-CoA oxidase inhibitor": 527,
    "Acyl-lysine deacylase inhibitor": 528,
    "Acyl-protein thioesterase 1 inhibitor": 529,
    "Acyl-protein thioesterase 2 inhibitor": 530,
    "Acylaminoacyl-peptidase inhibitor": 531,
    "Acylcarnitine hydrolase inhibitor": 532,
    "Acylglycerone-phosphate reductase inhibitor": 533,
    "Acyloxyacyl hydrolase inhibitor": 534,
    "Acylphosphatase inhibitor": 535,
    "Adamalysin inhibitor": 536,
    "Adenine deaminase inhibitor": 537,
    "Adenine nucleotide translocase inhibitor": 538,
    "Adenine nucleotide translocator 1 inhibitor": 539,
    "Adenine phosphoribosyltransferase inhibitor": 540,
    "Adenomatous polyposis treatment": 541,
    "Adenosine A1 receptor agonist": 542,
    "Adenosine A1 receptor agonist enhancer": 543,
    "Adenosine A1 receptor antagonist": 544,
    "Adenosine A2 receptor agonist": 545,
    "Adenosine A2 receptor antagonist": 546,
    "Adenosine A2a receptor agonist": 547,
    "Adenosine A2a receptor antagonist": 548,
    "Adenosine A2b receptor agonist": 549,
    "Adenosine A2b receptor antagonist": 550,
    "Adenosine A3 receptor agonist": 551,
    "Adenosine A3 receptor antagonist": 552,
    "Adenosine deaminase inhibitor": 553,
    "Adenosine kinase inhibitor": 554,
    "Adenosine receptor agonist": 555,
    "Adenosine receptor antagonist": 556,
    "Adenosine regulator": 557,
    "Adenosine transporter 1 inhibitor": 558,
    "Adenosine uptake inhibitor": 559,
    "Adenosylhomocysteine nucleosidase inhibitor": 560,
    "Adenosylmethionine cyclotransferase inhibitor": 561,
    "Adenosylmethionine-8-amino-7-oxononanoate transaminase inhibitor": 562,
    "Adenylate cyclase I inhibitor": 563,
    "Adenylate cyclase I stimulant": 564,
    "Adenylate cyclase II inhibitor": 565,
    "Adenylate cyclase III inhibitor": 566,
    "Adenylate cyclase IV inhibitor": 567,
    "Adenylate cyclase V inhibitor": 568,
    "Adenylate cyclase VI inhibitor": 569,
    "Adenylate cyclase VII inhibitor": 570,
    "Adenylate cyclase VIII inhibitor": 571,
    "Adenylate cyclase inhibitor": 572,
    "Adenylate cyclase stimulant": 573,
    "Adenylate kinase 2 inhibitor": 574,
    "Adenylate kinase inhibitor": 575,
    "Adenylosuccinate lyase inhibitor": 576,
    "Adenylosuccinate synthase inhibitor": 577,
    "Adenylosuccinate synthetase 2 inhibitor": 578,
    "Adenylyl-sulfate kinase inhibitor": 579,
    "Adenylylsulphatase inhibitor": 580,
    "Adhesin protein fimH inhibitor": 581,
    "Adrenal cortex hypoplasia": 582,
    "Adrenal insufficiency": 583,
    "Adrenaline agonist": 584,
    "Adrenaline antagonist": 585,
    "Adrenaline release stimulant": 586,
    "Adrenaline uptake inhibitor": 587,
    "Adrenergic": 588,
    "Adrenergic, ophthalmic": 589,
    "Aerobactin synthase inhibitor": 590,
    "Agaritine gamma-glutamyltransferase inhibitor": 591,
    "Age-related macular degeneration treatment": 592,
    "Aggrecanase 1 inhibitor": 593,
    "Aggrecanase 2 inhibitor": 594,
    "Aggrecanase inhibitor": 595,
    "Aggression": 596,
    "Agitation": 597,
    "Agmatinase inhibitor": 598,
    "AgrC-1 protein inhibitor": 599,
    "AgrC-2 protein inhibitor": 600,
    "Agranulocytosis": 601,
    "Akathisia": 602,
    "Akinesia": 603,
    "Alanine carboxypeptidase inhibitor": 604,
    "Alanine dehydrogenase inhibitor": 605,
    "Alanine racemase inhibitor": 606,
    "Alanine transaminase inhibitor": 607,
    "Alanine-tRNA ligase inhibitor": 608,
    "Albendazole monooxygenase inhibitor": 609,
    "Alcohol O-acetyltransferase inhibitor": 610,
    "Alcohol dehydrogenase (NADP+) inhibitor": 611,
    "Alcohol dehydrogenase (acceptor) inhibitor": 612,
    "Alcohol dehydrogenase I inhibitor": 613,
    "Alcohol dehydrogenase [NAD(P)+] inhibitor": 614,
    "Alcohol dehydrogenase alpha inhibitor": 615,
    "Alcohol dehydrogenase beta 1 inhibitor": 616,
    "Alcohol dehydrogenase beta inhibitor": 617,
    "Alcohol dehydrogenase gamma 2 inhibitor": 618,
    "Alcohol dehydrogenase gamma inhibitor": 619,
    "Alcohol dehydrogenase inhibitor": 620,
    "Alcohol dehydrogenase substrate": 621,
    "Alcohol oxidase inhibitor": 622,
    "Aldehyde dehydrogenase (NAD+) inhibitor": 623,
    "Aldehyde dehydrogenase (NADP+) inhibitor": 624,
    "Aldehyde dehydrogenase (pyrroloquinoline-quinone) inhibitor": 625,
    "Aldehyde dehydrogenase 1 substrate": 626,
    "Aldehyde dehydrogenase 1A2 inhibitor": 627,
    "Aldehyde dehydrogenase 2 substrate": 628,
    "Aldehyde dehydrogenase 3 substrate": 629,
    "Aldehyde dehydrogenase [NAD(P)+] inhibitor": 630,
    "Aldehyde dehydrogenase inhibitor": 631,
    "Aldehyde dehydrogenase stimulant": 632,
    "Aldehyde dehydrogenase substrate": 633,
    "Aldehyde ferredoxin oxidoreductase inhibitor": 634,
    "Aldehyde oxidase inhibitor": 635,
    "Aldehyde oxidase substrate": 636,
    "Aldose 1-epimerase inhibitor": 637,
    "Aldose reductase 2 inhibitor": 638,
    "Aldose reductase inhibitor": 639,
    "Aldose reductase substrate": 640,
    "Aldose reductase-like protein inhibitor": 641,
    "Aldosterone antagonist": 642,
    "Alkaline phosphatase inhibitor": 643,
    "Alkaline phosphatase placental-like inhibitor": 644,
    "Alkaline phosphatase stimulant": 645,
    "Alkanal monooxygenase (FMN-linked) inhibitor": 646,
    "Alkane 1-monooxygenase inhibitor": 647,
    "Alkene monooxygenase inhibitor": 648,
    "Alkenylglycerophosphocholine hydrolase inhibitor": 649,
    "Alkenylglycerophosphoethanolamine hydrolase inhibitor": 650,
    "Alkylacetylglycerophosphatase inhibitor": 651,
    "Alkylator": 652,
    "Alkylglycerone-phosphate synthase inhibitor": 653,
    "Alkylglycerophosphoethanolamine phosphodiesterase inhibitor": 654,
    "Alkylphospholipid": 655,
    "All-trans-retinyl-palmitate hydrolase inhibitor": 656,
    "Allantoate deiminase inhibitor": 657,
    "Allantoicase inhibitor": 658,
    "Allantoin racemase inhibitor": 659,
    "Allantoinase inhibitor": 660,
    "Allergic conjunctivitis treatment": 661,
    "Allergic contact dermatitis": 662,
    "Allergic dermatitis": 663,
    "Allergic reaction": 664,
    "Allergic rhinitis treatment": 665,
    "Allophanate hydrolase inhibitor": 666,
    "Allyl-alcohol dehydrogenase inhibitor": 667,
    "Alopecia treatment": 668,
    "Alpha 1 adrenoreceptor agonist": 669,
    "Alpha 1 adrenoreceptor antagonist": 670,
    "Alpha 1L adrenoreceptor agonist": 671,
    "Alpha 1L adrenoreceptor antagonist": 672,
    "Alpha 1a adrenoreceptor agonist": 673,
    "Alpha 1a adrenoreceptor antagonist": 674,
    "Alpha 1b adrenoreceptor agonist": 675,
    "Alpha 1b adrenoreceptor antagonist": 676,
    "Alpha 1d adrenoreceptor agonist": 677,
    "Alpha 1d adrenoreceptor antagonist": 678,
    "Alpha 2 adrenoreceptor agonist": 679,
    "Alpha 2 adrenoreceptor antagonist": 680,
    "Alpha 2a adrenoreceptor agonist": 681,
    "Alpha 2a adrenoreceptor antagonist": 682,
    "Alpha 2b adrenoreceptor agonist": 683,
    "Alpha 2b adrenoreceptor antagonist": 684,
    "Alpha 2c adrenoreceptor agonist": 685,
    "Alpha 2c adrenoreceptor antagonist": 686,
    "Alpha 2d adrenoreceptor agonist": 687,
    "Alpha 2d adrenoreceptor antagonist": 688,
    "Alpha 3 adrenoreceptor agonist": 689,
    "Alpha adrenoreceptor agonist": 690,
    "Alpha adrenoreceptor antagonist": 691,
    "Alpha glucosidase I inhibitor": 692,
    "Alpha glucosidase II inhibitor": 693,
    "Alpha trans-inducing protein (VP16) inhibitor": 694,
    "Alpha tubulin antagonist": 695,
    "Alpha,alpha-phosphotrehalase inhibitor": 696,
    "Alpha,alpha-trehalase inhibitor": 697,
    "Alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitor": 698,
    "Alpha,alpha-trehalose phosphorylase inhibitor": 699,
    "Alpha,alpha-trehalose-phosphate synthase (UDP-forming) inhibitor": 700,
    "Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitor": 701,
    "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitor": 702,
    "Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitor": 703,
    "Alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase inhibitor": 704,
    "Alpha-L-fucosidase 1 inhibitor": 705,
    "Alpha-L-fucosidase inhibitor": 706,
    "Alpha-L-rhamnosidase inhibitor": 707,
    "Alpha-Methylacyl-CoA racemase inhibitor": 708,
    "Alpha-N-acetylgalactosaminidase inhibitor": 709,
    "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase inhibitor": 710,
    "Alpha-N-acetylglucosaminidase inhibitor": 711,
    "Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase inhibitor": 712,
    "Alpha-N-arabinofuranosidase inhibitor": 713,
    "Alpha-amino-acid esterase inhibitor": 714,
    "Alpha-amylase inhibitor": 715,
    "Alpha-glucuronidase inhibitor": 716,
    "Alpha-mannosidase 2 inhibitor": 717,
    "Alpha-mannosidase inhibitor": 718,
    "Alpha-pinene-oxide decyclase inhibitor": 719,
    "Alternansucrase inhibitor": 720,
    "Altronate dehydratase inhibitor": 721,
    "Alzheimer's disease treatment": 722,
    "Amidase inhibitor": 723,
    "Amidophosphoribosyltransferase inhibitor": 724,
    "Amiloride-sensitive cation channel 1 blocker": 725,
    "Amiloride-sensitive cation channel 3 blocker": 726,
    "Amiloride-sensitive sodium channel 1 alpha-subunit blocker": 727,
    "Amiloride-sensitive sodium channel 1 subunit beta blocker": 728,
    "Amiloride-sensitive sodium channel 1 subunit gamma blocker": 729,
    "Amine dehydrogenase inhibitor": 730,
    "Amino acid-polyamine-organocation (APC) transporter antagonist": 731,
    "Amino-acid N-acetyltransferase inhibitor": 732,
    "Amino-acid racemase inhibitor": 733,
    "Aminoacyl-tRNA hydrolase inhibitor": 734,
    "Aminoacyl-tRNA synthetase inhibitor": 735,
    "Aminoacylase inhibitor": 736,
    "Aminobutyraldehyde dehydrogenase inhibitor": 737,
    "Aminocarboxymuconate-semialdehyde decarboxylase inhibitor": 738,
    "Aminoglycoside N6'-acetyltransferase inhibitor": 739,
    "Aminoglycoside acetyltransferase inhibitor": 740,
    "Aminolevulinate transaminase inhibitor": 741,
    "Aminomuconate-semialdehyde dehydrogenase inhibitor": 742,
    "Aminopeptidase A inhibitor": 743,
    "Aminopeptidase B inhibitor": 744,
    "Aminopeptidase I inhibitor": 745,
    "Aminopeptidase N inhibitor": 746,
    "Aminopeptidase P inhibitor": 747,
    "Aminopeptidase Y inhibitor": 748,
    "Aminopeptidase microsomal inhibitor": 749,
    "Amnesia": 750,
    "Amylase inhibitor": 751,
    "Amylin agonist": 752,
    "Amylo-alpha-1,6-glucosidase inhibitor": 753,
    "Amyloid beta aggregation inhibitor": 754,
    "Amyloid beta precursor protein antagonist": 755,
    "Amylosucrase inhibitor": 756,
    "Amyotrophic lateral sclerosis treatment": 757,
    "Anabolic": 758,
    "Analeptic": 759,
    "Analgesic": 760,
    "Analgesic stimulant": 761,
    "Analgesic, non-opioid": 762,
    "Analgesic, opioid": 763,
    "Anaphylatoxin receptor antagonist": 764,
    "Anaphylaxis": 765,
    "Androgen agonist": 766,
    "Androgen antagonist": 767,
    "Andropause treatment": 768,
    "Androst-4-ene-3,17-dione monooxygenase inhibitor": 769,
    "Anemia": 770,
    "Anemia, aplastic": 771,
    "Anemia, hemolytic": 772,
    "Anemia, sideroblastic": 773,
    "Anesthetic": 774,
    "Anesthetic general": 775,
    "Anesthetic inhalation": 776,
    "Anesthetic local": 777,
    "Angioedema": 778,
    "Angiogenesis inhibitor": 779,
    "Angiogenesis stimulant": 780,
    "Angiotensin AT1 receptor agonist": 781,
    "Angiotensin AT1 receptor antagonist": 782,
    "Angiotensin AT1A receptor antagonist": 783,
    "Angiotensin AT1B receptor antagonist": 784,
    "Angiotensin AT2 receptor agonist": 785,
    "Angiotensin AT2 receptor antagonist": 786,
    "Angiotensin II receptor agonist": 787,
    "Angiotensin II receptor antagonist": 788,
    "Angiotensin agonist": 789,
    "Angiotensin antagonist": 790,
    "Angiotensin-converting enzyme 2 inhibitor": 791,
    "Angiotensin-converting enzyme inhibitor": 792,
    "Anhydrotetracycline monooxygenase inhibitor": 793,
    "Anorexiant": 794,
    "Anorgasmia": 795,
    "Anthranilate 3-monooxygenase (deaminating) inhibitor": 796,
    "Anthranilate phosphoribosyltransferase inhibitor": 797,
    "Anthranilate synthase inhibitor": 798,
    "Anthranilate-CoA ligase inhibitor": 799,
    "Anthrax lethal factor inhibitor": 800,
    "Anti-Helicobacter pylori": 801,
    "Antiacne": 802,
    "Antiacromegalic": 803,
    "Antiadrenergic": 804,
    "Antialcoholic": 805,
    "Antiallergic": 806,
    "Antiamyloidogenic": 807,
    "Antianemic": 808,
    "Antianginal": 809,
    "Antianorexic": 810,
    "Antiarrhythmic": 811,
    "Antiarthritic": 812,
    "Antiasthmatic": 813,
    "Antibacterial": 814,
    "Antibacterial activity enhancer": 815,
    "Antibacterial, ophthalmic": 816,
    "Antibiotic": 817,
    "Antibiotic Aminoglycoside-like": 818,
    "Antibiotic Anthracycline-like": 819,
    "Antibiotic Carbacephem-like": 820,
    "Antibiotic Carbapenem-like": 821,
    "Antibiotic Cephalosporin-like": 822,
    "Antibiotic Glycopeptide-like": 823,
    "Antibiotic Isocephem-like": 824,
    "Antibiotic Macrolide-like": 825,
    "Antibiotic Naphthyridine-like": 826,
    "Antibiotic Oxacephem-like": 827,
    "Antibiotic Oxazolidinone-like": 828,
    "Antibiotic Penem-like": 829,
    "Antibiotic Penicillin-like": 830,
    "Antibiotic Quinolone-like": 831,
    "Antibiotic Rifamycin-like": 832,
    "Antibiotic Tetracycline-like": 833,
    "Antibiotic Tribactam-like": 834,
    "Antibiotic Trimethoprim-like": 835,
    "Antibiotic beta Lactam-like": 836,
    "Antibiotic resistance": 837,
    "Anticarcinogenic": 838,
    "Anticataract": 839,
    "Anticholelithogenic": 840,
    "Anticoagulant": 841,
    "Anticonvulsant": 842,
    "Antidepressant": 843,
    "Antidepressant, Imipramin-like": 844,
    "Antidiabetic": 845,
    "Antidiabetic (type 1)": 846,
    "Antidiabetic (type 2)": 847,
    "Antidiabetic symptomatic": 848,
    "Antidiarrheal": 849,
    "Antidiuretic hormone agonist": 850,
    "Antidiuretic hormone antagonist": 851,
    "Antidote": 852,
    "Antidote, cyanide": 853,
    "Antidote, heavy metal": 854,
    "Antidote, mercury": 855,
    "Antidote, organophosphates": 856,
    "Antidyskinetic": 857,
    "Antidyslipidemic": 858,
    "Antieczematic atopic": 859,
    "Antiemetic": 860,
    "Antiemphysemic": 861,
    "Antiepileptic": 862,
    "Antifibrinolytic": 863,
    "Antifungal": 864,
    "Antifungal (Aspergillus)": 865,
    "Antifungal (Candida)": 866,
    "Antifungal (Cryptococcus)": 867,
    "Antifungal (Pneumocystis)": 868,
    "Antifungal enhancer": 869,
    "Antiglaucomic": 870,
    "Antihelmintic": 871,
    "Antihelmintic (Fasciola)": 872,
    "Antihelmintic (Nematodes)": 873,
    "Antihelmintic (Trematoda)": 874,
    "Antihematotoxic": 875,
    "Antihemophilic": 876,
    "Antihemorrhagic": 877,
    "Antihistaminic": 878,
    "Antihyperaldosteronism": 879,
    "Antihyperammonemic": 880,
    "Antihypercholesterolemic": 881,
    "Antihyperlipoproteinemic": 882,
    "Antihypermotility": 883,
    "Antihypertensive": 884,
    "Antihypertriglyceridemic": 885,
    "Antihypotensive": 886,
    "Antihypoxic": 887,
    "Antiinfective": 888,
    "Antiinfertility, female": 889,
    "Antiinflammatory": 890,
    "Antiinflammatory Leumedin-like": 891,
    "Antiinflammatory steroid": 892,
    "Antiinflammatory, intestinal": 893,
    "Antiinflammatory, ophthalmic": 894,
    "Antiinflammatory, pancreatic": 895,
    "Antiischemic": 896,
    "Antiischemic, cerebral": 897,
    "Antileprosy": 898,
    "Antileukemic": 899,
    "Antimetabolite": 900,
    "Antimetastatic": 901,
    "Antimigraine": 902,
    "Antimitotic": 903,
    "Antimitotic, Podophyllotoxin-like": 904,
    "Antimitotic, Taxane-like": 905,
    "Antimutagenic": 906,
    "Antimycobacterial": 907,
    "Antimycoplasmal": 908,
    "Antimyopathies": 909,
    "Antinaupathic": 910,
    "Antineoplastic (astrocytoma)": 911,
    "Antineoplastic (bladder cancer)": 912,
    "Antineoplastic (bone cancer)": 913,
    "Antineoplastic (brain cancer)": 914,
    "Antineoplastic (breast cancer)": 915,
    "Antineoplastic (carcinoma)": 916,
    "Antineoplastic (cervical cancer)": 917,
    "Antineoplastic (colon cancer)": 918,
    "Antineoplastic (colorectal cancer)": 919,
    "Antineoplastic (endocrine cancer)": 920,
    "Antineoplastic (gastric cancer)": 921,
    "Antineoplastic (genitourinary cancer)": 922,
    "Antineoplastic (glioblastoma multiforme)": 923,
    "Antineoplastic (glioma)": 924,
    "Antineoplastic (head/neck cancer)": 925,
    "Antineoplastic (hematological cancer)": 926,
    "Antineoplastic (insulinoma)": 927,
    "Antineoplastic (liver cancer)": 928,
    "Antineoplastic (lung cancer)": 929,
    "Antineoplastic (lymphocytic leukemia)": 930,
    "Antineoplastic (lymphoma)": 931,
    "Antineoplastic (melanoma)": 932,
    "Antineoplastic (multiple myeloma)": 933,
    "Antineoplastic (myeloid leukemia)": 934,
    "Antineoplastic (non-Hodgkin's lymphoma)": 935,
    "Antineoplastic (non-small cell lung cancer)": 936,
    "Antineoplastic (oral cancer)": 937,
    "Antineoplastic (osteosarcoma)": 938,
    "Antineoplastic (ovarian cancer)": 939,
    "Antineoplastic (pancreatic cancer)": 940,
    "Antineoplastic (renal cancer)": 941,
    "Antineoplastic (sarcoma)": 942,
    "Antineoplastic (small cell lung cancer)": 943,
    "Antineoplastic (solid tumors)": 944,
    "Antineoplastic (squamous cell carcinoma)": 945,
    "Antineoplastic (testis)": 946,
    "Antineoplastic (thymoma)": 947,
    "Antineoplastic (thyroid cancer)": 948,
    "Antineoplastic (uterine cancer)": 949,
    "Antineoplastic alkaloid": 950,
    "Antineoplastic antibiotic": 951,
    "Antineoplastic antimetabolite": 952,
    "Antineoplastic enhancer": 953,
    "Antineoplastic, alkylator": 954,
    "Antinephritic": 955,
    "Antinephrotoxic": 956,
    "Antineurogenic pain": 957,
    "Antineurotic": 958,
    "Antineurotoxic": 959,
    "Antinociceptive": 960,
    "Antiobesity": 961,
    "Antiosteoporotic": 962,
    "Antioxidant": 963,
    "Antiparasitic": 964,
    "Antiparkinsonian": 965,
    "Antiparkinsonian, rigidity relieving": 966,
    "Antiparkinsonian, tremor relieving": 967,
    "Antiperistaltic": 968,
    "Antiperspirant": 969,
    "Antiprotozoal": 970,
    "Antiprotozoal (Amoeba)": 971,
    "Antiprotozoal (Babesia)": 972,
    "Antiprotozoal (Coccidial)": 973,
    "Antiprotozoal (Histomonas)": 974,
    "Antiprotozoal (Leishmania)": 975,
    "Antiprotozoal (Plasmodium)": 976,
    "Antiprotozoal (Toxoplasma)": 977,
    "Antiprotozoal (Trichomonas)": 978,
    "Antiprotozoal (Trypanosoma)": 979,
    "Antiprotozoal activity enhancer": 980,
    "Antipruritic": 981,
    "Antipruritic, allergic": 982,
    "Antipruritic, non-allergic": 983,
    "Antipsoriatic": 984,
    "Antipsychotic": 985,
    "Antipyretic": 986,
    "Antirickettsial": 987,
    "Antischistosomal": 988,
    "Antischizophrenic": 989,
    "Antiseborrheic": 990,
    "Antisecretoric": 991,
    "Antiseptic": 992,
    "Antismoking": 993,
    "Antispirochetal": 994,
    "Antithrombocytopenic": 995,
    "Antithrombotic": 996,
    "Antithyroid": 997,
    "Antitoxic": 998,
    "Antitreponemal": 999,
    "Antituberculosic": 1000,
    "Antitussive": 1001,
    "Antitussive, narcotic": 1002,
    "Antiulcerative": 1003,
    "Antiuremic": 1004,
    "Antiviral": 1005,
    "Antiviral (Adenovirus)": 1006,
    "Antiviral (Arbovirus)": 1007,
    "Antiviral (Bovine viral diarrhea virus)": 1008,
    "Antiviral (CMV)": 1009,
    "Antiviral (HIV)": 1010,
    "Antiviral (Hepatitis A)": 1011,
    "Antiviral (Hepatitis B)": 1012,
    "Antiviral (Hepatitis C)": 1013,
    "Antiviral (Hepatitis)": 1014,
    "Antiviral (Herpes)": 1015,
    "Antiviral (Herpesvirus 3, Human)": 1016,
    "Antiviral (Influenza A)": 1017,
    "Antiviral (Influenza B)": 1018,
    "Antiviral (Influenza)": 1019,
    "Antiviral (Papilloma)": 1020,
    "Antiviral (Parainfluenza)": 1021,
    "Antiviral (Picornavirus)": 1022,
    "Antiviral (Poxvirus)": 1023,
    "Antiviral (RSV)": 1024,
    "Antiviral (Retrovirus)": 1025,
    "Antiviral (Rhinovirus)": 1026,
    "Antiviral (Trachoma)": 1027,
    "Antiviral (poxvirus), cow-pox": 1028,
    "Antiviral (poxvirus), monkey": 1029,
    "Antiviral, ophthalmic": 1030,
    "Antixerophthalmic": 1031,
    "Anxiety": 1032,
    "Anxiolytic": 1033,
    "Apathy": 1034,
    "Aphasia": 1035,
    "Apical sodium codependent bile acid transporter inhibitor": 1036,
    "Apnea": 1037,
    "Apolipoprotein A inhibitor": 1038,
    "Apolipoprotein B inhibitor": 1039,
    "Apolipoprotein B-100 inhibitor": 1040,
    "Apoptosis agonist": 1041,
    "Apoptosis antagonist": 1042,
    "Apyrase inhibitor": 1043,
    "Arabinogalactan endo-1,4-beta-galactosidase inhibitor": 1044,
    "Arabinose isomerase inhibitor": 1045,
    "Arabinose-5-phosphate isomerase inhibitor": 1046,
    "Arachidonate-CoA ligase inhibitor": 1047,
    "Arachidonic acid antagonist": 1048,
    "Arachnoiditis": 1049,
    "Aralkylamine N-acetyltransferase inhibitor": 1050,
    "Aralkylamine dehydrogenase inhibitor": 1051,
    "Areflexia": 1052,
    "Arginase inhibitor": 1053,
    "Arginase-1 inhibitor": 1054,
    "Arginine 2-monooxygenase inhibitor": 1055,
    "Arginine N-succinyltransferase inhibitor": 1056,
    "Arginine decarboxylase inhibitor": 1057,
    "Arginine deiminase inhibitor": 1058,
    "Arginine kinase inhibitor": 1059,
    "Arginine racemase inhibitor": 1060,
    "Arginine-tRNA ligase inhibitor": 1061,
    "Argininosuccinate lyase inhibitor": 1062,
    "Argininosuccinate synthase inhibitor": 1063,
    "Arginyltransferase inhibitor": 1064,
    "Aromatase inhibitor": 1065,
    "Aromatic-amino-acid transaminase inhibitor": 1066,
    "Aromatic-hydroxylamine O-acetyltransferase inhibitor": 1067,
    "Arrhythmogenic": 1068,
    "Arterial thrombosis": 1069,
    "Arthralgia": 1070,
    "Arthritis": 1071,
    "Aryl hydrocarbon receptor agonist": 1072,
    "Aryl hydrocarbon receptor antagonist": 1073,
    "Aryl sulfotransferase inhibitor": 1074,
    "Aryl-acylamidase inhibitor": 1075,
    "Aryl-alcohol dehydrogenase (NADP+) inhibitor": 1076,
    "Aryl-alcohol dehydrogenase inhibitor": 1077,
    "Aryl-aldehyde dehydrogenase (NADP+) inhibitor": 1078,
    "Arylacetonitrilase inhibitor": 1079,
    "Arylalkyl acylamidase inhibitor": 1080,
    "Arylamine N-Acetyltransferase substrate": 1081,
    "Arylamine N-acetyltransferase 1 inhibitor": 1082,
    "Arylamine N-acetyltransferase 2 inhibitor": 1083,
    "Arylamine N-acetyltransferase inhibitor": 1084,
    "Aryldialkylphosphatase inhibitor": 1085,
    "Arylesterase inhibitor": 1086,
    "Arylformamidase inhibitor": 1087,
    "Arylmalonate decarboxylase inhibitor": 1088,
    "Arylsulfatase inhibitor": 1089,
    "Arylsulfate sulfotransferase inhibitor": 1090,
    "Aseptic meningitis": 1091,
    "Asparaginase inhibitor": 1092,
    "Asparagine synthase (glutamine-hydrolysing) inhibitor": 1093,
    "Asparagine synthetase inhibitor": 1094,
    "Asparagine-oxo-acid transaminase inhibitor": 1095,
    "Asparagine-tRNA ligase inhibitor": 1096,
    "Asparaginyl endopeptidase inhibitor": 1097,
    "Aspartate 1-decarboxylase inhibitor": 1098,
    "Aspartate 4-decarboxylase inhibitor": 1099,
    "Aspartate N-acetyltransferase inhibitor": 1100,
    "Aspartate ammonia-lyase inhibitor": 1101,
    "Aspartate carbamoyltransferase inhibitor": 1102,
    "Aspartate kinase inhibitor": 1103,
    "Aspartate racemase inhibitor": 1104,
    "Aspartate transaminase inhibitor": 1105,
    "Aspartate-ammonia ligase (ADP-forming) inhibitor": 1106,
    "Aspartate-ammonia ligase inhibitor": 1107,
    "Aspartate-phenylpyruvate transaminase inhibitor": 1108,
    "Aspartate-semialdehyde dehydrogenase inhibitor": 1109,
    "Aspartate-tRNA ligase inhibitor": 1110,
    "Aspartic protease inhibitor": 1111,
    "Aspartoacylase inhibitor": 1112,
    "Aspartyl aminopeptidase inhibitor": 1113,
    "Aspartyl protease inhibitor": 1114,
    "Aspartyltransferase inhibitor": 1115,
    "Aspergillopepsin I inhibitor": 1116,
    "Aspergillopepsin II inhibitor": 1117,
    "Aspergillus nuclease S1 inhibitor": 1118,
    "Assemblin inhibitor": 1119,
    "Astacin inhibitor": 1120,
    "Asthma": 1121,
    "Astringent": 1122,
    "Ataxia": 1123,
    "Atherosclerosis treatment": 1124,
    "Atrial natriuretic peptide A antagonist": 1125,
    "Atrial natriuretic peptide B antagonist": 1126,
    "Atrial natriuretic peptide C antagonist": 1127,
    "Atrial natriuretic peptide agonist": 1128,
    "Atrial natriuretic peptide antagonist": 1129,
    "Atrolysin A inhibitor": 1130,
    "Atrolysin C inhibitor": 1131,
    "Attention deficit/hyperactivity disorder treatment": 1132,
    "Aureolysin inhibitor": 1133,
    "Aurora kinase inhibitor": 1134,
    "Aurora-A kinase inhibitor": 1135,
    "Aurora-B kinase inhibitor": 1136,
    "Aurora-C kinase inhibitor": 1137,
    "Autoimmune disorders treatment": 1138,
    "Autoinducer 2-binding periplasmic protein luxP inhibitor": 1139,
    "Autophagy inducer": 1140,
    "Autotaxin inhibitor": 1141,
    "Azobenzene reductase inhibitor": 1142,
    "B cell inhibitor": 1143,
    "B4GALT5 expression inhibitor": 1144,
    "BACE1 expression inhibitor": 1145,
    "BAD expression enhancer": 1146,
    "BAD expression inhibitor": 1147,
    "BAG1 expression inhibitor": 1148,
    "BAG3 expression enhancer": 1149,
    "BAG5 expression inhibitor": 1150,
    "BAK1 expression enhancer": 1151,
    "BAK1 expression inhibitor": 1152,
    "BAMBI expression enhancer": 1153,
    "BARD1 expression inhibitor": 1154,
    "BAX expression enhancer": 1155,
    "BAX expression inhibitor": 1156,
    "BAZ2A expression inhibitor": 1157,
    "BBX expression inhibitor": 1158,
    "BCAT1 expression inhibitor": 1159,
    "BCL2 expression enhancer": 1160,
    "BCL2 expression inhibitor": 1161,
    "BCL2A1 expression enhancer": 1162,
    "BCL2L1 expression inhibitor": 1163,
    "BCL3 expression enhancer": 1164,
    "BCL6 expression enhancer": 1165,
    "BCR/ABL p210 fusion protein inhibitor": 1166,
    "BDNF expression enhancer": 1167,
    "BDNF expression inhibitor": 1168,
    "BFSP2 expression enhancer": 1169,
    "BGLAP expression enhancer": 1170,
    "BGLAP expression inhibitor": 1171,
    "BID expression inhibitor": 1172,
    "BIK expression enhancer": 1173,
    "BIK expression inhibitor": 1174,
    "BIRC2 expression inhibitor": 1175,
    "BIRC3 expression enhancer": 1176,
    "BIRC3 expression inhibitor": 1177,
    "BIRC5 expression enhancer": 1178,
    "BIRC5 expression inhibitor": 1179,
    "BLM expression inhibitor": 1180,
    "BLVRA expression enhancer": 1181,
    "BMP1 expression inhibitor": 1182,
    "BMP2 expression enhancer": 1183,
    "BMP4 expression enhancer": 1184,
    "BMP6 expression inhibitor": 1185,
    "BMP7 expression inhibitor": 1186,
    "BNIP1 expression enhancer": 1187,
    "BNIP3 expression inhibitor": 1188,
    "BORA expression inhibitor": 1189,
    "BRAF expression inhibitor": 1190,
    "BRCA1 expression enhancer": 1191,
    "BRCA1 expression inhibitor": 1192,
    "BRCA2 expression enhancer": 1193,
    "BRD2 expression enhancer": 1194,
    "BRF1 expression inhibitor": 1195,
    "BRIX1 expression inhibitor": 1196,
    "BST2 expression enhancer": 1197,
    "BST2 expression inhibitor": 1198,
    "BTBD11 expression inhibitor": 1199,
    "BTF3 expression inhibitor": 1200,
    "BTG1 expression enhancer": 1201,
    "BTG1 expression inhibitor": 1202,
    "BTG2 expression enhancer": 1203,
    "BUB1B expression enhancer": 1204,
    "BUB1B expression inhibitor": 1205,
    "Bacillus subtilis ribonuclease inhibitor": 1206,
    "Back pain": 1207,
    "Bacterial efflux pump inhibitor": 1208,
    "Bacterial leucyl aminopeptidase inhibitor": 1209,
    "Baculoviral IAP repeat-containing protein 2 inhibitor": 1210,
    "Baculoviral IAP repeat-containing protein 3 inhibitor": 1211,
    "Baculoviral IAP repeat-containing protein 4 inhibitor": 1212,
    "Baculoviral IAP repeat-containing protein inhibitor": 1213,
    "Bax channel blocker": 1214,
    "Bcl-2-related protein A1 inhibitor": 1215,
    "Bcl-w inhibitor": 1216,
    "Bcl-xL inhibitor": 1217,
    "Bcl2 antagonist": 1218,
    "Bcr-Abl kinase inhibitor": 1219,
    "Behavioral disturbance": 1220,
    "Benzaldehyde dehydrogenase (NAD+) inhibitor": 1221,
    "Benzaldehyde dehydrogenase (NADP+) inhibitor": 1222,
    "Benzoate 4-monooxygenase inhibitor": 1223,
    "Benzoate-CoA ligase inhibitor": 1224,
    "Benzodiazepine agonist": 1225,
    "Benzodiazepine agonist partial": 1226,
    "Benzodiazepine antagonist": 1227,
    "Benzodiazepine inverse agonist": 1228,
    "Benzodiazepine omega receptor agonist": 1229,
    "Benzodiazepine receptor peripheral-type antagonist": 1230,
    "Benzoin aldolase inhibitor": 1231,
    "Benzoylformate decarboxylase inhibitor": 1232,
    "Beta 1 adrenoreceptor agonist": 1233,
    "Beta 1 adrenoreceptor antagonist": 1234,
    "Beta 2 adrenoreceptor agonist": 1235,
    "Beta 2 adrenoreceptor antagonist": 1236,
    "Beta 3 adrenoreceptor agonist": 1237,
    "Beta 3 adrenoreceptor antagonist": 1238,
    "Beta adrenoreceptor agonist": 1239,
    "Beta adrenoreceptor antagonist": 1240,
    "Beta amyloid protein antagonist": 1241,
    "Beta galactosidase inhibitor": 1242,
    "Beta glucosidase inhibitor": 1243,
    "Beta glucuronidase inhibitor": 1244,
    "Beta lactamase II inhibitor": 1245,
    "Beta lactamase Imi-1 inhibitor": 1246,
    "Beta lactamase TEM-1 inhibitor": 1247,
    "Beta lactamase inhibitor": 1248,
    "Beta tubulin antagonist": 1249,
    "Beta-1,4-galactosyltransferase 1 inhibitor": 1250,
    "Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitor": 1251,
    "Beta-2-glycoprotein 1 inhibitor": 1252,
    "Beta-D-fucosidase inhibitor": 1253,
    "Beta-Lysine 5,6-aminomutase inhibitor": 1254,
    "Beta-N-acetylgalactosaminidase inhibitor": 1255,
    "Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase inhibitor": 1256,
    "Beta-N-acetylhexosaminidase inhibitor": 1257,
    "Beta-Phosphoglucomutase inhibitor": 1258,
    "Beta-adrenergic receptor kinase inhibitor": 1259,
    "Beta-alanine-pyruvate transaminase inhibitor": 1260,
    "Beta-amylase inhibitor": 1261,
    "Beta-carotene 15,15'-monooxygenase inhibitor": 1262,
    "Beta-cyclopiazonate dehydrogenase inhibitor": 1263,
    "Beta-fructofuranosidase inhibitor": 1264,
    "Beta-galactoside alpha-2,3-sialyltransferase inhibitor": 1265,
    "Beta-glucosidase cytosolic inhibitor": 1266,
    "Beta-glucosidase inhibitor": 1267,
    "Beta-lactamase AmpC inhibitor": 1268,
    "Beta-lactamase GES-13 inhibitor": 1269,
    "Beta-lactamase SCO-1 inhibitor": 1270,
    "Beta-lactamase TEM inhibitor": 1271,
    "Beta-mannosidase inhibitor": 1272,
    "Beta-ureidopropionase inhibitor": 1273,
    "Betaine transporter inhibitor": 1274,
    "Betaine--homocysteine S-methyltransferase 1 inhibitor": 1275,
    "Betaine-aldehyde dehydrogenase inhibitor": 1276,
    "Betaine-homocysteine S-methyltransferase inhibitor": 1277,
    "Bifunctional protein NCOAT inhibitor": 1278,
    "Bile salt export pump inhibitor": 1279,
    "Bile-salt sulfotransferase inhibitor": 1280,
    "Biliary tract disorders treatment": 1281,
    "Bilirubin oxidase inhibitor": 1282,
    "Biliverdin reductase inhibitor": 1283,
    "Biotin carboxylase inhibitor": 1284,
    "Biotin-CoA ligase inhibitor": 1285,
    "Biotin-[methylmalonyl-CoA-carboxytransferase] ligase inhibitor": 1286,
    "Biotin-[propionyl-CoA-carboxylase (ATP-hydrolysing)] ligase inhibitor": 1287,
    "Biotinidase inhibitor": 1288,
    "Biphenyl-2,3-diol 1,2-dioxygenase inhibitor": 1289,
    "Bipolar disorder treatment": 1290,
    "Bis(5'-adenosyl)-triphosphatase inhibitor": 1291,
    "Bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) inhibitor": 1292,
    "Bis(5'-nucleosyl)-tetraphosphatase (symmetrical) inhibitor": 1293,
    "Bisphosphoglycerate mutase inhibitor": 1294,
    "Bisphosphoglycerate phosphatase inhibitor": 1295,
    "Bisphosphonate": 1296,
    "Blasticidin-S deaminase inhibitor": 1297,
    "Blepharospasm": 1298,
    "Blindness": 1299,
    "Bombesin 1 receptor agonist": 1300,
    "Bombesin 1 receptor antagonist": 1301,
    "Bombesin 2 receptor antagonist": 1302,
    "Bombesin 3 receptor agonist": 1303,
    "Bombesin 3 receptor antagonist": 1304,
    "Bombesin agonist": 1305,
    "Bombesin antagonist": 1306,
    "Bone diseases treatment": 1307,
    "Bone formation stimulant": 1308,
    "Bone morphogenic protein 1 inhibitor": 1309,
    "Bone morphogenic protein 2 inhibitor": 1310,
    "Bone morphogenic protein 4 inhibitor": 1311,
    "Bone morphogenic protein inhibitor": 1312,
    "Bone morphogenic protein stimulant": 1313,
    "Bone pain": 1314,
    "Bontoxilysin inhibitor": 1315,
    "Bothrolysin inhibitor": 1316,
    "Botulin neurotoxin A light chain inhibitor": 1317,
    "Botulinum neurotoxin type A inhibitor": 1318,
    "Botulinum neurotoxin type B inhibitor": 1319,
    "Brachyurin inhibitor": 1320,
    "Bradycardic": 1321,
    "Bradykinin B1 receptor agonist": 1322,
    "Bradykinin B1 receptor antagonist": 1323,
    "Bradykinin B2 receptor agonist": 1324,
    "Bradykinin B2 receptor antagonist": 1325,
    "Bradykinin agonist": 1326,
    "Bradykinin antagonist": 1327,
    "Branched-chain-amino-acid transaminase inhibitor": 1328,
    "Breakpoint cluster region protein inhibitor": 1329,
    "Breast cancer type 1 susceptibility protein inhibitor": 1330,
    "Breast cancer-resistant protein inhibitor": 1331,
    "Breast enlargement": 1332,
    "Breast pain": 1333,
    "Breast tenderness": 1334,
    "Bromodomain-containing protein 2 inhibitor": 1335,
    "Bromodomain-containing protein 3 inhibitor": 1336,
    "Bromodomain-containing protein 4 inhibitor": 1337,
    "Bronchoconstrictor": 1338,
    "Bronchodilator": 1339,
    "Bruton tyrosine kinase inhibitor": 1340,
    "Bulimia treatment": 1341,
    "Bullous pemphigoid": 1342,
    "Butyrate-CoA ligase inhibitor": 1343,
    "Butyryl-CoA dehydrogenase inhibitor": 1344,
    "Butyrylcholinesterase inhibitor": 1345,
    "Butyrylcholinesterase stimulant": 1346,
    "C10ORF10 expression enhancer": 1347,
    "C11ORF68 expression enhancer": 1348,
    "C12ORF4 expression inhibitor": 1349,
    "C14ORF1 expression inhibitor": 1350,
    "C15ORF48 expression enhancer": 1351,
    "C22ORF29 expression enhancer": 1352,
    "C3 expression enhancer": 1353,
    "C6ORF106 expression inhibitor": 1354,
    "C6ORF48 expression inhibitor": 1355,
    "CA12 expression enhancer": 1356,
    "CA2 expression enhancer": 1357,
    "CAB39 expression inhibitor": 1358,
    "CABLES1 expression enhancer": 1359,
    "CADM1 expression enhancer": 1360,
    "CALCA expression enhancer": 1361,
    "CALCR expression enhancer": 1362,
    "CALM1 expression enhancer": 1363,
    "CALM3 expression enhancer": 1364,
    "CALR expression inhibitor": 1365,
    "CALU expression inhibitor": 1366,
    "CAMP expression enhancer": 1367,
    "CANX expression enhancer": 1368,
    "CAPN2 expression inhibitor": 1369,
    "CAPN7 expression inhibitor": 1370,
    "CAPN9 expression enhancer": 1371,
    "CARS expression inhibitor": 1372,
    "CASK expression inhibitor": 1373,
    "CASP1 expression inhibitor": 1374,
    "CASP2 expression enhancer": 1375,
    "CASP3 expression enhancer": 1376,
    "CASP3 expression inhibitor": 1377,
    "CASP8 expression inhibitor": 1378,
    "CASP9 expression enhancer": 1379,
    "CASP9 expression inhibitor": 1380,
    "CAT expression inhibitor": 1381,
    "CAV1 expression inhibitor": 1382,
    "CAV2 expression inhibitor": 1383,
    "CBFA2T3 expression enhancer": 1384,
    "CBLB expression inhibitor": 1385,
    "CBR1 expression enhancer": 1386,
    "CBS expression inhibitor": 1387,
    "CBX1 expression inhibitor": 1388,
    "CBX3 expression inhibitor": 1389,
    "CC chemokine 1 receptor antagonist": 1390,
    "CC chemokine 10 receptor antagonist": 1391,
    "CC chemokine 2 receptor antagonist": 1392,
    "CC chemokine 3 receptor antagonist": 1393,
    "CC chemokine 4 receptor antagonist": 1394,
    "CC chemokine 5 receptor agonist": 1395,
    "CC chemokine 5 receptor antagonist": 1396,
    "CC chemokine 8 receptor antagonist": 1397,
    "CC chemokine 9 receptor antagonist": 1398,
    "CC chemokine receptor 2B antagonist": 1399,
    "CC chemokine receptor agonist": 1400,
    "CC chemokine receptor antagonist": 1401,
    "CCDC88C expression inhibitor": 1402,
    "CCL11 expression enhancer": 1403,
    "CCL2 expression enhancer": 1404,
    "CCL2 expression inhibitor": 1405,
    "CCL20 expression enhancer": 1406,
    "CCL20 expression inhibitor": 1407,
    "CCL3 expression enhancer": 1408,
    "CCL4 expression enhancer": 1409,
    "CCL5 expression enhancer": 1410,
    "CCL5 expression inhibitor": 1411,
    "CCNA1 expression inhibitor": 1412,
    "CCNA2 expression enhancer": 1413,
    "CCNA2 expression inhibitor": 1414,
    "CCNB1 expression enhancer": 1415,
    "CCNB1 expression inhibitor": 1416,
    "CCNB2 expression enhancer": 1417,
    "CCNB2 expression inhibitor": 1418,
    "CCNC expression inhibitor": 1419,
    "CCND1 expression enhancer": 1420,
    "CCND1 expression inhibitor": 1421,
    "CCND2 expression enhancer": 1422,
    "CCNE1 expression inhibitor": 1423,
    "CCNE2 expression inhibitor": 1424,
    "CCNK expression inhibitor": 1425,
    "CCR2 expression inhibitor": 1426,
    "CCR5 expression enhancer": 1427,
    "CCR5 expression inhibitor": 1428,
    "CCR7 expression enhancer": 1429,
    "CCT2 expression inhibitor": 1430,
    "CD14 expression enhancer": 1431,
    "CD22 antagonist": 1432,
    "CD36 expression enhancer": 1433,
    "CD36 expression inhibitor": 1434,
    "CD38 expression enhancer": 1435,
    "CD4 antagonist": 1436,
    "CD4 expression enhancer": 1437,
    "CD40 expression enhancer": 1438,
    "CD44 expression enhancer": 1439,
    "CD44 expression inhibitor": 1440,
    "CD45 antagonist": 1441,
    "CD58 expression inhibitor": 1442,
    "CD59 expression enhancer": 1443,
    "CD74 antagonist": 1444,
    "CD74 expression inhibitor": 1445,
    "CD80 antagonist": 1446,
    "CD83 expression enhancer": 1447,
    "CD86 expression enhancer": 1448,
    "CDA expression enhancer": 1449,
    "CDC-like kinase 1 inhibitor": 1450,
    "CDC-like kinase 2 inhibitor": 1451,
    "CDC-like kinase 3 inhibitor": 1452,
    "CDC-like kinase 4 inhibitor": 1453,
    "CDC14B expression enhancer": 1454,
    "CDC16 expression inhibitor": 1455,
    "CDC20 expression enhancer": 1456,
    "CDC25 phosphatase inhibitor": 1457,
    "CDC25A inhibitor": 1458,
    "CDC25B expression enhancer": 1459,
    "CDC25B expression inhibitor": 1460,
    "CDC25B inhibitor": 1461,
    "CDC25C expression inhibitor": 1462,
    "CDC25C inhibitor": 1463,
    "CDC27 expression inhibitor": 1464,
    "CDC6 expression enhancer": 1465,
    "CDC7 expression inhibitor": 1466,
    "CDC7 inhibitor": 1467,
    "CDCA5 expression enhancer": 1468,
    "CDCA8 expression inhibitor": 1469,
    "CDH1 expression enhancer": 1470,
    "CDH1 expression inhibitor": 1471,
    "CDH11 expression inhibitor": 1472,
    "CDH2 expression enhancer": 1473,
    "CDH2 expression inhibitor": 1474,
    "CDK-activating kinase assembly factor MAT1 inhibitor": 1475,
    "CDK/Cyclin complex inhibitor": 1476,
    "CDK1 expression enhancer": 1477,
    "CDK1 expression inhibitor": 1478,
    "CDK1/cyclin B inhibitor": 1479,
    "CDK1/cyclin B1 inhibitor": 1480,
    "CDK2 expression enhancer": 1481,
    "CDK2 expression inhibitor": 1482,
    "CDK2-associated protein 1 inhibitor": 1483,
    "CDK2/cyclin A inhibitor": 1484,
    "CDK2/cyclin A3 inhibitor": 1485,
    "CDK2/cyclin E inhibitor": 1486,
    "CDK2/cyclin E2 inhibitor": 1487,
    "CDK2AP2 expression inhibitor": 1488,
    "CDK3/cyclin E inhibitor": 1489,
    "CDK4 expression inhibitor": 1490,
    "CDK4/cyclin D inhibitor": 1491,
    "CDK4/cyclin D1 inhibitor": 1492,
    "CDK4/cyclin D3 inhibitor": 1493,
    "CDK5 expression enhancer": 1494,
    "CDK5/p25 inhibitor": 1495,
    "CDK6 expression inhibitor": 1496,
    "CDK6/cyclin D3 inhibitor": 1497,
    "CDK7/cyclin H inhibitor": 1498,
    "CDK8 expression enhancer": 1499,
    "CDK9/cyclin T1 inhibitor": 1500,
    "CDKN1A expression enhancer": 1501,
    "CDKN1A expression inhibitor": 1502,
    "CDKN1B expression enhancer": 1503,
    "CDKN1B expression inhibitor": 1504,
    "CDKN1C expression enhancer": 1505,
    "CDKN1C expression inhibitor": 1506,
    "CDKN2A expression enhancer": 1507,
    "CDKN2A expression inhibitor": 1508,
    "CDKN2B expression enhancer": 1509,
    "CDKN2C expression enhancer": 1510,
    "CDKN2C expression inhibitor": 1511,
    "CDKN3 expression inhibitor": 1512,
    "CDO1 expression inhibitor": 1513,
    "CDP-4-dehydro-6-deoxyglucose reductase inhibitor": 1514,
    "CDP-diacylglycerol diphosphatase inhibitor": 1515,
    "CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase inhibitor": 1516,
    "CDP-diacylglycerol-inositol 3-phosphatidyltransferase inhibitor": 1517,
    "CDP-diacylglycerol-serine O-phosphatidyltransferase inhibitor": 1518,
    "CDP-glycerol diphosphatase inhibitor": 1519,
    "CDP-glycerol glycerophosphotransferase inhibitor": 1520,
    "CDT1 expression enhancer": 1521,
    "CEACAM1 expression enhancer": 1522,
    "CEACAM3 expression inhibitor": 1523,
    "CEBPA expression enhancer": 1524,
    "CEBPD expression enhancer": 1525,
    "CEBPD expression inhibitor": 1526,
    "CEBPG expression inhibitor": 1527,
    "CEBPZ expression inhibitor": 1528,
    "CELF2 expression inhibitor": 1529,
    "CENPA expression enhancer": 1530,
    "CENPA expression inhibitor": 1531,
    "CENPF expression enhancer": 1532,
    "CENPN expression enhancer": 1533,
    "CEP350 expression inhibitor": 1534,
    "CEP55 expression inhibitor": 1535,
    "CEP57 expression inhibitor": 1536,
    "CES1 expression inhibitor": 1537,
    "CF transmembrane conductance regulator agonist": 1538,
    "CF transmembrane conductance regulator antagonist": 1539,
    "CFB expression inhibitor": 1540,
    "CFLAR expression inhibitor": 1541,
    "CGB expression enhancer": 1542,
    "CHAC2 expression enhancer": 1543,
    "CHEK1 expression enhancer": 1544,
    "CHORDC1 expression enhancer": 1545,
    "CIRBP expression inhibitor": 1546,
    "CITED2 expression enhancer": 1547,
    "CITED2 expression inhibitor": 1548,
    "CKB expression enhancer": 1549,
    "CKS1B expression enhancer": 1550,
    "CLDN1 expression inhibitor": 1551,
    "CLDN4 expression enhancer": 1552,
    "CLDN4 expression inhibitor": 1553,
    "CLDN5 expression enhancer": 1554,
    "CLGN expression inhibitor": 1555,
    "CLIC6 expression enhancer": 1556,
    "CLMN expression enhancer": 1557,
    "CLMP expression inhibitor": 1558,
    "CLSTN1 expression inhibitor": 1559,
    "CLTB expression enhancer": 1560,
    "CLU expression enhancer": 1561,
    "CLU expression inhibitor": 1562,
    "CMP-KDO synthase inhibitor": 1563,
    "CMP-N-acetylneuraminate monooxygenase inhibitor": 1564,
    "CMP-N-acylneuraminate phosphodiesterase inhibitor": 1565,
    "CNN1 expression enhancer": 1566,
    "CNS active muscle relaxant": 1567,
    "CO-methylating acetyl-CoA synthase inhibitor": 1568,
    "COBLL1 expression inhibitor": 1569,
    "COL12A1 expression enhancer": 1570,
    "COL17A1 expression inhibitor": 1571,
    "COL1A1 expression enhancer": 1572,
    "COL1A1 expression inhibitor": 1573,
    "COL1A2 expression inhibitor": 1574,
    "COL2A1 expression enhancer": 1575,
    "COL3A1 expression inhibitor": 1576,
    "COL4A1 expression inhibitor": 1577,
    "COL4A2 expression inhibitor": 1578,
    "COL5A2 expression inhibitor": 1579,
    "COL6A1 expression inhibitor": 1580,
    "COL8A2 expression inhibitor": 1581,
    "COLEC12 expression enhancer": 1582,
    "COMP expression enhancer": 1583,
    "COMT expression inhibitor": 1584,
    "CORO1C expression enhancer": 1585,
    "COX7A2 expression inhibitor": 1586,
    "COX7A2L expression enhancer": 1587,
    "CP expression enhancer": 1588,
    "CPB protease inhibitor": 1589,
    "CPE expression enhancer": 1590,
    "CPM expression enhancer": 1591,
    "CPNE1 expression enhancer": 1592,
    "CPT1A expression enhancer": 1593,
    "CRABP2 expression enhancer": 1594,
    "CRABP2 expression inhibitor": 1595,
    "CREB-binding protein inhibitor": 1596,
    "CREB1 expression inhibitor": 1597,
    "CREBBP expression inhibitor": 1598,
    "CRH expression inhibitor": 1599,
    "CRP expression enhancer": 1600,
    "CRYAB expression enhancer": 1601,
    "CSE1L expression inhibitor": 1602,
    "CSF2 expression inhibitor": 1603,
    "CSF3 expression enhancer": 1604,
    "CSNK1D expression inhibitor": 1605,
    "CSNK2A1 expression inhibitor": 1606,
    "CSRP2BP expression enhancer": 1607,
    "CSTA expression inhibitor": 1608,
    "CTBP1 expression inhibitor": 1609,
    "CTDSPL expression inhibitor": 1610,
    "CTGF expression enhancer": 1611,
    "CTGF expression inhibitor": 1612,
    "CTH expression inhibitor": 1613,
    "CTNNA1 expression inhibitor": 1614,
    "CTNNB1 expression inhibitor": 1615,
    "CTNND2 expression inhibitor": 1616,
    "CTP synthase inhibitor": 1617,
    "CTPS expression enhancer": 1618,
    "CTSB expression inhibitor": 1619,
    "CTSD expression enhancer": 1620,
    "CTSD expression inhibitor": 1621,
    "CUL5 expression inhibitor": 1622,
    "CUX1 expression inhibitor": 1623,
    "CXC chemokine 1 receptor antagonist": 1624,
    "CXC chemokine 2 receptor antagonist": 1625,
    "CXC chemokine 3 receptor antagonist": 1626,
    "CXC chemokine 4 receptor antagonist": 1627,
    "CXC chemokine 5 receptor antagonist": 1628,
    "CXC chemokine L1/GRO-alpha antagonist": 1629,
    "CXC chemokine receptor agonist": 1630,
    "CXC chemokine receptor antagonist": 1631,
    "CXCL1 expression enhancer": 1632,
    "CXCL1 expression inhibitor": 1633,
    "CXCL10 expression enhancer": 1634,
    "CXCL11 expression enhancer": 1635,
    "CXCL12 expression enhancer": 1636,
    "CXCL2 expression inhibitor": 1637,
    "CXCL3 expression enhancer": 1638,
    "CXCR1 expression enhancer": 1639,
    "CXCR1 expression inhibitor": 1640,
    "CXCR2 expression inhibitor": 1641,
    "CXCR4 expression enhancer": 1642,
    "CYB5A expression enhancer": 1643,
    "CYB5R2 expression enhancer": 1644,
    "CYBA expression enhancer": 1645,
    "CYCS expression enhancer": 1646,
    "CYFIP2 expression enhancer": 1647,
    "CYP1 substrate": 1648,
    "CYP11A1 expression enhancer": 1649,
    "CYP11A1 expression inhibitor": 1650,
    "CYP11A1 inhibitor": 1651,
    "CYP11B substrate": 1652,
    "CYP11B1 expression enhancer": 1653,
    "CYP11B1 inhibitor": 1654,
    "CYP11B1 substrate": 1655,
    "CYP11B2 expression enhancer": 1656,
    "CYP11B2 inhibitor": 1657,
    "CYP11B2 substrate": 1658,
    "CYP17 inhibitor": 1659,
    "CYP17 substrate": 1660,
    "CYP17A substrate": 1661,
    "CYP17A1 expression enhancer": 1662,
    "CYP17A1 expression inhibitor": 1663,
    "CYP19 inducer": 1664,
    "CYP19 inhibitor": 1665,
    "CYP19 substrate": 1666,
    "CYP19A1 expression enhancer": 1667,
    "CYP19A1 expression inhibitor": 1668,
    "CYP19A1 substrate": 1669,
    "CYP1A inducer": 1670,
    "CYP1A inhibitor": 1671,
    "CYP1A substrate": 1672,
    "CYP1A1 expression enhancer": 1673,
    "CYP1A1 expression inhibitor": 1674,
    "CYP1A1 inducer": 1675,
    "CYP1A1 inhibitor": 1676,
    "CYP1A1 substrate": 1677,
    "CYP1A1* substrate": 1678,
    "CYP1A2 expression enhancer": 1679,
    "CYP1A2 inducer": 1680,
    "CYP1A2 inhibitor": 1681,
    "CYP1A2 substrate": 1682,
    "CYP1A3 substrate": 1683,
    "CYP1B substrate": 1684,
    "CYP1B1 expression enhancer": 1685,
    "CYP1B1 expression inhibitor": 1686,
    "CYP1B1 inducer": 1687,
    "CYP1B1 inhibitor": 1688,
    "CYP1B1 substrate": 1689,
    "CYP2 substrate": 1690,
    "CYP21A2 expression enhancer": 1691,
    "CYP24 inhibitor": 1692,
    "CYP24 substrate": 1693,
    "CYP24A1 expression enhancer": 1694,
    "CYP24A1 inhibitor": 1695,
    "CYP24A1 substrate": 1696,
    "CYP26 inhibitor": 1697,
    "CYP26 substrate": 1698,
    "CYP26A substrate": 1699,
    "CYP26A1 expression enhancer": 1700,
    "CYP26A1 inducer": 1701,
    "CYP26A1 inhibitor": 1702,
    "CYP26B1 expression enhancer": 1703,
    "CYP27 substrate": 1704,
    "CYP27A substrate": 1705,
    "CYP27A1 inhibitor": 1706,
    "CYP27A1 substrate": 1707,
    "CYP2A substrate": 1708,
    "CYP2A1 substrate": 1709,
    "CYP2A10 substrate": 1710,
    "CYP2A11 substrate": 1711,
    "CYP2A13 substrate": 1712,
    "CYP2A2 substrate": 1713,
    "CYP2A3 substrate": 1714,
    "CYP2A4 substrate": 1715,
    "CYP2A5 inhibitor": 1716,
    "CYP2A5 substrate": 1717,
    "CYP2A6 expression enhancer": 1718,
    "CYP2A6 inhibitor": 1719,
    "CYP2A6 substrate": 1720,
    "CYP2A8 substrate": 1721,
    "CYP2B substrate": 1722,
    "CYP2B1 substrate": 1723,
    "CYP2B10 substrate": 1724,
    "CYP2B11 substrate": 1725,
    "CYP2B18 substrate": 1726,
    "CYP2B2 substrate": 1727,
    "CYP2B4 substrate": 1728,
    "CYP2B5 substrate": 1729,
    "CYP2B6 expression enhancer": 1730,
    "CYP2B6 inhibitor": 1731,
    "CYP2B6 substrate": 1732,
    "CYP2C substrate": 1733,
    "CYP2C10 substrate": 1734,
    "CYP2C11 substrate": 1735,
    "CYP2C12 substrate": 1736,
    "CYP2C18 inhibitor": 1737,
    "CYP2C18 substrate": 1738,
    "CYP2C19 inducer": 1739,
    "CYP2C19 inhibitor": 1740,
    "CYP2C19 substrate": 1741,
    "CYP2C2 substrate": 1742,
    "CYP2C29 substrate": 1743,
    "CYP2C3 substrate": 1744,
    "CYP2C6 substrate": 1745,
    "CYP2C8 inducer": 1746,
    "CYP2C8 inhibitor": 1747,
    "CYP2C8 substrate": 1748,
    "CYP2C9 expression enhancer": 1749,
    "CYP2C9 inducer": 1750,
    "CYP2C9 inhibitor": 1751,
    "CYP2C9 substrate": 1752,
    "CYP2C9-Arg substrate": 1753,
    "CYP2C9-Arg144 substrate": 1754,
    "CYP2C9-Cys substrate": 1755,
    "CYP2D substrate": 1756,
    "CYP2D1 substrate": 1757,
    "CYP2D15 substrate": 1758,
    "CYP2D16 substrate": 1759,
    "CYP2D2 inhibitor": 1760,
    "CYP2D6 expression enhancer": 1761,
    "CYP2D6 inhibitor": 1762,
    "CYP2D6 substrate": 1763,
    "CYP2D6-Val substrate": 1764,
    "CYP2E substrate": 1765,
    "CYP2E1 expression enhancer": 1766,
    "CYP2E1 inducer": 1767,
    "CYP2E1 inhibitor": 1768,
    "CYP2E1 substrate": 1769,
    "CYP2F1 substrate": 1770,
    "CYP2G1 substrate": 1771,
    "CYP2H substrate": 1772,
    "CYP2J substrate": 1773,
    "CYP2J2 inhibitor": 1774,
    "CYP2J2 substrate": 1775,
    "CYP3A inducer": 1776,
    "CYP3A inhibitor": 1777,
    "CYP3A substrate": 1778,
    "CYP3A1 substrate": 1779,
    "CYP3A11 substrate": 1780,
    "CYP3A2 substrate": 1781,
    "CYP3A3 substrate": 1782,
    "CYP3A4 expression enhancer": 1783,
    "CYP3A4 expression inhibitor": 1784,
    "CYP3A4 inducer": 1785,
    "CYP3A4 inhibitor": 1786,
    "CYP3A4 substrate": 1787,
    "CYP3A5 expression enhancer": 1788,
    "CYP3A5 inducer": 1789,
    "CYP3A5 inhibitor": 1790,
    "CYP3A5 substrate": 1791,
    "CYP3A7 expression enhancer": 1792,
    "CYP3A7 expression inhibitor": 1793,
    "CYP3A7 substrate": 1794,
    "CYP3A9 substrate": 1795,
    "CYP3C substrate": 1796,
    "CYP4 substrate": 1797,
    "CYP4A substrate": 1798,
    "CYP4A1 inhibitor": 1799,
    "CYP4A1 substrate": 1800,
    "CYP4A11 expression enhancer": 1801,
    "CYP4A11 expression inhibitor": 1802,
    "CYP4A11 inhibitor": 1803,
    "CYP4A11 substrate": 1804,
    "CYP4A2 substrate": 1805,
    "CYP4B substrate": 1806,
    "CYP4B1 expression inhibitor": 1807,
    "CYP4B1 substrate": 1808,
    "CYP4F substrate": 1809,
    "CYP4F12 substrate": 1810,
    "CYP4F2 inhibitor": 1811,
    "CYP4F2 substrate": 1812,
    "CYP4F3 substrate": 1813,
    "CYP4F8 substrate": 1814,
    "CYP51 inhibitor": 1815,
    "CYP7 inhibitor": 1816,
    "CYP7 substrate": 1817,
    "CYP7A1 expression inhibitor": 1818,
    "CYP7A1 substrate": 1819,
    "CYP7B substrate": 1820,
    "CYP7B1 expression inhibitor": 1821,
    "CYP7B1 substrate": 1822,
    "CYTH1 expression enhancer": 1823,
    "Ca(v)22 blocker": 1824,
    "Ca2+-transporting ATPase inhibitor": 1825,
    "Ca2+/Calmodulin-dependent protein kinase kinase A inhibitor": 1826,
    "Ca2+/calmodulin-dependent kinase I alpha inhibitor": 1827,
    "Ca2+/calmodulin-dependent kinase I delta inhibitor": 1828,
    "Ca2+/calmodulin-dependent kinase I inhibitor": 1829,
    "Ca2+/calmodulin-dependent kinase II alpha inhibitor": 1830,
    "Ca2+/calmodulin-dependent kinase II beta inhibitor": 1831,
    "Ca2+/calmodulin-dependent kinase II delta inhibitor": 1832,
    "Ca2+/calmodulin-dependent kinase II gamma inhibitor": 1833,
    "Ca2+/calmodulin-dependent kinase II inhibitor": 1834,
    "Ca2+/calmodulin-dependent kinase IV inhibitor": 1835,
    "Ca2+/calmodulin-dependent protein kinase inhibitor": 1836,
    "Cachexia treatment": 1837,
    "Cadherin antagonist": 1838,
    "Calcineurin B beta inhibitor": 1839,
    "Calcineurin inhibitor": 1840,
    "Calcitonin gene-related peptide 1 receptor antagonist": 1841,
    "Calcitonin gene-related peptide antagonist": 1842,
    "Calcitonin receptor agonist": 1843,
    "Calcium antagonist": 1844,
    "Calcium channel (voltage-sensitive) activator": 1845,
    "Calcium channel (voltage-sensitive) blocker": 1846,
    "Calcium channel L-type activator": 1847,
    "Calcium channel L-type blocker": 1848,
    "Calcium channel N-type blocker": 1849,
    "Calcium channel P-type blocker": 1850,
    "Calcium channel T-type blocker": 1851,
    "Calcium channel activator": 1852,
    "Calcium channel blocker": 1853,
    "Calcium regulator": 1854,
    "Calcium release-activated channel blocker": 1855,
    "Calcium-activated potassium channel subunit alpha-1 activator": 1856,
    "Calcium-dependent phospholipase A2 inhibitor": 1857,
    "Calcium-independent phospholipase A2 inhibitor": 1858,
    "Calcium-sensing receptor agonist": 1859,
    "Calcium-sensing receptor antagonist": 1860,
    "Calmodulin antagonist": 1861,
    "Calmodulin-domain protein kinase 1 inhibitor": 1862,
    "Calmodulin-sensitive adenylate cyclase (Bacillus anthracis) inhibitor": 1863,
    "Calpain 1 inhibitor": 1864,
    "Calpain 2 inhibitor": 1865,
    "Calpain inhibitor": 1866,
    "Calpain small subunit 1 inhibitor": 1867,
    "Camphor 1,2-monooxygenase inhibitor": 1868,
    "Cancer associated disorders treatment": 1869,
    "Cancer procoagulant inhibitor": 1870,
    "Candidapepsin 2 inhibitor": 1871,
    "Candidapepsin inhibitor": 1872,
    "Cannabinoid CB1 receptor agonist": 1873,
    "Cannabinoid CB1 receptor antagonist": 1874,
    "Cannabinoid CB2 receptor agonist": 1875,
    "Cannabinoid CB2 receptor antagonist": 1876,
    "Cannabinoid receptor agonist": 1877,
    "Cannabinoid receptor antagonist": 1878,
    "Capillary fragility treatment": 1879,
    "Carbamoyl-phosphate synthase (ammonia) inhibitor": 1880,
    "Carbamoyl-serine ammonia-lyase inhibitor": 1881,
    "Carbon-monoxide dehydrogenase inhibitor": 1882,
    "Carbonic anhydrase I inhibitor": 1883,
    "Carbonic anhydrase I stimulant": 1884,
    "Carbonic anhydrase II inhibitor": 1885,
    "Carbonic anhydrase II stimulant": 1886,
    "Carbonic anhydrase III inhibitor": 1887,
    "Carbonic anhydrase IV inhibitor": 1888,
    "Carbonic anhydrase IV stimulant": 1889,
    "Carbonic anhydrase IX inhibitor": 1890,
    "Carbonic anhydrase V inhibitor": 1891,
    "Carbonic anhydrase VA inhibitor": 1892,
    "Carbonic anhydrase VB inhibitor": 1893,
    "Carbonic anhydrase VI inhibitor": 1894,
    "Carbonic anhydrase VII inhibitor": 1895,
    "Carbonic anhydrase VIII inhibitor": 1896,
    "Carbonic anhydrase X inhibitor": 1897,
    "Carbonic anhydrase XI inhibitor": 1898,
    "Carbonic anhydrase XII inhibitor": 1899,
    "Carbonic anhydrase XIII inhibitor": 1900,
    "Carbonic anhydrase XIV inhibitor": 1901,
    "Carbonic anhydrase XV inhibitor": 1902,
    "Carbonic anhydrase inhibitor": 1903,
    "Carbonic anhydrase stimulant": 1904,
    "Carbonyl reductase [NADPH] 1 inhibitor": 1905,
    "Carbonyl reductase [NADPH] inhibitor": 1906,
    "Carboxy-cis,cis-muconate cyclase inhibitor": 1907,
    "Carboxycyclohexadienyl dehydratase inhibitor": 1908,
    "Carboxylate reductase inhibitor": 1909,
    "Carboxylesterase 2 inhibitor": 1910,
    "Carboxylesterase inhibitor": 1911,
    "Carboxymethylenebutenolidase inhibitor": 1912,
    "Carboxypeptidase B inhibitor": 1913,
    "Carboxypeptidase B2 isoform A inhibitor": 1914,
    "Carboxypeptidase D inhibitor": 1915,
    "Carboxypeptidase E inhibitor": 1916,
    "Carboxypeptidase M inhibitor": 1917,
    "Carboxypeptidase Taq inhibitor": 1918,
    "Carboxypeptidase U inhibitor": 1919,
    "Carcinogenic": 1920,
    "Carcinogenic, breast": 1921,
    "Carcinogenic, endocrine": 1922,
    "Carcinogenic, endometrium": 1923,
    "Carcinogenic, group 1": 1924,
    "Carcinogenic, group 2A": 1925,
    "Carcinogenic, group 2B": 1926,
    "Carcinogenic, group 3": 1927,
    "Carcinogenic, liver": 1928,
    "Carcinogenic, lung": 1929,
    "Carcinogenic, mouse": 1930,
    "Carcinogenic, mouse, female": 1931,
    "Carcinogenic, mouse, female, esophagus": 1932,
    "Carcinogenic, mouse, female, harderian gland": 1933,
    "Carcinogenic, mouse, female, hematopoietic system": 1934,
    "Carcinogenic, mouse, female, kidney": 1935,
    "Carcinogenic, mouse, female, liver": 1936,
    "Carcinogenic, mouse, female, lung": 1937,
    "Carcinogenic, mouse, female, mammary gland": 1938,
    "Carcinogenic, mouse, female, nasal cavity": 1939,
    "Carcinogenic, mouse, female, oral cavity": 1940,
    "Carcinogenic, mouse, female, ovary": 1941,
    "Carcinogenic, mouse, female, peritoneal cavity": 1942,
    "Carcinogenic, mouse, female, pituitary gland": 1943,
    "Carcinogenic, mouse, female, skin": 1944,
    "Carcinogenic, mouse, female, small intestine": 1945,
    "Carcinogenic, mouse, female, stomach": 1946,
    "Carcinogenic, mouse, female, thyroid gland": 1947,
    "Carcinogenic, mouse, female, urinary bladder": 1948,
    "Carcinogenic, mouse, female, uterus": 1949,
    "Carcinogenic, mouse, female, vascular system": 1950,
    "Carcinogenic, mouse, male": 1951,
    "Carcinogenic, mouse, male, adrenal gland": 1952,
    "Carcinogenic, mouse, male, esophagus": 1953,
    "Carcinogenic, mouse, male, harderian gland": 1954,
    "Carcinogenic, mouse, male, hematopoietic system": 1955,
    "Carcinogenic, mouse, male, kidney": 1956,
    "Carcinogenic, mouse, male, liver": 1957,
    "Carcinogenic, mouse, male, lung": 1958,
    "Carcinogenic, mouse, male, mammary gland": 1959,
    "Carcinogenic, mouse, male, nasal cavity": 1960,
    "Carcinogenic, mouse, male, nervous system": 1961,
    "Carcinogenic, mouse, male, preputial gland": 1962,
    "Carcinogenic, mouse, male, skin": 1963,
    "Carcinogenic, mouse, male, small intestine": 1964,
    "Carcinogenic, mouse, male, stomach": 1965,
    "Carcinogenic, mouse, male, thyroid gland": 1966,
    "Carcinogenic, mouse, male, urinary bladder": 1967,
    "Carcinogenic, mouse, male, vascular system": 1968,
    "Carcinogenic, rat": 1969,
    "Carcinogenic, rat, female": 1970,
    "Carcinogenic, rat, female, adrenal gland": 1971,
    "Carcinogenic, rat, female, all tumor bearing animals": 1972,
    "Carcinogenic, rat, female, clitoral gland": 1973,
    "Carcinogenic, rat, female, ear Zymbals gland": 1974,
    "Carcinogenic, rat, female, esophagus": 1975,
    "Carcinogenic, rat, female, hematopoietic system": 1976,
    "Carcinogenic, rat, female, kidney": 1977,
    "Carcinogenic, rat, female, large intestine": 1978,
    "Carcinogenic, rat, female, liver": 1979,
    "Carcinogenic, rat, female, lung": 1980,
    "Carcinogenic, rat, female, mammary gland": 1981,
    "Carcinogenic, rat, female, nasal cavity": 1982,
    "Carcinogenic, rat, female, oral cavity": 1983,
    "Carcinogenic, rat, female, pituitary gland": 1984,
    "Carcinogenic, rat, female, skin": 1985,
    "Carcinogenic, rat, female, small intestine": 1986,
    "Carcinogenic, rat, female, stomach": 1987,
    "Carcinogenic, rat, female, thyroid gland": 1988,
    "Carcinogenic, rat, female, urinary bladder": 1989,
    "Carcinogenic, rat, female, uterus": 1990,
    "Carcinogenic, rat, female, vascular system": 1991,
    "Carcinogenic, rat, male": 1992,
    "Carcinogenic, rat, male, adrenal gland": 1993,
    "Carcinogenic, rat, male, all tumor bearing animals": 1994,
    "Carcinogenic, rat, male, ear Zymbals gland": 1995,
    "Carcinogenic, rat, male, esophagus": 1996,
    "Carcinogenic, rat, male, hematopoietic system": 1997,
    "Carcinogenic, rat, male, kidney": 1998,
    "Carcinogenic, rat, male, large intestine": 1999,
    "Carcinogenic, rat, male, liver": 2000,
    "Carcinogenic, rat, male, lung": 2001,
    "Carcinogenic, rat, male, mammary gland": 2002,
    "Carcinogenic, rat, male, nasal cavity": 2003,
    "Carcinogenic, rat, male, oral cavity": 2004,
    "Carcinogenic, rat, male, pancreas": 2005,
    "Carcinogenic, rat, male, peritoneal cavity": 2006,
    "Carcinogenic, rat, male, preputial gland": 2007,
    "Carcinogenic, rat, male, skin": 2008,
    "Carcinogenic, rat, male, small intestine": 2009,
    "Carcinogenic, rat, male, stomach": 2010,
    "Carcinogenic, rat, male, subcutaneous tissue": 2011,
    "Carcinogenic, rat, male, testes": 2012,
    "Carcinogenic, rat, male, thyroid gland": 2013,
    "Carcinogenic, rat, male, urinary bladder": 2014,
    "Carcinogenic, rat, male, vascular system": 2015,
    "Cardiac malformations": 2016,
    "Cardiac myosin stimulant": 2017,
    "Cardiodepressant": 2018,
    "Cardiomegaly": 2019,
    "Cardiomyopathy": 2020,
    "Cardioprotectant": 2021,
    "Cardiotonic": 2022,
    "Cardiotoxic": 2023,
    "Cardiovascular analeptic": 2024,
    "Carminative": 2025,
    "Carnitinamidase inhibitor": 2026,
    "Carnitine 3-dehydrogenase inhibitor": 2027,
    "Carnitine O-octanoyltransferase inhibitor": 2028,
    "Carnitine dehydratase inhibitor": 2029,
    "Carnitine palmitoyltransferase 1 inhibitor": 2030,
    "Carnitine palmitoyltransferase 1A inhibitor": 2031,
    "Carnitine palmitoyltransferase 1B inhibitor": 2032,
    "Carnitine palmitoyltransferase inhibitor": 2033,
    "Carnosine synthase inhibitor": 2034,
    "Caspase 10 inhibitor": 2035,
    "Caspase 2 inhibitor": 2036,
    "Caspase 3 inhibitor": 2037,
    "Caspase 3 stimulant": 2038,
    "Caspase 4 inhibitor": 2039,
    "Caspase 5 inhibitor": 2040,
    "Caspase 6 inhibitor": 2041,
    "Caspase 7 inhibitor": 2042,
    "Caspase 8 inhibitor": 2043,
    "Caspase 8 stimulant": 2044,
    "Caspase 9 inhibitor": 2045,
    "Caspase 9 stimulant": 2046,
    "Caspase inhibitor": 2047,
    "Caspase stimulant": 2048,
    "Catalase inhibitor": 2049,
    "Catalase stimulant": 2050,
    "Cataract": 2051,
    "Catatonia": 2052,
    "Catechol 1,2-dioxygenase inhibitor": 2053,
    "Catechol 2,3-dioxygenase inhibitor": 2054,
    "Catechol O methyltransferase inhibitor": 2055,
    "Catechol oxidase inhibitor": 2056,
    "Catenin beta inhibitor": 2057,
    "Cathepsin B inhibitor": 2058,
    "Cathepsin B-like cysteine protease inhibitor": 2059,
    "Cathepsin D inhibitor": 2060,
    "Cathepsin E inhibitor": 2061,
    "Cathepsin F inhibitor": 2062,
    "Cathepsin G inhibitor": 2063,
    "Cathepsin H inhibitor": 2064,
    "Cathepsin K inhibitor": 2065,
    "Cathepsin L inhibitor": 2066,
    "Cathepsin L1 inhibitor": 2067,
    "Cathepsin L2 inhibitor": 2068,
    "Cathepsin S inhibitor": 2069,
    "Cathepsin T inhibitor": 2070,
    "Cathepsin V inhibitor": 2071,
    "Cathepsin Z inhibitor": 2072,
    "Cationic amino acid transporter 4 inhibitor": 2073,
    "Cauda equina syndrome": 2074,
    "Celiac disease treatment": 2075,
    "Cell adhesion inhibitor": 2076,
    "Cell adhesion molecule inhibitor": 2077,
    "Cell division control protein 42 homolog inhibitor": 2078,
    "Cell wall synthesis inhibitor": 2079,
    "Cellobiose phosphorylase inhibitor": 2080,
    "Cellular retinoic acid binding protein antagonist": 2081,
    "Cellular retinoic acid-binding protein I antagonist": 2082,
    "Cellular retinoic acid-binding protein II antagonist": 2083,
    "Cellulase inhibitor": 2084,
    "Cellulose 1,4-beta-cellobiosidase inhibitor": 2085,
    "Cellulose synthase (UDP-forming) inhibitor": 2086,
    "Centromere associated protein inhibitor": 2087,
    "Ceramidase inhibitor": 2088,
    "Ceramide glucosyltransferase inhibitor": 2089,
    "Ceramide kinase inhibitor": 2090,
    "Cerebroside-sulfatase inhibitor": 2091,
    "Cerebrovascular disordes treatment": 2092,
    "Cerevisin inhibitor": 2093,
    "Chalcone isomerase inhibitor": 2094,
    "Channel-conductance-controlling ATPase inhibitor": 2095,
    "Chaperonin ATPase inhibitor": 2096,
    "Check point kinase 1 inhibitor": 2097,
    "Check point kinase 2 inhibitor": 2098,
    "Check point kinase inhibitor": 2099,
    "Chelator": 2100,
    "Chelator, Iron": 2101,
    "Chemokine receptor agonist": 2102,
    "Chemokine receptor antagonist": 2103,
    "Chemopreventive": 2104,
    "Chemoprotective": 2105,
    "Chemosensitizer": 2106,
    "Chenodeoxycholoyltaurine hydrolase inhibitor": 2107,
    "Chest pain": 2108,
    "Chills": 2109,
    "Chitin deacetylase inhibitor": 2110,
    "Chitin synthase inhibitor": 2111,
    "Chitinase 1 inhibitor": 2112,
    "Chitinase B inhibitor": 2113,
    "Chitinase inhibitor": 2114,
    "Chitobiosyldiphosphodolichol beta-mannosyltransferase inhibitor": 2115,
    "Chitosanase inhibitor": 2116,
    "Chloramphenicol O-acetyltransferase inhibitor": 2117,
    "Chlordecone reductase inhibitor": 2118,
    "Chloride channel activator": 2119,
    "Chloride channel blocker": 2120,
    "Chloride peroxidase inhibitor": 2121,
    "Chloride/bicarbonate exchanger inhibitor": 2122,
    "Cholate-CoA ligase inhibitor": 2123,
    "Cholecystokinin A agonist": 2124,
    "Cholecystokinin A antagonist": 2125,
    "Cholecystokinin B agonist": 2126,
    "Cholecystokinin B antagonist": 2127,
    "Cholecystokinin agonist": 2128,
    "Cholecystokinin antagonist": 2129,
    "Choleretic": 2130,
    "Cholestanetriol 26-monooxygenase inhibitor": 2131,
    "Cholestasis": 2132,
    "Cholestatic hepatitis": 2133,
    "Cholestenol delta-isomerase inhibitor": 2134,
    "Cholestenone 5alpha-reductase inhibitor": 2135,
    "Cholestenone 5beta-reductase inhibitor": 2136,
    "Cholesterol absorption inhibitor": 2137,
    "Cholesterol antagonist": 2138,
    "Cholesterol ester transfer protein antagonist": 2139,
    "Cholesterol esterase inhibitor": 2140,
    "Cholesterol monooxygenase (side-chain-cleaving) inhibitor": 2141,
    "Cholesterol oxidase inhibitor": 2142,
    "Cholesterol synthesis inhibitor": 2143,
    "Choline acetyltransferase stimulant": 2144,
    "Choline dehydrogenase inhibitor": 2145,
    "Choline kinase inhibitor": 2146,
    "Choline sulfotransferase inhibitor": 2147,
    "Choline-phosphate cytidylyltransferase inhibitor": 2148,
    "Choline-sulfatase inhibitor": 2149,
    "Cholinergic": 2150,
    "Cholinergic antagonist": 2151,
    "Choloylglycine hydrolase inhibitor": 2152,
    "Chondroitin 6-sulfotransferase inhibitor": 2153,
    "Chorea": 2154,
    "Choreoathetosis": 2155,
    "Chorismate mutase inhibitor": 2156,
    "Chorismate synthase inhibitor": 2157,
    "Chronic obstructive pulmonary disease treatment": 2158,
    "Chymase inhibitor": 2159,
    "Chymosin inhibitor": 2160,
    "Chymotrypsin B inhibitor": 2161,
    "Chymotrypsin C inhibitor": 2162,
    "Chymotrypsin inhibitor": 2163,
    "Chymotrypsin-like protease CTRL-1 inhibitor": 2164,
    "Cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase inhibitor": 2165,
    "Citrate (Si)-synthase inhibitor": 2166,
    "Cl--transporting ATPase inhibitor": 2167,
    "Class C beta-lactamase CMY-36 inhibitor": 2168,
    "Clavaminate synthase inhibitor": 2169,
    "Cleft palate": 2170,
    "Clk dual-specificity kinase inhibitor": 2171,
    "Clostripain inhibitor": 2172,
    "Coactivator-associated arginine methyltransferase 1 inhibitor": 2173,
    "Coagulant": 2174,
    "Cocain dependency treatment": 2175,
    "Coccolysin inhibitor": 2176,
    "Coenzyme-B sulfoethylthiotransferase inhibitor": 2177,
    "Cognition disorders treatment": 2178,
    "Colic": 2179,
    "Colitis": 2180,
    "Collagen inhibitor": 2181,
    "Collagenase 3 inhibitor": 2182,
    "Collagenase inhibitor": 2183,
    "Colony stimulating factor agonist": 2184,
    "Colony stimulating factor antagonist": 2185,
    "Colorectum cell-derived growth factor antagonist": 2186,
    "Coma": 2187,
    "Complement C3 convertase inhibitor": 2188,
    "Complement C3a chemotactic receptor antagonist": 2189,
    "Complement C5a chemotactic receptor antagonist": 2190,
    "Complement C5a convertase stimulant": 2191,
    "Complement factor 1 inhibitor": 2192,
    "Complement factor 1r inhibitor": 2193,
    "Complement factor 1s inhibitor": 2194,
    "Complement factor D inhibitor": 2195,
    "Complement inhibitor": 2196,
    "Complement stimulant": 2197,
    "Confusion": 2198,
    "Conjunctivitis": 2199,
    "Consciousness alteration": 2200,
    "Constipation": 2201,
    "Constipation treatment": 2202,
    "Constitutive androstane receptor antagonist": 2203,
    "Contraceptive": 2204,
    "Contraceptive female": 2205,
    "Contraceptive male": 2206,
    "Convulsant": 2207,
    "Coproporphyrinogen oxidase inhibitor": 2208,
    "Corneal wound healing stimulator": 2209,
    "Coronary artery spasm": 2210,
    "Corticosteroid antagonist": 2211,
    "Corticosteroid side-chain-isomerase inhibitor": 2212,
    "Corticosteroid-like": 2213,
    "Corticotropin releasing factor 1 receptor antagonist": 2214,
    "Corticotropin releasing factor 2 receptor antagonist": 2215,
    "Corticotropin releasing factor antagonist": 2216,
    "Corticotropin-like": 2217,
    "Corticotropin-releasing factor-binding protein inhibitor": 2218,
    "Cortisol sulfotransferase inhibitor": 2219,
    "Cortisone alpha-reductase inhibitor": 2220,
    "Cortisone beta-reductase inhibitor": 2221,
    "Cough": 2222,
    "CpG DNA methylase inhibitor": 2223,
    "CpG-Oligodeoxynucleotides inhibitor": 2224,
    "Creatinase inhibitor": 2225,
    "Creatine kinase inhibitor": 2226,
    "Creatininase inhibitor": 2227,
    "Creatinine deaminase inhibitor": 2228,
    "Crohn's disease treatment": 2229,
    "Crotonoyl-[acyl-carrier-protein] hydratase inhibitor": 2230,
    "Cruzipain inhibitor": 2231,
    "Crystalluria": 2232,
    "Cushing's syndrome treatment": 2233,
    "Cutinase inhibitor": 2234,
    "Cyanate hydratase inhibitor": 2235,
    "Cyanoalanine nitrilase inhibitor": 2236,
    "Cyanosis": 2237,
    "Cyclamate sulfohydrolase inhibitor": 2238,
    "Cyclic AMP agonist": 2239,
    "Cyclic AMP antagonist": 2240,
    "Cyclic AMP modulator": 2241,
    "Cyclic AMP phosphodiesterase inhibitor": 2242,
    "Cyclic GMP phosphodiesterase inhibitor": 2243,
    "Cyclic nucleotide specific phosphodiesterase inhibitor": 2244,
    "Cyclin A inhibitor": 2245,
    "Cyclin A1 inhibitor": 2246,
    "Cyclin A2 inhibitor": 2247,
    "Cyclin B inhibitor": 2248,
    "Cyclin B1 inhibitor": 2249,
    "Cyclin B2 inhibitor": 2250,
    "Cyclin B3 inhibitor": 2251,
    "Cyclin D1 inhibitor": 2252,
    "Cyclin D2 inhibitor": 2253,
    "Cyclin D3 inhibitor": 2254,
    "Cyclin E inhibitor": 2255,
    "Cyclin E1 inhibitor": 2256,
    "Cyclin E2 inhibitor": 2257,
    "Cyclin H inhibitor": 2258,
    "Cyclin T1 inhibitor": 2259,
    "Cyclin-dependent kinase 1 inhibitor": 2260,
    "Cyclin-dependent kinase 2 inhibitor": 2261,
    "Cyclin-dependent kinase 3 inhibitor": 2262,
    "Cyclin-dependent kinase 4 inhibitor": 2263,
    "Cyclin-dependent kinase 5 activator 1 inhibitor": 2264,
    "Cyclin-dependent kinase 5 inhibitor": 2265,
    "Cyclin-dependent kinase 6 inhibitor": 2266,
    "Cyclin-dependent kinase 7 inhibitor": 2267,
    "Cyclin-dependent kinase 8 inhibitor": 2268,
    "Cyclin-dependent kinase 9 inhibitor": 2269,
    "Cyclin-dependent kinase inhibitor": 2270,
    "Cyclin-dependent kinase-like 1 inhibitor": 2271,
    "Cycloartenol synthase inhibitor": 2272,
    "Cyclohexadienyl dehydrogenase inhibitor": 2273,
    "Cyclohexanone monooxygenase inhibitor": 2274,
    "Cyclohexyl-isocyanide hydratase inhibitor": 2275,
    "Cyclomaltodextrin glucanotransferase inhibitor": 2276,
    "Cyclomaltodextrinase inhibitor": 2277,
    "Cyclooxygenase 1 inhibitor": 2278,
    "Cyclooxygenase 1 substrate": 2279,
    "Cyclooxygenase 2 inhibitor": 2280,
    "Cyclooxygenase 3 inhibitor": 2281,
    "Cyclooxygenase inhibitor": 2282,
    "Cyclooxygenase stimulant": 2283,
    "Cyclooxygenase substrate": 2284,
    "Cyclopentanone monooxygenase inhibitor": 2285,
    "Cyclophilin A inhibitor": 2286,
    "Cyclophilin B inhibitor": 2287,
    "Cyclophilin D inhibitor": 2288,
    "Cyclopropane-fatty-acyl-phospholipid synthase inhibitor": 2289,
    "Cystathionine beta-lyase inhibitor": 2290,
    "Cystathionine beta-synthase inhibitor": 2291,
    "Cystathionine gamma-lyase inhibitor": 2292,
    "Cysteamine dioxygenase inhibitor": 2293,
    "Cysteine desulfurase inhibitor": 2294,
    "Cysteine dioxygenase inhibitor": 2295,
    "Cysteine protease ATG4B inhibitor": 2296,
    "Cysteine protease B inhibitor": 2297,
    "Cysteine synthase inhibitor": 2298,
    "Cysteine transaminase inhibitor": 2299,
    "Cysteine-S-conjugate beta-lyase inhibitor": 2300,
    "Cysteine-tRNA ligase inhibitor": 2301,
    "Cystic fibrosis treatment": 2302,
    "Cystinyl aminopeptidase inhibitor": 2303,
    "Cytidine deaminase inhibitor": 2304,
    "Cytidylate kinase inhibitor": 2305,
    "Cytochrome P450 inhibitor": 2306,
    "Cytochrome P450 oxidoreductase inhibitor": 2307,
    "Cytochrome P450 stimulant": 2308,
    "Cytochrome b-245 heavy chain inhibitor": 2309,
    "Cytochrome b-245 light chain inhibitor": 2310,
    "Cytochrome c oxidase inhibitor": 2311,
    "Cytochrome c oxidase subunit 1 inhibitor": 2312,
    "Cytochrome c oxidase subunit 2 inhibitor": 2313,
    "Cytochrome oxidase inhibitor": 2314,
    "Cytochrome-b5 reductase inhibitor": 2315,
    "Cytochrome-b5 reductase substrate": 2316,
    "Cytochrome-c release inhibitor": 2317,
    "Cytochrome-c3 hydrogenase inhibitor": 2318,
    "Cytokine modulator": 2319,
    "Cytokine production inhibitor": 2320,
    "Cytokine production stimulant": 2321,
    "Cytokine release inhibitor": 2322,
    "Cytokinin dehydrogenase 2 inhibitor": 2323,
    "Cytokinin dehydrogenase inhibitor": 2324,
    "Cytoplasmic zinc-finger protein inhibitor": 2325,
    "Cytoprotectant": 2326,
    "Cytosine deaminase inhibitor": 2327,
    "Cytosol alanyl aminopeptidase inhibitor": 2328,
    "Cytosole dipeptidase inhibitor": 2329,
    "Cytosolic phospholipase A2 beta inhibitor": 2330,
    "Cytosolic phospholipase A2 delta inhibitor": 2331,
    "Cytosolic phospholipase A2 gamma inhibitor": 2332,
    "Cytosolic phospholipase A2 inhibitor": 2333,
    "Cytostatic": 2334,
    "Cytotoxic": 2335,
    "D(-)-tartrate dehydratase inhibitor": 2336,
    "D-2-hydroxy-acid dehydrogenase inhibitor": 2337,
    "D-Ala-D-Ala ligase inhibitor": 2338,
    "D-Alanine-alanyl-poly(glycerolphosphate) ligase inhibitor": 2339,
    "D-Alanine-poly(phosphoribitol) ligase inhibitor": 2340,
    "D-Amino-acid oxidase inhibitor": 2341,
    "D-Lysine 5,6-aminomutase inhibitor": 2342,
    "D-Octopine dehydrogenase inhibitor": 2343,
    "D-Ornithine 4,5-aminomutase inhibitor": 2344,
    "D-Serine ammonia-lyase inhibitor": 2345,
    "D-alanine 2-hydroxymethyltransferase inhibitor": 2346,
    "D-alanine transaminase inhibitor": 2347,
    "D-amino-acid dehydrogenase inhibitor": 2348,
    "D-arabinonolactone oxidase inhibitor": 2349,
    "D-aspartate oxidase inhibitor": 2350,
    "D-benzoylarginine-4-nitroanilide amidase inhibitor": 2351,
    "D-cysteine desulfhydrase inhibitor": 2352,
    "D-glutamate oxidase inhibitor": 2353,
    "D-lactaldehyde dehydrogenase inhibitor": 2354,
    "D-lactate dehydrogenase (cytochrome) inhibitor": 2355,
    "D-lactate dehydrogenase inhibitor": 2356,
    "D-lactate-2-sulfatase inhibitor": 2357,
    "D-malate dehydrogenase (decarboxylating) inhibitor": 2358,
    "D-proline reductase (dithiol) inhibitor": 2359,
    "D-stereospecific aminopeptidase inhibitor": 2360,
    "D-threo-aldose 1-dehydrogenase inhibitor": 2361,
    "D-xylulose reductase inhibitor": 2362,
    "DAB2 expression enhancer": 2363,
    "DAB2 expression inhibitor": 2364,
    "DAD1 expression enhancer": 2365,
    "DAPK1 expression inhibitor": 2366,
    "DCC expression enhancer": 2367,
    "DCN expression enhancer": 2368,
    "DCT expression inhibitor": 2369,
    "DDB2 expression enhancer": 2370,
    "DDEF1 expression inhibitor": 2371,
    "DDEF2 expression inhibitor": 2372,
    "DDIT3 expression enhancer": 2373,
    "DDIT4 expression enhancer": 2374,
    "DDIT4 expression inhibitor": 2375,
    "DDX10 expression inhibitor": 2376,
    "DDX17 expression inhibitor": 2377,
    "DDX18 expression inhibitor": 2378,
    "DDX21 expression enhancer": 2379,
    "DDX21 expression inhibitor": 2380,
    "DDX24 expression inhibitor": 2381,
    "DDX3X expression inhibitor": 2382,
    "DDX58 expression enhancer": 2383,
    "DEFA3 expression enhancer": 2384,
    "DEK expression inhibitor": 2385,
    "DELTA14-sterol reductase inhibitor": 2386,
    "DELTA24-sterol reductase inhibitor": 2387,
    "DENND1B expression inhibitor": 2388,
    "DENND5A expression enhancer": 2389,
    "DEPDC1B expression enhancer": 2390,
    "DEPTOR expression enhancer": 2391,
    "DFFA expression inhibitor": 2392,
    "DFFB expression inhibitor": 2393,
    "DHCR7 expression inhibitor": 2394,
    "DHFR expression inhibitor": 2395,
    "DHRS2 expression enhancer": 2396,
    "DHRS3 expression enhancer": 2397,
    "DICER1 expression inhibitor": 2398,
    "DIO2 expression enhancer": 2399,
    "DIP2B expression inhibitor": 2400,
    "DKK1 expression enhancer": 2401,
    "DLC1 expression enhancer": 2402,
    "DLEU2 expression enhancer": 2403,
    "DLK1 expression inhibitor": 2404,
    "DLX2 expression enhancer": 2405,
    "DLX4 expression enhancer": 2406,
    "DLX4 expression inhibitor": 2407,
    "DMXL1 expression inhibitor": 2408,
    "DNA damaging": 2409,
    "DNA directed RNA polymerase inhibitor": 2410,
    "DNA directed RNA polymerase stimulant": 2411,
    "DNA excision repair protein ERCC-5 inhibitor": 2412,
    "DNA gyrase inhibitor": 2413,
    "DNA gyrase subunit A inhibitor": 2414,
    "DNA gyrase subunit B inhibitor": 2415,
    "DNA helicase inhibitor": 2416,
    "DNA intercalator": 2417,
    "DNA ligase (ATP) inhibitor": 2418,
    "DNA ligase 1 inhibitor": 2419,
    "DNA methylase inhibitor": 2420,
    "DNA methyltransferase 3B inhibitor": 2421,
    "DNA methyltransferase I inhibitor": 2422,
    "DNA nucleotidylexotransferase inhibitor": 2423,
    "DNA polymerase I inhibitor": 2424,
    "DNA polymerase III inhibitor": 2425,
    "DNA polymerase III polC-type inhibitor": 2426,
    "DNA polymerase III subunit alpha inhibitor": 2427,
    "DNA polymerase gamma inhibitor": 2428,
    "DNA polymerase gamma subunit 1 inhibitor": 2429,
    "DNA primase (HHV-1) inhibitor": 2430,
    "DNA primase inhibitor": 2431,
    "DNA repair enzyme inhibitor": 2432,
    "DNA synthesis inhibitor": 2433,
    "DNA topoisomerase III inhibitor": 2434,
    "DNA topoisomerase IV inhibitor": 2435,
    "DNA-3-methyladenine glycosylase I inhibitor": 2436,
    "DNA-3-methyladenine glycosylase II inhibitor": 2437,
    "DNA-dependent protein kinase inhibitor": 2438,
    "DNA-directed RNA polymerase beta chain inhibitor": 2439,
    "DNAJB1 expression enhancer": 2440,
    "DNAJB4 expression enhancer": 2441,
    "DNAJB9 expression enhancer": 2442,
    "DNAJC12 expression inhibitor": 2443,
    "DNASE2 expression inhibitor": 2444,
    "DNMBP expression enhancer": 2445,
    "DNMT1 expression inhibitor": 2446,
    "DNMT3A expression inhibitor": 2447,
    "DOCK4 expression enhancer": 2448,
    "DOK4 expression enhancer": 2449,
    "DOPA decarboxylase inhibitor": 2450,
    "DPP4 expression enhancer": 2451,
    "DPYD expression enhancer": 2452,
    "DRG2 expression inhibitor": 2453,
    "DST expression inhibitor": 2454,
    "DTL expression enhancer": 2455,
    "DTYMK expression enhancer": 2456,
    "DUSP1 expression enhancer": 2457,
    "DUSP1 expression inhibitor": 2458,
    "DUSP10 expression enhancer": 2459,
    "DUSP4 expression inhibitor": 2460,
    "DUSP5 expression enhancer": 2461,
    "DUSP5 expression inhibitor": 2462,
    "DUSP6 expression enhancer": 2463,
    "DUSP6 expression inhibitor": 2464,
    "DYNLL1 expression enhancer": 2465,
    "Dactylysin inhibitor": 2466,
    "Deacetoxycephalosporin-C synthase inhibitor": 2467,
    "Death-associated protein kinase 1 inhibitor": 2468,
    "Death-associated protein kinase 2 inhibitor": 2469,
    "Death-associated protein kinase 3 inhibitor": 2470,
    "Death-associated protein kinase inhibitor": 2471,
    "Decylcitrate synthase inhibitor": 2472,
    "Dehydro-L-gulonate decarboxylase inhibitor": 2473,
    "Dehydrosqualene synthase inhibitor": 2474,
    "Delayed rectifier potassium channel activator": 2475,
    "Delayed rectifier potassium channel blocker": 2476,
    "Delirium": 2477,
    "Delta-5 fatty acid desaturase inhibitor": 2478,
    "Delta-6 fatty acid desaturase inhibitor": 2479,
    "Delusion": 2480,
    "Dementia": 2481,
    "Dementia treatment": 2482,
    "Demethylmacrocin O-methyltransferase inhibitor": 2483,
    "Demethylsterigmatocystin 6-O-methyltransferase inhibitor": 2484,
    "Demyelination": 2485,
    "Dengue virus type 2 NS3 protein inhibitor": 2486,
    "Deodorant": 2487,
    "Deoxyadenosine kinase inhibitor": 2488,
    "Deoxycytidine deaminase inhibitor": 2489,
    "Deoxycytidine kinase inhibitor": 2490,
    "Deoxycytidylate 5-hydroxymethyltransferase inhibitor": 2491,
    "Deoxyguanosine kinase inhibitor": 2492,
    "Deoxyhypusine monooxygenase inhibitor": 2493,
    "Deoxyhypusine synthase inhibitor": 2494,
    "Deoxynucleoside kinase inhibitor": 2495,
    "Deoxyribonuclease (pyrimidine dimer) inhibitor": 2496,
    "Deoxyribonuclease I inhibitor": 2497,
    "Deoxyribonuclease II inhibitor": 2498,
    "Deoxyribonuclease X inhibitor": 2499,
    "Deoxyribose-phosphate aldolase inhibitor": 2500,
    "Dependence": 2501,
    "Dependence treatment": 2502,
    "Depression": 2503,
    "Dermatitis": 2504,
    "Dermatologic": 2505,
    "Dermatomyositis": 2506,
    "Dethiobiotin synthase inhibitor": 2507,
    "Dextranase inhibitor": 2508,
    "Dextransucrase inhibitor": 2509,
    "Di-trans,poly-cis-decaprenylcistransferase inhibitor": 2510,
    "Diabetes": 2511,
    "Diabetes insipidus treatment": 2512,
    "Diabetes mellitus": 2513,
    "Diabetic nephropathy treatment": 2514,
    "Diabetic neuropathy treatment": 2515,
    "Diabetic retinopathy treatment": 2516,
    "Diacylglycerol O-acyltransferase 1 inhibitor": 2517,
    "Diacylglycerol O-acyltransferase inhibitor": 2518,
    "Diacylglycerol cholinephosphotransferase inhibitor": 2519,
    "Diacylglycerol kinase inhibitor": 2520,
    "Diamine N-acetyltransferase inhibitor": 2521,
    "Diamine oxidase inhibitor": 2522,
    "Diaminopimelate decarboxylase inhibitor": 2523,
    "Diaminopimelate dehydrogenase inhibitor": 2524,
    "Diaminopimelate epimerase inhibitor": 2525,
    "Diaminopropionate ammonia-lyase inhibitor": 2526,
    "Diarrhea": 2527,
    "Dichloromethane dehalogenase inhibitor": 2528,
    "Dichloromuconate cycloisomerase inhibitor": 2529,
    "Diguanidinobutanase inhibitor": 2530,
    "Dihydrodipicolinate reductase inhibitor": 2531,
    "Dihydrodipicolinate synthase inhibitor": 2532,
    "Dihydrofolate reductase (Mycobacterium avium) inhibitor": 2533,
    "Dihydrofolate reductase (Pneumocystis carinii) inhibitor": 2534,
    "Dihydrofolate reductase (Toxoplasma gondii) inhibitor": 2535,
    "Dihydrofolate reductase 1 (Escherichia coli) inhibitor": 2536,
    "Dihydrofolate reductase inhibitor": 2537,
    "Dihydrofolate synthase inhibitor": 2538,
    "Dihydrolipoamide S-acetyltransferase inhibitor": 2539,
    "Dihydroneopterin aldolase inhibitor": 2540,
    "Dihydroorotase inhibitor": 2541,
    "Dihydroorotate dehydrogenase inhibitor": 2542,
    "Dihydroorotate oxidase inhibitor": 2543,
    "Dihydropteridine reductase inhibitor": 2544,
    "Dihydropteroate synthase inhibitor": 2545,
    "Dihydropyrimidinase inhibitor": 2546,
    "Dihydropyrimidine dehydrogenase inhibitor": 2547,
    "Dihydrouracil dehydrogenase (NAD+) inhibitor": 2548,
    "Dihydrouracil oxidase inhibitor": 2549,
    "Dihydroxy-acid dehydratase inhibitor": 2550,
    "Dihydroxyacetanilide dehydrogenase inhibitor": 2551,
    "Dihydroxyacetanilide epoxidase inhibitor": 2552,
    "Diiodophenylpyruvate reductase inhibitor": 2553,
    "Diiodotyrosine transaminase inhibitor": 2554,
    "Diisopropyl-fluorophosphatase inhibitor": 2555,
    "Dimethylallyltranstransferase inhibitor": 2556,
    "Dimethylargininase inhibitor": 2557,
    "Dimethylhistidine N-methyltransferase inhibitor": 2558,
    "Dimethylmaleate hydratase inhibitor": 2559,
    "Dimethylpropiothetin dethiomethylase inhibitor": 2560,
    "Dipeptidase E inhibitor": 2561,
    "Dipeptidyl peptidase I inhibitor": 2562,
    "Dipeptidyl peptidase II inhibitor": 2563,
    "Dipeptidyl peptidase III inhibitor": 2564,
    "Dipeptidyl peptidase IV inhibitor": 2565,
    "Dipeptidyl peptidase IX inhibitor": 2566,
    "Dipeptidyl peptidase VI inhibitor": 2567,
    "Dipeptidyl peptidase VIII inhibitor": 2568,
    "Dipeptidyl peptidase inhibitor": 2569,
    "Diphenylpicrylhydrazyl (DPPH) scavenger": 2570,
    "Diphosphate-fructose-6-phosphate 1-phosphotransferase inhibitor": 2571,
    "Diphosphate-serine phosphotransferase inhibitor": 2572,
    "Diphosphomevalonate decarboxylase inhibitor": 2573,
    "Diplopia": 2574,
    "Diuretic": 2575,
    "Diuretic inhibitor": 2576,
    "Dizziness": 2577,
    "DnaC helicase inhibitor": 2578,
    "Dodecenoyl-CoA Delta-isomerase inhibitor": 2579,
    "Dolichol kinase inhibitor": 2580,
    "Dolichyl-diphosphooligosaccharide-protein glycotransferase inhibitor": 2581,
    "Dolichyl-phosphatase inhibitor": 2582,
    "Dolichyl-phosphate beta-D-mannosyltransferase (T brucei) inhibitor": 2583,
    "Dolichyl-phosphate beta-D-mannosyltransferase inhibitor": 2584,
    "Dolichyl-phosphate beta-glucosyltransferase inhibitor": 2585,
    "Dolichyl-phosphate-mannose-protein mannosyltransferase 1 inhibitor": 2586,
    "Dolichyl-phosphate-mannose-protein mannosyltransferase inhibitor": 2587,
    "Dolichyldiphosphatase inhibitor": 2588,
    "Dopachrome isomerase inhibitor": 2589,
    "Dopamine D1 agonist": 2590,
    "Dopamine D1 antagonist": 2591,
    "Dopamine D1A antagonist": 2592,
    "Dopamine D1B antagonist": 2593,
    "Dopamine D2 agonist": 2594,
    "Dopamine D2 agonist inducer": 2595,
    "Dopamine D2 antagonist": 2596,
    "Dopamine D2A antagonist": 2597,
    "Dopamine D2B antagonist": 2598,
    "Dopamine D2L antagonist": 2599,
    "Dopamine D2S antagonist": 2600,
    "Dopamine D3 agonist": 2601,
    "Dopamine D3 antagonist": 2602,
    "Dopamine D4 agonist": 2603,
    "Dopamine D4 antagonist": 2604,
    "Dopamine D5 agonist": 2605,
    "Dopamine D5 antagonist": 2606,
    "Dopamine agonist": 2607,
    "Dopamine antagonist": 2608,
    "Dopamine autoreceptor agonist": 2609,
    "Dopamine beta hydroxylase inhibitor": 2610,
    "Dopamine precursors": 2611,
    "Dopamine release inhibitor": 2612,
    "Dopamine release stimulant": 2613,
    "Dopamine transporter inhibitor": 2614,
    "Dopamine uptake inhibitor": 2615,
    "Drowsiness": 2616,
    "Drug dependence treatment": 2617,
    "Drug eruption": 2618,
    "Dry eye": 2619,
    "Dry eye syndrome treatment": 2620,
    "Dual specificity phosphatase 1 inhibitor": 2621,
    "Dual specificity phosphatase 22 inhibitor": 2622,
    "Dual specificity phosphatase 3 inhibitor": 2623,
    "Dual specificity phosphatase 6 inhibitor": 2624,
    "Dual specificity phosphatase inhibitor": 2625,
    "Dual specificity protein phosphatase VHR inhibitor": 2626,
    "Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor": 2627,
    "Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor": 2628,
    "Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor": 2629,
    "Dual-specificity tyrosine-phosphorylation regulated kinase 2 inhibitor": 2630,
    "Dual-specificity tyrosine-phosphorylation regulated kinase 3 inhibitor": 2631,
    "Dynamin GTPase inhibitor": 2632,
    "Dynamin-1 inhibitor": 2633,
    "Dynamin-2 inhibitor": 2634,
    "Dynein ATPase inhibitor": 2635,
    "Dyrk kinase inhibitor": 2636,
    "Dysarthria": 2637,
    "Dyskinesia": 2638,
    "Dysmenorrhea treatment": 2639,
    "Dyspepsia": 2640,
    "Dyspepsia treatment": 2641,
    "Dysphagia": 2642,
    "Dysphoria": 2643,
    "Dyspnea": 2644,
    "Dystonia": 2645,
    "Dysuria": 2646,
    "E2F1 expression enhancer": 2647,
    "E2F1 expression inhibitor": 2648,
    "E2F8 expression inhibitor": 2649,
    "EBAG9 expression enhancer": 2650,
    "EBP expression enhancer": 2651,
    "ECE1 expression enhancer": 2652,
    "ECT2 expression enhancer": 2653,
    "ECT2 expression inhibitor": 2654,
    "EDN1 expression enhancer": 2655,
    "EDN1 expression inhibitor": 2656,
    "EDNRB expression enhancer": 2657,
    "EEF1A2 expression enhancer": 2658,
    "EFHD1 expression inhibitor": 2659,
    "EFNA1 expression inhibitor": 2660,
    "EFNB2 expression inhibitor": 2661,
    "EGFR expression enhancer": 2662,
    "EGFR expression inhibitor": 2663,
    "EGLN3 expression enhancer": 2664,
    "EGR1 expression enhancer": 2665,
    "EGR1 expression inhibitor": 2666,
    "EGR3 expression enhancer": 2667,
    "EGR3 expression inhibitor": 2668,
    "EHD1 expression enhancer": 2669,
    "EI24 expression enhancer": 2670,
    "EID1 expression enhancer": 2671,
    "EIF2B4 expression enhancer": 2672,
    "EIF2S1 expression enhancer": 2673,
    "EIF2S1 expression inhibitor": 2674,
    "EIF3B expression inhibitor": 2675,
    "EIF3D expression inhibitor": 2676,
    "EIF4A1 expression inhibitor": 2677,
    "EIF4A2 expression inhibitor": 2678,
    "EIF4E expression inhibitor": 2679,
    "EIF4EBP2 expression inhibitor": 2680,
    "EIF4G2 expression inhibitor": 2681,
    "EIF5 expression enhancer": 2682,
    "EIF5A expression inhibitor": 2683,
    "ELAVL1 expression enhancer": 2684,
    "ELF3 expression enhancer": 2685,
    "ELL2 expression enhancer": 2686,
    "ELOVL5 expression inhibitor": 2687,
    "ELOVL6 expression enhancer": 2688,
    "EML4 expression inhibitor": 2689,
    "EMP1 expression enhancer": 2690,
    "EMP2 expression enhancer": 2691,
    "ENC1 expression enhancer": 2692,
    "ENC1 expression inhibitor": 2693,
    "ENO1 expression enhancer": 2694,
    "ENO1 expression inhibitor": 2695,
    "ENO2 expression inhibitor": 2696,
    "ENO3 expression inhibitor": 2697,
    "ENTPD1 expression enhancer": 2698,
    "ENTPD5 expression inhibitor": 2699,
    "EP300 expression enhancer": 2700,
    "EP300 expression inhibitor": 2701,
    "EPB41L2 expression enhancer": 2702,
    "EPB41L2 expression inhibitor": 2703,
    "EPHA3 expression inhibitor": 2704,
    "EPHB4 expression inhibitor": 2705,
    "EPHX1 expression enhancer": 2706,
    "EPM2AIP1 expression enhancer": 2707,
    "EPO expression enhancer": 2708,
    "EPRS expression inhibitor": 2709,
    "EPS15 expression inhibitor": 2710,
    "ER mannosyl-oligosaccharide 1,2-alpha-mannosidase inhibitor": 2711,
    "ERBB2 expression enhancer": 2712,
    "ERBB2 expression inhibitor": 2713,
    "ERBB3 expression inhibitor": 2714,
    "ERBB4 expression inhibitor": 2715,
    "ERCC2 expression inhibitor": 2716,
    "ERCC3 expression enhancer": 2717,
    "EREG expression enhancer": 2718,
    "ERMP1 expression enhancer": 2719,
    "ERP27 expression inhibitor": 2720,
    "ESD expression enhancer": 2721,
    "ESPN expression enhancer": 2722,
    "ESR1 expression enhancer": 2723,
    "ESR1 expression inhibitor": 2724,
    "ESR2 expression enhancer": 2725,
    "ESR2 expression inhibitor": 2726,
    "ESRRA expression enhancer": 2727,
    "ETFB expression inhibitor": 2728,
    "ETNK2 expression enhancer": 2729,
    "ETS1 expression inhibitor": 2730,
    "ETS2 expression inhibitor": 2731,
    "ETV5 expression inhibitor": 2732,
    "EVI2A expression enhancer": 2733,
    "EVI5 expression enhancer": 2734,
    "EXT1 expression inhibitor": 2735,
    "EZH1 expression enhancer": 2736,
    "EZR expression enhancer": 2737,
    "EZR expression inhibitor": 2738,
    "Ecdysone 20-monooxygenase inhibitor": 2739,
    "Ecdysone receptor agonist": 2740,
    "Ecdysone receptor antagonist": 2741,
    "Ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitor": 2742,
    "Ectopic pregnancy": 2743,
    "Ectropion": 2744,
    "Edema": 2745,
    "Egl nine homolog 1 inhibitor": 2746,
    "Egl nine homolog 2 inhibitor": 2747,
    "Egl nine homolog 3 inhibitor": 2748,
    "Eicosanoid agonist": 2749,
    "Elastase 1 inhibitor": 2750,
    "Elastase 2 inhibitor": 2751,
    "Elastase 2A inhibitor": 2752,
    "Elastase 2B inhibitor": 2753,
    "Elastase 3A inhibitor": 2754,
    "Elastase 3B inhibitor": 2755,
    "Elastase inhibitor": 2756,
    "Electrolyte absorption agonist": 2757,
    "Electrolyte absorption antagonist": 2758,
    "Electrolyte imbalance": 2759,
    "Electron transport complex I inhibitor": 2760,
    "Electron-transferring-flavoprotein dehydrogenase inhibitor": 2761,
    "Elongation of very long chain fatty acids protein 3 inhibitor": 2762,
    "Elongation of very long chain fatty acids protein 6 inhibitor": 2763,
    "Embryotoxic": 2764,
    "Emetic": 2765,
    "Encephalitis": 2766,
    "Endo-1,3(4)-beta-glucanase inhibitor": 2767,
    "Endo-1,4-beta-xylanase inhibitor": 2768,
    "Endo-beta-N-acetylglucosaminidase inhibitor": 2769,
    "Endocannabinoid uptake inhibitor": 2770,
    "Endocrine disorders treatment": 2771,
    "Endocrine disruptor": 2772,
    "Endoglycosylceramidase inhibitor": 2773,
    "Endometrios treatment": 2774,
    "Endonuclease (influenza) inhibitor": 2775,
    "Endopeptidase La inhibitor": 2776,
    "Endopeptidase So inhibitor": 2777,
    "Endopeptidase inhibitor": 2778,
    "Endothelial growth factor antagonist": 2779,
    "Endothelial lipase inhibitor": 2780,
    "Endothelial nitric-oxide synthase inhibitor": 2781,
    "Endothelin A receptor antagonist": 2782,
    "Endothelin B receptor antagonist": 2783,
    "Endothelin converting enzyme 1 inhibitor": 2784,
    "Endothelin receptor agonist": 2785,
    "Endothelin receptor antagonist": 2786,
    "Endothelin-converting enzyme 1 inhibitor": 2787,
    "Endothelin-converting enzyme inhibitor": 2788,
    "Endothiapepsin inhibitor": 2789,
    "Enoyl-CoA hydratase inhibitor": 2790,
    "Enoyl-[acyl-carrier-protein] reductase (NADH) inhibitor": 2791,
    "Enoyl-[acyl-carrier-protein] reductase inhibitor": 2792,
    "Enterocolitis": 2793,
    "Enteropeptidase inhibitor": 2794,
    "Enuresis": 2795,
    "Envelope glycoprotein gp160 inhibitor": 2796,
    "Envelope glycoprotein gp70 inhibitor": 2797,
    "Envelysin inhibitor": 2798,
    "Eosinophilia": 2799,
    "EphA1 antagonist": 2800,
    "EphA2 antagonist": 2801,
    "EphA3 antagonist": 2802,
    "EphA4 antagonist": 2803,
    "EphA5 antagonist": 2804,
    "EphA6 antagonist": 2805,
    "EphA8 antagonist": 2806,
    "EphB1 antagonist": 2807,
    "EphB2 antagonist": 2808,
    "EphB2 kinase inhibitor": 2809,
    "EphB3 antagonist": 2810,
    "EphB4 antagonist": 2811,
    "Ephrin antagonist": 2812,
    "Epidermal growth factor antagonist": 2813,
    "Epidermal growth factor receptor kinase inhibitor": 2814,
    "Epididymis-specific alpha-mannosidase inhibitor": 2815,
    "Epilepsy": 2816,
    "Epistaxis": 2817,
    "Epithelial discoidin domain-containing receptor 1 inhibitor": 2818,
    "Epithelial sodium channel blocker": 2819,
    "Epoxide hydrolase 1 inhibitor": 2820,
    "Epoxide hydrolase 2 inhibitor": 2821,
    "Epoxide hydrolase inhibitor": 2822,
    "Epoxide hydrolase substrate": 2823,
    "Epstein-Barr nuclear antigen 1 inhibitor": 2824,
    "Equilibrative nucleoside transport protein 1 inhibitor": 2825,
    "Equilibrative nucleoside transport protein inhibitor": 2826,
    "ErbB antagonist": 2827,
    "ErbB-1 antagonist": 2828,
    "ErbB-2 antagonist": 2829,
    "ErbB-2 expression inhibitor": 2830,
    "ErbB-3 antagonist": 2831,
    "ErbB-4 antagonist": 2832,
    "Erectile dysfunction": 2833,
    "Erectile dysfunction treatment": 2834,
    "Erythema": 2835,
    "Erythema multiforme": 2836,
    "Erythro-3-hydroxyaspartate ammonia-lyase inhibitor": 2837,
    "Erythropoiesis stimulant": 2838,
    "Erythropoietin receptor agonist": 2839,
    "Erythropoietin receptor antagonist": 2840,
    "Estradiol 17 beta dehydrogenase 2 inhibitor": 2841,
    "Estradiol 17 beta dehydrogenase 3 inhibitor": 2842,
    "Estradiol 17 beta dehydrogenase inhibitor": 2843,
    "Estradiol 17 beta dehydrogenase stimulant": 2844,
    "Estradiol 17 beta-dehydrogenase 1 inhibitor": 2845,
    "Estradiol 17alpha-dehydrogenase inhibitor": 2846,
    "Estrogen agonist": 2847,
    "Estrogen alpha receptor agonist": 2848,
    "Estrogen antagonist": 2849,
    "Estrogen beta receptor agonist": 2850,
    "Estrogen receptor alpha antagonist": 2851,
    "Estrogen receptor beta antagonist": 2852,
    "Estrogen-related receptor alpha agonist": 2853,
    "Estrogen-related receptor alpha antagonist": 2854,
    "Estrogen-related receptor beta antagonist": 2855,
    "Estrogen-related receptor gamma agonist": 2856,
    "Estrogen-related receptor gamma antagonist": 2857,
    "Estrone sulfatase inhibitor": 2858,
    "Estrone sulfotransferase inhibitor": 2859,
    "Estrone sulfotransferase stimulant": 2860,
    "Ethanolamine ammonia-lyase inhibitor": 2861,
    "Ethanolamine kinase inhibitor": 2862,
    "Ethanolamine oxidase inhibitor": 2863,
    "Ethanolamine-phosphate cytidylyltransferase inhibitor": 2864,
    "Ethanolaminephosphotransferase inhibitor": 2865,
    "Ether-a-go-go potassium channel 1 blocker": 2866,
    "Ether-a-go-go potassium channel blocker": 2867,
    "Euglycemic": 2868,
    "Eukaryotic elongation factor 2 kinase inhibitor": 2869,
    "Eukaryotic translation initiation factor 2-alpha kinase 3 inhibitor": 2870,
    "Eukaryotic translation initiation factor 4 gamma 1 inhibitor": 2871,
    "Eukaryotic translation initiation factor 4E inhibitor": 2872,
    "Eukaryotic translation initiation factor 4H inhibitor": 2873,
    "Eukaryotic translation initiation factor inhibitor": 2874,
    "Euphoria": 2875,
    "Exanthema": 2876,
    "Excitability": 2877,
    "Excitatory amino acid transporter 1 inhibitor": 2878,
    "Excitatory amino acid transporter 2 inhibitor": 2879,
    "Excitatory amino acid transporter 3 inhibitor": 2880,
    "Excitatory amino acid transporter EAAC1 inhibitor": 2881,
    "Exoenzyme S synthesis regulatory protein exsA inhibitor": 2882,
    "Exoribonuclease II inhibitor": 2883,
    "Expectorant": 2884,
    "Extrapyramidal disorders treatment": 2885,
    "Extrapyramidal effect": 2886,
    "Extravasation": 2887,
    "Eye irritation, high": 2888,
    "Eye irritation, inactive": 2889,
    "Eye irritation, moderate": 2890,
    "Eye irritation, weak": 2891,
    "Eye pain": 2892,
    "Eyelash growth": 2893,
    "F2R expression enhancer": 2894,
    "F2R expression inhibitor": 2895,
    "F3 expression enhancer": 2896,
    "FABP1 expression enhancer": 2897,
    "FABP4 expression enhancer": 2898,
    "FABP5 expression inhibitor": 2899,
    "FAD diphosphatase inhibitor": 2900,
    "FADD expression enhancer": 2901,
    "FADS1 expression enhancer": 2902,
    "FAH expression enhancer": 2903,
    "FAM105A expression enhancer": 2904,
    "FAM107A expression inhibitor": 2905,
    "FAM129A expression inhibitor": 2906,
    "FAM129B expression inhibitor": 2907,
    "FAM208A expression inhibitor": 2908,
    "FAM3C expression enhancer": 2909,
    "FAM49A expression enhancer": 2910,
    "FANCC expression inhibitor": 2911,
    "FANCI expression enhancer": 2912,
    "FARS2 expression inhibitor": 2913,
    "FAS expression enhancer": 2914,
    "FAS expression inhibitor": 2915,
    "FASLG expression enhancer": 2916,
    "FASN expression enhancer": 2917,
    "FASN expression inhibitor": 2918,
    "FASTK expression inhibitor": 2919,
    "FBLN1 expression enhancer": 2920,
    "FBP1 expression inhibitor": 2921,
    "FBXO5 expression enhancer": 2922,
    "FDFT1 expression enhancer": 2923,
    "FDXR expression enhancer": 2924,
    "FEN1 expression inhibitor": 2925,
    "FGA expression inhibitor": 2926,
    "FGF1 expression inhibitor": 2927,
    "FGF2 expression inhibitor": 2928,
    "FGF5 expression inhibitor": 2929,
    "FGF9 expression enhancer": 2930,
    "FGFR1 expression enhancer": 2931,
    "FGFR1 expression inhibitor": 2932,
    "FGFR2 expression enhancer": 2933,
    "FGFR3 expression inhibitor": 2934,
    "FGG expression inhibitor": 2935,
    "FILIP1L expression enhancer": 2936,
    "FKBP14 expression inhibitor": 2937,
    "FKBP1A expression enhancer": 2938,
    "FKBP5 expression enhancer": 2939,
    "FKBP5 expression inhibitor": 2940,
    "FKBP8 expression inhibitor": 2941,
    "FLNA expression enhancer": 2942,
    "FLNC expression inhibitor": 2943,
    "FLOT1 expression enhancer": 2944,
    "FLT1 expression inhibitor": 2945,
    "FMN adenylyltransferase inhibitor": 2946,
    "FMN reductase inhibitor": 2947,
    "FMO1 substrate": 2948,
    "FMO3 substrate": 2949,
    "FMO5 expression inhibitor": 2950,
    "FN1 expression enhancer": 2951,
    "FN1 expression inhibitor": 2952,
    "FNBP1 expression inhibitor": 2953,
    "FNDC3B expression inhibitor": 2954,
    "FNDC4 expression enhancer": 2955,
    "FOLH1 expression inhibitor": 2956,
    "FOLR1 expression inhibitor": 2957,
    "FOS expression enhancer": 2958,
    "FOS expression inhibitor": 2959,
    "FOSB expression enhancer": 2960,
    "FOSL1 expression enhancer": 2961,
    "FOSL2 expression inhibitor": 2962,
    "FOXA1 expression enhancer": 2963,
    "FOXC1 expression enhancer": 2964,
    "FOXD1 expression enhancer": 2965,
    "FOXD1 expression inhibitor": 2966,
    "FOXJ1 expression inhibitor": 2967,
    "FOXM1 expression inhibitor": 2968,
    "FOXN3 expression inhibitor": 2969,
    "FOXO1 expression enhancer": 2970,
    "FSHB expression inhibitor": 2971,
    "FST expression enhancer": 2972,
    "FTH1 expression enhancer": 2973,
    "FTH1 expression inhibitor": 2974,
    "FTL expression enhancer": 2975,
    "FUBP1 expression inhibitor": 2976,
    "FUS expression inhibitor": 2977,
    "FXR1 expression inhibitor": 2978,
    "FYTTD1 expression inhibitor": 2979,
    "Factor III inhibitor": 2980,
    "Factor IX inhibitor": 2981,
    "Factor IXa inhibitor": 2982,
    "Factor V inhibitor": 2983,
    "Factor VII inhibitor": 2984,
    "Factor VIIa inhibitor": 2985,
    "Factor X inhibitor": 2986,
    "Factor XI inhibitor": 2987,
    "Factor XII inhibitor": 2988,
    "Factor XIII inhibitor": 2989,
    "Factor XIIIa inhibitor": 2990,
    "Factor XIIIa stimulant": 2991,
    "Factor XIa inhibitor": 2992,
    "Factor Xa inhibitor": 2993,
    "Falcipain 2 inhibitor": 2994,
    "Falcipain 3 inhibitor": 2995,
    "Falcipain inhibitor": 2996,
    "Fanconi syndrome": 2997,
    "Farnesoid X receptor agonist": 2998,
    "Farnesoid X receptor antagonist": 2999,
    "Farnesyltransferase inhibitor": 3000,
    "Farnesyltransferase, putative inhibitor": 3001,
    "Farnesyltranstransferase inhibitor": 3002,
    "Fas antagonist": 3003,
    "Fasciculation": 3004,
    "Fatty acid binding protein adipocyte inhibitor": 3005,
    "Fatty acid binding protein epidermal inhibitor": 3006,
    "Fatty acid binding protein inhibitor": 3007,
    "Fatty acid binding protein muscle inhibitor": 3008,
    "Fatty acid elongase inhibitor": 3009,
    "Fatty acid oxidation inhibitor": 3010,
    "Fatty acid synthase inhibitor": 3011,
    "Fatty acid transport protein 4 inhibitor": 3012,
    "Fatty liver": 3013,
    "Fatty-acyl-CoA synthase inhibitor": 3014,
    "Fatty-acyl-ethyl-ester synthase inhibitor": 3015,
    "Female germline-specific tumor suppressor gld-1 inhibitor": 3016,
    "Female sexual dysfunction treatment": 3017,
    "Ferredoxin hydrogenase inhibitor": 3018,
    "Ferredoxin-NAD+ reductase inhibitor": 3019,
    "Ferredoxin-NADP+ reductase inhibitor": 3020,
    "Ferredoxin-nitrite reductase inhibitor": 3021,
    "Ferriprotoporphyrin IX inhibitor": 3022,
    "Ferrochelatase inhibitor": 3023,
    "Ferroxidase inhibitor": 3024,
    "Feruloyl esterase inhibitor": 3025,
    "Fibrillation, atrial": 3026,
    "Fibrillation, ventricular": 3027,
    "Fibrinogen alpha chain inhibitor": 3028,
    "Fibrinogen beta chain inhibitor": 3029,
    "Fibrinogen gamma chain inhibitor": 3030,
    "Fibrinogen inhibitor": 3031,
    "Fibrinogen receptor antagonist": 3032,
    "Fibrinolytic": 3033,
    "Fibroblast activation protein alpha inhibitor": 3034,
    "Fibroblast growth factor 1 agonist": 3035,
    "Fibroblast growth factor 1 antagonist": 3036,
    "Fibroblast growth factor 2 antagonist": 3037,
    "Fibroblast growth factor 3 antagonist": 3038,
    "Fibroblast growth factor 4 antagonist": 3039,
    "Fibroblast growth factor agonist": 3040,
    "Fibroblast growth factor antagonist": 3041,
    "Fibrolase inhibitor": 3042,
    "Fibromyalgia syndrome treatment": 3043,
    "Fibronectin-binding protein C inhibitor": 3044,
    "Fibrosis": 3045,
    "Fibrosis treatment": 3046,
    "Fibrosis, focal": 3047,
    "Fibrosis, interstitial": 3048,
    "Flap endonuclease 1 inhibitor": 3049,
    "Flatulence": 3050,
    "Flavin-containing monooxygenase inhibitor": 3051,
    "Flavin-containing monooxygenase substrate": 3052,
    "Flavonoid 3'-monooxygenase inhibitor": 3053,
    "Fluid retention": 3054,
    "Flushing": 3055,
    "Focal adhesion kinase 1 inhibitor": 3056,
    "Focal adhesion kinase 2 inhibitor": 3057,
    "Focal adhesion kinase inhibitor": 3058,
    "Folate antagonist": 3059,
    "Folate deficiency": 3060,
    "Folate transporter 1 inhibitor": 3061,
    "Follicle-stimulating hormone agonist": 3062,
    "Follicle-stimulating hormone antagonist": 3063,
    "Folylpolyglutamate synthase inhibitor": 3064,
    "Formaldehyde dehydrogenase (glutathione) inhibitor": 3065,
    "Formaldehyde dehydrogenase inhibitor": 3066,
    "Formaldehyde transketolase inhibitor": 3067,
    "Formate C-acetyltransferase inhibitor": 3068,
    "Formate dehydrogenase inhibitor": 3069,
    "Formate-dihydrofolate ligase inhibitor": 3070,
    "Formimidoylglutamase inhibitor": 3071,
    "Formimidoyltetrahydrofolate cyclodeaminase inhibitor": 3072,
    "Formyl peptide receptor 1 antagonist": 3073,
    "Formyl peptide receptor antagonist": 3074,
    "Formyltetrahydrofolate dehydrogenase inhibitor": 3075,
    "Fragilysin inhibitor": 3076,
    "Free fatty acid receptor 1 agonist": 3077,
    "Free fatty acid receptor 1 antagonist": 3078,
    "Free radical scavenger": 3079,
    "Fructan beta-fructosidase inhibitor": 3080,
    "Fructokinase inhibitor": 3081,
    "Fructose 5-dehydrogenase (NADP+) inhibitor": 3082,
    "Fructose 5-dehydrogenase inhibitor": 3083,
    "Fructose-1,6-bisphosphatase 1 inhibitor": 3084,
    "Fructose-1,6-bisphosphatase 2 inhibitor": 3085,
    "Fructose-1,6-bisphosphatase inhibitor": 3086,
    "Fructose-2,6-bisphosphate 2-phosphatase inhibitor": 3087,
    "Fructose-2,6-bisphosphate 6-phosphatase inhibitor": 3088,
    "Fructose-bisphosphate aldolase A inhibitor": 3089,
    "Fructose-bisphosphate aldolase inhibitor": 3090,
    "Fructuronate reductase inhibitor": 3091,
    "FtsZ polymerization inhibitor": 3092,
    "Fucokinase inhibitor": 3093,
    "Fucosterol-epoxide lyase inhibitor": 3094,
    "Fumarate hydratase inhibitor": 3095,
    "Fumarate reductase (NADH) inhibitor": 3096,
    "Fumarylacetoacetase inhibitor": 3097,
    "Furin inhibitor": 3098,
    "Fusarinine-C ornithinesterase inhibitor": 3099,
    "Fusion protein inhibitor": 3100,
    "G protein-coupled receptor 7 antagonist": 3101,
    "G protein-coupled receptor agonist": 3102,
    "G protein-coupled receptor antagonist": 3103,
    "G-protein coupled bile acid receptor 1 antagonist": 3104,
    "G-protein coupled receptor 35 agonist": 3105,
    "G-protein coupled receptor 35 antagonist": 3106,
    "G-protein coupled receptor 55 agonist": 3107,
    "G-protein coupled receptor 55 antagonist": 3108,
    "G-protein-coupled bile acid receptor 1 agonist": 3109,
    "G-protein-coupled receptor 120 agonist": 3110,
    "G-protein-coupled receptor kinase 2 inhibitor": 3111,
    "G-protein-coupled receptor kinase 3 inhibitor": 3112,
    "G-protein-coupled receptor kinase 5 inhibitor": 3113,
    "G-protein-coupled receptor kinase 6 inhibitor": 3114,
    "G-protein-coupled receptor kinase 7 inhibitor": 3115,
    "G-protein-coupled receptor kinase inhibitor": 3116,
    "G0S2 expression enhancer": 3117,
    "G6PD expression enhancer": 3118,
    "GAA expression enhancer": 3119,
    "GABA A inverse agonist": 3120,
    "GABA A receptor agonist": 3121,
    "GABA A receptor antagonist": 3122,
    "GABA B receptor agonist": 3123,
    "GABA B receptor antagonist": 3124,
    "GABA C receptor agonist": 3125,
    "GABA C receptor antagonist": 3126,
    "GABA C receptor rho-1 antagonist": 3127,
    "GABA C receptor rho-2 antagonist": 3128,
    "GABA C receptor rho-3 antagonist": 3129,
    "GABA aminotransferase inhibitor": 3130,
    "GABA inverse agonist": 3131,
    "GABA receptor agonist": 3132,
    "GABA receptor antagonist": 3133,
    "GABA transporter 1 inhibitor": 3134,
    "GABA transporter 2 inhibitor": 3135,
    "GABA transporter 3 inhibitor": 3136,
    "GABA transporter inhibitor": 3137,
    "GABA uptake inhibitor": 3138,
    "GABARAPL3 expression enhancer": 3139,
    "GABRE expression enhancer": 3140,
    "GADD45A expression enhancer": 3141,
    "GADD45B expression enhancer": 3142,
    "GAK expression inhibitor": 3143,
    "GALNT1 expression inhibitor": 3144,
    "GALNT4 expression enhancer": 3145,
    "GALR2 expression enhancer": 3146,
    "GALR2 expression inhibitor": 3147,
    "GAPDH expression enhancer": 3148,
    "GARS expression inhibitor": 3149,
    "GAS1 expression inhibitor": 3150,
    "GAS6 expression enhancer": 3151,
    "GAS6 expression inhibitor": 3152,
    "GATA1 expression enhancer": 3153,
    "GATA2 expression enhancer": 3154,
    "GATA3 expression enhancer": 3155,
    "GATA3 expression inhibitor": 3156,
    "GATA6 expression enhancer": 3157,
    "GBP1 expression enhancer": 3158,
    "GBP1 expression inhibitor": 3159,
    "GCLC expression enhancer": 3160,
    "GCLM expression enhancer": 3161,
    "GCNT3 expression enhancer": 3162,
    "GDF1 expression enhancer": 3163,
    "GDF15 expression enhancer": 3164,
    "GDP-L-fucose synthase inhibitor": 3165,
    "GDP-mannose 4,6-dehydratase inhibitor": 3166,
    "GDP-mannose 6-dehydrogenase inhibitor": 3167,
    "GDPD3 expression enhancer": 3168,
    "GDPD5 expression enhancer": 3169,
    "GFOD1 expression inhibitor": 3170,
    "GFPT2 expression enhancer": 3171,
    "GFRA1 expression enhancer": 3172,
    "GGH expression enhancer": 3173,
    "GHS receptor agonist": 3174,
    "GHS receptor antagonist": 3175,
    "GINS1 expression enhancer": 3176,
    "GINS2 expression enhancer": 3177,
    "GJA1 expression enhancer": 3178,
    "GJA1 expression inhibitor": 3179,
    "GJA4 expression inhibitor": 3180,
    "GLG1 expression inhibitor": 3181,
    "GLIS2 expression inhibitor": 3182,
    "GLRX2 expression enhancer": 3183,
    "GLUL expression enhancer": 3184,
    "GMNN expression enhancer": 3185,
    "GMP reductase inhibitor": 3186,
    "GMP synthase inhibitor": 3187,
    "GNA11 expression inhibitor": 3188,
    "GNAS expression inhibitor": 3189,
    "GNG11 expression enhancer": 3190,
    "GNL3 expression inhibitor": 3191,
    "GNPDA1 expression inhibitor": 3192,
    "GP IIb/IIIa receptor antagonist": 3193,
    "GP120env antagonist": 3194,
    "GPI expression enhancer": 3195,
    "GPR142 expression enhancer": 3196,
    "GPRC5A expression enhancer": 3197,
    "GPRC5A expression inhibitor": 3198,
    "GPRC5C expression enhancer": 3199,
    "GPX1 expression enhancer": 3200,
    "GPX2 expression enhancer": 3201,
    "GPX3 expression enhancer": 3202,
    "GRB2 expression enhancer": 3203,
    "GRB2 expression inhibitor": 3204,
    "GRB7 expression inhibitor": 3205,
    "GREB1 expression enhancer": 3206,
    "GRHL1 expression enhancer": 3207,
    "GRN expression enhancer": 3208,
    "GRP78 expression inhibitor": 3209,
    "GSK3B expression inhibitor": 3210,
    "GSN expression enhancer": 3211,
    "GSS expression inhibitor": 3212,
    "GST A substrate": 3213,
    "GST M substrate": 3214,
    "GST M1-1 substrate": 3215,
    "GST P substrate": 3216,
    "GST P1-1 substrate": 3217,
    "GST T substrate": 3218,
    "GST T1-1 substrate": 3219,
    "GSTA1 expression enhancer": 3220,
    "GSTA1 expression inhibitor": 3221,
    "GSTA4 expression enhancer": 3222,
    "GSTK1 expression inhibitor": 3223,
    "GSTM1 expression enhancer": 3224,
    "GSTM1 expression inhibitor": 3225,
    "GSTM2 expression inhibitor": 3226,
    "GSTM3 expression enhancer": 3227,
    "GSTM4 expression inhibitor": 3228,
    "GSTO1 expression inhibitor": 3229,
    "GSTP1 expression enhancer": 3230,
    "GSTP1 expression inhibitor": 3231,
    "GTF2F1 expression inhibitor": 3232,
    "GTF2H3 expression inhibitor": 3233,
    "GTF2IRD1 expression inhibitor": 3234,
    "GTF3C4 expression enhancer": 3235,
    "GTP cyclohydrolase I inhibitor": 3236,
    "GTP cyclohydrolase IIa inhibitor": 3237,
    "GUCY1B3 expression enhancer": 3238,
    "GULP1 expression inhibitor": 3239,
    "GUSB expression enhancer": 3240,
    "Gait disturbance": 3241,
    "Galactokinase inhibitor": 3242,
    "Galactolipase inhibitor": 3243,
    "Galactorrhea": 3244,
    "Galactose 1-dehydrogenase (NADP+) inhibitor": 3245,
    "Galactose oxidase inhibitor": 3246,
    "Galactoside 2-alpha-L-fucosyltransferase inhibitor": 3247,
    "Galactoside O-acetyltransferase inhibitor": 3248,
    "Galactosylceramidase inhibitor": 3249,
    "Galactosylceramide sulfotransferase inhibitor": 3250,
    "Galactosylgalactosylglucosylceramidase inhibitor": 3251,
    "Galacturan 1,4-alpha-galacturonidase inhibitor": 3252,
    "Galanin receptor 1 antagonist": 3253,
    "Galanin receptor 2 antagonist": 3254,
    "Galanin receptor 3 antagonist": 3255,
    "Galanin receptor antagonist": 3256,
    "Galectin 3 antagonist": 3257,
    "Gallate decarboxylase inhibitor": 3258,
    "Gametolysin inhibitor": 3259,
    "Gamma-D-Glutamyl-meso-diaminopimelate peptidase inhibitor": 3260,
    "Gamma-butyrobetaine dioxygenase inhibitor": 3261,
    "Gamma-glutamyl hydrolase inhibitor": 3262,
    "Gamma-glutamylcysteine synthetase inhibitor": 3263,
    "Gamma-glutamyltransferase inhibitor": 3264,
    "Gamma-guanidinobutyraldehyde dehydrogenase inhibitor": 3265,
    "Gamma-renin inhibitor": 3266,
    "Gamma-secretase subunit APH-1A inhibitor": 3267,
    "Gamma-secretase subunit APH-1B inhibitor": 3268,
    "Gamma-secretase subunit PEN-2 inhibitor": 3269,
    "Ganglioside galactosyltransferase inhibitor": 3270,
    "Gangrene": 3271,
    "Gastric antisecretory": 3272,
    "Gastric emptying disorders treatment": 3273,
    "Gastric emptying impairment": 3274,
    "Gastric inhibitory polypeptide receptor antagonist": 3275,
    "Gastric secretion stimulant": 3276,
    "Gastricsin inhibitor": 3277,
    "Gastrin inhibitor": 3278,
    "Gastrin-releasing peptide antagonist": 3279,
    "Gastritis treatment": 3280,
    "Gastroesophageal reflux disease treatment": 3281,
    "Gastrointestinal disorders treatment": 3282,
    "Gastrointestinal disturbance": 3283,
    "Gastrointestinal hemorrhage": 3284,
    "Gastrointestinal motility stimulant": 3285,
    "Gastroprotector": 3286,
    "Gaucher disease treatment": 3287,
    "Gelatinase inhibitor": 3288,
    "Gene expression stimulant": 3289,
    "General pump inhibitor": 3290,
    "Genotoxic": 3291,
    "Gentamicin 2''-nucleotidyltransferase inhibitor": 3292,
    "Gentamicin 3'-N-acetyltransferase inhibitor": 3293,
    "Gentisate 1,2-dioxygenase inhibitor": 3294,
    "Geranylgeranyl-diphosphate geranylgeranyltransferase inhibitor": 3295,
    "Geranylgeranyltransferase I inhibitor": 3296,
    "Geranylgeranyltransferase inhibitor": 3297,
    "Geranyltranstransferase (Leishmania) inhibitor": 3298,
    "Geranyltranstransferase inhibitor": 3299,
    "Gestagen antagonist": 3300,
    "Gestagen-like": 3301,
    "Giant cell myocarditis": 3302,
    "Gingipain K inhibitor": 3303,
    "Gingipain R inhibitor": 3304,
    "Gingival hyperplasia": 3305,
    "Glaucoma": 3306,
    "Globoside alpha-N-acetylgalactosaminyltransferase inhibitor": 3307,
    "Glucagon agonist": 3308,
    "Glucagon receptor antagonist": 3309,
    "Glucagon-like peptide 1 agonist": 3310,
    "Glucagon-like peptide 1 receptor antagonist": 3311,
    "Glucan 1,3-alpha-glucosidase inhibitor": 3312,
    "Glucan 1,3-beta-glucosidase inhibitor": 3313,
    "Glucan 1,4-alpha-glucosidase inhibitor": 3314,
    "Glucan 1,4-alpha-maltotetraohydrolase inhibitor": 3315,
    "Glucan 1,4-alpha-maltotriohydrolase inhibitor": 3316,
    "Glucan 1,4-beta-glucosidase inhibitor": 3317,
    "Glucan 1,6-alpha-glucosidase inhibitor": 3318,
    "Glucan endo-1,3-alpha-glucosidase inhibitor": 3319,
    "Glucan endo-1,3-beta-D-glucosidase inhibitor": 3320,
    "Glucan endo-1,6-beta-glucosidase inhibitor": 3321,
    "Glucarate dehydratase inhibitor": 3322,
    "Glucocorticoid agonist": 3323,
    "Glucocorticoid antagonist": 3324,
    "Glucokinase regulatory protein inhibitor": 3325,
    "Gluconate 5-dehydrogenase inhibitor": 3326,
    "Gluconate dehydratase inhibitor": 3327,
    "Gluconokinase inhibitor": 3328,
    "Gluconolactonase inhibitor": 3329,
    "Glucosamine 6-phosphate N-acetyltransferase inhibitor": 3330,
    "Glucosamine N-acetyltransferase inhibitor": 3331,
    "Glucosamine-1-phosphate N-acetyltransferase inhibitor": 3332,
    "Glucosamine-6-phosphate deaminase inhibitor": 3333,
    "Glucose 1-dehydrogenase inhibitor": 3334,
    "Glucose oxidase inhibitor": 3335,
    "Glucose-1,6-bisphosphate synthase inhibitor": 3336,
    "Glucose-1-phosphatase inhibitor": 3337,
    "Glucose-1-phosphate adenylyltransferase inhibitor": 3338,
    "Glucose-1-phosphate cytidylyltransferase inhibitor": 3339,
    "Glucose-6-phosphate dehydrogenase inhibitor": 3340,
    "Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor": 3341,
    "Glucose-6-phosphate isomerase inhibitor": 3342,
    "Glucose-6-phosphate translocase inhibitor": 3343,
    "Glucose-dependent insulinotropic receptor agonist": 3344,
    "Glucose-dependent insulinotropic receptor antagonist": 3345,
    "Glucosyl transferase inhibitor": 3346,
    "Glucosylceramidase inhibitor": 3347,
    "Glucuronate isomerase inhibitor": 3348,
    "Glucuronolactone reductase inhibitor": 3349,
    "Glutamate (mGluR group I) agonist": 3350,
    "Glutamate (mGluR group I) antagonist": 3351,
    "Glutamate (mGluR group II) agonist": 3352,
    "Glutamate (mGluR group II) antagonist": 3353,
    "Glutamate (mGluR group III) agonist": 3354,
    "Glutamate (mGluR group III) antagonist": 3355,
    "Glutamate (mGluR) agonist": 3356,
    "Glutamate (mGluR) antagonist": 3357,
    "Glutamate (mGluR1) agonist": 3358,
    "Glutamate (mGluR1) antagonist": 3359,
    "Glutamate (mGluR1a) agonist": 3360,
    "Glutamate (mGluR1a) antagonist": 3361,
    "Glutamate (mGluR2) agonist": 3362,
    "Glutamate (mGluR2) antagonist": 3363,
    "Glutamate (mGluR3) agonist": 3364,
    "Glutamate (mGluR3) antagonist": 3365,
    "Glutamate (mGluR4) agonist": 3366,
    "Glutamate (mGluR4) antagonist": 3367,
    "Glutamate (mGluR5) agonist": 3368,
    "Glutamate (mGluR5) antagonist": 3369,
    "Glutamate (mGluR5a) agonist": 3370,
    "Glutamate (mGluR6) agonist": 3371,
    "Glutamate (mGluR6) antagonist": 3372,
    "Glutamate (mGluR7) antagonist": 3373,
    "Glutamate (mGluR8) agonist": 3374,
    "Glutamate (mGluR8) antagonist": 3375,
    "Glutamate 5-kinase inhibitor": 3376,
    "Glutamate N-acetyltransferase inhibitor": 3377,
    "Glutamate carboxypeptidase inhibitor": 3378,
    "Glutamate decarboxylase inhibitor": 3379,
    "Glutamate dehydrogenase (NADP+) inhibitor": 3380,
    "Glutamate dehydrogenase [NAD(P)+] inhibitor": 3381,
    "Glutamate dehydrogenase inhibitor": 3382,
    "Glutamate formimidoyltransferase inhibitor": 3383,
    "Glutamate racemase inhibitor": 3384,
    "Glutamate receptor agonist": 3385,
    "Glutamate receptor antagonist": 3386,
    "Glutamate release inhibitor": 3387,
    "Glutamate synthase (NADPH) inhibitor": 3388,
    "Glutamate synthase (ferredoxin) inhibitor": 3389,
    "Glutamate uptake inhibitor": 3390,
    "Glutamate-1-semialdehyde 2,1-aminomutase inhibitor": 3391,
    "Glutamate-5-semialdehyde dehydrogenase inhibitor": 3392,
    "Glutamate-cysteine ligase inhibitor": 3393,
    "Glutamate-tRNA ligase inhibitor": 3394,
    "Glutamin-(asparagin-)ase inhibitor": 3395,
    "Glutaminase inhibitor": 3396,
    "Glutamine synthetase inhibitor": 3397,
    "Glutamine synthetase stimulant": 3398,
    "Glutamine-fructose-6-phosphate transaminase inhibitor": 3399,
    "Glutamine-phenylpyruvate transaminase inhibitor": 3400,
    "Glutamine-pyruvate transaminase inhibitor": 3401,
    "Glutamine-tRNA ligase inhibitor": 3402,
    "Glutaminyl-peptide cyclotransferase inhibitor": 3403,
    "Glutaminyl-tRNA synthase (glutamine-hydrolysing) inhibitor": 3404,
    "Glutamyl endopeptidase II inhibitor": 3405,
    "Glutamyl endopeptidase inhibitor": 3406,
    "Glutamyl-tRNA(Gln) amidotransferase subunit C inhibitor": 3407,
    "Glutarate-semialdehyde dehydrogenase inhibitor": 3408,
    "Glutaryl-CoA dehydrogenase inhibitor": 3409,
    "Glutathione S-transferase A1 inhibitor": 3410,
    "Glutathione S-transferase A2 inhibitor": 3411,
    "Glutathione S-transferase Mu 1 inhibitor": 3412,
    "Glutathione S-transferase P1 inhibitor": 3413,
    "Glutathione S-transferase inhibitor": 3414,
    "Glutathione S-transferase stimulant": 3415,
    "Glutathione S-transferase substrate": 3416,
    "Glutathione dehydrogenase (ascorbate) inhibitor": 3417,
    "Glutathione peroxidase inhibitor": 3418,
    "Glutathione reductase (NADPH) stimulant": 3419,
    "Glutathione reductase inhibitor": 3420,
    "Glutathione reductase stimulant": 3421,
    "Glutathione synthase inhibitor": 3422,
    "Glutathione thiolesterase inhibitor": 3423,
    "Glutathione transferase omega 1 inhibitor": 3424,
    "Glutathione-disulfide reductase inhibitor": 3425,
    "Glutathionylspermidine synthase inhibitor": 3426,
    "Gly-X carboxypeptidase inhibitor": 3427,
    "Glyceraldehyde-3-phosphate dehydrogenase (NADP+) inhibitor": 3428,
    "Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) inhibitor": 3429,
    "Glyceraldehyde-3-phosphate dehydrogenase inhibitor": 3430,
    "Glyceraldehyde-3-phosphate dehydrogenase, cytosolic inhibitor": 3431,
    "Glycerate kinase inhibitor": 3432,
    "Glycerol 2-dehydrogenase (NADP+) inhibitor": 3433,
    "Glycerol dehydratase inhibitor": 3434,
    "Glycerol dehydrogenase (NADP+) inhibitor": 3435,
    "Glycerol dehydrogenase inhibitor": 3436,
    "Glycerol kinase inhibitor": 3437,
    "Glycerol-1,2-cyclic-phosphate 2-phosphodiesterase inhibitor": 3438,
    "Glycerol-1-phosphatase inhibitor": 3439,
    "Glycerol-2-phosphatase inhibitor": 3440,
    "Glycerol-3-phosphate O-acyltransferase inhibitor": 3441,
    "Glycerol-3-phosphate dehydrogenase (NAD+) inhibitor": 3442,
    "Glycerol-3-phosphate dehydrogenase [NAD(P)+] inhibitor": 3443,
    "Glycerol-3-phosphate dehydrogenase inhibitor": 3444,
    "Glycerol-3-phosphate oxidase inhibitor": 3445,
    "Glycerone-phosphate O-acyltransferase inhibitor": 3446,
    "Glycerophosphocholine cholinephosphodiesterase inhibitor": 3447,
    "Glycerophosphocholine phosphodiesterase inhibitor": 3448,
    "Glycerophospholipid arachidonoyl-transferase (CoA-independent) inhibitor": 3449,
    "Glyceryl-ether monooxygenase inhibitor": 3450,
    "Glycine C-acetyltransferase inhibitor": 3451,
    "Glycine N-acyltransferase inhibitor": 3452,
    "Glycine N-benzoyltransferase inhibitor": 3453,
    "Glycine N-choloyltransferase inhibitor": 3454,
    "Glycine N-methyltransferase inhibitor": 3455,
    "Glycine amidinotransferase inhibitor": 3456,
    "Glycine dehydrogenase (cytochrome) inhibitor": 3457,
    "Glycine dehydrogenase (decarboxylating) inhibitor": 3458,
    "Glycine hydroxymethyltransferase inhibitor": 3459,
    "Glycine receptor agonist": 3460,
    "Glycine receptor antagonist": 3461,
    "Glycine transaminase inhibitor": 3462,
    "Glycine transporter 1 inhibitor": 3463,
    "Glycine transporter 2 inhibitor": 3464,
    "Glycine transporter inhibitor": 3465,
    "Glycine-tRNA ligase inhibitor": 3466,
    "Glycogen (starch) synthase inhibitor": 3467,
    "Glycogen debranching enzyme inhibitor": 3468,
    "Glycogen phosphorylase, liver form inhibitor": 3469,
    "Glycogen phosphorylase, muscle form inhibitor": 3470,
    "Glycogen synthase kinase-3 alpha inhibitor": 3471,
    "Glycogen synthase kinase-3 beta inhibitor": 3472,
    "Glycogen synthase kinase-3 inhibitor": 3473,
    "Glycogen synthase stimulant": 3474,
    "Glycogenin glucosyltransferase inhibitor": 3475,
    "Glycolaldehyde dehydrogenase inhibitor": 3476,
    "Glycolate dehydrogenase inhibitor": 3477,
    "Glycolipid 2-alpha-mannosyltransferase inhibitor": 3478,
    "Glycolipid 3-alpha-mannosyltransferase inhibitor": 3479,
    "Glycopeptide alpha-N-acetylgalactosaminidase inhibitor": 3480,
    "Glycoprotein 3-alpha-L-fucosyltransferase inhibitor": 3481,
    "Glycoprotein 6-alpha-L-fucosyltransferase inhibitor": 3482,
    "Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase inhibitor": 3483,
    "Glycosoaminoglycans antagonist": 3484,
    "Glycosuria": 3485,
    "Glycosylceramidase inhibitor": 3486,
    "Glycosylphosphatidylinositol diacylglycerol-lyase inhibitor": 3487,
    "Glycosylphosphatidylinositol phospholipase D inhibitor": 3488,
    "Glyoxylate oxidase inhibitor": 3489,
    "Glyoxylate reductase (NADP+) inhibitor": 3490,
    "Glyoxylate reductase inhibitor": 3491,
    "Gonadotropin antagonist": 3492,
    "Gonadotropin-releasing hormone": 3493,
    "Gonadotropin-releasing hormone receptor agonist": 3494,
    "Gonadotropin-releasing hormone receptor antagonist": 3495,
    "Gout treatment": 3496,
    "Granulocyte colony stimulating factor receptor agonist": 3497,
    "Granulocyte macrophage colony stimulating factor agonist": 3498,
    "Granulocyte macrophage colony stimulating factor antagonist": 3499,
    "Granzyme A inhibitor": 3500,
    "Granzyme B inhibitor": 3501,
    "Growth factor agonist": 3502,
    "Growth factor antagonist": 3503,
    "Growth factor receptor-bound protein 2 antagonist": 3504,
    "Growth hormone agonist": 3505,
    "Growth hormone release inhibitor": 3506,
    "Growth hormone release promoting": 3507,
    "Growth hormone releasing factor agonist": 3508,
    "Growth hormone releasing factor antagonist": 3509,
    "Growth hormone secretagogue receptor agonist": 3510,
    "Growth hormone secretagogue receptor antagonist": 3511,
    "Growth retardation": 3512,
    "Growth stimulant": 3513,
    "Guanidinoacetase inhibitor": 3514,
    "Guanidinoacetate N-methyltransferase inhibitor": 3515,
    "Guanidinoacetate kinase inhibitor": 3516,
    "Guanidinobutyrase inhibitor": 3517,
    "Guanidinodeoxy-scyllo-inositol-4-phosphatase inhibitor": 3518,
    "Guanidinopropionase inhibitor": 3519,
    "Guanine deaminase inhibitor": 3520,
    "Guanosine-3',5'-bis(diphosphate) 3'-diphosphatase inhibitor": 3521,
    "Guanylate cyclase 1 inhibitor": 3522,
    "Guanylate cyclase 1 stimulant": 3523,
    "Guanylate cyclase inhibitor": 3524,
    "Guanylate cyclase stimulant": 3525,
    "Guanylate kinase inhibitor": 3526,
    "Gynaecomastia": 3527,
    "Gynecological disorders treatment": 3528,
    "H+-exporting ATPase inhibitor": 3529,
    "H+-transporting two-sector ATPase inhibitor": 3530,
    "H+/K+-transporting ATPase inhibitor": 3531,
    "H19 expression enhancer": 3532,
    "H1FX expression inhibitor": 3533,
    "H2AFX expression enhancer": 3534,
    "H2AFX expression inhibitor": 3535,
    "H2AFZ expression enhancer": 3536,
    "HADH expression enhancer": 3537,
    "HAPLN3 expression inhibitor": 3538,
    "HBEGF expression enhancer": 3539,
    "HCV IRES inhibitor": 3540,
    "HCV NS3-helicase inhibitor": 3541,
    "HCV NS3/NS4A protease inhibitor": 3542,
    "HCV NS5A inhibitor": 3543,
    "HCV NS5B polymerase inhibitor": 3544,
    "HCV polyprotein inhibitor": 3545,
    "HDAC3 expression inhibitor": 3546,
    "HDC expression inhibitor": 3547,
    "HDL-cholesterol increasing": 3548,
    "HERG 1 channel blocker": 3549,
    "HERG channel activator": 3550,
    "HERG channel blocker": 3551,
    "HERPUD1 expression inhibitor": 3552,
    "HES1 expression enhancer": 3553,
    "HES2 expression enhancer": 3554,
    "HEY1 expression enhancer": 3555,
    "HEY2 expression enhancer": 3556,
    "HIC1 expression inhibitor": 3557,
    "HIF1A expression enhancer": 3558,
    "HIF1A expression inhibitor": 3559,
    "HIPK2 expression inhibitor": 3560,
    "HIRA expression inhibitor": 3561,
    "HIST1H1C expression enhancer": 3562,
    "HIST1H2AC expression inhibitor": 3563,
    "HIST1H2AE expression enhancer": 3564,
    "HIST1H2BD expression enhancer": 3565,
    "HIST1H2BD expression inhibitor": 3566,
    "HIST1H2BG expression enhancer": 3567,
    "HIST1H2BI expression enhancer": 3568,
    "HIST1H2BJ expression enhancer": 3569,
    "HIST1H4B expression inhibitor": 3570,
    "HIST1H4C expression inhibitor": 3571,
    "HIST2H2BE expression inhibitor": 3572,
    "HIV TAT protein inhibitor": 3573,
    "HIV attachment inhibitor": 3574,
    "HIV fusion inhibitor": 3575,
    "HIV rev inhibitor": 3576,
    "HIV-1 integrase (3'-Processing) inhibitor": 3577,
    "HIV-1 integrase (Overall Integration) inhibitor": 3578,
    "HIV-1 integrase (Strand Transfer) inhibitor": 3579,
    "HIV-1 integrase inhibitor": 3580,
    "HIV-1 protease inhibitor": 3581,
    "HIV-1 reverse transcriptase inhibitor": 3582,
    "HIV-2 integrase inhibitor": 3583,
    "HIV-2 pol protein inhibitor": 3584,
    "HIV-2 retropepsin inhibitor": 3585,
    "HIV-2 reverse transcriptase inhibitor": 3586,
    "HIVEP1 expression enhancer": 3587,
    "HIVEP2 expression enhancer": 3588,
    "HK2 expression enhancer": 3589,
    "HK2 expression inhibitor": 3590,
    "HLA class I histocompatibility antigen A-3 inhibitor": 3591,
    "HLA-A2 antigen antagonist": 3592,
    "HLA-B expression enhancer": 3593,
    "HLA-C expression enhancer": 3594,
    "HLA-E expression enhancer": 3595,
    "HLA-F expression enhancer": 3596,
    "HLA-G expression enhancer": 3597,
    "HLF expression inhibitor": 3598,
    "HMBS expression inhibitor": 3599,
    "HMG CoA reductase inhibitor": 3600,
    "HMG CoA synthase inhibitor": 3601,
    "HMGA1 expression enhancer": 3602,
    "HMGA1 expression inhibitor": 3603,
    "HMGB1 expression inhibitor": 3604,
    "HMGB2 expression enhancer": 3605,
    "HMGB2 expression inhibitor": 3606,
    "HMGCR expression enhancer": 3607,
    "HMGCR expression inhibitor": 3608,
    "HMGCS1 expression enhancer": 3609,
    "HMGCS1 expression inhibitor": 3610,
    "HMGCS2 expression enhancer": 3611,
    "HMGN2 expression inhibitor": 3612,
    "HMMR expression inhibitor": 3613,
    "HMOX1 expression enhancer": 3614,
    "HNRNPA2B1 expression enhancer": 3615,
    "HNRNPH3 expression inhibitor": 3616,
    "HNRPC expression inhibitor": 3617,
    "HOMER1 expression inhibitor": 3618,
    "HOXA10 expression enhancer": 3619,
    "HOXA10 expression inhibitor": 3620,
    "HOXA11 expression enhancer": 3621,
    "HOXA7 expression enhancer": 3622,
    "HPGD expression inhibitor": 3623,
    "HPN expression enhancer": 3624,
    "HPS5 expression inhibitor": 3625,
    "HRAS expression enhancer": 3626,
    "HRH2 expression enhancer": 3627,
    "HS3ST3A1 expression enhancer": 3628,
    "HS6ST2 expression inhibitor": 3629,
    "HSD11B2 expression enhancer": 3630,
    "HSD11B2 expression inhibitor": 3631,
    "HSD17B1 expression enhancer": 3632,
    "HSD17B1 expression inhibitor": 3633,
    "HSD17B2 expression enhancer": 3634,
    "HSD3B1 expression enhancer": 3635,
    "HSD3B2 expression enhancer": 3636,
    "HSD3B2 expression inhibitor": 3637,
    "HSP27 expression enhancer": 3638,
    "HSP90AA1 expression enhancer": 3639,
    "HSP90AA1 expression inhibitor": 3640,
    "HSP90AB1 expression inhibitor": 3641,
    "HSP90B1 expression enhancer": 3642,
    "HSPA1A expression enhancer": 3643,
    "HSPA1A expression inhibitor": 3644,
    "HSPA1B expression enhancer": 3645,
    "HSPA2 expression enhancer": 3646,
    "HSPA2 expression inhibitor": 3647,
    "HSPA4 expression enhancer": 3648,
    "HSPA4L expression enhancer": 3649,
    "HSPA5 expression enhancer": 3650,
    "HSPA6 expression enhancer": 3651,
    "HSPA6 expression inhibitor": 3652,
    "HSPB1 expression enhancer": 3653,
    "HSPB1 expression inhibitor": 3654,
    "HSPB8 expression enhancer": 3655,
    "HSPCB expression enhancer": 3656,
    "HSPE1 expression inhibitor": 3657,
    "HSPH1 expression enhancer": 3658,
    "Haem oxygenase 1 inhibitor": 3659,
    "Hair growth stimulant": 3660,
    "Hallucinogen": 3661,
    "Haloacetate dehalogenase inhibitor": 3662,
    "Haloalkane dehalogenase inhibitor": 3663,
    "Headache": 3664,
    "Heart failure": 3665,
    "Heart failure treatment": 3666,
    "Heat shock 70 kDa protein 1 antagonist": 3667,
    "Heat shock factor protein 1 inhibitor": 3668,
    "Heat shock protein 27 antagonist": 3669,
    "Heat shock protein 70 agonist": 3670,
    "Heat shock protein 70 antagonist": 3671,
    "Heat shock protein 90 alpha antagonist": 3672,
    "Heat shock protein 90 antagonist": 3673,
    "Heat shock protein 90 beta antagonist": 3674,
    "Heat shock protein HSP 90 (HSC82) inhibitor": 3675,
    "Heat shock protein agonist": 3676,
    "Heat shock protein antagonist": 3677,
    "Hedgehog signaling activator": 3678,
    "Hedgehog signaling inhibitor": 3679,
    "Helicase E1 (Human papillomavirus) inhibitor": 3680,
    "Hematemesis": 3681,
    "Hematinic": 3682,
    "Hematopoietic": 3683,
    "Hematopoietic inhibitor": 3684,
    "Hematotoxic": 3685,
    "Hematuria": 3686,
    "Heme oxygenase 2 inhibitor": 3687,
    "Heme oxygenase inhibitor": 3688,
    "Heme oxygenase stimulant": 3689,
    "Hemorrhage": 3690,
    "Hemostatic": 3691,
    "Hemozoin inhibitor": 3692,
    "Henoch-Schonlein purpura": 3693,
    "Heparan-alpha-glucosaminide N-acetyltransferase inhibitor": 3694,
    "Heparanase inhibitor": 3695,
    "Heparin epidermal growth factor antagonist": 3696,
    "Hepatic disorders treatment": 3697,
    "Hepatic failure": 3698,
    "Hepatic lipase inhibitor": 3699,
    "Hepatic necrosis": 3700,
    "Hepatitis": 3701,
    "Hepatitis treatment": 3702,
    "Hepatocyte growth factor agonist": 3703,
    "Hepatocyte growth factor antagonist": 3704,
    "Hepatocyte nuclear factor 4 alpha agonist": 3705,
    "Hepatocyte nuclear factor 4 alpha antagonist": 3706,
    "Hepatocyte nuclear factor agonist": 3707,
    "Hepatocyte nuclear factor antagonist": 3708,
    "Hepatoprotectant": 3709,
    "Hepatotoxic": 3710,
    "Hexokinase inhibitor": 3711,
    "Hexokinase stimulant": 3712,
    "Hiccups": 3713,
    "High-mannose-oligosaccharide beta-1,4-N-acetylglucosaminyltransferase inhibitor": 3714,
    "Hippurate hydrolase inhibitor": 3715,
    "Hirsutism": 3716,
    "Hirsutism treatment": 3717,
    "Histamine H1 receptor agonist": 3718,
    "Histamine H1 receptor antagonist": 3719,
    "Histamine H2 receptor agonist": 3720,
    "Histamine H2 receptor antagonist": 3721,
    "Histamine H3 receptor agonist": 3722,
    "Histamine H3 receptor antagonist": 3723,
    "Histamine H4 receptor agonist": 3724,
    "Histamine H4 receptor antagonist": 3725,
    "Histamine N-methyltransferase inhibitor": 3726,
    "Histamine agonist": 3727,
    "Histamine antagonist": 3728,
    "Histamine release inhibitor": 3729,
    "Histamine release stimulant": 3730,
    "Histidine N-acetyltransferase inhibitor": 3731,
    "Histidine ammonia-lyase inhibitor": 3732,
    "Histidine decarboxylase inhibitor": 3733,
    "Histidine kinase inhibitor": 3734,
    "Histidine-rich protein PFHRP-II inhibitor": 3735,
    "Histidine-tRNA ligase inhibitor": 3736,
    "Histidinol dehydrogenase inhibitor": 3737,
    "Histidinol-phosphatase inhibitor": 3738,
    "Histone acetylation inducer": 3739,
    "Histone acetyltransferase PCAF inhibitor": 3740,
    "Histone acetyltransferase inhibitor": 3741,
    "Histone acetyltransferase p300 inhibitor": 3742,
    "Histone deacetylase 1 inhibitor": 3743,
    "Histone deacetylase 10 inhibitor": 3744,
    "Histone deacetylase 11 inhibitor": 3745,
    "Histone deacetylase 1A inhibitor": 3746,
    "Histone deacetylase 1B inhibitor": 3747,
    "Histone deacetylase 2 inhibitor": 3748,
    "Histone deacetylase 3 inhibitor": 3749,
    "Histone deacetylase 4 inhibitor": 3750,
    "Histone deacetylase 5 inhibitor": 3751,
    "Histone deacetylase 6 inhibitor": 3752,
    "Histone deacetylase 7 inhibitor": 3753,
    "Histone deacetylase 8 inhibitor": 3754,
    "Histone deacetylase 9 inhibitor": 3755,
    "Histone deacetylase SIRT1 inhibitor": 3756,
    "Histone deacetylase SIRT1 stimulant": 3757,
    "Histone deacetylase SIRT2 inhibitor": 3758,
    "Histone deacetylase SIRT2 stimulant": 3759,
    "Histone deacetylase class I inhibitor": 3760,
    "Histone deacetylase class II inhibitor": 3761,
    "Histone deacetylase class III inhibitor": 3762,
    "Histone deacetylase class IIa inhibitor": 3763,
    "Histone deacetylase class IIb inhibitor": 3764,
    "Histone deacetylase class IV inhibitor": 3765,
    "Histone deacetylase inhibitor": 3766,
    "Histone deacetylase stimulant": 3767,
    "Histone deacetylase-like amidohydrolase inhibitor": 3768,
    "Histone-arginine N-methyltransferase inhibitor": 3769,
    "Histone-lysine N-methyltransferase EZH2 inhibitor": 3770,
    "Histone-lysine N-methyltransferase SETD7 inhibitor": 3771,
    "Histone-lysine N-methyltransferase inhibitor": 3772,
    "Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 inhibitor": 3773,
    "Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 inhibitor": 3774,
    "Homeodomain-interacting protein kinase 2 inhibitor": 3775,
    "Homeodomain-interacting protein kinase 4 inhibitor": 3776,
    "Homoaconitate hydratase inhibitor": 3777,
    "Homocitrate synthase inhibitor": 3778,
    "Homocysteine S-methyltransferase inhibitor": 3779,
    "Homocysteine desulfhydrase inhibitor": 3780,
    "Homogentisate 1,2-dioxygenase inhibitor": 3781,
    "Homoisocitrate dehydrogenase inhibitor": 3782,
    "Homoserine O-acetyltransferase inhibitor": 3783,
    "Homoserine O-succinyltransferase inhibitor": 3784,
    "Homoserine dehydrogenase inhibitor": 3785,
    "Homoserine kinase inhibitor": 3786,
    "Homospermidine synthase inhibitor": 3787,
    "Horrilysin inhibitor": 3788,
    "Hot flush": 3789,
    "Hot flush treatment": 3790,
    "HslV component of HslUV peptidase inhibitor": 3791,
    "Human T-cell leukemia virus type I protease inhibitor": 3792,
    "Human herpes virus 5 capsid protein P40 inhibitor": 3793,
    "Human herpesvirus 2 protease inhibitor": 3794,
    "Human herpesvirus 4 protease/capsid scaffold protein inhibitor": 3795,
    "Human herpesvirus 5 DNA polymerase inhibitor": 3796,
    "Human herpesvirus 6 protease inhibitor": 3797,
    "Human papillomavirus - 16 inhibitor": 3798,
    "Human rhinovirus A protease inhibitor": 3799,
    "Huntington's disease treatment": 3800,
    "Hyaluronic acid agonist": 3801,
    "Hydrogen dehydrogenase inhibitor": 3802,
    "Hydrolase inhibitor": 3803,
    "Hydroperoxide dehydratase inhibitor": 3804,
    "Hydroxyacid oxidase 2 inhibitor": 3805,
    "Hydroxyacylglutathione hydrolase inhibitor": 3806,
    "Hydroxylamine oxidase inhibitor": 3807,
    "Hydroxylamine reductase (NADH) inhibitor": 3808,
    "Hydroxylamine reductase inhibitor": 3809,
    "Hydroxylysine kinase inhibitor": 3810,
    "Hydroxymethylbilane synthase inhibitor": 3811,
    "Hydroxymethylglutaryl-CoA lyase inhibitor": 3812,
    "Hydroxymethylglutaryl-CoA reductase inhibitor": 3813,
    "Hydroxypyruvate reductase inhibitor": 3814,
    "Hydroxyquinol 1,2-dioxygenase inhibitor": 3815,
    "Hydroxysteroid dehydrogenase inhibitor": 3816,
    "Hyperbilirubinemia": 3817,
    "Hypercalcaemic": 3818,
    "Hypercalcemia treatment": 3819,
    "Hypercholesterolemic": 3820,
    "Hyperglycemic": 3821,
    "Hyperkinesia": 3822,
    "Hyperparathyroidism treatment": 3823,
    "Hyperprolactinemia treatment": 3824,
    "Hyperreflexia": 3825,
    "Hypersexuality": 3826,
    "Hypertensive": 3827,
    "Hypertensive, ophthalmic": 3828,
    "Hyperthermic": 3829,
    "Hypertrichosis": 3830,
    "Hyperuricemia": 3831,
    "Hypnotic": 3832,
    "Hypocalcaemic": 3833,
    "Hypoglycemic": 3834,
    "Hypogonadism treatment": 3835,
    "Hypokalemia": 3836,
    "Hypolipemic": 3837,
    "Hypomagnesemia": 3838,
    "Hypomania": 3839,
    "Hyponitrite reductase inhibitor": 3840,
    "Hypotension": 3841,
    "Hypothermic": 3842,
    "Hypotonia": 3843,
    "Hypoventilation": 3844,
    "Hypoxanthine phosphoribosyltransferase inhibitor": 3845,
    "Hypoxia inducible factor 1 alpha inhibitor": 3846,
    "I kappa B kinase 1 inhibitor": 3847,
    "I kappa B kinase 2 inhibitor": 3848,
    "I kappa B kinase epsilon inhibitor": 3849,
    "I kappa B kinase inhibitor": 3850,
    "I(Ks) voltage-gated potassium channel blocker": 3851,
    "IARS expression inhibitor": 3852,
    "ICAM 1 antagonist": 3853,
    "ICAM1 expression enhancer": 3854,
    "ICAM1 expression inhibitor": 3855,
    "ICMT expression inhibitor": 3856,
    "ID1 expression enhancer": 3857,
    "ID1 expression inhibitor": 3858,
    "ID2 expression enhancer": 3859,
    "ID3 expression enhancer": 3860,
    "ID3 expression inhibitor": 3861,
    "IDI1 expression inhibitor": 3862,
    "IER2 expression enhancer": 3863,
    "IER3 expression enhancer": 3864,
    "IER3 expression inhibitor": 3865,
    "IFI27 expression enhancer": 3866,
    "IFI30 expression enhancer": 3867,
    "IFI6 expression enhancer": 3868,
    "IFIT1 expression enhancer": 3869,
    "IFIT2 expression enhancer": 3870,
    "IFIT3 expression enhancer": 3871,
    "IFIT3 expression inhibitor": 3872,
    "IFITM1 expression enhancer": 3873,
    "IFITM1 expression inhibitor": 3874,
    "IFNAR1 expression inhibitor": 3875,
    "IFNG expression inhibitor": 3876,
    "IFNGR1 expression enhancer": 3877,
    "IFNGR2 expression enhancer": 3878,
    "IGF1 expression enhancer": 3879,
    "IGF1 expression inhibitor": 3880,
    "IGF1R expression enhancer": 3881,
    "IGF1R expression inhibitor": 3882,
    "IGF2 expression enhancer": 3883,
    "IGF2 expression inhibitor": 3884,
    "IGFBP1 expression enhancer": 3885,
    "IGFBP2 expression enhancer": 3886,
    "IGFBP2 expression inhibitor": 3887,
    "IGFBP3 expression enhancer": 3888,
    "IGFBP3 expression inhibitor": 3889,
    "IGFBP4 expression enhancer": 3890,
    "IGFBP5 expression inhibitor": 3891,
    "IGFBP6 expression enhancer": 3892,
    "IGFBP6 expression inhibitor": 3893,
    "IL10 expression enhancer": 3894,
    "IL10 expression inhibitor": 3895,
    "IL10RA expression inhibitor": 3896,
    "IL12B expression enhancer": 3897,
    "IL12B expression inhibitor": 3898,
    "IL12RB1 expression inhibitor": 3899,
    "IL16 expression enhancer": 3900,
    "IL1A expression enhancer": 3901,
    "IL1A expression inhibitor": 3902,
    "IL1B expression enhancer": 3903,
    "IL1B expression inhibitor": 3904,
    "IL1R1 expression inhibitor": 3905,
    "IL1RL1 expression enhancer": 3906,
    "IL1RN expression inhibitor": 3907,
    "IL2 expression inhibitor": 3908,
    "IL24 expression enhancer": 3909,
    "IL24 expression inhibitor": 3910,
    "IL2RA expression inhibitor": 3911,
    "IL3RA expression inhibitor": 3912,
    "IL4 expression enhancer": 3913,
    "IL4 expression inhibitor": 3914,
    "IL4R expression enhancer": 3915,
    "IL4R expression inhibitor": 3916,
    "IL5 expression enhancer": 3917,
    "IL5 expression inhibitor": 3918,
    "IL6 expression enhancer": 3919,
    "IL6 expression inhibitor": 3920,
    "IL6ST expression inhibitor": 3921,
    "IL9 expression inhibitor": 3922,
    "ILF2 expression inhibitor": 3923,
    "ILF3 expression inhibitor": 3924,
    "ILVBL expression inhibitor": 3925,
    "IMP cyclohydrolase inhibitor": 3926,
    "IMPDH2 expression enhancer": 3927,
    "INCENP expression inhibitor": 3928,
    "INHBA expression enhancer": 3929,
    "INHBB expression inhibitor": 3930,
    "INHBE expression enhancer": 3931,
    "INHBE expression inhibitor": 3932,
    "INPP4B expression inhibitor": 3933,
    "INS expression inhibitor": 3934,
    "INSIG1 expression enhancer": 3935,
    "INSM1 expression inhibitor": 3936,
    "INTS2 expression inhibitor": 3937,
    "IPO13 expression enhancer": 3938,
    "IQCK expression inhibitor": 3939,
    "IQGAP1 expression inhibitor": 3940,
    "IRF7 expression enhancer": 3941,
    "IRF9 expression enhancer": 3942,
    "IRS1 expression enhancer": 3943,
    "IRS1 expression inhibitor": 3944,
    "ISG15 expression enhancer": 3945,
    "ISG20 expression enhancer": 3946,
    "ISL1 expression inhibitor": 3947,
    "ISYNA1 expression enhancer": 3948,
    "ITGA3 expression enhancer": 3949,
    "ITGA4 expression enhancer": 3950,
    "ITGA6 expression enhancer": 3951,
    "ITGA6 expression inhibitor": 3952,
    "ITGAM expression enhancer": 3953,
    "ITGB1 expression enhancer": 3954,
    "ITGB1 expression inhibitor": 3955,
    "ITGB2 expression enhancer": 3956,
    "ITGB3 expression enhancer": 3957,
    "ITGB4 expression inhibitor": 3958,
    "ITGB6 expression inhibitor": 3959,
    "ITGB7 expression enhancer": 3960,
    "ITM2B expression inhibitor": 3961,
    "ITPK1 expression enhancer": 3962,
    "ITPR1 expression inhibitor": 3963,
    "ITSN1 expression inhibitor": 3964,
    "IVL expression enhancer": 3965,
    "IVL expression inhibitor": 3966,
    "IVNS1ABP expression inhibitor": 3967,
    "Iduronate-2-sulfatase inhibitor": 3968,
    "IgA-specific metalloendopeptidase inhibitor": 3969,
    "IgA-specific serine endopeptidase inhibitor": 3970,
    "Ileal bile acid transport inhibitor": 3971,
    "Imidazoleacetate 4-monooxygenase inhibitor": 3972,
    "Imidazoleglycerol-phosphate dehydratase inhibitor": 3973,
    "Imidazoline I1 receptor agonist": 3974,
    "Imidazoline I1 receptor antagonist": 3975,
    "Imidazoline I2 receptor antagonist": 3976,
    "Imidazoline receptor agonist": 3977,
    "Imidazoline receptor antagonist": 3978,
    "Immunoglobulin E antagonist": 3979,
    "Immunoglobulin Fc receptor antagonist": 3980,
    "Immunomodulator": 3981,
    "Immunomodulator (HIV)": 3982,
    "Immunostimulant": 3983,
    "Immunosuppressant": 3984,
    "Immunosuppressant Cyclosporine-like": 3985,
    "Immunotoxin": 3986,
    "Incontinence": 3987,
    "Indanol dehydrogenase inhibitor": 3988,
    "Indole-3-acetaldehyde reductase (NADPH) inhibitor": 3989,
    "Indoleacetaldoxime dehydratase inhibitor": 3990,
    "Indoleamine-pyrrole 2,3-dioxygenase inhibitor": 3991,
    "Indolepyruvate C-methyltransferase inhibitor": 3992,
    "Inducible nitric-oxide synthase inhibitor": 3993,
    "Induration": 3994,
    "Infection": 3995,
    "Inflammation": 3996,
    "Inflammatory Bowel disease treatment": 3997,
    "Injection site pain": 3998,
    "Inner centromere protein inhibitor": 3999,
    "Inorganic diphosphatase inhibitor": 4000,
    "Inosine kinase inhibitor": 4001,
    "Inosine monophosphate dehydrogenase 1 inhibitor": 4002,
    "Inosine monophosphate dehydrogenase 2 inhibitor": 4003,
    "Inosine monophosphate dehydrogenase inhibitor": 4004,
    "Inosine nucleosidase inhibitor": 4005,
    "Inosine-adenosine-guanosine-nucleoside hydrolase inhibitor": 4006,
    "Inositol 1,4,5-triphosphate receptor 1 antagonist": 4007,
    "Inositol 1,4,5-triphosphate receptor 3 antagonist": 4008,
    "Inositol 1,4,5-triphosphate receptor antagonist": 4009,
    "Inositol 1,4,5-trisphosphate 3-kinase B inhibitor": 4010,
    "Inositol 1,4,5-trisphosphate 3-kinase inhibitor": 4011,
    "Inositol monophosphatase 2 inhibitor": 4012,
    "Inositol monophosphatase inhibitor": 4013,
    "Inositol oxygenase inhibitor": 4014,
    "Inositol polyphosphate-5-phosphatase D inhibitor": 4015,
    "Inositol polyphosphate-5-phosphatase D stimulant": 4016,
    "Inositol-3-phosphate synthase inhibitor": 4017,
    "Inositol-polyphosphate 5-phosphatase inhibitor": 4018,
    "Inotropic": 4019,
    "Insecticide": 4020,
    "Insomnia": 4021,
    "Insomnia treatment": 4022,
    "Insulin growth factor agonist": 4023,
    "Insulin growth factor antagonist": 4024,
    "Insulin like growth factor 1 agonist": 4025,
    "Insulin like growth factor 1 antagonist": 4026,
    "Insulin like growth factor 2 antagonist": 4027,
    "Insulin like growth factor 3 antagonist": 4028,
    "Insulin promoter": 4029,
    "Insulin receptor agonist": 4030,
    "Insulin receptor antagonist": 4031,
    "Insulin secretagoues": 4032,
    "Insulin sensitizer": 4033,
    "Insulinotropin antagonist": 4034,
    "Insulysin inhibitor": 4035,
    "Integrin alpha1beta1 antagonist": 4036,
    "Integrin alpha2 antagonist": 4037,
    "Integrin alpha2beta1 antagonist": 4038,
    "Integrin alpha3 antagonist": 4039,
    "Integrin alpha4 antagonist": 4040,
    "Integrin alpha4beta1 antagonist": 4041,
    "Integrin alpha4beta7 antagonist": 4042,
    "Integrin alpha5beta1 antagonist": 4043,
    "Integrin alpha5beta6 antagonist": 4044,
    "Integrin alphaLbeta2 antagonist": 4045,
    "Integrin alphaVbeta1 antagonist": 4046,
    "Integrin alphaVbeta3 antagonist": 4047,
    "Integrin alphaVbeta5 antagonist": 4048,
    "Integrin alphaVbeta6 antagonist": 4049,
    "Integrin antagonist": 4050,
    "Integrin beta2 antagonist": 4051,
    "Integrin beta3 antagonist": 4052,
    "Integrin beta5 antagonist": 4053,
    "Integrin beta6 antagonist": 4054,
    "Integrin beta7 antagonist": 4055,
    "Integrin-linked kinase inhibitor": 4056,
    "Interferon agonist": 4057,
    "Interferon alpha agonist": 4058,
    "Interferon antagonist": 4059,
    "Interferon gamma antagonist": 4060,
    "Interferon inducer": 4061,
    "Interleukin 1 antagonist": 4062,
    "Interleukin 1 beta converting enzyme inhibitor": 4063,
    "Interleukin 10 agonist": 4064,
    "Interleukin 10 antagonist": 4065,
    "Interleukin 12 antagonist": 4066,
    "Interleukin 1a antagonist": 4067,
    "Interleukin 1b antagonist": 4068,
    "Interleukin 2 agonist": 4069,
    "Interleukin 2 antagonist": 4070,
    "Interleukin 4 antagonist": 4071,
    "Interleukin 5 antagonist": 4072,
    "Interleukin 6 antagonist": 4073,
    "Interleukin 8 antagonist": 4074,
    "Interleukin agonist": 4075,
    "Interleukin antagonist": 4076,
    "Interleukin-1 receptor-associated protein kinase 1 inhibitor": 4077,
    "Interleukin-1 receptor-associated protein kinase 4 inhibitor": 4078,
    "Interleukin-1 receptor-associated protein kinase inhibitor": 4079,
    "Intermittent claudication treatment": 4080,
    "Interstitial nephritis": 4081,
    "Intestinal alkaline phosphatase inhibitor": 4082,
    "Intestinal peptide-proton cotransporter inhibitor": 4083,
    "Inulinase inhibitor": 4084,
    "Iodide peroxidase inhibitor": 4085,
    "Iris pigmentation": 4086,
    "Iritis": 4087,
    "Iron antagonist": 4088,
    "Iron-cytochrome-c reductase inhibitor": 4089,
    "Irritable Bowel syndrome treatment": 4090,
    "Irritation": 4091,
    "Isoamylase inhibitor": 4092,
    "Isocitrate dehydrogenase (NAD+) inhibitor": 4093,
    "Isocitrate dehydrogenase (NADP+) inhibitor": 4094,
    "Isocitrate lyase inhibitor": 4095,
    "Isoleucine-tRNA ligase inhibitor": 4096,
    "Isomaltulose synthase inhibitor": 4097,
    "Isopenicillin-N epimerase inhibitor": 4098,
    "Isopenicillin-N synthase inhibitor": 4099,
    "Isopentenyl-diphosphate DELTA-isomerase inhibitor": 4100,
    "Isoquinoline 1-oxidoreductase inhibitor": 4101,
    "Isovaleryl-CoA dehydrogenase inhibitor": 4102,
    "JAG1 expression enhancer": 4103,
    "JAG1 expression inhibitor": 4104,
    "JAG2 expression inhibitor": 4105,
    "JNK mitogen-activated protein kinase inhibitor": 4106,
    "JUN expression enhancer": 4107,
    "JUN expression inhibitor": 4108,
    "JUNB expression inhibitor": 4109,
    "JUND expression inhibitor": 4110,
    "JUP expression inhibitor": 4111,
    "Janus tyrosine kinase 1 inhibitor": 4112,
    "Janus tyrosine kinase 2 inhibitor": 4113,
    "Janus tyrosine kinase 3 inhibitor": 4114,
    "Janus tyrosine kinase inhibitor": 4115,
    "Jaundice": 4116,
    "Juvenile-hormone esterase inhibitor": 4117,
    "K(Ca) 31 channel activator": 4118,
    "K(Ca) 31 channel blocker": 4119,
    "K(ir) 61 channel blocker": 4120,
    "K(ir) 62 channel activator": 4121,
    "KARS expression inhibitor": 4122,
    "KCNF1 expression enhancer": 4123,
    "KCNH2 expression inhibitor": 4124,
    "KCNJ5 expression enhancer": 4125,
    "KCTD20 expression enhancer": 4126,
    "KDR expression inhibitor": 4127,
    "KEAP1 expression inhibitor": 4128,
    "KIAA0101 expression enhancer": 4129,
    "KIAA0101 expression inhibitor": 4130,
    "KIAA0256 expression inhibitor": 4131,
    "KIAA0930 expression enhancer": 4132,
    "KIAA1804 expression enhancer": 4133,
    "KIF11 expression enhancer": 4134,
    "KIF11 expression inhibitor": 4135,
    "KIF14 expression enhancer": 4136,
    "KIF15 expression enhancer": 4137,
    "KIF15 expression inhibitor": 4138,
    "KIF20A expression enhancer": 4139,
    "KIF20B expression inhibitor": 4140,
    "KIF23 expression enhancer": 4141,
    "KIF2C expression inhibitor": 4142,
    "KIF4A expression enhancer": 4143,
    "KITLG expression enhancer": 4144,
    "KITLG expression inhibitor": 4145,
    "KLF10 expression inhibitor": 4146,
    "KLF4 expression enhancer": 4147,
    "KLF5 expression enhancer": 4148,
    "KLF9 expression enhancer": 4149,
    "KLHL24 expression inhibitor": 4150,
    "KLK2 expression enhancer": 4151,
    "KLK2 expression inhibitor": 4152,
    "KLK3 expression enhancer": 4153,
    "KLK3 expression inhibitor": 4154,
    "KLK6 expression enhancer": 4155,
    "KLK7 expression enhancer": 4156,
    "KLRC1 expression enhancer": 4157,
    "KLRC3 expression enhancer": 4158,
    "KPNA1 expression enhancer": 4159,
    "KPNA1 expression inhibitor": 4160,
    "KPNA2 expression inhibitor": 4161,
    "KPNB1 expression enhancer": 4162,
    "KPNB1 expression inhibitor": 4163,
    "KRAS expression inhibitor": 4164,
    "KRT1 expression enhancer": 4165,
    "KRT1 expression inhibitor": 4166,
    "KRT10 expression inhibitor": 4167,
    "KRT15 expression enhancer": 4168,
    "KRT17 expression inhibitor": 4169,
    "KRT18 expression enhancer": 4170,
    "KRT19 expression enhancer": 4171,
    "KRT2 expression enhancer": 4172,
    "KRT23 expression inhibitor": 4173,
    "KRT5 expression inhibitor": 4174,
    "KRT6A expression enhancer": 4175,
    "KRT7 expression enhancer": 4176,
    "KRT8 expression enhancer": 4177,
    "KRT8 expression inhibitor": 4178,
    "Kainate receptor 1 agonist": 4179,
    "Kainate receptor 1 antagonist": 4180,
    "Kainate receptor 2 antagonist": 4181,
    "Kainate receptor 3 antagonist": 4182,
    "Kainate receptor 4 antagonist": 4183,
    "Kainate receptor 5 antagonist": 4184,
    "Kainate receptor agonist": 4185,
    "Kainate receptor antagonist": 4186,
    "Kallikrein 1 inhibitor": 4187,
    "Kallikrein 10 inhibitor": 4188,
    "Kallikrein 11 inhibitor": 4189,
    "Kallikrein 12 inhibitor": 4190,
    "Kallikrein 13 inhibitor": 4191,
    "Kallikrein 14 inhibitor": 4192,
    "Kallikrein 15 inhibitor": 4193,
    "Kallikrein 2 inhibitor": 4194,
    "Kallikrein 3 inhibitor": 4195,
    "Kallikrein 4 inhibitor": 4196,
    "Kallikrein 5 inhibitor": 4197,
    "Kallikrein 6 inhibitor": 4198,
    "Kallikrein 7 inhibitor": 4199,
    "Kallikrein 8 inhibitor": 4200,
    "Kallikrein 9 inhibitor": 4201,
    "Kallikrein inhibitor": 4202,
    "Kanamycin kinase inhibitor": 4203,
    "Keratan sulfotransferase inhibitor": 4204,
    "Keratitis": 4205,
    "Keratolytic": 4206,
    "Keratopathy": 4207,
    "Ketoacidosis": 4208,
    "Ketohexokinase inhibitor": 4209,
    "Ketol-acid reductoisomerase inhibitor": 4210,
    "Ketosteroid monooxygenase inhibitor": 4211,
    "Kexin inhibitor": 4212,
    "KiSS-1 receptor agonist": 4213,
    "KiSS-1 receptor antagonist": 4214,
    "Kinase inhibitor": 4215,
    "Kinesin antagonist": 4216,
    "Kinesin-like protein 1 inhibitor": 4217,
    "Kruppel-like factor 5 inhibitor": 4218,
    "Kynureninase inhibitor": 4219,
    "Kynurenine 3 monooxygenase inhibitor": 4220,
    "Kynurenine aminotransferase II inhibitor": 4221,
    "Kynurenine aminotransferase inhibitor": 4222,
    "L lactate dehydrogenase A inhibitor": 4223,
    "L lactate dehydrogenase A4 inhibitor": 4224,
    "L lactate dehydrogenase B inhibitor": 4225,
    "L lactate dehydrogenase B4 inhibitor": 4226,
    "L lactate dehydrogenase C inhibitor": 4227,
    "L lactate dehydrogenase C4 inhibitor": 4228,
    "L lactate dehydrogenase inhibitor": 4229,
    "L lactate dehydrogenase stimulant": 4230,
    "L(+)-Tartrate dehydratase inhibitor": 4231,
    "L-3-cyanoalanine synthase inhibitor": 4232,
    "L-Serine ammonia-lyase inhibitor": 4233,
    "L-amino-acid oxidase inhibitor": 4234,
    "L-aminoadipate-semialdehyde dehydrogenase inhibitor": 4235,
    "L-ascorbate peroxidase inhibitor": 4236,
    "L-fuconate dehydratase inhibitor": 4237,
    "L-galactonolactone oxidase inhibitor": 4238,
    "L-glucuronate reductase inhibitor": 4239,
    "L-glutamate oxidase inhibitor": 4240,
    "L-iditol 2-dehydrogenase inhibitor": 4241,
    "L-iduronidase inhibitor": 4242,
    "L-lactate dehydrogenase (cytochrome) inhibitor": 4243,
    "L-lysine 6-transaminase inhibitor": 4244,
    "L-lysine oxidase inhibitor": 4245,
    "L-pipecolate oxidase inhibitor": 4246,
    "L-threonine 3-dehydrogenase inhibitor": 4247,
    "L1CAM expression inhibitor": 4248,
    "LAMA2 expression inhibitor": 4249,
    "LAMA3 expression enhancer": 4250,
    "LAMA5 expression inhibitor": 4251,
    "LAMB3 expression enhancer": 4252,
    "LAMC1 expression enhancer": 4253,
    "LAMC2 expression enhancer": 4254,
    "LAMP3 expression inhibitor": 4255,
    "LBR expression inhibitor": 4256,
    "LCN2 expression enhancer": 4257,
    "LDLR expression enhancer": 4258,
    "LDLR expression inhibitor": 4259,
    "LDOC1 expression inhibitor": 4260,
    "LECT1 expression enhancer": 4261,
    "LEFTY2 expression inhibitor": 4262,
    "LEP expression inhibitor": 4263,
    "LFA antagonist": 4264,
    "LFA-1 antagonist": 4265,
    "LGALS1 expression enhancer": 4266,
    "LGALS1 expression inhibitor": 4267,
    "LGALS3 expression enhancer": 4268,
    "LGALS8 expression enhancer": 4269,
    "LHB expression inhibitor": 4270,
    "LHX3 expression enhancer": 4271,
    "LIF expression enhancer": 4272,
    "LIM domain kinase 1 inhibitor": 4273,
    "LIM domain kinase 2 inhibitor": 4274,
    "LIMA1 expression enhancer": 4275,
    "LIN7A expression inhibitor": 4276,
    "LINC00467 expression enhancer": 4277,
    "LIPG expression enhancer": 4278,
    "LMCD1 expression enhancer": 4279,
    "LMNA expression inhibitor": 4280,
    "LMNB1 expression inhibitor": 4281,
    "LOXL2 expression enhancer": 4282,
    "LPIN1 expression enhancer": 4283,
    "LPL expression enhancer": 4284,
    "LPL expression inhibitor": 4285,
    "LPPR2 expression enhancer": 4286,
    "LRP5 expression enhancer": 4287,
    "LRP6 expression enhancer": 4288,
    "LRP6 expression inhibitor": 4289,
    "LRP8 expression inhibitor": 4290,
    "LRRC25 expression enhancer": 4291,
    "LSS expression enhancer": 4292,
    "LTB expression enhancer": 4293,
    "LUC7L3 expression inhibitor": 4294,
    "LUM expression enhancer": 4295,
    "LYN expression enhancer": 4296,
    "LYN expression inhibitor": 4297,
    "Laccase inhibitor": 4298,
    "Lacrimal secretion stimulant": 4299,
    "Lactaldehyde dehydrogenase inhibitor": 4300,
    "Lactaldehyde reductase (NADPH) inhibitor": 4301,
    "Lactaldehyde reductase inhibitor": 4302,
    "Lactamase A inhibitor": 4303,
    "Lactamase C inhibitor": 4304,
    "Lactamase D inhibitor": 4305,
    "Lactase inhibitor": 4306,
    "Lactate 2-monooxygenase inhibitor": 4307,
    "Lactate-malate transhydrogenase inhibitor": 4308,
    "Lactose synthase inhibitor": 4309,
    "Lactosylceramide alpha-2,3-sialyltransferase inhibitor": 4310,
    "Lactoylglutathione lyase inhibitor": 4311,
    "Laminaribiose phosphorylase inhibitor": 4312,
    "Lanosterol 14 alpha demethylase inhibitor": 4313,
    "Laryngospasm": 4314,
    "Lassitude": 4315,
    "Lassitude treatment": 4316,
    "Laxative": 4317,
    "Lck kinase inhibitor": 4318,
    "Leishmanolysin inhibitor": 4319,
    "Lethal(3)malignant brain tumor-like protein 3 inhibitor": 4320,
    "Lethargy": 4321,
    "Leucine aminopeptidase inhibitor": 4322,
    "Leucine dehydrogenase inhibitor": 4323,
    "Leucine transaminase inhibitor": 4324,
    "Leucine-rich repeat kinase 2 inhibitor": 4325,
    "Leucine-tRNA ligase inhibitor": 4326,
    "Leucolysin inhibitor": 4327,
    "Leucyltransferase inhibitor": 4328,
    "Leukemia": 4329,
    "Leukocyte elastase inhibitor": 4330,
    "Leukocyte tyrosine kinase receptor inhibitor": 4331,
    "Leukoencephalopathy": 4332,
    "Leukopenia": 4333,
    "Leukopoiesis inhibitor": 4334,
    "Leukopoiesis stimulant": 4335,
    "Leukotriene A4 hydrolase inhibitor": 4336,
    "Leukotriene B4 agonist": 4337,
    "Leukotriene B4 antagonist": 4338,
    "Leukotriene B4 receptor 1 antagonist": 4339,
    "Leukotriene B4 receptor 2 antagonist": 4340,
    "Leukotriene C antagonist": 4341,
    "Leukotriene C4 antagonist": 4342,
    "Leukotriene D4 antagonist": 4343,
    "Leukotriene E4 antagonist": 4344,
    "Leukotriene agonist": 4345,
    "Leukotriene antagonist": 4346,
    "Leukotriene synthesis inhibitor": 4347,
    "Leukotriene-B4 20-monooxygenase inhibitor": 4348,
    "Leukotriene-C4 synthase inhibitor": 4349,
    "Levanase inhibitor": 4350,
    "Levansucrase inhibitor": 4351,
    "Licheninase inhibitor": 4352,
    "Ligase inhibitor": 4353,
    "Limulus clotting factor B inhibitor": 4354,
    "Limulus clotting factor C inhibitor": 4355,
    "Linoleate diol synthase inhibitor": 4356,
    "Linoleate isomerase inhibitor": 4357,
    "Linoleoyl-CoA desaturase inhibitor": 4358,
    "Lipase inhibitor": 4359,
    "Lipid metabolism regulator": 4360,
    "Lipid peroxidase inhibitor": 4361,
    "Lipocortins synthesis agonist": 4362,
    "Lipocortins synthesis antagonist": 4363,
    "Lipoprotein disorders treatment": 4364,
    "Lipoprotein lipase inhibitor": 4365,
    "Lipoprotein lipase stimulant": 4366,
    "Lipotropic": 4367,
    "Lipoxin receptor agonist": 4368,
    "Lipoxygenase inhibitor": 4369,
    "Lipoxygenase stimulant": 4370,
    "Lipoxygenase substrate": 4371,
    "Liver X receptor agonist": 4372,
    "Liver X receptor alpha agonist": 4373,
    "Liver X receptor antagonist": 4374,
    "Liver X receptor beta agonist": 4375,
    "Liver cirrhosis treatment": 4376,
    "Liver fibrosis treatment": 4377,
    "Lombricine kinase inhibitor": 4378,
    "Long-chain-acyl-CoA dehydrogenase inhibitor": 4379,
    "Long-chain-aldehyde dehydrogenase inhibitor": 4380,
    "Long-chain-fatty-acid-CoA ligase inhibitor": 4381,
    "Loop diuretic": 4382,
    "Low molecular weight phosphotyrosine protein phosphatase inhibitor": 4383,
    "Luteolytic": 4384,
    "Lymphocyte kinase inhibitor": 4385,
    "Lymphocytopoiesis inhibitor": 4386,
    "Lymphocytosis": 4387,
    "Lymphoproliferative disorder": 4388,
    "Lysase inhibitor": 4389,
    "Lysine 2,3-aminomutase inhibitor": 4390,
    "Lysine 2-monooxygenase inhibitor": 4391,
    "Lysine 6-dehydrogenase inhibitor": 4392,
    "Lysine carboxypeptidase inhibitor": 4393,
    "Lysine carboxypeptidase, catalytic subunit inhibitor": 4394,
    "Lysine decarboxylase inhibitor": 4395,
    "Lysine-tRNA ligase inhibitor": 4396,
    "Lysophosphatidic acid 1 receptor antagonist": 4397,
    "Lysophosphatidic acid 2 receptor antagonist": 4398,
    "Lysophosphatidic acid 3 receptor antagonist": 4399,
    "Lysophosphatidic acid receptor 3 agonist": 4400,
    "Lysophosphatidic acid receptor agonist": 4401,
    "Lysophosphatidic acid receptor antagonist": 4402,
    "Lysosomal Pro-X carboxypeptidase inhibitor": 4403,
    "Lysostaphin inhibitor": 4404,
    "Lysozyme inhibitor": 4405,
    "Lysyl endopeptidase inhibitor": 4406,
    "Lysyl oxidase inhibitor": 4407,
    "M17 leucyl aminopeptidase inhibitor": 4408,
    "M18 aspartyl aminopeptidase inhibitor": 4409,
    "M7G(5')pppN diphosphatase inhibitor": 4410,
    "MACF1 expression inhibitor": 4411,
    "MAD1L1 expression enhancer": 4412,
    "MAD1L1 expression inhibitor": 4413,
    "MADD expression inhibitor": 4414,
    "MAF expression enhancer": 4415,
    "MAFB expression enhancer": 4416,
    "MAFB expression inhibitor": 4417,
    "MAFF expression enhancer": 4418,
    "MAGED2 expression enhancer": 4419,
    "MAGOH expression inhibitor": 4420,
    "MANSC1 expression inhibitor": 4421,
    "MAO A inhibitor": 4422,
    "MAO A substrate": 4423,
    "MAO B inhibitor": 4424,
    "MAO B substrate": 4425,
    "MAO inhibitor": 4426,
    "MAOA expression enhancer": 4427,
    "MAOB expression enhancer": 4428,
    "MAP kinase 1 inhibitor": 4429,
    "MAP kinase 10 inhibitor": 4430,
    "MAP kinase 11 inhibitor": 4431,
    "MAP kinase 12 inhibitor": 4432,
    "MAP kinase 13 inhibitor": 4433,
    "MAP kinase 14 inhibitor": 4434,
    "MAP kinase 3 inhibitor": 4435,
    "MAP kinase 7 inhibitor": 4436,
    "MAP kinase 8 inhibitor": 4437,
    "MAP kinase 9 inhibitor": 4438,
    "MAP kinase inhibitor": 4439,
    "MAP kinase kinase 1 inhibitor": 4440,
    "MAP kinase kinase 2 inhibitor": 4441,
    "MAP kinase kinase 3 inhibitor": 4442,
    "MAP kinase kinase 4 inhibitor": 4443,
    "MAP kinase kinase 5 inhibitor": 4444,
    "MAP kinase kinase 6 inhibitor": 4445,
    "MAP kinase kinase 7 inhibitor": 4446,
    "MAP kinase kinase inhibitor": 4447,
    "MAP kinase kinase kinase inhibitor": 4448,
    "MAP kinase signal-integrating kinase 1 inhibitor": 4449,
    "MAP kinase signal-integrating kinase 2 inhibitor": 4450,
    "MAP kinase stimulant": 4451,
    "MAP-kinase-activated kinase 1 inhibitor": 4452,
    "MAP-kinase-activated kinase 2 inhibitor": 4453,
    "MAP-kinase-activated kinase 3 inhibitor": 4454,
    "MAP-kinase-activated kinase 5 inhibitor": 4455,
    "MAP-kinase-activated kinase inhibitor": 4456,
    "MAP/microtubule affinity-regulating kinase 2 inhibitor": 4457,
    "MAP1B expression enhancer": 4458,
    "MAP2K1 expression enhancer": 4459,
    "MAP2K3 expression enhancer": 4460,
    "MAP2K4 expression inhibitor": 4461,
    "MAP2K5 expression inhibitor": 4462,
    "MAP3K MLT inhibitor": 4463,
    "MAP3K10 inhibitor": 4464,
    "MAP3K11 inhibitor": 4465,
    "MAP3K5 expression inhibitor": 4466,
    "MAP3K5 inhibitor": 4467,
    "MAP3K7 inhibitor": 4468,
    "MAP3K8 expression enhancer": 4469,
    "MAP3K8 inhibitor": 4470,
    "MAP3K9 inhibitor": 4471,
    "MAP4 expression inhibitor": 4472,
    "MAP4K4 expression inhibitor": 4473,
    "MAP7 expression enhancer": 4474,
    "MAPK13 expression inhibitor": 4475,
    "MAPK3 expression inhibitor": 4476,
    "MAPK8 expression inhibitor": 4477,
    "MAPT expression enhancer": 4478,
    "MAPT expression inhibitor": 4479,
    "MARK1 protein inhibitor": 4480,
    "MARK3 expression inhibitor": 4481,
    "MASTL expression enhancer": 4482,
    "MAT2A expression inhibitor": 4483,
    "MBNL2 expression inhibitor": 4484,
    "MCCC1 expression enhancer": 4485,
    "MCL1 expression enhancer": 4486,
    "MCL1 expression inhibitor": 4487,
    "MCM10 expression enhancer": 4488,
    "MCM2 expression enhancer": 4489,
    "MCM2 expression inhibitor": 4490,
    "MCM3 expression inhibitor": 4491,
    "MCM3AP expression inhibitor": 4492,
    "MCM4 expression inhibitor": 4493,
    "MCM5 expression inhibitor": 4494,
    "MCM6 expression enhancer": 4495,
    "MCM7 expression enhancer": 4496,
    "MDFI expression inhibitor": 4497,
    "MDK expression inhibitor": 4498,
    "MDM1 expression enhancer": 4499,
    "MDM2 expression enhancer": 4500,
    "MDM2 inhibitor": 4501,
    "ME1 expression enhancer": 4502,
    "MED13L expression inhibitor": 4503,
    "MEF2C expression enhancer": 4504,
    "MEGF9 expression inhibitor": 4505,
    "MEIS1 expression enhancer": 4506,
    "MEIS2 expression enhancer": 4507,
    "MELK expression enhancer": 4508,
    "MEOX1 expression enhancer": 4509,
    "MEOX1 expression inhibitor": 4510,
    "MET expression enhancer": 4511,
    "MET expression inhibitor": 4512,
    "METRNL expression enhancer": 4513,
    "METTL7A expression enhancer": 4514,
    "MFAP4 expression inhibitor": 4515,
    "MFGE8 expression inhibitor": 4516,
    "MFN2 expression enhancer": 4517,
    "MGEA5 expression inhibitor": 4518,
    "MGMT expression enhancer": 4519,
    "MGMT expression inhibitor": 4520,
    "MGP expression inhibitor": 4521,
    "MGST1 expression enhancer": 4522,
    "MGST1 expression inhibitor": 4523,
    "MHC Class II antagonist": 4524,
    "MIR22HG expression enhancer": 4525,
    "MITF expression enhancer": 4526,
    "MITF expression inhibitor": 4527,
    "MKI67 expression inhibitor": 4528,
    "MLF1 expression enhancer": 4529,
    "MLPH expression enhancer": 4530,
    "MMD expression enhancer": 4531,
    "MMP1 expression enhancer": 4532,
    "MMP1 expression inhibitor": 4533,
    "MMP10 expression enhancer": 4534,
    "MMP13 expression enhancer": 4535,
    "MMP13 expression inhibitor": 4536,
    "MMP14 expression inhibitor": 4537,
    "MMP15 expression inhibitor": 4538,
    "MMP16 expression inhibitor": 4539,
    "MMP2 expression enhancer": 4540,
    "MMP2 expression inhibitor": 4541,
    "MMP3 expression enhancer": 4542,
    "MMP7 expression enhancer": 4543,
    "MMP9 expression enhancer": 4544,
    "MMP9 expression inhibitor": 4545,
    "MND1 expression inhibitor": 4546,
    "MO15-related protein kinase Pfmrk inhibitor": 4547,
    "MOB1A expression inhibitor": 4548,
    "MOD2 expression enhancer": 4549,
    "MOK expression enhancer": 4550,
    "MPHOSPH9 expression enhancer": 4551,
    "MR1 expression enhancer": 4552,
    "MSH2 expression enhancer": 4553,
    "MSH6 expression inhibitor": 4554,
    "MSI2 expression inhibitor": 4555,
    "MSMB expression enhancer": 4556,
    "MSN expression enhancer": 4557,
    "MST1 expression inhibitor": 4558,
    "MSX2 expression enhancer": 4559,
    "MT1A expression enhancer": 4560,
    "MT1A expression inhibitor": 4561,
    "MT1B expression enhancer": 4562,
    "MT1E expression enhancer": 4563,
    "MT1F expression enhancer": 4564,
    "MT1F expression inhibitor": 4565,
    "MT1G expression enhancer": 4566,
    "MT1H expression enhancer": 4567,
    "MT1H expression inhibitor": 4568,
    "MT1L expression enhancer": 4569,
    "MT1M expression enhancer": 4570,
    "MT1X expression enhancer": 4571,
    "MT1X expression inhibitor": 4572,
    "MT2A expression enhancer": 4573,
    "MT2A expression inhibitor": 4574,
    "MTFR1 expression inhibitor": 4575,
    "MTHFD1L expression inhibitor": 4576,
    "MTHFD2 expression inhibitor": 4577,
    "MTUS1 expression inhibitor": 4578,
    "MUC5AC expression enhancer": 4579,
    "MVD expression inhibitor": 4580,
    "MXD1 expression enhancer": 4581,
    "MXD4 expression inhibitor": 4582,
    "MYB expression enhancer": 4583,
    "MYB expression inhibitor": 4584,
    "MYBL1 expression enhancer": 4585,
    "MYBL2 expression enhancer": 4586,
    "MYBL2 expression inhibitor": 4587,
    "MYC expression enhancer": 4588,
    "MYC expression inhibitor": 4589,
    "MYCBP2 expression inhibitor": 4590,
    "MYH6 expression inhibitor": 4591,
    "MYL6 expression enhancer": 4592,
    "MYLIP expression enhancer": 4593,
    "MYNN expression inhibitor": 4594,
    "MYO10 expression enhancer": 4595,
    "MYO10 expression inhibitor": 4596,
    "MYO5A expression enhancer": 4597,
    "Macrocin O-methyltransferase inhibitor": 4598,
    "Macrophage colony stimulating factor agonist": 4599,
    "Macrophage colony stimulating factor antagonist": 4600,
    "Macrophage colony-stimulating factor 1 receptor antagonist": 4601,
    "Macrophage elastase inhibitor": 4602,
    "Macrophage inhibitor": 4603,
    "Macrophage migration inhibitory factor inhibitor": 4604,
    "Macrophage scavenger receptor antagonist": 4605,
    "Macrophage stimulant": 4606,
    "Macular degeneration treatment": 4607,
    "Magnesium-protoporphyrin IX methyltransferase inhibitor": 4608,
    "Magnesium-protoporphyrin IX monomethyl ester (oxidative) cyclase inhibitor": 4609,
    "Magnolysin inhibitor": 4610,
    "Maillard reaction inhibitor": 4611,
    "Malaise": 4612,
    "Malate dehydrogenase (NADP+) inhibitor": 4613,
    "Malate dehydrogenase (acceptor) inhibitor": 4614,
    "Malate dehydrogenase (decarboxylating) inhibitor": 4615,
    "Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) inhibitor": 4616,
    "Malate dehydrogenase (oxaloacetate-decarboxylating) inhibitor": 4617,
    "Malate dehydrogenase inhibitor": 4618,
    "Malate oxidase inhibitor": 4619,
    "Malate synthase inhibitor": 4620,
    "Malate-CoA ligase inhibitor": 4621,
    "Male reproductive disfunction treatment": 4622,
    "Maleate hydratase inhibitor": 4623,
    "Maleate isomerase inhibitor": 4624,
    "Maleylacetate reductase inhibitor": 4625,
    "Maleylacetoacetate isomerase inhibitor": 4626,
    "Malonate-semialdehyde dehydrogenase inhibitor": 4627,
    "Malonyl-CoA decarboxylase inhibitor": 4628,
    "Maltose-transporting ATPase inhibitor": 4629,
    "Malyl-CoA lyase inhibitor": 4630,
    "Mandelate 4-monooxygenase inhibitor": 4631,
    "Mandelate racemase inhibitor": 4632,
    "Manganese peroxidase inhibitor": 4633,
    "Mania": 4634,
    "Mannan endo-1,4-beta-mannosidase inhibitor": 4635,
    "Mannan endo-1,6-alpha-mannosidase inhibitor": 4636,
    "Mannitol 2-dehydrogenase inhibitor": 4637,
    "Mannitol-1-phosphatase inhibitor": 4638,
    "Mannitol-1-phosphate 5-dehydrogenase inhibitor": 4639,
    "Mannokinase inhibitor": 4640,
    "Mannonate dehydratase inhibitor": 4641,
    "Mannose isomerase inhibitor": 4642,
    "Mannose-1-phosphate guanylyltransferase inhibitor": 4643,
    "Mannose-6-phosphate isomerase inhibitor": 4644,
    "Mannosidase inhibitor": 4645,
    "Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase inhibitor": 4646,
    "Mannosyl-oligosaccharide 1,2-alpha-mannosidase inhibitor": 4647,
    "Mannosyl-oligosaccharide glucosidase inhibitor": 4648,
    "Mannotetraose 2-alpha-N-acetylglucosaminyltransferase inhibitor": 4649,
    "MarA inhibitor": 4650,
    "Mas-related G-protein coupled receptor member X1 agonist": 4651,
    "Mas-related G-protein coupled receptor member X1 antagonist": 4652,
    "Maternal embryonic leucine zipper kinase inhibitor": 4653,
    "Matrilysin inhibitor": 4654,
    "Matriptase inhibitor": 4655,
    "Matrix metalloproteinase (membrane-type) inhibitor": 4656,
    "Matrix metalloproteinase 1 (membrane-type) inhibitor": 4657,
    "Matrix metalloproteinase 1 inhibitor": 4658,
    "Matrix metalloproteinase 2 (membrane-type) inhibitor": 4659,
    "Matrix metalloproteinase 26 inhibitor": 4660,
    "Matrix metalloproteinase 3 (membrane-type) inhibitor": 4661,
    "Matrix metalloproteinase 4 (membrane-type) inhibitor": 4662,
    "Matrix metalloproteinase inhibitor": 4663,
    "Matrix protein 2 inhibitor": 4664,
    "Mcl-1 antagonist": 4665,
    "Mediator release inhibitor": 4666,
    "Melanin inhibitor": 4667,
    "Melanin-concentrating hormone receptor 1 antagonist": 4668,
    "Melanin-concentrating hormone receptor 2 antagonist": 4669,
    "Melanin-concentrating hormone receptor antagonist": 4670,
    "Melanocortin 1 agonist": 4671,
    "Melanocortin 1 antagonist": 4672,
    "Melanocortin 3 agonist": 4673,
    "Melanocortin 3 antagonist": 4674,
    "Melanocortin 4 agonist": 4675,
    "Melanocortin 4 antagonist": 4676,
    "Melanocortin 5 agonist": 4677,
    "Melanocortin 5 antagonist": 4678,
    "Melanocortin agonist": 4679,
    "Melanocortin antagonist": 4680,
    "Melatonin 1 agonist": 4681,
    "Melatonin 1 antagonist": 4682,
    "Melatonin 1a antagonist": 4683,
    "Melatonin 1b antagonist": 4684,
    "Melatonin 2 agonist": 4685,
    "Melatonin 2 antagonist": 4686,
    "Melatonin 3 antagonist": 4687,
    "Melatonin 5 antagonist": 4688,
    "Melatonin agonist": 4689,
    "Melatonin antagonist": 4690,
    "Membrane dipeptidase inhibitor": 4691,
    "Membrane integrity agonist": 4692,
    "Membrane integrity antagonist": 4693,
    "Membrane permeability enhancer": 4694,
    "Membrane-oligosaccharide glycerophosphotransferase inhibitor": 4695,
    "Memory impairment": 4696,
    "Menopausal disorders treatment": 4697,
    "Menorrhagia treatment": 4698,
    "Menstruation disorders treatment": 4699,
    "Menstruation disturbance": 4700,
    "Mental retardation treatment": 4701,
    "Meprin A inhibitor": 4702,
    "Meprin B inhibitor": 4703,
    "Metabolic disease treatment": 4704,
    "Metabolic disorders": 4705,
    "Metallocarboxypeptidase D inhibitor": 4706,
    "Metalloproteinase inhibitor": 4707,
    "Metalloproteinase-11 inhibitor": 4708,
    "Metalloproteinase-2 inhibitor": 4709,
    "Metalloproteinase-3 inhibitor": 4710,
    "Metalloproteinase-9 inhibitor": 4711,
    "Metallothionein-3 inhibitor": 4712,
    "Methane monooxygenase inhibitor": 4713,
    "Methanol dehydrogenase inhibitor": 4714,
    "Methemoglobinemia": 4715,
    "Methenyltetrahydrofolate cyclohydrolase inhibitor": 4716,
    "Methionine adenosyltransferase inhibitor": 4717,
    "Methionine decarboxylase inhibitor": 4718,
    "Methionine synthase inhibitor": 4719,
    "Methionine-tRNA ligase inhibitor": 4720,
    "Methionyl aminopeptidase 1 inhibitor": 4721,
    "Methionyl aminopeptidase 2 inhibitor": 4722,
    "Methionyl aminopeptidase inhibitor": 4723,
    "Methionyl-tRNA formyltransferase inhibitor": 4724,
    "Methylamine-glutamate N-methyltransferase inhibitor": 4725,
    "Methylaspartate ammonia-lyase inhibitor": 4726,
    "Methylaspartate mutase inhibitor": 4727,
    "Methylcrotonoyl-CoA carboxylase inhibitor": 4728,
    "Methylenetetrahydrofolate dehydrogenase (NADP+) inhibitor": 4729,
    "Methylenetetrahydrofolate reductase (NADPH) inhibitor": 4730,
    "Methylglutamate dehydrogenase inhibitor": 4731,
    "Methylglyoxal synthase inhibitor": 4732,
    "Methylmalonyl-CoA carboxytransferase inhibitor": 4733,
    "Methylmalonyl-CoA decarboxylase inhibitor": 4734,
    "Methylmalonyl-CoA epimerase inhibitor": 4735,
    "Methylmalonyl-CoA mutase inhibitor": 4736,
    "Methylquercetagetin 6-O-methyltransferase inhibitor": 4737,
    "Methylthioadenosine nucleosidase inhibitor": 4738,
    "Methyltransferase inhibitor": 4739,
    "Methyltransferase substrate": 4740,
    "Methylumbelliferyl-acetate deacetylase inhibitor": 4741,
    "Mevalonate kinase inhibitor": 4742,
    "MexAB-OprM inhibitor": 4743,
    "Microbial collagenase inhibitor": 4744,
    "Microsomal triglyceride transfer protein inhibitor": 4745,
    "Microtubule formation inhibitor": 4746,
    "Microtubule formation stimulant": 4747,
    "Microtubule stabilization": 4748,
    "Migraine": 4749,
    "Mineralocorticoid receptor agonist": 4750,
    "Mineralocorticoid receptor antagonist": 4751,
    "Miotic": 4752,
    "Misshapen-like kinase 1 inhibitor": 4753,
    "Mitochondrial electron transport inhibitor": 4754,
    "Mitochondrial intermediate peptidase inhibitor": 4755,
    "Mitochondrial processing peptidase inhibitor": 4756,
    "Mitogen-activated protein kinase kinase kinase kinase 2 inhibitor": 4757,
    "Mitogen-activated protein kinase kinase kinase kinase 4 inhibitor": 4758,
    "Mitogen-activated protein kinase kinase kinase kinase 5 inhibitor": 4759,
    "Monoacylglycerol lipase inhibitor": 4760,
    "Monoamine oxidase substrate": 4761,
    "Monoamine uptake inhibitor": 4762,
    "Monocarboxylic acid transporter 1 inhibitor": 4763,
    "Monocarboxylic acid transporter inhibitor": 4764,
    "Monodehydroascorbate reductase (NADH) inhibitor": 4765,
    "Monophenol monooxygenase inhibitor": 4766,
    "Mood disorders treatment": 4767,
    "Morphine 6-dehydrogenase inhibitor": 4768,
    "Motilin receptor agonist": 4769,
    "Motilin receptor antagonist": 4770,
    "Movement disorders treatment": 4771,
    "Mucinaminylserine mucinaminidase inhibitor": 4772,
    "Mucolipin-3 activator": 4773,
    "Mucolytic": 4774,
    "Muconate cycloisomerase inhibitor": 4775,
    "Mucorpepsin inhibitor": 4776,
    "Mucosal addressin cell adhesion molecule 1 inhibitor": 4777,
    "Mucositis treatment": 4778,
    "Multidrug resistance-associated protein 1 inhibitor": 4779,
    "Multidrug resistance-associated protein 2 inhibitor": 4780,
    "Multidrug resistance-associated protein inhibitor": 4781,
    "Multiple inositol-polyphosphate phosphatase inhibitor": 4782,
    "Multiple organ failure": 4783,
    "Multiple sclerosis treatment": 4784,
    "Muramoyltetrapeptide carboxypeptidase inhibitor": 4785,
    "Muscle relaxant": 4786,
    "Muscle rigidity": 4787,
    "Muscle weakness": 4788,
    "Muscular dystrophy treatment": 4789,
    "Mutagenic": 4790,
    "Mutagenic, Salmonella": 4791,
    "Myalgia": 4792,
    "Myasthenia Gravis": 4793,
    "Myasthenia Gravis treatment": 4794,
    "Myc inhibitor": 4795,
    "Mycodextranase inhibitor": 4796,
    "Mycolysin inhibitor": 4797,
    "Mycothiol-S-conjugate amidase inhibitor": 4798,
    "Mydriatic": 4799,
    "Myelin associated glycoprotein antagonist": 4800,
    "Myeloblastin inhibitor": 4801,
    "Myelodysplastic syndrome treatment": 4802,
    "Myeloperoxidase inhibitor": 4803,
    "Myocardial infarction": 4804,
    "Myocardial infarction treatment": 4805,
    "Myocardial ischemia treatment": 4806,
    "Myocarditis": 4807,
    "Myoclonus": 4808,
    "Myoglobinuria": 4809,
    "Myopathy": 4810,
    "Myopia": 4811,
    "Myosin ATPase inhibitor": 4812,
    "Myosin-light-chain-phosphatase inhibitor": 4813,
    "Myotonin-protein kinase inhibitor": 4814,
    "Myristoyl transferase 1 inhibitor": 4815,
    "Myristoyl transferase 2 inhibitor": 4816,
    "Myristoyl transferase inhibitor": 4817,
    "Myt1 kinase inhibitor": 4818,
    "N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase inhibitor": 4819,
    "N-(long-chain-acyl)ethanolamine deacylase inhibitor": 4820,
    "N-Acetylated alpha-linked acidic dipeptidase inhibitor": 4821,
    "N-Acyl-D-amino-acid deacylase inhibitor": 4822,
    "N-Acyl-D-aspartate deacylase inhibitor": 4823,
    "N-Carbamoyl-D-amino acid hydrolase inhibitor": 4824,
    "N-acetyl-gamma-glutamyl-phosphate reductase inhibitor": 4825,
    "N-acetylgalactosamine-4-sulfatase inhibitor": 4826,
    "N-acetylglucosamine kinase inhibitor": 4827,
    "N-acetylglucosamine-6-phosphate deacetylase inhibitor": 4828,
    "N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase inhibitor": 4829,
    "N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase inhibitor": 4830,
    "N-acetyllactosamine synthase inhibitor": 4831,
    "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase inhibitor": 4832,
    "N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase inhibitor": 4833,
    "N-acetylmuramoyl-L-alanine amidase inhibitor": 4834,
    "N-acetylneuraminate 4-O-acetyltransferase inhibitor": 4835,
    "N-acetylneuraminate 7-O(or 9-O)-acetyltransferase inhibitor": 4836,
    "N-acetylneuraminate lyase inhibitor": 4837,
    "N-acetylneuraminate synthase inhibitor": 4838,
    "N-acylmannosamine kinase inhibitor": 4839,
    "N-acylneuraminate cytidylyltransferase inhibitor": 4840,
    "N-benzyloxycarbonylglycine hydrolase inhibitor": 4841,
    "N-carbamoyl-L-amino-acid hydrolase inhibitor": 4842,
    "N-formyl receptor agonist": 4843,
    "N-formylglutamate deformylase inhibitor": 4844,
    "N-formylmethionyl-peptidase inhibitor": 4845,
    "N-hydroxy-2-acetamidofluorene reductase inhibitor": 4846,
    "N-hydroxyarylamine O-acetyltransferase inhibitor": 4847,
    "N-methyl-2-oxoglutaramate hydrolase inhibitor": 4848,
    "N-methylhydantoinase (ATP-hydrolysing) inhibitor": 4849,
    "N1L inhibitor": 4850,
    "N4-(beta-N-acetylglucosaminyl)-L-asparaginase inhibitor": 4851,
    "N4BP1 expression inhibitor": 4852,
    "N6-methyl-lysine oxidase inhibitor": 4853,
    "NAA15 expression enhancer": 4854,
    "NACA expression inhibitor": 4855,
    "NACHT, LRR and PYD domains-containing protein 3 inhibitor": 4856,
    "NAD(P)+ transhydrogenase (AB-specific) inhibitor": 4857,
    "NAD(P)+ transhydrogenase (B-specific) inhibitor": 4858,
    "NAD(P)+-arginine ADP-ribosyltransferase inhibitor": 4859,
    "NAD(P)H dehydrogenase (quinone) 1 inhibitor": 4860,
    "NAD(P)H dehydrogenase (quinone) inhibitor": 4861,
    "NAD+ diphosphatase inhibitor": 4862,
    "NAD+ kinase inhibitor": 4863,
    "NAD+ nucleosidase inhibitor": 4864,
    "NAD+ synthase (glutamine-hydrolysing) inhibitor": 4865,
    "NAD+-dinitrogen-reductase ADP-D-ribosyltransferase inhibitor": 4866,
    "NADH dehydrogenase inhibitor": 4867,
    "NADH kinase inhibitor": 4868,
    "NADH oxidase inhibitor": 4869,
    "NADH peroxidase inhibitor": 4870,
    "NADPH oxidase 1 inhibitor": 4871,
    "NADPH oxidase 4 inhibitor": 4872,
    "NADPH oxidase inhibitor": 4873,
    "NADPH oxidoreductase inhibitor": 4874,
    "NADPH peroxidase inhibitor": 4875,
    "NADPH-cytochrome-c2 reductase inhibitor": 4876,
    "NADPH-ferrihemoprotein reductase inhibitor": 4877,
    "NAMPT expression enhancer": 4878,
    "NARS expression inhibitor": 4879,
    "NASP expression inhibitor": 4880,
    "NAT1 expression enhancer": 4881,
    "NAT1 expression inhibitor": 4882,
    "NAT1 substrate": 4883,
    "NAT2 substrate": 4884,
    "NAV1 expression inhibitor": 4885,
    "NAV2 expression inhibitor": 4886,
    "NBL1 expression enhancer": 4887,
    "NBN expression inhibitor": 4888,
    "NCAPD2 expression enhancer": 4889,
    "NCAPG expression enhancer": 4890,
    "NCAPH expression inhibitor": 4891,
    "NCF1 expression enhancer": 4892,
    "NCF2 expression enhancer": 4893,
    "NCK2 expression inhibitor": 4894,
    "NCL expression inhibitor": 4895,
    "NCOA1 expression enhancer": 4896,
    "NCOA1 expression inhibitor": 4897,
    "NCOA2 expression enhancer": 4898,
    "NCOA3 expression inhibitor": 4899,
    "NCOR2 expression enhancer": 4900,
    "NCOR2 expression inhibitor": 4901,
    "NDC80 expression enhancer": 4902,
    "NDC80 expression inhibitor": 4903,
    "NDE1 expression inhibitor": 4904,
    "NDRG1 expression enhancer": 4905,
    "NDUFV1 expression enhancer": 4906,
    "NEDD4L expression inhibitor": 4907,
    "NEDD9 expression enhancer": 4908,
    "NEDD9 expression inhibitor": 4909,
    "NEFL expression inhibitor": 4910,
    "NEIL2 expression enhancer": 4911,
    "NEIL3 expression inhibitor": 4912,
    "NEK4 expression inhibitor": 4913,
    "NENF expression enhancer": 4914,
    "NEU4 expression enhancer": 4915,
    "NF-E2-related factor 2 stimulant": 4916,
    "NF-kappa-B essential modulator inhibitor": 4917,
    "NF1 expression inhibitor": 4918,
    "NFAT5 expression enhancer": 4919,
    "NFE2L2 expression enhancer": 4920,
    "NFE2L2 expression inhibitor": 4921,
    "NFIB expression enhancer": 4922,
    "NFKB1 expression enhancer": 4923,
    "NFKB1 expression inhibitor": 4924,
    "NFKBIA expression enhancer": 4925,
    "NFKBIA expression inhibitor": 4926,
    "NFKBIE expression inhibitor": 4927,
    "NFYB expression inhibitor": 4928,
    "NGFR expression enhancer": 4929,
    "NHLRC2 expression inhibitor": 4930,
    "NKD1 expression inhibitor": 4931,
    "NKTR expression inhibitor": 4932,
    "NKX3-1 expression enhancer": 4933,
    "NKX3-1 expression inhibitor": 4934,
    "NLRP1 expression enhancer": 4935,
    "NMDA 2 receptor antagonist": 4936,
    "NMDA 2A receptor antagonist": 4937,
    "NMDA 2B receptor antagonist": 4938,
    "NMDA receptor agonist": 4939,
    "NMDA receptor antagonist": 4940,
    "NMDA receptor glutamate site antagonist": 4941,
    "NMDA receptor glycine site B antagonist": 4942,
    "NMDA receptor glycine site agonist": 4943,
    "NMDA receptor glycine site antagonist": 4944,
    "NMDA receptor phencyclidine site antagonist": 4945,
    "NMDA receptor polyamine site agonist": 4946,
    "NMDA receptor polyamine site antagonist": 4947,
    "NMDA receptor subunit 3A antagonist": 4948,
    "NMDA receptor subunit 3B antagonist": 4949,
    "NME1 expression enhancer": 4950,
    "NME1 expression inhibitor": 4951,
    "NME2 expression inhibitor": 4952,
    "NMN nucleosidase inhibitor": 4953,
    "NMT1 expression inhibitor": 4954,
    "NOC3L expression inhibitor": 4955,
    "NOLC1 expression inhibitor": 4956,
    "NOM1 expression inhibitor": 4957,
    "NOS1 expression enhancer": 4958,
    "NOS1 expression inhibitor": 4959,
    "NOS2 expression enhancer": 4960,
    "NOS2 expression inhibitor": 4961,
    "NOS3 expression enhancer": 4962,
    "NOS3 expression inhibitor": 4963,
    "NOTCH1 expression enhancer": 4964,
    "NOTCH1 expression inhibitor": 4965,
    "NOV expression inhibitor": 4966,
    "NPC1 expression inhibitor": 4967,
    "NPM1 expression inhibitor": 4968,
    "NPM3 expression inhibitor": 4969,
    "NPTX2 expression enhancer": 4970,
    "NQO1 expression enhancer": 4971,
    "NQO1 expression inhibitor": 4972,
    "NR0B2 expression enhancer": 4973,
    "NR0B2 expression inhibitor": 4974,
    "NR1H2 expression inhibitor": 4975,
    "NR1H3 expression enhancer": 4976,
    "NR1H4 expression inhibitor": 4977,
    "NR2F1 expression enhancer": 4978,
    "NR3C1 expression inhibitor": 4979,
    "NR4A1 expression enhancer": 4980,
    "NR4A2 expression enhancer": 4981,
    "NR4A2 expression inhibitor": 4982,
    "NR5A1 expression enhancer": 4983,
    "NR5A2 expression enhancer": 4984,
    "NRG1 expression inhibitor": 4985,
    "NRIP1 expression enhancer": 4986,
    "NRP1 expression inhibitor": 4987,
    "NRTN expression enhancer": 4988,
    "NT5DC2 expression enhancer": 4989,
    "NTN4 expression enhancer": 4990,
    "NTPase/helicase (JEV) inhibitor": 4991,
    "NTPase/helicase (WNF) inhibitor": 4992,
    "NUDT11 expression enhancer": 4993,
    "NUDT3 expression inhibitor": 4994,
    "NUMA1 expression inhibitor": 4995,
    "NUPR1 expression enhancer": 4996,
    "NUSAP1 expression enhancer": 4997,
    "NXT2 expression enhancer": 4998,
    "Na+ K+ transporting ATPase inhibitor": 4999,
    "Na+-transporting two-sector ATPase inhibitor": 5000,
    "Naphthalene 1,2-dioxygenase inhibitor": 5001,
    "Narcolepsy treatment": 5002,
    "Narcotic": 5003,
    "Narcotic antagonist": 5004,
    "Nardilysin inhibitor": 5005,
    "Nasal congestion": 5006,
    "Natural killer cell stimulant": 5007,
    "Nausea": 5008,
    "Nav11 sodium channel blocker": 5009,
    "Nav12 sodium channel blocker": 5010,
    "Nav13 sodium channel blocker": 5011,
    "Nav14 sodium channel blocker": 5012,
    "Nav15 sodium channel blocker": 5013,
    "Nav16 sodium channel blocker": 5014,
    "Nav17 sodium channel blocker": 5015,
    "Nav18 sodium channel blocker": 5016,
    "Neck pain": 5017,
    "Necroptosis inhibitor": 5018,
    "Necrosis": 5019,
    "Necrosis treatment": 5020,
    "Neolactotetraosylceramide alpha-2,3-sialyltransferase inhibitor": 5021,
    "Nephritis": 5022,
    "Nephrotic syndrome": 5023,
    "Nephrotoxic": 5024,
    "Nerve growth factor agonist": 5025,
    "Nerve growth factor antagonist": 5026,
    "Neuraminidase (Influenza A) inhibitor": 5027,
    "Neuraminidase (Influenza B) inhibitor": 5028,
    "Neuraminidase (influenza) inhibitor": 5029,
    "Neuraminidase inhibitor": 5030,
    "Neuritis": 5031,
    "Neurodegenerative diseases treatment": 5032,
    "Neurokinin 1 agonist": 5033,
    "Neurokinin 1 antagonist": 5034,
    "Neurokinin 2 agonist": 5035,
    "Neurokinin 2 antagonist": 5036,
    "Neurokinin 3 agonist": 5037,
    "Neurokinin 3 antagonist": 5038,
    "Neurokinin agonist": 5039,
    "Neurokinin antagonist": 5040,
    "Neuroleptic malignant syndrome": 5041,
    "Neurolysin inhibitor": 5042,
    "Neuronal K-Cl cotransporter inhibitor": 5043,
    "Neuronal nicotinic receptor antagonist": 5044,
    "Neuronal nitric-oxide synthase inhibitor": 5045,
    "Neuropathy treatment": 5046,
    "Neuropeptide FF agonist": 5047,
    "Neuropeptide FF antagonist": 5048,
    "Neuropeptide FF1 agonist": 5049,
    "Neuropeptide FF1 antagonist": 5050,
    "Neuropeptide FF2 agonist": 5051,
    "Neuropeptide FF2 antagonist": 5052,
    "Neuropeptide S antagonist": 5053,
    "Neuropeptide Y agonist": 5054,
    "Neuropeptide Y antagonist": 5055,
    "Neuropeptide Y1 agonist": 5056,
    "Neuropeptide Y1 antagonist": 5057,
    "Neuropeptide Y2 antagonist": 5058,
    "Neuropeptide Y4 agonist": 5059,
    "Neuropeptide Y4 antagonist": 5060,
    "Neuropeptide Y5 antagonist": 5061,
    "Neuropeptide agonist": 5062,
    "Neuropeptide antagonist": 5063,
    "Neuropilin-1 inhibitor": 5064,
    "Neuroprotector": 5065,
    "Neuropsin inhibitor": 5066,
    "Neurotensin 1 receptor agonist": 5067,
    "Neurotensin 1 receptor antagonist": 5068,
    "Neurotensin 2 receptor antagonist": 5069,
    "Neurotensin 3 receptor antagonist": 5070,
    "Neurotensin receptor 1 agonist": 5071,
    "Neurotensin receptor 2 agonist": 5072,
    "Neurotensin receptor agonist": 5073,
    "Neurotensin receptor antagonist": 5074,
    "Neurotoxic": 5075,
    "Neurotransmitter agonist": 5076,
    "Neurotransmitter antagonist": 5077,
    "Neurotransmitter uptake inhibitor": 5078,
    "Neurotrophic factor": 5079,
    "Neurotrophic factor enhancer": 5080,
    "Neutral endopeptidase inhibitor": 5081,
    "Neutropenia": 5082,
    "Neutropenia treatment": 5083,
    "Neutrophil collagenase inhibitor": 5084,
    "Neutrophil fMLF receptor antagonist": 5085,
    "Nicastrin inhibitor": 5086,
    "Nicotinamidase inhibitor": 5087,
    "Nicotinamide phosphoribosyltransferase inhibitor": 5088,
    "Nicotinamide-nucleotide adenylyltransferase inhibitor": 5089,
    "Nicotinamide-nucleotide amidase inhibitor": 5090,
    "Nicotinate dehydrogenase inhibitor": 5091,
    "Nicotinate phosphoribosyltransferase inhibitor": 5092,
    "Nicotinate-nucleotide diphosphorylase (carboxylating) inhibitor": 5093,
    "Nicotine dehydrogenase inhibitor": 5094,
    "Nicotinic acid receptor 1 agonist": 5095,
    "Nicotinic acid receptor 1 antagonist": 5096,
    "Nicotinic acid receptor 2 agonist": 5097,
    "Nicotinic acid receptor 2 antagonist": 5098,
    "Nicotinic acid receptor agonist": 5099,
    "Nicotinic acid receptor antagonist": 5100,
    "Nicotinic alpha1beta1deltagamma receptor antagonist": 5101,
    "Nicotinic alpha2beta2 receptor antagonist": 5102,
    "Nicotinic alpha2beta4 receptor agonist": 5103,
    "Nicotinic alpha3beta2 receptor antagonist": 5104,
    "Nicotinic alpha3beta4 receptor agonist": 5105,
    "Nicotinic alpha3beta4 receptor antagonist": 5106,
    "Nicotinic alpha4 receptor agonist": 5107,
    "Nicotinic alpha4beta2 receptor agonist": 5108,
    "Nicotinic alpha4beta2 receptor antagonist": 5109,
    "Nicotinic alpha4beta4 receptor agonist": 5110,
    "Nicotinic alpha4beta4 receptor antagonist": 5111,
    "Nicotinic alpha6 receptor agonist": 5112,
    "Nicotinic alpha6beta3beta4alpha5 receptor antagonist": 5113,
    "Nicotinic alpha7 receptor agonist": 5114,
    "Nicotinic neuronal receptor agonist": 5115,
    "Nicotinic receptor alpha1 subunit agonist": 5116,
    "Nicotinic receptor alpha1 subunit antagonist": 5117,
    "Nicotinic receptor alpha10 subunit antagonist": 5118,
    "Nicotinic receptor alpha2 subunit antagonist": 5119,
    "Nicotinic receptor alpha3 subunit antagonist": 5120,
    "Nicotinic receptor alpha4 subunit antagonist": 5121,
    "Nicotinic receptor alpha5 subunit antagonist": 5122,
    "Nicotinic receptor alpha6 subunit antagonist": 5123,
    "Nicotinic receptor alpha7 subunit antagonist": 5124,
    "Nicotinic receptor alpha9 subunit antagonist": 5125,
    "Nicotinic receptor beta1 subunit antagonist": 5126,
    "Nicotinic receptor beta2 subunit antagonist": 5127,
    "Nicotinic receptor beta3 subunit antagonist": 5128,
    "Nicotinic receptor beta4 subunit antagonist": 5129,
    "Nicotinic receptor delta subunit antagonist": 5130,
    "Nicotinic receptor epsilon subunit antagonist": 5131,
    "Nicotinic receptor gamma subunit antagonist": 5132,
    "Niemann-Pick C1-like 1 protein antagonist": 5133,
    "Nightmare": 5134,
    "Nitrate reductase (cytochrome) inhibitor": 5135,
    "Nitrate reductase inhibitor": 5136,
    "Nitric oxide antagonist": 5137,
    "Nitric oxide donor": 5138,
    "Nitric oxide scavenger": 5139,
    "Nitric-oxide reductase inhibitor": 5140,
    "Nitric-oxide synthase inhibitor": 5141,
    "Nitric-oxide synthase stimulant": 5142,
    "Nitrilase inhibitor": 5143,
    "Nitrile hydratase inhibitor": 5144,
    "Nitrite reductase (NO-forming) inhibitor": 5145,
    "Nitrite reductase [NAD(P)H] inhibitor": 5146,
    "Nitrous-oxide reductase inhibitor": 5147,
    "Nociceptin (N/OFQ) receptor agonist": 5148,
    "Nociceptin (N/OFQ) receptor antagonist": 5149,
    "Non mutagenic, Salmonella": 5150,
    "Non-steroidal antiinflammatory agent": 5151,
    "Nonstructural protein 1 (Influenza A) inhibitor": 5152,
    "Nootropic": 5153,
    "Nuclear factor of activated T-cells cytoplasmic 2 inhibitor": 5154,
    "Nuclear receptor ROR-alpha inhibitor": 5155,
    "Nuclear receptor ROR-gamma inhibitor": 5156,
    "Nuclear receptor coactivator 3 inhibitor": 5157,
    "Nuclear receptor corepressor 2 inhibitor": 5158,
    "Nuclear receptor subfamily 1 group D member 1 agonist": 5159,
    "Nuclear receptor subfamily 2, group E, member 3 agonist": 5160,
    "Nuclear receptor subfamily 4, group A, member 2 agonist": 5161,
    "Nuclease inhibitor": 5162,
    "Nucleophosmin inhibitor": 5163,
    "Nucleoside deoxyribosyltransferase inhibitor": 5164,
    "Nucleoside oxidase (H2O2-forming) inhibitor": 5165,
    "Nucleoside phosphoacylhydrolase inhibitor": 5166,
    "Nucleoside transporters inhibitor": 5167,
    "Nucleoside-diphosphatase inhibitor": 5168,
    "Nucleoside-triphosphate diphosphatase inhibitor": 5169,
    "Nucleoside-triphosphate-adenylate kinase inhibitor": 5170,
    "Nucleotidase inhibitor": 5171,
    "Nucleotide diphosphatase inhibitor": 5172,
    "Nucleotide metabolism regulator": 5173,
    "Nucleotide-binding oligomerization domain-containing protein 1 inhibitor": 5174,
    "Nucleotide-binding oligomerization domain-containing protein 2 inhibitor": 5175,
    "Nucleotidyltransferase (FIV) inhibitor": 5176,
    "Nucleotidyltransferase inhibitor": 5177,
    "Nystagmus": 5178,
    "O-acetylhomoserine aminocarboxypropyltransferase inhibitor": 5179,
    "O-aminophenol oxidase inhibitor": 5180,
    "O6-alkylguanine-DNA alkyltransferase inhibitor": 5181,
    "O6-alkylguanine-DNA alkyltransferase stimulant": 5182,
    "OAS1 expression enhancer": 5183,
    "OAS2 expression enhancer": 5184,
    "OCLN expression enhancer": 5185,
    "ODC1 expression enhancer": 5186,
    "ODC1 expression inhibitor": 5187,
    "ODZ3 expression inhibitor": 5188,
    "OLFM1 expression enhancer": 5189,
    "OLFM4 expression enhancer": 5190,
    "OLFML3 expression enhancer": 5191,
    "OLR1 expression enhancer": 5192,
    "OPN3 expression enhancer": 5193,
    "OPRK1 expression inhibitor": 5194,
    "ORC4 expression enhancer": 5195,
    "OS9 expression enhancer": 5196,
    "OSBP2 expression inhibitor": 5197,
    "OSBPL1A expression inhibitor": 5198,
    "OSBPL7 expression enhancer": 5199,
    "OSGIN1 expression enhancer": 5200,
    "OSR2 expression enhancer": 5201,
    "Obsessive-compulsive disorder treatment": 5202,
    "Occult bleeding": 5203,
    "Octadecanal decarbonylase inhibitor": 5204,
    "Octopamine agonist": 5205,
    "Octopamine antagonist": 5206,
    "Ocular toxicity": 5207,
    "Oculogyric crisis": 5208,
    "Odynophagia": 5209,
    "Oleamide hydrolase inhibitor": 5210,
    "Oligo-1,6-glucosidase inhibitor": 5211,
    "Oligonucleotidase inhibitor": 5212,
    "Oligopeptidase B inhibitor": 5213,
    "Oliguria": 5214,
    "Omega-amidase inhibitor": 5215,
    "Omptin inhibitor": 5216,
    "Onycholysis": 5217,
    "Opheline kinase inhibitor": 5218,
    "Ophthalmic drug": 5219,
    "Ophthalmoplegia": 5220,
    "Opine dehydrogenase inhibitor": 5221,
    "Opioid agonist": 5222,
    "Opioid antagonist": 5223,
    "Opioid delta 1 receptor antagonist": 5224,
    "Opioid delta 2 receptor antagonist": 5225,
    "Opioid delta receptor agonist": 5226,
    "Opioid delta receptor antagonist": 5227,
    "Opioid dependency treatment": 5228,
    "Opioid kappa 1 receptor antagonist": 5229,
    "Opioid kappa 2 receptor antagonist": 5230,
    "Opioid kappa 2b receptor antagonist": 5231,
    "Opioid kappa 3 receptor antagonist": 5232,
    "Opioid kappa receptor agonist": 5233,
    "Opioid kappa receptor antagonist": 5234,
    "Opioid mu 1 receptor antagonist": 5235,
    "Opioid mu 2 receptor antagonist": 5236,
    "Opioid mu receptor agonist": 5237,
    "Opioid mu receptor antagonist": 5238,
    "Opioid partial agonist": 5239,
    "Optic neuritis": 5240,
    "Optic neuropathy": 5241,
    "Orcinol 2-monooxygenase inhibitor": 5242,
    "Orexin receptor 1 antagonist": 5243,
    "Orexin receptor 2 antagonist": 5244,
    "Orexin receptor antagonist": 5245,
    "Ornithine carbamoyltransferase inhibitor": 5246,
    "Ornithine cyclodeaminase inhibitor": 5247,
    "Ornithine decarboxylase inhibitor": 5248,
    "Ornithine-oxo-acid transaminase inhibitor": 5249,
    "Orotate phosphoribosyltransferase inhibitor": 5250,
    "Orotate reductase (NADH) inhibitor": 5251,
    "Orotate reductase (NADPH) inhibitor": 5252,
    "Orotidylate decarboxylase inhibitor": 5253,
    "Orsellinate decarboxylase inhibitor": 5254,
    "Oryzin inhibitor": 5255,
    "Osmosis stimulant non-diuretic": 5256,
    "Osmotic diuretic": 5257,
    "Osteoarthritis treatment": 5258,
    "Osteoclast antagonist": 5259,
    "Osteoporosis": 5260,
    "Ototoxicity": 5261,
    "Ovulation inhibitor": 5262,
    "Oxalate oxidase inhibitor": 5263,
    "Oxaloacetate decarboxylase inhibitor": 5264,
    "Oxaloacetate tautomerase inhibitor": 5265,
    "Oxidizing agent": 5266,
    "Oxidoreductase inhibitor": 5267,
    "Oxoglutarate dehydrogenase (lipoamide) inhibitor": 5268,
    "Oxygen scavenger": 5269,
    "Oxytocic": 5270,
    "Oxytocin agonist": 5271,
    "Oxytocin antagonist": 5272,
    "P-benzoquinone reductase (NADPH) inhibitor": 5273,
    "P-glycoprotein 1 inhibitor": 5274,
    "P-glycoprotein 3 inhibitor": 5275,
    "P-glycoprotein inhibitor": 5276,
    "P-glycoprotein substrate": 5277,
    "P2 nucleoside transporter inhibitor": 5278,
    "P3 purinoceptor-like protein antagonist": 5279,
    "PA2G4 expression inhibitor": 5280,
    "PABPC1 expression inhibitor": 5281,
    "PACSIN2 expression inhibitor": 5282,
    "PADI3 expression enhancer": 5283,
    "PAFAH1B1 expression inhibitor": 5284,
    "PAH expression inhibitor": 5285,
    "PAICS expression enhancer": 5286,
    "PAK2 expression inhibitor": 5287,
    "PAPPA expression enhancer": 5288,
    "PAPSS1 expression inhibitor": 5289,
    "PAPSS2 expression inhibitor": 5290,
    "PARD3 expression inhibitor": 5291,
    "PARG expression enhancer": 5292,
    "PARP1 expression enhancer": 5293,
    "PARP14 expression enhancer": 5294,
    "PAWR expression inhibitor": 5295,
    "PBK expression enhancer": 5296,
    "PBK expression inhibitor": 5297,
    "PCBP2 expression inhibitor": 5298,
    "PCDH8 expression enhancer": 5299,
    "PCNA expression enhancer": 5300,
    "PCNA expression inhibitor": 5301,
    "PCOLCE2 expression enhancer": 5302,
    "PCP4 expression enhancer": 5303,
    "PDAP1 expression inhibitor": 5304,
    "PDCD4 expression enhancer": 5305,
    "PDCD4 expression inhibitor": 5306,
    "PDCD7 expression enhancer": 5307,
    "PDE4DIP expression inhibitor": 5308,
    "PDE9A expression inhibitor": 5309,
    "PDGFA expression enhancer": 5310,
    "PDIA3 expression enhancer": 5311,
    "PDK1 expression inhibitor": 5312,
    "PDK4 expression enhancer": 5313,
    "PDLIM5 expression enhancer": 5314,
    "PDS5B expression enhancer": 5315,
    "PDSS2 expression inhibitor": 5316,
    "PDXK expression inhibitor": 5317,
    "PDZ-binding kinase inhibitor": 5318,
    "PDZK1 expression enhancer": 5319,
    "PDZK1 expression inhibitor": 5320,
    "PECAM1 expression inhibitor": 5321,
    "PEG10 expression inhibitor": 5322,
    "PELI1 expression enhancer": 5323,
    "PER1 expression enhancer": 5324,
    "PFKFB3 expression inhibitor": 5325,
    "PFKP expression enhancer": 5326,
    "PFN1 expression inhibitor": 5327,
    "PGM2 expression enhancer": 5328,
    "PGR expression enhancer": 5329,
    "PGR expression inhibitor": 5330,
    "PHB expression inhibitor": 5331,
    "PHF17 expression inhibitor": 5332,
    "PHF20 expression inhibitor": 5333,
    "PHGDH expression inhibitor": 5334,
    "PHLDA1 expression enhancer": 5335,
    "PHLDA2 expression enhancer": 5336,
    "PHYH expression enhancer": 5337,
    "PI4-kinase alpha inhibitor": 5338,
    "PI4-kinase beta inhibitor": 5339,
    "PI4-kinase type II inhibitor": 5340,
    "PI4KA expression inhibitor": 5341,
    "PICALM expression inhibitor": 5342,
    "PIK3CD expression enhancer": 5343,
    "PIK3CD expression inhibitor": 5344,
    "PIM1 expression enhancer": 5345,
    "PIM1 expression inhibitor": 5346,
    "PIN1 expression inhibitor": 5347,
    "PIP5K1B expression inhibitor": 5348,
    "PIR expression enhancer": 5349,
    "PJA1 expression enhancer": 5350,
    "PKP4 expression inhibitor": 5351,
    "PLA2G16 expression enhancer": 5352,
    "PLA2G2A expression enhancer": 5353,
    "PLA2G4A expression enhancer": 5354,
    "PLA2G7 expression inhibitor": 5355,
    "PLAGL1 expression enhancer": 5356,
    "PLAT expression enhancer": 5357,
    "PLAU expression enhancer": 5358,
    "PLAU expression inhibitor": 5359,
    "PLAUR expression enhancer": 5360,
    "PLAUR expression inhibitor": 5361,
    "PLCB1 expression enhancer": 5362,
    "PLCB1 expression inhibitor": 5363,
    "PLD1 expression enhancer": 5364,
    "PLD2 expression enhancer": 5365,
    "PLEC expression inhibitor": 5366,
    "PLIN2 expression enhancer": 5367,
    "PLK3 expression enhancer": 5368,
    "PLK4 expression enhancer": 5369,
    "PLOD1 expression enhancer": 5370,
    "PLOD2 expression enhancer": 5371,
    "PLSCR1 expression enhancer": 5372,
    "PLXDC2 expression enhancer": 5373,
    "PLXNA2 expression enhancer": 5374,
    "PLXNA2 expression inhibitor": 5375,
    "PMAIP1 expression enhancer": 5376,
    "PMEPA1 expression inhibitor": 5377,
    "PML expression inhibitor": 5378,
    "PNN expression inhibitor": 5379,
    "PNPT1 expression inhibitor": 5380,
    "POLE2 expression enhancer": 5381,
    "POLE2 expression inhibitor": 5382,
    "POLR2A expression enhancer": 5383,
    "POLR2C expression enhancer": 5384,
    "PON1 expression enhancer": 5385,
    "POR expression enhancer": 5386,
    "PPAP2B expression inhibitor": 5387,
    "PPAP2C expression inhibitor": 5388,
    "PPARA expression enhancer": 5389,
    "PPARA expression inhibitor": 5390,
    "PPARD expression enhancer": 5391,
    "PPARD expression inhibitor": 5392,
    "PPARG expression enhancer": 5393,
    "PPARG expression inhibitor": 5394,
    "PPARGC1A expression enhancer": 5395,
    "PPIC expression enhancer": 5396,
    "PPIF expression enhancer": 5397,
    "PPL expression inhibitor": 5398,
    "PPM1D expression enhancer": 5399,
    "PPP1CA expression inhibitor": 5400,
    "PPP1R15A expression enhancer": 5401,
    "PPP1R3C expression inhibitor": 5402,
    "PPP1R9A expression inhibitor": 5403,
    "PPP2R2C expression enhancer": 5404,
    "PPP3CA expression inhibitor": 5405,
    "PRC1 expression enhancer": 5406,
    "PRDM2 expression inhibitor": 5407,
    "PRDX1 expression enhancer": 5408,
    "PRDX1 expression inhibitor": 5409,
    "PRDX2 expression enhancer": 5410,
    "PRDX4 expression enhancer": 5411,
    "PRDX6 expression enhancer": 5412,
    "PRIM1 expression enhancer": 5413,
    "PRKAR2A expression enhancer": 5414,
    "PRKAR2B expression enhancer": 5415,
    "PRKCA expression enhancer": 5416,
    "PRKCA expression inhibitor": 5417,
    "PRKCB expression enhancer": 5418,
    "PRKCD expression inhibitor": 5419,
    "PRKDC expression inhibitor": 5420,
    "PRKX expression enhancer": 5421,
    "PRL phosphatase inhibitor": 5422,
    "PRMT2 expression enhancer": 5423,
    "PRNP expression enhancer": 5424,
    "PRRX1 expression inhibitor": 5425,
    "PRSS23 expression enhancer": 5426,
    "PRUNE2 expression inhibitor": 5427,
    "PSAP expression enhancer": 5428,
    "PSAT1 expression enhancer": 5429,
    "PSAT1 expression inhibitor": 5430,
    "PSCA expression inhibitor": 5431,
    "PSMB4 expression enhancer": 5432,
    "PSMB6 expression inhibitor": 5433,
    "PSMB8 expression enhancer": 5434,
    "PSMB9 expression enhancer": 5435,
    "PSMC1 expression enhancer": 5436,
    "PSMD3 expression inhibitor": 5437,
    "PSMD6 expression enhancer": 5438,
    "PSPH expression inhibitor": 5439,
    "PSRC1 expression inhibitor": 5440,
    "PTAFR expression inhibitor": 5441,
    "PTEN expression enhancer": 5442,
    "PTEN expression inhibitor": 5443,
    "PTGER2 expression enhancer": 5444,
    "PTGER3 expression enhancer": 5445,
    "PTGER4 expression enhancer": 5446,
    "PTGES expression enhancer": 5447,
    "PTGR1 expression enhancer": 5448,
    "PTGS1 expression enhancer": 5449,
    "PTGS2 expression enhancer": 5450,
    "PTGS2 expression inhibitor": 5451,
    "PTHLH expression inhibitor": 5452,
    "PTK2 expression inhibitor": 5453,
    "PTN expression enhancer": 5454,
    "PTP4A1 expression enhancer": 5455,
    "PTPN1 expression inhibitor": 5456,
    "PTPN13 expression enhancer": 5457,
    "PTPN3 expression inhibitor": 5458,
    "PTPRC expression enhancer": 5459,
    "PTPRE expression enhancer": 5460,
    "PTPRK expression inhibitor": 5461,
    "PTPRM expression enhancer": 5462,
    "PTPRO expression inhibitor": 5463,
    "PTX3 expression inhibitor": 5464,
    "Paget's disease treatment": 5465,
    "Pain": 5466,
    "Pallor": 5467,
    "Palmitoyl-CoA hydrolase inhibitor": 5468,
    "Palmitoyl-CoA oxidase inhibitor": 5469,
    "Palpitation": 5470,
    "Pancreatic alpha-amylase inhibitor": 5471,
    "Pancreatic disorders treatment": 5472,
    "Pancreatic elastase inhibitor": 5473,
    "Pancreatic endopeptidase E inhibitor": 5474,
    "Pancreatic ribonuclease inhibitor": 5475,
    "Pancreatitis": 5476,
    "Pancytopenia": 5477,
    "Panic": 5478,
    "Pantetheine-phosphate adenylyltransferase inhibitor": 5479,
    "Pantoate 4-dehydrogenase inhibitor": 5480,
    "Pantoate-beta-alanine ligase inhibitor": 5481,
    "Pantothenase inhibitor": 5482,
    "Pantothenate kinase inhibitor": 5483,
    "Papain inhibitor": 5484,
    "Papillary necrosis": 5485,
    "Pappalysin-1 inhibitor": 5486,
    "Papules": 5487,
    "Para amino benzoic acid antagonist": 5488,
    "Paralysis": 5489,
    "Paranoia": 5490,
    "Paraoxonase substrate": 5491,
    "Paraplegia": 5492,
    "Parathyroid hormone antagonist": 5493,
    "Parathyroid hormone secretion stimulant": 5494,
    "Parkinsonism": 5495,
    "Parotid gland enlargement": 5496,
    "Pectate lyase inhibitor": 5497,
    "Pectin lyase inhibitor": 5498,
    "Pediculicide": 5499,
    "Pemphigus": 5500,
    "Penicillin amidase inhibitor": 5501,
    "Penicillin binding protein 2 antagonist": 5502,
    "Penicillin binding protein antagonist": 5503,
    "Penicillin-binding protein ampH inhibitor": 5504,
    "Penicillopepsin inhibitor": 5505,
    "Pepsin inhibitor": 5506,
    "Peptide agonist": 5507,
    "Peptide alpha-N-acetyltransferase inhibitor": 5508,
    "Peptide deformylase inhibitor": 5509,
    "Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase inhibitor": 5510,
    "Peptide-tryptophan 2,3-dioxygenase inhibitor": 5511,
    "Peptidoglycan beta-N-acetylmuramidase inhibitor": 5512,
    "Peptidoglycan glycosyltransferase inhibitor": 5513,
    "Peptidyl-Lys metalloendopeptidase inhibitor": 5514,
    "Peptidyl-dipeptidase B inhibitor": 5515,
    "Peptidyl-dipeptidase Dcp inhibitor": 5516,
    "Peptidyl-glycinamidase inhibitor": 5517,
    "Peptidyl-prolyl cis-trans isomerase FKBP1A inhibitor": 5518,
    "Peptidyl-prolyl cis-trans isomerase FKBP1B inhibitor": 5519,
    "Peptidyl-prolyl cis-trans isomerase FKBP3 inhibitor": 5520,
    "Peptidyl-prolyl cis-trans isomerase FKBP4 inhibitor": 5521,
    "Peptidyl-prolyl cis-trans isomerase inhibitor": 5522,
    "Peptidylamidoglycolate lyase inhibitor": 5523,
    "Peptidylglycine monooxygenase inhibitor": 5524,
    "Peptidyltransferase inhibitor": 5525,
    "Perforin-1 inhibitor": 5526,
    "Perilipin-1 inhibitor": 5527,
    "Perilipin-5 inhibitor": 5528,
    "Periodontitis treatment": 5529,
    "Peristaltic stimulant": 5530,
    "Peroxidase inhibitor": 5531,
    "Peroxidase substrate": 5532,
    "Peroxisome proliferator-activated receptor agonist": 5533,
    "Peroxisome proliferator-activated receptor alpha agonist": 5534,
    "Peroxisome proliferator-activated receptor alpha antagonist": 5535,
    "Peroxisome proliferator-activated receptor antagonist": 5536,
    "Peroxisome proliferator-activated receptor delta agonist": 5537,
    "Peroxisome proliferator-activated receptor delta antagonist": 5538,
    "Peroxisome proliferator-activated receptor gamma agonist": 5539,
    "Peroxisome proliferator-activated receptor gamma antagonist": 5540,
    "PfA-M1 aminopeptidase inhibitor": 5541,
    "Pharyngitis": 5542,
    "Phenol 2-monooxygenase inhibitor": 5543,
    "Phenol O-methyltransferase inhibitor": 5544,
    "Phenylacetaldehyde dehydrogenase inhibitor": 5545,
    "Phenylacetate-CoA ligase inhibitor": 5546,
    "Phenylalanine 2-monooxygenase inhibitor": 5547,
    "Phenylalanine 4-hydroxylase inhibitor": 5548,
    "Phenylalanine decarboxylase inhibitor": 5549,
    "Phenylalanine dehydrogenase inhibitor": 5550,
    "Phenylalanine racemase (ATP-hydrolysing) inhibitor": 5551,
    "Phenylalanine(histidine) transaminase inhibitor": 5552,
    "Phenylalanine-tRNA ligase inhibitor": 5553,
    "Phenylethanolamine N methyltransferase inhibitor": 5554,
    "Phenylpyruvate decarboxylase inhibitor": 5555,
    "Phenylpyruvate tautomerase inhibitor": 5556,
    "Phlebitis": 5557,
    "Phloroglucinol reductase inhibitor": 5558,
    "Phosphatase inhibitor": 5559,
    "Phosphate acetyltransferase inhibitor": 5560,
    "Phosphate butyryltransferase inhibitor": 5561,
    "Phosphate transporter inhibitor": 5562,
    "Phosphatidate cytidylyltransferase inhibitor": 5563,
    "Phosphatidate phosphatase inhibitor": 5564,
    "Phosphatidylcholine-retinol O-acyltransferase inhibitor": 5565,
    "Phosphatidylcholine-sterol O-acyltransferase inhibitor": 5566,
    "Phosphatidylethanolamine N-methyltransferase inhibitor": 5567,
    "Phosphatidylglycerol-membrane-oligosaccharide glycerophosphotransferase inhibitor": 5568,
    "Phosphatidylglycerophosphatase inhibitor": 5569,
    "Phosphatidylinositol 3-kinase C2beta inhibitor": 5570,
    "Phosphatidylinositol 3-kinase alpha inhibitor": 5571,
    "Phosphatidylinositol 3-kinase beta inhibitor": 5572,
    "Phosphatidylinositol 3-kinase delta inhibitor": 5573,
    "Phosphatidylinositol 3-kinase gamma inhibitor": 5574,
    "Phosphatidylinositol 3-kinase inhibitor": 5575,
    "Phosphatidylinositol 3-kinase stimulant": 5576,
    "Phosphatidylinositol 4-kinase inhibitor": 5577,
    "Phosphatidylinositol diacylglycerol-lyase inhibitor": 5578,
    "Phosphatidylinositol kinase inhibitor": 5579,
    "Phosphatidylserine decarboxylase inhibitor": 5580,
    "Phospho-N-acetylmuramoyl-pentapeptide-transferase inhibitor": 5581,
    "Phosphoadenylylsulfatase inhibitor": 5582,
    "Phosphodiesterase 10A inhibitor": 5583,
    "Phosphodiesterase 11A inhibitor": 5584,
    "Phosphodiesterase 1A inhibitor": 5585,
    "Phosphodiesterase 1B inhibitor": 5586,
    "Phosphodiesterase 1C inhibitor": 5587,
    "Phosphodiesterase 2A inhibitor": 5588,
    "Phosphodiesterase 3A inhibitor": 5589,
    "Phosphodiesterase 3B inhibitor": 5590,
    "Phosphodiesterase 4A inhibitor": 5591,
    "Phosphodiesterase 4B inhibitor": 5592,
    "Phosphodiesterase 4C inhibitor": 5593,
    "Phosphodiesterase 4D inhibitor": 5594,
    "Phosphodiesterase 5A inhibitor": 5595,
    "Phosphodiesterase 6A inhibitor": 5596,
    "Phosphodiesterase 6B inhibitor": 5597,
    "Phosphodiesterase 6C inhibitor": 5598,
    "Phosphodiesterase 6D inhibitor": 5599,
    "Phosphodiesterase 6G inhibitor": 5600,
    "Phosphodiesterase 6H inhibitor": 5601,
    "Phosphodiesterase 7A inhibitor": 5602,
    "Phosphodiesterase 7B inhibitor": 5603,
    "Phosphodiesterase 8A inhibitor": 5604,
    "Phosphodiesterase 8B inhibitor": 5605,
    "Phosphodiesterase 9A inhibitor": 5606,
    "Phosphodiesterase I inhibitor": 5607,
    "Phosphodiesterase II inhibitor": 5608,
    "Phosphodiesterase III inhibitor": 5609,
    "Phosphodiesterase IV inhibitor": 5610,
    "Phosphodiesterase IX inhibitor": 5611,
    "Phosphodiesterase V inhibitor": 5612,
    "Phosphodiesterase VI inhibitor": 5613,
    "Phosphodiesterase VII inhibitor": 5614,
    "Phosphodiesterase VIII inhibitor": 5615,
    "Phosphodiesterase X inhibitor": 5616,
    "Phosphodiesterase XI inhibitor": 5617,
    "Phosphodiesterase inhibitor": 5618,
    "Phosphoenolpyruvate carboxykinase (ATP) inhibitor": 5619,
    "Phosphoenolpyruvate carboxykinase (GTP) inhibitor": 5620,
    "Phosphoenolpyruvate carboxykinase (diphosphate) inhibitor": 5621,
    "Phosphoenolpyruvate carboxylase inhibitor": 5622,
    "Phosphoenolpyruvate mutase inhibitor": 5623,
    "Phosphoenolpyruvate-protein phosphotransferase inhibitor": 5624,
    "Phosphoethanolamine/phosphocholine phosphatase inhibitor": 5625,
    "Phosphofructokinase-1 inhibitor": 5626,
    "Phosphoglucomutase inhibitor": 5627,
    "Phosphogluconate 2-dehydrogenase inhibitor": 5628,
    "Phosphogluconate dehydrogenase (decarboxylating) inhibitor": 5629,
    "Phosphoglycerate dehydrogenase inhibitor": 5630,
    "Phosphoglycerate kinase 1 inhibitor": 5631,
    "Phosphoglycerate kinase 2 inhibitor": 5632,
    "Phosphoglycerate kinase inhibitor": 5633,
    "Phosphoglycerate mutase inhibitor": 5634,
    "Phosphoglycerate phosphatase inhibitor": 5635,
    "Phosphoglycolate phosphatase inhibitor": 5636,
    "Phosphoinositide 5-phosphatase inhibitor": 5637,
    "Phosphoinositide dependent kinase 1 inhibitor": 5638,
    "Phosphoinositide phospholipase C inhibitor": 5639,
    "Phosphoketolase inhibitor": 5640,
    "Phospholipase A-2-activating protein inhibitor": 5641,
    "Phospholipase A1 inhibitor": 5642,
    "Phospholipase A2 IID inhibitor": 5643,
    "Phospholipase A2 IIE inhibitor": 5644,
    "Phospholipase A2 IIF inhibitor": 5645,
    "Phospholipase A2 IIa inhibitor": 5646,
    "Phospholipase A2 VII inhibitor": 5647,
    "Phospholipase A2 X inhibitor": 5648,
    "Phospholipase A2 inhibitor": 5649,
    "Phospholipase C gamma 1 inhibitor": 5650,
    "Phospholipase C gamma inhibitor": 5651,
    "Phospholipase C inhibitor": 5652,
    "Phospholipase D inhibitor": 5653,
    "Phospholipase D1 inhibitor": 5654,
    "Phospholipase D2 inhibitor": 5655,
    "Phospholipase inhibitor": 5656,
    "Phospholipid-translocating ATPase inhibitor": 5657,
    "Phosphomannomutase 2 inhibitor": 5658,
    "Phosphomannomutase inhibitor": 5659,
    "Phosphomevalonate kinase inhibitor": 5660,
    "Phosphonoacetate hydrolase inhibitor": 5661,
    "Phosphopantothenoylcysteine decarboxylase inhibitor": 5662,
    "Phosphopyruvate hydratase inhibitor": 5663,
    "Phosphoribosylformylglycinamidine cyclo-ligase inhibitor": 5664,
    "Phosphoribosylformylglycinamidine synthase inhibitor": 5665,
    "Phosphoribosylglycinamide formyltransferase inhibitor": 5666,
    "Phosphoribulokinase inhibitor": 5667,
    "Phosphorylase a inhibitor": 5668,
    "Phosphorylase b inhibitor": 5669,
    "Phosphorylase inhibitor": 5670,
    "Phosphorylase kinase gamma subunit 1 inhibitor": 5671,
    "Phosphorylase kinase gamma subunit 2 inhibitor": 5672,
    "Phosphorylase kinase inhibitor": 5673,
    "Phosphoserine phosphatase inhibitor": 5674,
    "Phosphoserine transaminase inhibitor": 5675,
    "Phosphotyrosine-protein phosphatase PTPB inhibitor": 5676,
    "Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) inhibitor": 5677,
    "Photoallergy dermatitis": 5678,
    "Photophobia": 5679,
    "Photosensitizer": 5680,
    "Phthalate 4,5-dioxygenase inhibitor": 5681,
    "Phytanoyl-CoA dioxygenase inhibitor": 5682,
    "Picornain 2A inhibitor": 5683,
    "Picornain 3C inhibitor": 5684,
    "Piloerection": 5685,
    "Pim kinase inhibitor": 5686,
    "Pim-1 kinase inhibitor": 5687,
    "Pim-2 kinase inhibitor": 5688,
    "Pim-3 kinase inhibitor": 5689,
    "Pin1 inhibitor": 5690,
    "Pitrilysin inhibitor": 5691,
    "Plasma kallikrein inhibitor": 5692,
    "Plasmanylethanolamine desaturase inhibitor": 5693,
    "Plasmepsin I inhibitor": 5694,
    "Plasmepsin II inhibitor": 5695,
    "Plasmepsin IV inhibitor": 5696,
    "Plasmepsin inhibitor": 5697,
    "Plasmin inhibitor": 5698,
    "Plasminogen activator inhibitor": 5699,
    "Plasminogen activator inhibitor antagonist": 5700,
    "Plasminogen activator stimulant": 5701,
    "Plastoquinol-plastocyanin reductase inhibitor": 5702,
    "Platelet activating factor agonist": 5703,
    "Platelet activating factor alpha antagonist": 5704,
    "Platelet activating factor antagonist": 5705,
    "Platelet activating factor beta antagonist": 5706,
    "Platelet adhesion inhibitor": 5707,
    "Platelet aggregation inhibitor": 5708,
    "Platelet aggregation stimulant": 5709,
    "Platelet antagonist": 5710,
    "Platelet derived growth factor receptor kinase inhibitor": 5711,
    "Platelet growth factor antagonist": 5712,
    "Platelet growth factor beta antagonist": 5713,
    "Plectin inhibitor": 5714,
    "Pleural effusion": 5715,
    "Plus-end-directed kinesin ATPase inhibitor": 5716,
    "Pneumonia": 5717,
    "Pneumotoxic": 5718,
    "Polar-amino-acid-transporting ATPase inhibitor": 5719,
    "Polarisation inhibitor": 5720,
    "Polarisation stimulant": 5721,
    "Polo-like kinase inhibitor": 5722,
    "Polo-like kinase-1 inhibitor": 5723,
    "Polo-like kinase-2 inhibitor": 5724,
    "Polo-like kinase-3 inhibitor": 5725,
    "Polo-like kinase-4 inhibitor": 5726,
    "Poly(3-hydroxybutyrate) depolymerase inhibitor": 5727,
    "Poly(ADP-ribose) glycohydrolase inhibitor": 5728,
    "Poly(ADP-ribose) polymerase 1 inhibitor": 5729,
    "Poly(ADP-ribose) polymerase 2 inhibitor": 5730,
    "Poly(ADP-ribose) polymerase inhibitor": 5731,
    "Poly(alpha-L-guluronate) lyase inhibitor": 5732,
    "Poly(beta-D-mannuronate) lyase inhibitor": 5733,
    "Polyadenylate-binding protein 1 inhibitor": 5734,
    "Polyamine biosynthesis inhibitor": 5735,
    "Polyamine oxidase inhibitor": 5736,
    "Polyamine-transporting ATPase inhibitor": 5737,
    "Polycystin-1 inhibitor": 5738,
    "Polycystin-2 inhibitor": 5739,
    "Polydipsia": 5740,
    "Polygalacturonase inhibitor": 5741,
    "Polyneuridine-aldehyde esterase inhibitor": 5742,
    "Polynucleotide 5'-hydroxy-kinase inhibitor": 5743,
    "Polynucleotide adenylyltransferase inhibitor": 5744,
    "Polypeptide N-acetylgalactosaminyltransferase inhibitor": 5745,
    "Polyphosphate kinase inhibitor": 5746,
    "Polyphosphate-glucose phosphotransferase inhibitor": 5747,
    "Polyporopepsin inhibitor": 5748,
    "Polyribonucleotide nucleotidyltransferase inhibitor": 5749,
    "Polyuria": 5750,
    "Porphobilinogen synthase inhibitor": 5751,
    "Porphyria": 5752,
    "Postcoital contraceptive": 5753,
    "Postmenopausal disorders treatment": 5754,
    "Postsynaptic density protein 95 inhibitor": 5755,
    "Posttraumatic stress disorder treatment": 5756,
    "Postural (orthostatic) hypotension": 5757,
    "Potassium channel (ATP-sensitive) activator": 5758,
    "Potassium channel (ATP-sensitive) blocker": 5759,
    "Potassium channel (Ca-activated) activator": 5760,
    "Potassium channel (Ca-activated) blocker": 5761,
    "Potassium channel (Inward rectifier) 1 blocker": 5762,
    "Potassium channel (Inward rectifier) 11 blocker": 5763,
    "Potassium channel (Inward rectifier) activator": 5764,
    "Potassium channel (Inward rectifier) blocker": 5765,
    "Potassium channel (Voltage-sensitive) activator": 5766,
    "Potassium channel (Voltage-sensitive) blocker": 5767,
    "Potassium channel KCNQ activator": 5768,
    "Potassium channel KCNQ blocker": 5769,
    "Potassium channel KCNQ2 activator": 5770,
    "Potassium channel KCNQ3 activator": 5771,
    "Potassium channel Kv11 blocker": 5772,
    "Potassium channel Kv12 blocker": 5773,
    "Potassium channel Kv13 blocker": 5774,
    "Potassium channel Kv14 blocker": 5775,
    "Potassium channel Kv15 blocker": 5776,
    "Potassium channel Kv21 blocker": 5777,
    "Potassium channel Kv43 blocker": 5778,
    "Potassium channel Kv71 blocker": 5779,
    "Potassium channel activator": 5780,
    "Potassium channel blocker": 5781,
    "Potassium channel intermediate-conductance Ca-activated 4 blocker": 5782,
    "Potassium channel intermediate-conductance Ca-activated activator": 5783,
    "Potassium channel intermediate-conductance Ca-activated blocker": 5784,
    "Potassium channel large-conductance Ca-activated activator": 5785,
    "Potassium channel small-conductance Ca-activated 1 blocker": 5786,
    "Potassium channel small-conductance Ca-activated 2 blocker": 5787,
    "Potassium channel small-conductance Ca-activated 3 activator": 5788,
    "Potassium channel small-conductance Ca-activated 3 blocker": 5789,
    "Potassium channel small-conductance Ca-activated activator": 5790,
    "Potassium channel small-conductance Ca-activated blocker": 5791,
    "Potassium sparing diuretic": 5792,
    "Pregnane X receptor agonist": 5793,
    "Pregnane X receptor antagonist": 5794,
    "Premature ejaculation treatment": 5795,
    "Premenstrual syndrome treatment": 5796,
    "Preneoplastic conditions treatment": 5797,
    "Prenyl-diphosphatase inhibitor": 5798,
    "Prephenate dehydratase inhibitor": 5799,
    "Prephenate dehydrogenase inhibitor": 5800,
    "Prepilin peptidase inhibitor": 5801,
    "Presenilin 1 inhibitor": 5802,
    "Presenilin 2 inhibitor": 5803,
    "Preterm labor treatment": 5804,
    "Priapism": 5805,
    "Prion diseases treatment": 5806,
    "Pro-opiomelanocortin converting enzyme inhibitor": 5807,
    "Probable DNA dC->dU-editing enzyme APOBEC-3A inhibitor": 5808,
    "Probable G-protein coupled receptor 142 agonist": 5809,
    "Probable protein-cysteine N-palmitoyltransferase porcupine inhibitor": 5810,
    "Probable transmembrane carbonic anhydrase (Carbonate dehydratase) inhibitor": 5811,
    "Procollagen C-endopeptidase inhibitor": 5812,
    "Procollagen N-endopeptidase inhibitor": 5813,
    "Procollagen galactosyltransferase inhibitor": 5814,
    "Procollagen glucosyltransferase inhibitor": 5815,
    "Procollagen-lysine 5-dioxygenase inhibitor": 5816,
    "Procollagen-proline 3-dioxygenase inhibitor": 5817,
    "Progesterone agonist": 5818,
    "Progesterone antagonist": 5819,
    "Progesterone receptor A antagonist": 5820,
    "Progesterone receptor B antagonist": 5821,
    "Progesterone receptor B1 antagonist": 5822,
    "Prokinetic": 5823,
    "Prokineticin receptor 1 antagonist": 5824,
    "Prolactin inhibitor": 5825,
    "Prolactin release inhibitor": 5826,
    "Prolactin stimulant": 5827,
    "Proliferative diseases treatment": 5828,
    "Proline dehydrogenase inhibitor": 5829,
    "Proline racemase inhibitor": 5830,
    "Proline transporter inhibitor": 5831,
    "Prolyl aminopeptidase inhibitor": 5832,
    "Prolyl endopeptidase inhibitor": 5833,
    "Propanediol dehydratase inhibitor": 5834,
    "Propionate CoA-transferase inhibitor": 5835,
    "Propionate-CoA ligase inhibitor": 5836,
    "Prostacyclin agonist": 5837,
    "Prostacyclin antagonist": 5838,
    "Prostaglandin A1 agonist": 5839,
    "Prostaglandin D synthase inhibitor": 5840,
    "Prostaglandin D2 agonist": 5841,
    "Prostaglandin D2 antagonist": 5842,
    "Prostaglandin E1 agonist": 5843,
    "Prostaglandin E1 antagonist": 5844,
    "Prostaglandin E2 agonist": 5845,
    "Prostaglandin E2 antagonist": 5846,
    "Prostaglandin EP1 antagonist": 5847,
    "Prostaglandin EP12 antagonist": 5848,
    "Prostaglandin EP2 agonist": 5849,
    "Prostaglandin EP2 antagonist": 5850,
    "Prostaglandin EP3 antagonist": 5851,
    "Prostaglandin EP4 agonist": 5852,
    "Prostaglandin EP4 antagonist": 5853,
    "Prostaglandin F2 alpha agonist": 5854,
    "Prostaglandin F2 alpha antagonist": 5855,
    "Prostaglandin H2 antagonist": 5856,
    "Prostaglandin agonist": 5857,
    "Prostaglandin antagonist": 5858,
    "Prostaglandin dehydrogenase inhibitor": 5859,
    "Prostaglandin-A1 DELTA-isomerase inhibitor": 5860,
    "Prostaglandin-E synthase inhibitor": 5861,
    "Prostaglandin-E2 9-reductase inhibitor": 5862,
    "Prostaglandin-E2 synthase 1 inhibitor": 5863,
    "Prostaglandin-I synthase inhibitor": 5864,
    "Prostate cancer treatment": 5865,
    "Prostate disorders treatment": 5866,
    "Prostatic (benign) hyperplasia treatment": 5867,
    "Protease (Human cytomegalovirus) inhibitor": 5868,
    "Protease 3C (Human rhinovirus) inhibitor": 5869,
    "Protease activated receptor 1 agonist": 5870,
    "Protease activated receptor 1 antagonist": 5871,
    "Protease activated receptor 2 agonist": 5872,
    "Protease activated receptor 2 antagonist": 5873,
    "Protease activated receptor 4 antagonist": 5874,
    "Protease activated receptor agonist": 5875,
    "Protease activated receptor antagonist": 5876,
    "Protease inhibitor": 5877,
    "Proteasome 26S inhibitor": 5878,
    "Proteasome ATPase inhibitor": 5879,
    "Proteasome endopeptidase complex inhibitor": 5880,
    "Proteasome inhibitor": 5881,
    "Proteasome subunit beta type-5 inhibitor": 5882,
    "Proteasome subunit beta type-8 inhibitor": 5883,
    "Protein 23S ribosomal subunit inhibitor": 5884,
    "Protein 30S ribosomal subunit inhibitor": 5885,
    "Protein 50S ribosomal subunit inhibitor": 5886,
    "Protein C (activated) inhibitor": 5887,
    "Protein N-acetylglucosaminyltransferase inhibitor": 5888,
    "Protein RecA inhibitor": 5889,
    "Protein S100-A10 inhibitor": 5890,
    "Protein Wnt-2 inhibitor": 5891,
    "Protein disulfide-isomerase inhibitor": 5892,
    "Protein glycation inhibitor": 5893,
    "Protein kinase (CK1) delta inhibitor": 5894,
    "Protein kinase (CK1) epsilon inhibitor": 5895,
    "Protein kinase (CK1) gamma 1 inhibitor": 5896,
    "Protein kinase (CK1) gamma 2 inhibitor": 5897,
    "Protein kinase (CK1) gamma 3 inhibitor": 5898,
    "Protein kinase (CK1) gamma inhibitor": 5899,
    "Protein kinase (CK1) inhibitor": 5900,
    "Protein kinase (CK2) alpha inhibitor": 5901,
    "Protein kinase (CK2) beta inhibitor": 5902,
    "Protein kinase (CK2) inhibitor": 5903,
    "Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor": 5904,
    "Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor": 5905,
    "Protein kinase (PKA, PKC, AKT, GRK, AGC-related, RSK, DBF2, SGK) inhibitor": 5906,
    "Protein kinase A anchoring protein 1 inhibitor": 5907,
    "Protein kinase A anchoring protein 2 inhibitor": 5908,
    "Protein kinase A inhibitor": 5909,
    "Protein kinase B alpha inhibitor": 5910,
    "Protein kinase B beta inhibitor": 5911,
    "Protein kinase B gamma inhibitor": 5912,
    "Protein kinase B inhibitor": 5913,
    "Protein kinase B stimulant": 5914,
    "Protein kinase C alpha inhibitor": 5915,
    "Protein kinase C alpha stimulant": 5916,
    "Protein kinase C beta I inhibitor": 5917,
    "Protein kinase C beta II inhibitor": 5918,
    "Protein kinase C beta inhibitor": 5919,
    "Protein kinase C delta inhibitor": 5920,
    "Protein kinase C delta stimulant": 5921,
    "Protein kinase C epsilon inhibitor": 5922,
    "Protein kinase C eta inhibitor": 5923,
    "Protein kinase C gamma inhibitor": 5924,
    "Protein kinase C inhibitor": 5925,
    "Protein kinase C iota inhibitor": 5926,
    "Protein kinase C mu inhibitor": 5927,
    "Protein kinase C nu inhibitor": 5928,
    "Protein kinase C stimulant": 5929,
    "Protein kinase C theta inhibitor": 5930,
    "Protein kinase C zeta inhibitor": 5931,
    "Protein kinase C-related protein kinase 2 inhibitor": 5932,
    "Protein kinase C-related protein kinase inhibitor": 5933,
    "Protein kinase G inhibitor": 5934,
    "Protein kinase inhibitor": 5935,
    "Protein kinase stimulant": 5936,
    "Protein phosphatase 1B inhibitor": 5937,
    "Protein phosphatase 2A inhibitor": 5938,
    "Protein phosphatase 2B inhibitor": 5939,
    "Protein phosphatase PP1 inhibitor": 5940,
    "Protein phosphatase PP2 inhibitor": 5941,
    "Protein phosphatase inhibitor": 5942,
    "Protein phosphatase methylesterase 1 inhibitor": 5943,
    "Protein synthesis inhibitor": 5944,
    "Protein synthesis stimulant": 5945,
    "Protein-L-isoaspartate (D-aspartate) O-methyltransferase inhibitor": 5946,
    "Protein-Npi-phosphohistidine-sugar phosphotransferase inhibitor": 5947,
    "Protein-S-isoprenylcysteine O-methyltransferase inhibitor": 5948,
    "Protein-arginine N-methyltransferase inhibitor": 5949,
    "Protein-arginine deiminase inhibitor": 5950,
    "Protein-disulfide reductase (glutathione) inhibitor": 5951,
    "Protein-glucosylgalactosylhydroxylysine glucosidase inhibitor": 5952,
    "Protein-glutamate O-methyltransferase inhibitor": 5953,
    "Protein-glutamate methylesterase inhibitor": 5954,
    "Protein-glutamine gamma-glutamyltransferase K inhibitor": 5955,
    "Protein-serine-threonine kinase inhibitor": 5956,
    "Protein-synthesizing GTPase inhibitor": 5957,
    "Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor": 5958,
    "Protein-tyrosine kinase Lyn inhibitor": 5959,
    "Protein-tyrosine kinase p55(blk) inhibitor": 5960,
    "Protein-tyrosine phosphatase 1B inhibitor": 5961,
    "Protein-tyrosine phosphatase 1C inhibitor": 5962,
    "Protein-tyrosine phosphatase 1E inhibitor": 5963,
    "Protein-tyrosine phosphatase 2C inhibitor": 5964,
    "Protein-tyrosine phosphatase C inhibitor": 5965,
    "Protein-tyrosine phosphatase F inhibitor": 5966,
    "Protein-tyrosine phosphatase G1 inhibitor": 5967,
    "Protein-tyrosine phosphatase LC-PTP inhibitor": 5968,
    "Protein-tyrosine phosphatase MEG2 inhibitor": 5969,
    "Protein-tyrosine phosphatase alpha inhibitor": 5970,
    "Protein-tyrosine phosphatase beta inhibitor": 5971,
    "Protein-tyrosine phosphatase epsilon inhibitor": 5972,
    "Protein-tyrosine phosphatase inhibitor": 5973,
    "Protein-tyrosine phosphatase mu inhibitor": 5974,
    "Protein-tyrosine phosphatase non-receptor type 22 inhibitor": 5975,
    "Protein-tyrosine phosphatase yopH inhibitor": 5976,
    "Protein-tyrosine sulfotransferase inhibitor": 5977,
    "Proteinuria": 5978,
    "Proto-oncogene protein Wnt-3 inhibitor": 5979,
    "Proto-oncogene protein c-fos inhibitor": 5980,
    "Proto-oncogene tyrosine-protein kinase CSK inhibitor": 5981,
    "Proto-oncogene tyrosine-protein kinase Fgr inhibitor": 5982,
    "Proto-oncogene tyrosine-protein kinase Fyn inhibitor": 5983,
    "Proto-oncogene tyrosine-protein kinase Kit inhibitor": 5984,
    "Proto-oncogene tyrosine-protein kinase MER inhibitor": 5985,
    "Proto-oncogene tyrosine-protein kinase Met inhibitor": 5986,
    "Proto-oncogene tyrosine-protein kinase ROS inhibitor": 5987,
    "Proto-oncogene tyrosine-protein kinase Yes inhibitor": 5988,
    "Proto-oncogene tyrosine-protein kinase c-hck inhibitor": 5989,
    "Protocatechuate 3,4-dioxygenase inhibitor": 5990,
    "Protocatechuate 4,5-dioxygenase inhibitor": 5991,
    "Protocollagen prolyl hydroxylase inhibitor": 5992,
    "Protoporphyrinogen oxidase inhibitor": 5993,
    "Prunasin beta-glucosidase inhibitor": 5994,
    "Pruritus": 5995,
    "Pseudolysin inhibitor": 5996,
    "Pseudoporphyria": 5997,
    "Pseudouridylate synthase inhibitor": 5998,
    "Psoriasis": 5999,
    "Psychomotor impairment": 6000,
    "Psychoses": 6001,
    "Psychosexual disorder": 6002,
    "Psychosexual dysfunction treatment": 6003,
    "Psychostimulant": 6004,
    "Psychotropic": 6005,
    "Pteridine reductase inhibitor": 6006,
    "Pterin deaminase inhibitor": 6007,
    "Pullulanase inhibitor": 6008,
    "Pulmonary edema": 6009,
    "Pulmonary embolism": 6010,
    "Pulmonary hypertension treatment": 6011,
    "Pure red cell aplasia": 6012,
    "Purine antagonist": 6013,
    "Purine biosynthesis inhibitor": 6014,
    "Purine nucleosidase inhibitor": 6015,
    "Purine nucleoside phosphorylase inhibitor": 6016,
    "Purine nucleoside phosphorylase stimulant": 6017,
    "Purinergic P2 agonist": 6018,
    "Purinergic P2 antagonist": 6019,
    "Purinergic P2T antagonist": 6020,
    "Purinergic P2X agonist": 6021,
    "Purinergic P2X antagonist": 6022,
    "Purinergic P2X1 antagonist": 6023,
    "Purinergic P2X2 antagonist": 6024,
    "Purinergic P2X3 antagonist": 6025,
    "Purinergic P2X4 antagonist": 6026,
    "Purinergic P2X7 antagonist": 6027,
    "Purinergic P2Y agonist": 6028,
    "Purinergic P2Y antagonist": 6029,
    "Purinergic P2Y1 agonist": 6030,
    "Purinergic P2Y1 antagonist": 6031,
    "Purinergic P2Y12 antagonist": 6032,
    "Purinergic P2Y14 antagonist": 6033,
    "Purinergic P2Y15 antagonist": 6034,
    "Purinergic P2Y2 agonist": 6035,
    "Purinergic P2Y2 antagonist": 6036,
    "Purinergic P2Y4 agonist": 6037,
    "Purinergic P2Y6 agonist": 6038,
    "Purinergic receptor agonist": 6039,
    "Purinergic receptor antagonist": 6040,
    "Puromycin-sensitive aminopeptidase inhibitor": 6041,
    "Purpura": 6042,
    "Putative carbonate dehydratase-like protein Rv1284 inhibitor": 6043,
    "Putative hexokinase HKDC1 inhibitor": 6044,
    "Putative hydrolase RBBP9 inhibitor": 6045,
    "Putrescine carbamoyltransferase inhibitor": 6046,
    "Putrescine oxidase inhibitor": 6047,
    "Pyridoxal 4-dehydrogenase inhibitor": 6048,
    "Pyridoxal kinase inhibitor": 6049,
    "Pyridoxamine-oxaloacetate transaminase inhibitor": 6050,
    "Pyridoxamine-phosphate oxidase inhibitor": 6051,
    "Pyridoxamine-pyruvate transaminase inhibitor": 6052,
    "Pyridoxine 4-oxidase inhibitor": 6053,
    "Pyridoxine 5-dehydrogenase inhibitor": 6054,
    "Pyrimidine antagonist": 6055,
    "Pyrimidine-deoxynucleoside 2'-dioxygenase inhibitor": 6056,
    "Pyroglutamyl-peptidase I inhibitor": 6057,
    "Pyroglutamyl-peptidase II inhibitor": 6058,
    "Pyrroline-5-carboxylate reductase inhibitor": 6059,
    "Pyruvate carboxylase inhibitor": 6060,
    "Pyruvate decarboxylase inhibitor": 6061,
    "Pyruvate dehydrogenase (cytochrome) inhibitor": 6062,
    "Pyruvate dehydrogenase (lipoamide) inhibitor": 6063,
    "Pyruvate dehydrogenase inhibitor": 6064,
    "Pyruvate dehydrogenase kinase 1 inhibitor": 6065,
    "Pyruvate dehydrogenase kinase 2 inhibitor": 6066,
    "Pyruvate dehydrogenase kinase 3 inhibitor": 6067,
    "Pyruvate dehydrogenase kinase 4 inhibitor": 6068,
    "Pyruvate dehydrogenase kinase inhibitor": 6069,
    "Pyruvate dehydrogenase stimulant": 6070,
    "Pyruvate kinase PKM stimulant": 6071,
    "Pyruvate kinase inhibitor": 6072,
    "Pyruvate synthase inhibitor": 6073,
    "Pyruvate, phosphate dikinase inhibitor": 6074,
    "Pyruvate, water dikinase inhibitor": 6075,
    "QKI expression inhibitor": 6076,
    "QT interval prolongation": 6077,
    "Quercetin 2,3-dioxygenase inhibitor": 6078,
    "Queuine tRNA-ribosyltransferase inhibitor": 6079,
    "Quinate 5-dehydrogenase inhibitor": 6080,
    "Quinoline-4-carboxylate 2-oxidoreductase inhibitor": 6081,
    "Quinone reductase 2 inhibitor": 6082,
    "Quinoprotein glucose dehydrogenase inhibitor": 6083,
    "Quisqualate antagonist": 6084,
    "RAB20 expression inhibitor": 6085,
    "RAB31 expression enhancer": 6086,
    "RAB3B expression enhancer": 6087,
    "RAB40C expression enhancer": 6088,
    "RABGAP1 expression inhibitor": 6089,
    "RABGAP1L expression inhibitor": 6090,
    "RAC1 expression inhibitor": 6091,
    "RACGAP1 expression enhancer": 6092,
    "RAD17 expression inhibitor": 6093,
    "RAD51 expression enhancer": 6094,
    "RAD51AP1 expression enhancer": 6095,
    "RAD51AP1 expression inhibitor": 6096,
    "RAD51C expression enhancer": 6097,
    "RAD51D expression enhancer": 6098,
    "RAI14 expression enhancer": 6099,
    "RALA expression inhibitor": 6100,
    "RANTES antagonist": 6101,
    "RAP1A expression enhancer": 6102,
    "RAPGEF2 expression enhancer": 6103,
    "RARA expression enhancer": 6104,
    "RARA expression inhibitor": 6105,
    "RARB expression enhancer": 6106,
    "RARB expression inhibitor": 6107,
    "RARG expression enhancer": 6108,
    "RARG expression inhibitor": 6109,
    "RARRES1 expression enhancer": 6110,
    "RARRES2 expression enhancer": 6111,
    "RARRES3 expression enhancer": 6112,
    "RAS guanyl releasing protein antagonist": 6113,
    "RASD1 expression enhancer": 6114,
    "RASEF expression inhibitor": 6115,
    "RB1 expression enhancer": 6116,
    "RB1 expression inhibitor": 6117,
    "RBBP4 expression enhancer": 6118,
    "RBBP8 expression enhancer": 6119,
    "RBM12 expression inhibitor": 6120,
    "RBM13 expression enhancer": 6121,
    "RBM24 expression enhancer": 6122,
    "RBM34 expression inhibitor": 6123,
    "RBMS1 expression inhibitor": 6124,
    "RBP1 expression enhancer": 6125,
    "RBP1 expression inhibitor": 6126,
    "RBP4 expression enhancer": 6127,
    "RCC2 expression inhibitor": 6128,
    "RECQL expression inhibitor": 6129,
    "REEP1 expression inhibitor": 6130,
    "RELA expression enhancer": 6131,
    "RELA expression inhibitor": 6132,
    "RELB expression enhancer": 6133,
    "RELN expression enhancer": 6134,
    "RET inhibitor": 6135,
    "RFC4 expression enhancer": 6136,
    "RFTN1 expression enhancer": 6137,
    "RGS10 expression enhancer": 6138,
    "RGS2 expression enhancer": 6139,
    "RGS20 expression enhancer": 6140,
    "RHBDD2 expression enhancer": 6141,
    "RHOA expression enhancer": 6142,
    "RHOA expression inhibitor": 6143,
    "RHOB expression enhancer": 6144,
    "RHOB expression inhibitor": 6145,
    "RHOBTB1 expression enhancer": 6146,
    "RHOC expression enhancer": 6147,
    "RHOU expression enhancer": 6148,
    "RIN2 expression inhibitor": 6149,
    "RMI2 expression inhibitor": 6150,
    "RNA agonist": 6151,
    "RNA directed DNA polymerase inhibitor": 6152,
    "RNA ligase (ATP) inhibitor": 6153,
    "RNA synthesis inhibitor": 6154,
    "RNA-directed RNA polymerase (Influenza A) inhibitor": 6155,
    "RNA-directed RNA polymerase inhibitor": 6156,
    "RNA-directed RNA polymerase stimulant": 6157,
    "RND1 expression enhancer": 6158,
    "RND3 expression inhibitor": 6159,
    "RNF114 expression enhancer": 6160,
    "RNF144A expression inhibitor": 6161,
    "RNF149 expression enhancer": 6162,
    "RNF4 expression inhibitor": 6163,
    "RNF43 expression inhibitor": 6164,
    "ROCK1 expression inhibitor": 6165,
    "ROCK2 expression inhibitor": 6166,
    "RORA expression enhancer": 6167,
    "RPGRIP1L expression inhibitor": 6168,
    "RPL10 expression inhibitor": 6169,
    "RPL27A expression enhancer": 6170,
    "RPL27A expression inhibitor": 6171,
    "RPL6 expression inhibitor": 6172,
    "RPL7A expression inhibitor": 6173,
    "RPRM expression inhibitor": 6174,
    "RPS19 expression inhibitor": 6175,
    "RPS25 expression enhancer": 6176,
    "RPS27 expression inhibitor": 6177,
    "RPS6KA3 expression enhancer": 6178,
    "RPS6KA3 expression inhibitor": 6179,
    "RRAD expression enhancer": 6180,
    "RRAS expression enhancer": 6181,
    "RRBP1 expression enhancer": 6182,
    "RRM2 expression enhancer": 6183,
    "RRM2 expression inhibitor": 6184,
    "RRM2B expression enhancer": 6185,
    "RSAD2 expression enhancer": 6186,
    "RSBN1 expression inhibitor": 6187,
    "RUNX2 expression enhancer": 6188,
    "RUNX2 expression inhibitor": 6189,
    "RXRA expression enhancer": 6190,
    "RXRA expression inhibitor": 6191,
    "RXRB expression inhibitor": 6192,
    "RXRG expression enhancer": 6193,
    "RYBP expression inhibitor": 6194,
    "Radical formation agonist": 6195,
    "Radioprotector": 6196,
    "Radiosensitizer": 6197,
    "Raf kinase B inhibitor": 6198,
    "Raf kinase C inhibitor": 6199,
    "Raf kinase inhibitor": 6200,
    "Raynaud's phenomenon": 6201,
    "Raynaud's phenomenon treatment": 6202,
    "Receptor activity-modifying protein 1 antagonist": 6203,
    "Receptor-histidine kinase AgrC inhibitor": 6204,
    "Reductant": 6205,
    "Reductase inhibitor": 6206,
    "Releasing hormone agonist": 6207,
    "Renal colic": 6208,
    "Renal disease treatment": 6209,
    "Renal failure treatment": 6210,
    "Renal insufficiency": 6211,
    "Renal papillary necrosis": 6212,
    "Renal tissue kallikrein inhibitor": 6213,
    "Renilla-luciferin 2-monooxygenase inhibitor": 6214,
    "Renin inhibitor": 6215,
    "Replicase polyprotein 1ab inhibitor": 6216,
    "Replication protein E1 (HPV) antagonist": 6217,
    "Reproductive dysfunction": 6218,
    "Respiratory analeptic": 6219,
    "Respiratory failure": 6220,
    "Respiratory impairment": 6221,
    "Restenosis treatment": 6222,
    "Restless leg syndrome treatment": 6223,
    "Reticulocytosis": 6224,
    "Retinal dehydrogenase inhibitor": 6225,
    "Retinoic acid alpha receptor agonist": 6226,
    "Retinoic acid alpha receptor antagonist": 6227,
    "Retinoic acid beta receptor agonist": 6228,
    "Retinoic acid beta receptor antagonist": 6229,
    "Retinoic acid gamma receptor agonist": 6230,
    "Retinoic acid metabolism inhibitor": 6231,
    "Retinoic acid receptor agonist": 6232,
    "Retinoic acid receptor antagonist": 6233,
    "Retinoic acid receptor gamma antagonist": 6234,
    "Retinoid X alpha receptor agonist": 6235,
    "Retinoid X alpha receptor antagonist": 6236,
    "Retinoid X beta receptor agonist": 6237,
    "Retinoid X beta receptor antagonist": 6238,
    "Retinoid X gamma receptor agonist": 6239,
    "Retinoid X gamma receptor antagonist": 6240,
    "Retinoid X receptor agonist": 6241,
    "Retinoid X receptor antagonist": 6242,
    "Retinol O-fatty-acyltransferase inhibitor": 6243,
    "Retinol dehydrogenase inhibitor": 6244,
    "Retinopathy": 6245,
    "Retinopathy treatment": 6246,
    "Retinoprotector": 6247,
    "Retinyl-palmitate esterase inhibitor": 6248,
    "Retroperitoneal fibrosis": 6249,
    "Reverse transcriptase (Hepatitis B) inhibitor": 6250,
    "Rhamnulose-1-phosphate aldolase inhibitor": 6251,
    "Rheumatism": 6252,
    "Rheumatoid arthritis treatment": 6253,
    "Rhinitis": 6254,
    "Rhinitis treatment": 6255,
    "Rhizopuspepsin inhibitor": 6256,
    "Rho-associated kinase I inhibitor": 6257,
    "Rho-associated kinase II inhibitor": 6258,
    "Rho-associated kinase inhibitor": 6259,
    "Rhodesain inhibitor": 6260,
    "Rhodopsin kinase inhibitor": 6261,
    "Rhodotorulapepsin inhibitor": 6262,
    "Ribitol 2-dehydrogenase inhibitor": 6263,
    "Riboflavin kinase inhibitor": 6264,
    "Riboflavin phosphotransferase inhibitor": 6265,
    "Riboflavin synthase inhibitor": 6266,
    "Ribonuclease L inhibitor": 6267,
    "Ribonuclease T1 inhibitor": 6268,
    "Ribonuclease T2 inhibitor": 6269,
    "Ribonuclease U2 inhibitor": 6270,
    "Ribonuclease inhibitor": 6271,
    "Ribonucleoside diphosphate reductase inhibitor": 6272,
    "Ribonucleoside triphosphate reductase inhibitor": 6273,
    "Ribonucleoside-diphosphate reductase M1 chain inhibitor": 6274,
    "Ribonucleoside-diphosphate reductase M2 chain inhibitor": 6275,
    "Ribonucleoside-diphosphate reductase large chain inhibitor": 6276,
    "Ribonucleotide reductase inhibitor": 6277,
    "Ribose-5-phosphate adenylyltransferase inhibitor": 6278,
    "Ribose-5-phosphate isomerase inhibitor": 6279,
    "Ribose-5-phosphate-ammonia ligase inhibitor": 6280,
    "Ribose-phosphate diphosphokinase inhibitor": 6281,
    "Ribosomal protein S6 kinase 1, 70-kDa inhibitor": 6282,
    "Ribosomal protein S6 kinase 2 inhibitor": 6283,
    "Ribosomal protein S6 kinase alpha 1 inhibitor": 6284,
    "Ribosomal protein S6 kinase alpha 2 inhibitor": 6285,
    "Ribosomal protein S6 kinase alpha 3 inhibitor": 6286,
    "Ribosomal protein S6 kinase alpha 4 inhibitor": 6287,
    "Ribosomal protein S6 kinase alpha 5 inhibitor": 6288,
    "Ribosomal protein S6 kinase alpha 6 inhibitor": 6289,
    "Ribosomal protein S6 kinase inhibitor": 6290,
    "Ribosomal protein S6 kinase, 70-kDa inhibitor": 6291,
    "Ribosomal protein S6 kinase, 90-kDa inhibitor": 6292,
    "Ribosomal protein S6 kinase, 90kD, polypeptide 5 inhibitor": 6293,
    "Ribosylpyrimidine nucleosidase inhibitor": 6294,
    "Ribulose-bisphosphate carboxylase inhibitor": 6295,
    "Ribulose-phosphate 3-epimerase inhibitor": 6296,
    "Rotamase (FKBP) inhibitor": 6297,
    "Rotamase (FKBP12) inhibitor": 6298,
    "Rotamase (FKBP14) inhibitor": 6299,
    "Rubefacient": 6300,
    "Rubredoxin-NAD+ reductase inhibitor": 6301,
    "Runt-related transcription factor 1 inhibitor": 6302,
    "Ryanodine receptor 1 antagonist": 6303,
    "Ryanodine receptor antagonist": 6304,
    "S-100 protein beta antagonist": 6305,
    "S-adenosyl-L-homocysteine hydrolase inhibitor": 6306,
    "S-adenosyl-L-methionine decarboxylase inhibitor": 6307,
    "S-alkylcysteine lyase inhibitor": 6308,
    "S-formylglutathione hydrolase inhibitor": 6309,
    "S-methyl-5-thioadenosine phosphorylase inhibitor": 6310,
    "S-methyl-5-thioribose kinase inhibitor": 6311,
    "S100A10 expression enhancer": 6312,
    "S100A11 expression enhancer": 6313,
    "S100A2 expression enhancer": 6314,
    "S100A3 expression enhancer": 6315,
    "S100A4 expression enhancer": 6316,
    "S100A4 expression inhibitor": 6317,
    "S100A7 expression enhancer": 6318,
    "S100A8 expression enhancer": 6319,
    "S100A8 expression inhibitor": 6320,
    "S100A9 expression enhancer": 6321,
    "S100P expression enhancer": 6322,
    "S100P expression inhibitor": 6323,
    "SAC3D1 expression enhancer": 6324,
    "SAP18 expression inhibitor": 6325,
    "SASH1 expression enhancer": 6326,
    "SASH1 expression inhibitor": 6327,
    "SAT expression enhancer": 6328,
    "SAT expression inhibitor": 6329,
    "SAT1 expression enhancer": 6330,
    "SATB1 expression inhibitor": 6331,
    "SCAMP1 expression inhibitor": 6332,
    "SCARB1 expression enhancer": 6333,
    "SCARB1 expression inhibitor": 6334,
    "SCD expression enhancer": 6335,
    "SCD expression inhibitor": 6336,
    "SCGB2A1 expression enhancer": 6337,
    "SCML1 expression enhancer": 6338,
    "SCN1A expression inhibitor": 6339,
    "SCNN1A expression enhancer": 6340,
    "SDCBP expression enhancer": 6341,
    "SDPR expression enhancer": 6342,
    "SEC14L1 expression enhancer": 6343,
    "SEC16A expression inhibitor": 6344,
    "SELE expression enhancer": 6345,
    "SELENBP1 expression inhibitor": 6346,
    "SELL expression enhancer": 6347,
    "SELP expression enhancer": 6348,
    "SEMA3B expression enhancer": 6349,
    "SEMA3C expression inhibitor": 6350,
    "SEPHS1 expression inhibitor": 6351,
    "SEPP1 expression inhibitor": 6352,
    "SEPT7 expression inhibitor": 6353,
    "SEPW1 expression enhancer": 6354,
    "SERPINA1 expression enhancer": 6355,
    "SERPINA3 expression enhancer": 6356,
    "SERPINA6 expression inhibitor": 6357,
    "SERPINB2 expression enhancer": 6358,
    "SERPINB2 expression inhibitor": 6359,
    "SERPINB5 expression enhancer": 6360,
    "SERPINB9 expression enhancer": 6361,
    "SERPINE1 expression enhancer": 6362,
    "SERPINE1 expression inhibitor": 6363,
    "SERPINE2 expression enhancer": 6364,
    "SERTAD1 expression enhancer": 6365,
    "SESN1 expression enhancer": 6366,
    "SESN1 expression inhibitor": 6367,
    "SESN2 expression enhancer": 6368,
    "SETBP1 expression inhibitor": 6369,
    "SETD5 expression inhibitor": 6370,
    "SF1 expression inhibitor": 6371,
    "SF3B5 expression enhancer": 6372,
    "SFN expression enhancer": 6373,
    "SFPQ expression enhancer": 6374,
    "SFPQ expression inhibitor": 6375,
    "SFRP1 expression enhancer": 6376,
    "SFTPB expression enhancer": 6377,
    "SFTPC expression enhancer": 6378,
    "SFXN2 expression enhancer": 6379,
    "SH2B3 expression enhancer": 6380,
    "SH2D4A expression inhibitor": 6381,
    "SH3BGRL3 expression enhancer": 6382,
    "SH3D19 expression inhibitor": 6383,
    "SHBG expression enhancer": 6384,
    "SHBG expression inhibitor": 6385,
    "SHCBP1 expression enhancer": 6386,
    "SHCBP1 expression inhibitor": 6387,
    "SHMT2 expression inhibitor": 6388,
    "SIAH1 expression inhibitor": 6389,
    "SIAH2 expression inhibitor": 6390,
    "SIRT1 expression inhibitor": 6391,
    "SKP2 expression inhibitor": 6392,
    "SLA expression enhancer": 6393,
    "SLC10A1 expression inhibitor": 6394,
    "SLC12A2 expression inhibitor": 6395,
    "SLC16A2 expression enhancer": 6396,
    "SLC16A6 expression enhancer": 6397,
    "SLC16A6 expression inhibitor": 6398,
    "SLC17A2 expression inhibitor": 6399,
    "SLC1A1 expression enhancer": 6400,
    "SLC1A2 expression enhancer": 6401,
    "SLC1A2 expression inhibitor": 6402,
    "SLC1A5 expression enhancer": 6403,
    "SLC20A1 expression enhancer": 6404,
    "SLC22A18 expression enhancer": 6405,
    "SLC22A3 expression inhibitor": 6406,
    "SLC23A2 expression enhancer": 6407,
    "SLC24A3 expression inhibitor": 6408,
    "SLC25A1 expression enhancer": 6409,
    "SLC25A3 expression inhibitor": 6410,
    "SLC25A30 expression enhancer": 6411,
    "SLC25A36 expression inhibitor": 6412,
    "SLC25A37 expression inhibitor": 6413,
    "SLC26A2 expression inhibitor": 6414,
    "SLC2A1 expression enhancer": 6415,
    "SLC2A1 expression inhibitor": 6416,
    "SLC2A2 expression inhibitor": 6417,
    "SLC2A3 expression inhibitor": 6418,
    "SLC2A4 expression enhancer": 6419,
    "SLC2A5 expression enhancer": 6420,
    "SLC30A1 expression enhancer": 6421,
    "SLC30A5 expression inhibitor": 6422,
    "SLC31A1 expression enhancer": 6423,
    "SLC38A2 expression enhancer": 6424,
    "SLC39A8 expression enhancer": 6425,
    "SLC3A2 expression enhancer": 6426,
    "SLC5A5 expression enhancer": 6427,
    "SLC6A14 expression enhancer": 6428,
    "SLC6A2 expression inhibitor": 6429,
    "SLC6A6 expression enhancer": 6430,
    "SLC7A1 expression inhibitor": 6431,
    "SLC7A11 expression enhancer": 6432,
    "SLC7A11 expression inhibitor": 6433,
    "SLC7A5 expression enhancer": 6434,
    "SLC9A3R2 expression inhibitor": 6435,
    "SLCO2A1 expression enhancer": 6436,
    "SLCO3A1 expression inhibitor": 6437,
    "SLTM expression inhibitor": 6438,
    "SMAD1 expression inhibitor": 6439,
    "SMAD3 expression enhancer": 6440,
    "SMAD3 inhibitor": 6441,
    "SMAD4 expression inhibitor": 6442,
    "SMAD5 expression inhibitor": 6443,
    "SMAD7 expression enhancer": 6444,
    "SMAD9 expression enhancer": 6445,
    "SMARCC1 expression inhibitor": 6446,
    "SMC2 expression enhancer": 6447,
    "SMC4 expression enhancer": 6448,
    "SMC4 expression inhibitor": 6449,
    "SMC5 expression inhibitor": 6450,
    "SMG1 expression inhibitor": 6451,
    "SMN2 expression enhancer": 6452,
    "SMOX expression enhancer": 6453,
    "SMS expression enhancer": 6454,
    "SNAI1 expression enhancer": 6455,
    "SNAI2 expression enhancer": 6456,
    "SNAI2 expression inhibitor": 6457,
    "SNRPB expression inhibitor": 6458,
    "SOCS1 expression inhibitor": 6459,
    "SOCS2 expression enhancer": 6460,
    "SOCS2 expression inhibitor": 6461,
    "SOCS3 expression enhancer": 6462,
    "SOD1 expression enhancer": 6463,
    "SOD1 expression inhibitor": 6464,
    "SOD2 expression enhancer": 6465,
    "SOD2 expression inhibitor": 6466,
    "SOX11 expression inhibitor": 6467,
    "SOX2 expression inhibitor": 6468,
    "SOX4 expression inhibitor": 6469,
    "SOX9 expression enhancer": 6470,
    "SOX9 expression inhibitor": 6471,
    "SP1 expression enhancer": 6472,
    "SP2 expression inhibitor": 6473,
    "SPAG6 expression enhancer": 6474,
    "SPARC expression inhibitor": 6475,
    "SPATA20 expression enhancer": 6476,
    "SPP1 expression enhancer": 6477,
    "SPSB3 expression inhibitor": 6478,
    "SPTLC2 expression enhancer": 6479,
    "SQLE expression inhibitor": 6480,
    "SQRDL expression enhancer": 6481,
    "SQSTM1 expression enhancer": 6482,
    "SQSTM1 expression inhibitor": 6483,
    "SREBF2 expression inhibitor": 6484,
    "SRGAP2 expression inhibitor": 6485,
    "SRPK1 expression inhibitor": 6486,
    "SRPK2 expression inhibitor": 6487,
    "SRRM2 expression inhibitor": 6488,
    "SRSF2 expression enhancer": 6489,
    "SRSF3 expression inhibitor": 6490,
    "SRSF5 expression inhibitor": 6491,
    "SRSF6 expression enhancer": 6492,
    "SRSF7 expression inhibitor": 6493,
    "SRXN1 expression enhancer": 6494,
    "SST expression inhibitor": 6495,
    "ST3GAL1 expression enhancer": 6496,
    "ST3GAL2 expression enhancer": 6497,
    "ST7 expression inhibitor": 6498,
    "STAG1 expression inhibitor": 6499,
    "STAR expression enhancer": 6500,
    "STAR expression inhibitor": 6501,
    "STAT1 expression enhancer": 6502,
    "STAT1 expression inhibitor": 6503,
    "STAT2 expression inhibitor": 6504,
    "STAT3 expression enhancer": 6505,
    "STAT3 expression inhibitor": 6506,
    "STC2 expression enhancer": 6507,
    "STCH expression enhancer": 6508,
    "STEAP1 expression inhibitor": 6509,
    "STIP1 expression enhancer": 6510,
    "STK17A expression enhancer": 6511,
    "STK25 expression enhancer": 6512,
    "STK39 expression enhancer": 6513,
    "STK39 expression inhibitor": 6514,
    "STMN1 expression enhancer": 6515,
    "STMN1 expression inhibitor": 6516,
    "STOM expression enhancer": 6517,
    "STRBP expression inhibitor": 6518,
    "STX11 expression enhancer": 6519,
    "SULF2 expression enhancer": 6520,
    "SULT1A1 substrate": 6521,
    "SULT1A2 substrate": 6522,
    "SULT1A3 substrate": 6523,
    "SULT1E1 substrate": 6524,
    "SULT2A1 expression inhibitor": 6525,
    "SULT2A1 substrate": 6526,
    "SUMO-activating enzyme subunit 1 inhibitor": 6527,
    "SUMO-activating enzyme subunit 2 inhibitor": 6528,
    "SUMO-conjugating enzyme UBC9 inhibitor": 6529,
    "SUMO1 expression inhibitor": 6530,
    "SUOX expression inhibitor": 6531,
    "SUSD4 expression enhancer": 6532,
    "SUV420H1 expression inhibitor": 6533,
    "SUZ12 expression inhibitor": 6534,
    "SV40 T antigen inhibitor": 6535,
    "SVIL expression inhibitor": 6536,
    "SWAP70 expression enhancer": 6537,
    "SYMPK expression inhibitor": 6538,
    "SYNCRIP expression inhibitor": 6539,
    "SYNGR3 expression enhancer": 6540,
    "SYNJ2 expression enhancer": 6541,
    "SYNPO expression enhancer": 6542,
    "Saccharolysin inhibitor": 6543,
    "Saccharopepsin inhibitor": 6544,
    "Saccharopine dehydrogenase (NAD+, L-glutamate-forming) inhibitor": 6545,
    "Saccharopine dehydrogenase (NAD+, L-lysine-forming) inhibitor": 6546,
    "Saccharopine dehydrogenase (NADP+, L-glutamate-forming) inhibitor": 6547,
    "Saccharopine dehydrogenase (NADP+, L-lysine-forming) inhibitor": 6548,
    "Salicylate 1-monooxygenase inhibitor": 6549,
    "Saluretic": 6550,
    "Saponin-like": 6551,
    "Sarcopenia treatment": 6552,
    "Sarcoplasmic reticulum calcium ATPase 2 inhibitor": 6553,
    "Sarcoplasmic reticulum calcium ATPase inhibitor": 6554,
    "Sarcosine oxidase inhibitor": 6555,
    "Scleroderma": 6556,
    "Scleroderma treatment": 6557,
    "Sclerosant": 6558,
    "Scotoma": 6559,
    "Scyllo-inosamine-4-phosphate amidinotransferase inhibitor": 6560,
    "Scytalone dehydratase inhibitor": 6561,
    "Secretase alpha stimulant": 6562,
    "Secretase beta 1 inhibitor": 6563,
    "Secretase beta 2 inhibitor": 6564,
    "Secretase beta inhibitor": 6565,
    "Secretase gamma inhibitor": 6566,
    "Secretase inhibitor": 6567,
    "Secretase stimulant": 6568,
    "Secreted frizzled-related protein 1 inhibitor": 6569,
    "Secretory phospholipase A2 inhibitor": 6570,
    "Sedative": 6571,
    "Sedoheptulose-bisphosphatase inhibitor": 6572,
    "Selectin E antagonist": 6573,
    "Selectin L antagonist": 6574,
    "Selectin P antagonist": 6575,
    "Selectin antagonist": 6576,
    "Selenide, water dikinase inhibitor": 6577,
    "Selenocysteine lyase inhibitor": 6578,
    "Sensitization": 6579,
    "Sensory disturbance": 6580,
    "Sentrin-specific protease 6 inhibitor": 6581,
    "Sentrin-specific protease 7 inhibitor": 6582,
    "Sentrin-specific protease 8 inhibitor": 6583,
    "Sepiapterin deaminase inhibitor": 6584,
    "Sepiapterin reductase inhibitor": 6585,
    "Sepsis": 6586,
    "Sepsis treatment": 6587,
    "Septic shock treatment": 6588,
    "Serine 3-dehydrogenase inhibitor": 6589,
    "Serine O-acetyltransferase inhibitor": 6590,
    "Serine carboxypeptidase inhibitor": 6591,
    "Serine protease inhibitor": 6592,
    "Serine-glyoxylate transaminase inhibitor": 6593,
    "Serine-phosphoethanolamine synthase inhibitor": 6594,
    "Serine-pyruvate transaminase inhibitor": 6595,
    "Serine-sulfate ammonia-lyase inhibitor": 6596,
    "Serine-tRNA ligase inhibitor": 6597,
    "Serine-type D-Ala-D-Ala carboxypeptidase inhibitor": 6598,
    "Serine/threonine-protein kinase 17A inhibitor": 6599,
    "Serine/threonine-protein kinase BRSK1 inhibitor": 6600,
    "Serine/threonine-protein kinase BRSK2 inhibitor": 6601,
    "Serine/threonine-protein kinase D2 inhibitor": 6602,
    "Serine/threonine-protein kinase DCLK1 inhibitor": 6603,
    "Serine/threonine-protein kinase MRCK-A inhibitor": 6604,
    "Serine/threonine-protein kinase MST2 inhibitor": 6605,
    "Serine/threonine-protein kinase NEK2 inhibitor": 6606,
    "Serine/threonine-protein kinase NEK6 inhibitor": 6607,
    "Serine/threonine-protein kinase Nek4 inhibitor": 6608,
    "Serine/threonine-protein kinase PRKX inhibitor": 6609,
    "Serine/threonine-protein kinase RIPK2 inhibitor": 6610,
    "Serine/threonine-protein kinase SRPK1 inhibitor": 6611,
    "Serine/threonine-protein kinase Sgk2 inhibitor": 6612,
    "Serine/threonine-protein kinase TAO1 inhibitor": 6613,
    "Serine/threonine-protein kinase TBK1 inhibitor": 6614,
    "Serine/threonine-protein kinase WEE1 inhibitor": 6615,
    "Serine/threonine-protein kinase c-TAK1 inhibitor": 6616,
    "Serine/threonine-protein phosphatase 2A activator inhibitor": 6617,
    "Serralysin inhibitor": 6618,
    "Serratia marcescens nuclease inhibitor": 6619,
    "Serum paraoxonase/arylesterase 1 inhibitor": 6620,
    "Serum sickness": 6621,
    "Serum-glucocorticoid regulated kinase 1 inhibitor": 6622,
    "Serum-glucocorticoid regulated kinase inhibitor": 6623,
    "Severe acute respiratory syndrome treatment": 6624,
    "Sexual dysfunction": 6625,
    "Shab potassium channel blocker": 6626,
    "Shaker potassium channel blocker": 6627,
    "Shal potassium channel blocker": 6628,
    "Shikimate 5-dehydrogenase inhibitor": 6629,
    "Shikimate O-hydroxycinnamoyltransferase inhibitor": 6630,
    "Shikimate kinase inhibitor": 6631,
    "Shivering": 6632,
    "Shock": 6633,
    "Shock treatment": 6634,
    "Sialidase 1 inhibitor": 6635,
    "Sialidase 3 inhibitor": 6636,
    "Sialorrhea": 6637,
    "Sickle-cell anemia treatment": 6638,
    "Sigma 1 receptor agonist": 6639,
    "Sigma 1 receptor antagonist": 6640,
    "Sigma 2 receptor antagonist": 6641,
    "Sigma 3 receptor antagonist": 6642,
    "Sigma receptor agonist": 6643,
    "Sigma receptor antagonist": 6644,
    "Signal peptidase I inhibitor": 6645,
    "Signal peptidase IB inhibitor": 6646,
    "Signal peptidase II inhibitor": 6647,
    "Simian immunodeficiency virus proteinase inhibitor": 6648,
    "Simian sarcoma virus Pol protein inhibitor": 6649,
    "Sinus arrest": 6650,
    "Sinusitis": 6651,
    "Sirtuin 1 inhibitor": 6652,
    "Sirtuin 2 inhibitor": 6653,
    "Sirtuin inhibitor": 6654,
    "Site-specific DNA-methyltransferase (adenine-specific) inhibitor": 6655,
    "Skeletal muscle relaxant": 6656,
    "Skin diseases treatment": 6657,
    "Skin irritation, corrasive": 6658,
    "Skin irritation, high": 6659,
    "Skin irritation, inactive": 6660,
    "Skin irritation, moderate": 6661,
    "Skin irritation, weak": 6662,
    "Skin irritative effect": 6663,
    "Skin necrosis": 6664,
    "Skin whitener": 6665,
    "Sleep apnea treatment": 6666,
    "Sleep disorders treatment": 6667,
    "Sleep disturbance": 6668,
    "Small monomeric GTPase inhibitor": 6669,
    "Smo receptor agonist": 6670,
    "Smo receptor antagonist": 6671,
    "Smooth muscle myosin light chain kinase inhibitor": 6672,
    "Sn1-specific diacylglycerol lipase alpha inhibitor": 6673,
    "Snapalysin inhibitor": 6674,
    "Sneezing": 6675,
    "Sodium channel (voltage-gated) blocker": 6676,
    "Sodium channel activator": 6677,
    "Sodium channel beta-1 subunit blocker": 6678,
    "Sodium channel beta-2 subunit blocker": 6679,
    "Sodium channel beta-3 subunit blocker": 6680,
    "Sodium channel beta-4 subunit blocker": 6681,
    "Sodium channel blocker": 6682,
    "Sodium channel blocker class Ib": 6683,
    "Sodium-dependent vitamin C transporter 2 inhibitor": 6684,
    "Sodium/bile acid cotransporter inhibitor": 6685,
    "Sodium/calcium exchanger 1 inhibitor": 6686,
    "Sodium/calcium exchanger inhibitor": 6687,
    "Sodium/glucose cotransporter 1 inhibitor": 6688,
    "Sodium/glucose cotransporter 2 inhibitor": 6689,
    "Sodium/glucose cotransporter 3 inhibitor": 6690,
    "Sodium/glucose cotransporter inhibitor": 6691,
    "Sodium/hydrogen exchanger 1 inhibitor": 6692,
    "Sodium/hydrogen exchanger 2 inhibitor": 6693,
    "Sodium/hydrogen exchanger 3 inhibitor": 6694,
    "Sodium/hydrogen exchanger 5 inhibitor": 6695,
    "Sodium/hydrogen exchanger inhibitor": 6696,
    "Solute carrier family 22 member 12 inhibitor": 6697,
    "Solute carrier organic anion transporter family member 1B1 inhibitor": 6698,
    "Solute carrier organic anion transporter family member 1B3 inhibitor": 6699,
    "Somatostatin 1 agonist": 6700,
    "Somatostatin 1 antagonist": 6701,
    "Somatostatin 2 agonist": 6702,
    "Somatostatin 2 antagonist": 6703,
    "Somatostatin 3 agonist": 6704,
    "Somatostatin 3 antagonist": 6705,
    "Somatostatin 4 agonist": 6706,
    "Somatostatin 4 antagonist": 6707,
    "Somatostatin 5 agonist": 6708,
    "Somatostatin 5 antagonist": 6709,
    "Somatostatin agonist": 6710,
    "Somatostatin antagonist": 6711,
    "Sonic hedgehog protein inhibitor": 6712,
    "Sorbitol accumulation inhibitor": 6713,
    "Sorbitol dehydrogenase inhibitor": 6714,
    "Sorbitol-6-phosphate 2-dehydrogenase inhibitor": 6715,
    "Sorbose dehydrogenase inhibitor": 6716,
    "Spasmogenic": 6717,
    "Spasmolytic": 6718,
    "Spasmolytic, Papaverin-like": 6719,
    "Spasmolytic, urinary": 6720,
    "Spasticity": 6721,
    "Speech disturbance": 6722,
    "Spermicide": 6723,
    "Spermidine dehydrogenase inhibitor": 6724,
    "Spermidine synthase inhibitor": 6725,
    "Spermine antagonist": 6726,
    "Spermine synthase inhibitor": 6727,
    "Sphinganine kinase inhibitor": 6728,
    "Sphinganine-1-phosphate aldolase inhibitor": 6729,
    "Sphingomyelinase inhibitor": 6730,
    "Sphingosine 1-phosphate receptor 1 agonist": 6731,
    "Sphingosine 1-phosphate receptor 1 antagonist": 6732,
    "Sphingosine 1-phosphate receptor 2 agonist": 6733,
    "Sphingosine 1-phosphate receptor 2 antagonist": 6734,
    "Sphingosine 1-phosphate receptor 3 agonist": 6735,
    "Sphingosine 1-phosphate receptor 3 antagonist": 6736,
    "Sphingosine 1-phosphate receptor 4 agonist": 6737,
    "Sphingosine 1-phosphate receptor 4 antagonist": 6738,
    "Sphingosine 1-phosphate receptor 5 agonist": 6739,
    "Sphingosine 1-phosphate receptor 5 antagonist": 6740,
    "Sphingosine 1-phosphate receptor agonist": 6741,
    "Sphingosine 1-phosphate receptor antagonist": 6742,
    "Sphingosine kinase 1 inhibitor": 6743,
    "Sphingosine kinase 2 inhibitor": 6744,
    "Sphingosine kinase inhibitor": 6745,
    "Sphingosine kinase stimulant": 6746,
    "Splenomegaly": 6747,
    "Splicing factor 3B subunit 3 inhibitor": 6748,
    "Sporulation kinase A inhibitor": 6749,
    "Squalene epoxidase inhibitor": 6750,
    "Squalene synthetase inhibitor": 6751,
    "Squalene-hopene cyclase inhibitor": 6752,
    "Src kinase inhibitor": 6753,
    "Status epilepticus": 6754,
    "Stearoyl-CoA desaturase inhibitor": 6755,
    "Stem cell growth factor agonist": 6756,
    "Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor": 6757,
    "Steroid 9alpha-monooxygenase inhibitor": 6758,
    "Steroid DELTA-isomerase inhibitor": 6759,
    "Steroid N-acetylglucosaminyltransferase inhibitor": 6760,
    "Steroid sulfotransferase inhibitor": 6761,
    "Steroid synthesis inhibitor": 6762,
    "Steroid-like": 6763,
    "Steroidogenic factor 1 receptor antagonist": 6764,
    "Sterol 24-C-methyltransferase inhibitor": 6765,
    "Sterol 3-beta-glucosyltransferase inhibitor": 6766,
    "Stipitatonate decarboxylase inhibitor": 6767,
    "Stomatitis": 6768,
    "Streptogrisin A inhibitor": 6769,
    "Streptokinase A inhibitor": 6770,
    "Streptomycin 6-kinase inhibitor": 6771,
    "Streptopain inhibitor": 6772,
    "Stridor": 6773,
    "Stroke treatment": 6774,
    "Strombine dehydrogenase inhibitor": 6775,
    "Stromelysin 2 inhibitor": 6776,
    "Styrene-oxide isomerase inhibitor": 6777,
    "Substance P antagonist": 6778,
    "Subtilisin inhibitor": 6779,
    "Succinate dehydrogenase inhibitor": 6780,
    "Succinate-CoA ligase (ADP-forming) inhibitor": 6781,
    "Succinate-hydroxymethylglutarate CoA-transferase inhibitor": 6782,
    "Succinate-semialdehyde dehydrogenase [NAD(P)+] inhibitor": 6783,
    "Succinate-semialdehyde dehydrogenase inhibitor": 6784,
    "Succinic dehydrogenase inhibitor": 6785,
    "Succinyl-diaminopimelate desuccinylase inhibitor": 6786,
    "Sucrase-isomaltase inhibitor": 6787,
    "Sucrose alpha-glucosidase inhibitor": 6788,
    "Sucrose phosphorylase inhibitor": 6789,
    "Sucrose synthase inhibitor": 6790,
    "Sucrose-phosphate phosphatase inhibitor": 6791,
    "Sucrose-phosphate synthase inhibitor": 6792,
    "Sugar-phosphatase inhibitor": 6793,
    "Sulfate adenylyltransferase (ADP) inhibitor": 6794,
    "Sulfate adenylyltransferase inhibitor": 6795,
    "Sulfinoalanine decarboxylase inhibitor": 6796,
    "Sulfite dehydrogenase inhibitor": 6797,
    "Sulfite oxidase inhibitor": 6798,
    "Sulfite reductase inhibitor": 6799,
    "Sulfonylureas": 6800,
    "Sulfotransferase substrate": 6801,
    "Sulfur dioxygenase inhibitor": 6802,
    "Sulfur reductase inhibitor": 6803,
    "Superoxide dismutase inhibitor": 6804,
    "Superoxide dismutase stimulant": 6805,
    "Sweating": 6806,
    "Sweetener": 6807,
    "Swelling": 6808,
    "Syk tyrosine kinase inhibitor": 6809,
    "Synaptic vesicle protein SV2, levetiracetam binding site antagonist": 6810,
    "Syncope": 6811,
    "Systemic lupus erythematosus": 6812,
    "Systemic lupus erythematosus treatment": 6813,
    "T cell inhibitor": 6814,
    "T cell receptor antagonist": 6815,
    "T cell receptor gamma-delta antagonist": 6816,
    "T-cell protein-tyrosine phosphatase inhibitor": 6817,
    "T2-induced deoxynucleotide kinase inhibitor": 6818,
    "TAC1 expression enhancer": 6819,
    "TACC1 expression enhancer": 6820,
    "TACC1 expression inhibitor": 6821,
    "TACC3 expression enhancer": 6822,
    "TAF5 expression inhibitor": 6823,
    "TAGLN expression inhibitor": 6824,
    "TANC1 expression inhibitor": 6825,
    "TAOK3 expression inhibitor": 6826,
    "TAR RNA binding protein 1 inhibitor": 6827,
    "TAR RNA binding protein 2 inhibitor": 6828,
    "TARDBP expression inhibitor": 6829,
    "TARS expression inhibitor": 6830,
    "TAX1BP3 expression enhancer": 6831,
    "TBC1D1 expression inhibitor": 6832,
    "TBC1D7 expression enhancer": 6833,
    "TBC1D9 expression inhibitor": 6834,
    "TBL1XR1 expression inhibitor": 6835,
    "TCEB2 expression inhibitor": 6836,
    "TCEB3 expression inhibitor": 6837,
    "TCF12 expression enhancer": 6838,
    "TCF25 expression inhibitor": 6839,
    "TCF3 expression inhibitor": 6840,
    "TCF7 expression enhancer": 6841,
    "TEC kinase inhibitor": 6842,
    "TERF1 expression inhibitor": 6843,
    "TERT expression enhancer": 6844,
    "TERT expression inhibitor": 6845,
    "TFAM expression inhibitor": 6846,
    "TFAP2A expression enhancer": 6847,
    "TFDP1 expression inhibitor": 6848,
    "TFDP2 expression inhibitor": 6849,
    "TFF1 expression enhancer": 6850,
    "TFF1 expression inhibitor": 6851,
    "TFF3 expression enhancer": 6852,
    "TFF3 expression inhibitor": 6853,
    "TFPI2 expression enhancer": 6854,
    "TFRC expression enhancer": 6855,
    "TGF beta receptor type I kinase inhibitor": 6856,
    "TGF beta receptor type II kinase inhibitor": 6857,
    "TGFA expression enhancer": 6858,
    "TGFB1 expression enhancer": 6859,
    "TGFB1 expression inhibitor": 6860,
    "TGFB1I1 expression enhancer": 6861,
    "TGFB2 expression inhibitor": 6862,
    "TGFB3 expression enhancer": 6863,
    "TGFBI expression enhancer": 6864,
    "TGFBR1 expression inhibitor": 6865,
    "TGFBR2 expression enhancer": 6866,
    "TGM1 expression enhancer": 6867,
    "TGM1 expression inhibitor": 6868,
    "TGM2 expression enhancer": 6869,
    "TGOLN2 expression inhibitor": 6870,
    "TH expression enhancer": 6871,
    "THAP2 expression enhancer": 6872,
    "THBD expression enhancer": 6873,
    "THBS1 expression enhancer": 6874,
    "THBS1 expression inhibitor": 6875,
    "THRB expression enhancer": 6876,
    "TIA1 expression inhibitor": 6877,
    "TIE antagonist": 6878,
    "TIE-2 agonist": 6879,
    "TIE-2 antagonist": 6880,
    "TIMP1 expression enhancer": 6881,
    "TIMP1 expression inhibitor": 6882,
    "TIMP2 expression enhancer": 6883,
    "TIMP2 expression inhibitor": 6884,
    "TIMP3 expression enhancer": 6885,
    "TIMP3 expression inhibitor": 6886,
    "TINF2 expression inhibitor": 6887,
    "TIPARP expression enhancer": 6888,
    "TK1 expression enhancer": 6889,
    "TK1 expression inhibitor": 6890,
    "TLE3 expression inhibitor": 6891,
    "TLE4 expression inhibitor": 6892,
    "TLR2 expression enhancer": 6893,
    "TM7SF2 expression inhibitor": 6894,
    "TMC6 expression enhancer": 6895,
    "TMEM158 expression enhancer": 6896,
    "TMEM38B expression enhancer": 6897,
    "TMEM59L expression inhibitor": 6898,
    "TMEM97 expression enhancer": 6899,
    "TMPO expression enhancer": 6900,
    "TMPO expression inhibitor": 6901,
    "TMPRSS2 expression enhancer": 6902,
    "TMPRSS2 expression inhibitor": 6903,
    "TMSB4X expression enhancer": 6904,
    "TMSB4X expression inhibitor": 6905,
    "TNC expression enhancer": 6906,
    "TNC expression inhibitor": 6907,
    "TNF convertase inhibitor": 6908,
    "TNF expression enhancer": 6909,
    "TNF expression inhibitor": 6910,
    "TNFAIP2 expression enhancer": 6911,
    "TNFAIP3 expression enhancer": 6912,
    "TNFAIP8 expression enhancer": 6913,
    "TNFRSF10A expression enhancer": 6914,
    "TNFRSF10B expression enhancer": 6915,
    "TNFRSF10B expression inhibitor": 6916,
    "TNFRSF11A expression enhancer": 6917,
    "TNFRSF11B expression enhancer": 6918,
    "TNFRSF11B expression inhibitor": 6919,
    "TNFRSF12A expression enhancer": 6920,
    "TNFRSF1A expression inhibitor": 6921,
    "TNFRSF1B expression enhancer": 6922,
    "TNFRSF21 expression enhancer": 6923,
    "TNFRSF21 expression inhibitor": 6924,
    "TNFRSF25 expression inhibitor": 6925,
    "TNFRSF9 expression enhancer": 6926,
    "TNFSF10 expression enhancer": 6927,
    "TNFSF10 expression inhibitor": 6928,
    "TNFSF11 expression inhibitor": 6929,
    "TNFSF15 expression enhancer": 6930,
    "TNFSF9 expression enhancer": 6931,
    "TNIK expression inhibitor": 6932,
    "TNNC1 expression enhancer": 6933,
    "TNNT1 expression inhibitor": 6934,
    "TNPO1 expression inhibitor": 6935,
    "TNPO2 expression inhibitor": 6936,
    "TNS3 expression inhibitor": 6937,
    "TOB1 expression inhibitor": 6938,
    "TOP1 expression inhibitor": 6939,
    "TOP2A expression enhancer": 6940,
    "TOP2A expression inhibitor": 6941,
    "TOPBP1 expression inhibitor": 6942,
    "TP53 expression enhancer": 6943,
    "TP53 expression inhibitor": 6944,
    "TP53I11 expression inhibitor": 6945,
    "TP53I3 expression enhancer": 6946,
    "TP63 expression enhancer": 6947,
    "TP73 expression enhancer": 6948,
    "TPBG expression enhancer": 6949,
    "TPD52L1 expression enhancer": 6950,
    "TPI1 expression enhancer": 6951,
    "TPM3 expression enhancer": 6952,
    "TPM4 expression inhibitor": 6953,
    "TPX2 expression enhancer": 6954,
    "TRA2A expression inhibitor": 6955,
    "TRAF2 expression enhancer": 6956,
    "TRAF3 expression enhancer": 6957,
    "TRAF5 expression inhibitor": 6958,
    "TRAF6 expression enhancer": 6959,
    "TRAIP expression enhancer": 6960,
    "TRAK2 expression enhancer": 6961,
    "TRAM1 expression inhibitor": 6962,
    "TRAM2 expression inhibitor": 6963,
    "TRIAP1 expression enhancer": 6964,
    "TRIB1 expression enhancer": 6965,
    "TRIB3 expression inhibitor": 6966,
    "TRIM16 expression enhancer": 6967,
    "TRIM16 expression inhibitor": 6968,
    "TRIM24 expression inhibitor": 6969,
    "TRIM8 expression enhancer": 6970,
    "TRIP13 expression enhancer": 6971,
    "TRKA antagonist": 6972,
    "TRKB antagonist": 6973,
    "TRKC antagonist": 6974,
    "TRPA1 agonist": 6975,
    "TRPA1 antagonist": 6976,
    "TRPM8 blocker": 6977,
    "TRPV1 expression inhibitor": 6978,
    "TRPV2 expression enhancer": 6979,
    "TRRAP expression inhibitor": 6980,
    "TSC2 expression enhancer": 6981,
    "TSC22D3 expression enhancer": 6982,
    "TSKU expression enhancer": 6983,
    "TSPAN12 expression inhibitor": 6984,
    "TSPAN5 expression inhibitor": 6985,
    "TSPAN8 expression enhancer": 6986,
    "TSR1 expression inhibitor": 6987,
    "TTC3 expression inhibitor": 6988,
    "TTK expression inhibitor": 6989,
    "TTK protein kinase inhibitor": 6990,
    "TUBA1A expression enhancer": 6991,
    "TUBA1A expression inhibitor": 6992,
    "TUBA4A expression enhancer": 6993,
    "TUBB expression inhibitor": 6994,
    "TUBB3 expression enhancer": 6995,
    "TUBB6 expression enhancer": 6996,
    "TUBGCP3 expression inhibitor": 6997,
    "TUFT1 expression enhancer": 6998,
    "TULP3 expression inhibitor": 6999,
    "TXN expression enhancer": 7000,
    "TXN expression inhibitor": 7001,
    "TXNIP expression inhibitor": 7002,
    "TXNRD1 expression enhancer": 7003,
    "TXNRD1 expression inhibitor": 7004,
    "TYMS expression enhancer": 7005,
    "Tachycardia, supraventricular": 7006,
    "Tachycardiac": 7007,
    "Tagaturonate reductase inhibitor": 7008,
    "Tankyrase 1 inhibitor": 7009,
    "Tankyrase 2 inhibitor": 7010,
    "Tankyrase inhibitor": 7011,
    "Tannase inhibitor": 7012,
    "Tardive dyskinesia treatment": 7013,
    "Targeting protein for Xklp2 inhibitor": 7014,
    "Tartrate decarboxylase inhibitor": 7015,
    "Tartrate dehydrogenase inhibitor": 7016,
    "Taste, bitter": 7017,
    "Tau aggregation inhibitor": 7018,
    "Taurine dehydrogenase inhibitor": 7019,
    "Taurine-2-oxoglutarate transaminase inhibitor": 7020,
    "Taurocyamine kinase inhibitor": 7021,
    "Tauropine dehydrogenase inhibitor": 7022,
    "Telangiectasia": 7023,
    "Telomerase inhibitor": 7024,
    "Telomerase stimulant": 7025,
    "Tenderness": 7026,
    "Tentoxilysin inhibitor": 7027,
    "Teratogen": 7028,
    "Testicular atrophy": 7029,
    "Testis-specific androgen-binding protein inhibitor": 7030,
    "Testis-specific serine/threonine-protein kinase 1 antagonist": 7031,
    "Testis-specific serine/threonine-protein kinase 1 inhibitor": 7032,
    "Testosterone 17beta-dehydrogenase inhibitor": 7033,
    "Testosterone agonist": 7034,
    "Tetanus neurotoxin inhibitor": 7035,
    "Tetany": 7036,
    "Tetracycline antiport transporter antagonist": 7037,
    "Tetrahydroxynaphthalene reductase inhibitor": 7038,
    "Theanine hydrolase inhibitor": 7039,
    "Thermitase inhibitor": 7040,
    "Thermolysin inhibitor": 7041,
    "Thermomycolin inhibitor": 7042,
    "Thiamine pyridinylase inhibitor": 7043,
    "Thiamine-phosphate diphosphorylase inhibitor": 7044,
    "Thiamine-phosphate kinase inhibitor": 7045,
    "Thiamine-triphosphatase inhibitor": 7046,
    "Thiazolidinedione": 7047,
    "Thimet oligopeptidase inhibitor": 7048,
    "Thioether S-methyltransferase inhibitor": 7049,
    "Thiol S-methyltransferase inhibitor": 7050,
    "Thiol oxidase inhibitor": 7051,
    "Thiol protease inhibitor": 7052,
    "Thiol sulfotransferase inhibitor": 7053,
    "Thiopurine S-methyltransferase inhibitor": 7054,
    "Thioredoxin glutathione reductase inhibitor": 7055,
    "Thioredoxin inhibitor": 7056,
    "Thioredoxin reductase 1 inhibitor": 7057,
    "Thioredoxin reductase 2 inhibitor": 7058,
    "Thioredoxin reductase 3 inhibitor": 7059,
    "Thioredoxin reductase inhibitor": 7060,
    "Thiosulfate dehydrogenase inhibitor": 7061,
    "Thiosulfate sulfurtransferase inhibitor": 7062,
    "Thirst": 7063,
    "Threonine aldolase inhibitor": 7064,
    "Threonine ammonia-lyase inhibitor": 7065,
    "Threonine synthase inhibitor": 7066,
    "Threonine-tRNA ligase inhibitor": 7067,
    "Thrombin inhibitor": 7068,
    "Thrombin receptor antagonist": 7069,
    "Thrombin stimulant": 7070,
    "Thrombocytopenia": 7071,
    "Thrombocytopoiesis inhibitor": 7072,
    "Thromboembolism treatment": 7073,
    "Thrombolytic": 7074,
    "Thrombophlebitis": 7075,
    "Thrombopoietin agonist": 7076,
    "Thrombosis": 7077,
    "Thromboxane A2 antagonist": 7078,
    "Thromboxane B2 antagonist": 7079,
    "Thromboxane agonist": 7080,
    "Thromboxane antagonist": 7081,
    "Thromboxane synthase inhibitor": 7082,
    "Thromboxane synthase stimulant": 7083,
    "Thymidine kinase (Herpes simplex virus 1) inhibitor": 7084,
    "Thymidine kinase (Herpes simplex virus 2) inhibitor": 7085,
    "Thymidine kinase 1 inhibitor": 7086,
    "Thymidine kinase 2 inhibitor": 7087,
    "Thymidine kinase inhibitor": 7088,
    "Thymidine phosphorylase inhibitor": 7089,
    "Thymidine-triphosphatase inhibitor": 7090,
    "Thymidylate 5'-phosphatase inhibitor": 7091,
    "Thymidylate synthase inhibitor": 7092,
    "Thymine dioxygenase inhibitor": 7093,
    "Thyroid hormone agonist": 7094,
    "Thyroid hormone alpha 1 agonist": 7095,
    "Thyroid hormone alpha 1 antagonist": 7096,
    "Thyroid hormone alpha agonist": 7097,
    "Thyroid hormone alpha antagonist": 7098,
    "Thyroid hormone antagonist": 7099,
    "Thyroid hormone beta 1 agonist": 7100,
    "Thyroid hormone beta 1 antagonist": 7101,
    "Thyroid hormone beta agonist": 7102,
    "Thyroid hormone beta antagonist": 7103,
    "Thyrotropin receptor antagonist": 7104,
    "Thyrotropin releasing hormone agonist": 7105,
    "Thyrotropin releasing hormone antagonist": 7106,
    "Thyroxine 5-deiodinase inhibitor": 7107,
    "Tinnitus": 7108,
    "Tocolytic": 7109,
    "Toll-Like receptor 2 agonist": 7110,
    "Toll-Like receptor 2 antagonist": 7111,
    "Toll-Like receptor 4 agonist": 7112,
    "Toll-Like receptor 4 antagonist": 7113,
    "Toll-Like receptor 7 agonist": 7114,
    "Toll-Like receptor 7 antagonist": 7115,
    "Toll-Like receptor 8 agonist": 7116,
    "Toll-Like receptor 8 antagonist": 7117,
    "Toll-Like receptor 9 antagonist": 7118,
    "Toll-Like receptor agonist": 7119,
    "Toll-Like receptor antagonist": 7120,
    "Topoisomerase I inhibitor": 7121,
    "Topoisomerase I stimulant": 7122,
    "Topoisomerase II alpha inhibitor": 7123,
    "Topoisomerase II beta inhibitor": 7124,
    "Topoisomerase II inhibitor": 7125,
    "Torsades de pointes": 7126,
    "Torticollis": 7127,
    "Toxic": 7128,
    "Toxic epidermal necrolysis": 7129,
    "Toxic, gastrointestinal": 7130,
    "Toxic, respiration": 7131,
    "Toxic, respiratory center": 7132,
    "Toxic, vascular": 7133,
    "Tpr proteinase (Porphyromonas gingivalis) inhibitor": 7134,
    "Trace amine-associated receptor 1 agonist": 7135,
    "Trace amine-associated receptor 1 antagonist": 7136,
    "Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase inhibitor": 7137,
    "Trans-2-enoyl-CoA reductase (NAD+) inhibitor": 7138,
    "Trans-2-enoyl-CoA reductase (NADPH) inhibitor": 7139,
    "Trans-acenaphthene-1,2-diol dehydrogenase inhibitor": 7140,
    "Trans-octaprenyltranstransferase inhibitor": 7141,
    "Trans-pentaprenyltranstransferase inhibitor": 7142,
    "Transactivator transcription protein inhibitor": 7143,
    "Transaldolase inhibitor": 7144,
    "Transcortin receptor antagonist": 7145,
    "Transcription factor AP-1 inhibitor": 7146,
    "Transcription factor E2F1 inhibitor": 7147,
    "Transcription factor NF kappa A inhibitor": 7148,
    "Transcription factor NF kappa B inhibitor": 7149,
    "Transcription factor NF kappa B stimulant": 7150,
    "Transcription factor NF kappa B1 inhibitor": 7151,
    "Transcription factor NF kappa B2 inhibitor": 7152,
    "Transcription factor RelA inhibitor": 7153,
    "Transcription factor STAT inhibitor": 7154,
    "Transcription factor STAT1 inhibitor": 7155,
    "Transcription factor STAT1 stimulant": 7156,
    "Transcription factor STAT3 inhibitor": 7157,
    "Transcription factor STAT6 inhibitor": 7158,
    "Transcription factor inhibitor": 7159,
    "Transcription factor rho inhibitor": 7160,
    "Transcription factor stimulant": 7161,
    "Transferase inhibitor": 7162,
    "Transforming growth factor agonist": 7163,
    "Transforming growth factor antagonist": 7164,
    "Transforming growth factor beta 1 agonist": 7165,
    "Transforming growth factor beta 1 antagonist": 7166,
    "Transforming growth factor beta 2 antagonist": 7167,
    "Transforming growth factor beta 3 antagonist": 7168,
    "Transforming growth factor beta agonist": 7169,
    "Transforming growth factor beta antagonist": 7170,
    "Transforming protein p21/H-Ras-1 inhibitor": 7171,
    "Transglutaminase 2 inhibitor": 7172,
    "Transitional endoplasmic reticulum ATPase inhibitor": 7173,
    "Transketolase inhibitor": 7174,
    "Translation initiation factor IF-2 antagonist": 7175,
    "Transplant rejection treatment": 7176,
    "Transthyretin amyloid fibril formation inhibitor": 7177,
    "Trehalose-phosphatase inhibitor": 7178,
    "Tremor": 7179,
    "Triacetate-lactonase inhibitor": 7180,
    "Trimerelysin II inhibitor": 7181,
    "Trimethylamine dehydrogenase inhibitor": 7182,
    "Trimethylamine-N-oxide reductase inhibitor": 7183,
    "Trimethylamine-oxide aldolase inhibitor": 7184,
    "Trimethyllysine dioxygenase inhibitor": 7185,
    "Triose-phosphate isomerase inhibitor": 7186,
    "Tripeptide aminopeptidase inhibitor": 7187,
    "Tripeptidyl peptidase II inhibitor": 7188,
    "Tripeptidyl-peptidase I inhibitor": 7189,
    "Tropinesterase inhibitor": 7190,
    "Troponin C inhibitor": 7191,
    "Troponin I, cardiac muscle inhibitor": 7192,
    "Troponin T, cardiac muscle inhibitor": 7193,
    "Trypanothione-disulfide reductase inhibitor": 7194,
    "Trypsin I inhibitor": 7195,
    "Trypsin II inhibitor": 7196,
    "Trypsin III inhibitor": 7197,
    "Trypsin inhibitor": 7198,
    "Tryptase 1 inhibitor": 7199,
    "Tryptase 3 inhibitor": 7200,
    "Tryptase gamma inhibitor": 7201,
    "Tryptase inhibitor": 7202,
    "Tryptophan 2,3-dioxygenase inhibitor": 7203,
    "Tryptophan 2-monooxygenase inhibitor": 7204,
    "Tryptophan 5 hydroxylase inhibitor": 7205,
    "Tryptophan alpha,beta-oxidase inhibitor": 7206,
    "Tryptophan dimethylallyltransferase inhibitor": 7207,
    "Tryptophan hydroxylase 1 inhibitor": 7208,
    "Tryptophan synthase inhibitor": 7209,
    "Tryptophan transaminase inhibitor": 7210,
    "Tryptophan-tRNA ligase inhibitor": 7211,
    "Tryptophanamidase inhibitor": 7212,
    "Tryptophanyl aminopeptidase inhibitor": 7213,
    "Tubulin GTPase inhibitor": 7214,
    "Tubulin agonist": 7215,
    "Tubulin antagonist": 7216,
    "Tubulin-tyrosine ligase inhibitor": 7217,
    "Tubulinyl-Tyr carboxypeptidase inhibitor": 7218,
    "Tumour necrosis factor agonist": 7219,
    "Tumour necrosis factor alpha antagonist": 7220,
    "Tumour necrosis factor alpha release inhibitor": 7221,
    "Tumour necrosis factor antagonist": 7222,
    "Tyk2 inhibitor": 7223,
    "Tyrosine 2,3-aminomutase inhibitor": 7224,
    "Tyrosine 3 hydroxylase inhibitor": 7225,
    "Tyrosine 3 hydroxylase stimulant": 7226,
    "Tyrosine kinase inhibitor": 7227,
    "Tyrosine kinase non-receptor protein 2 inhibitor": 7228,
    "Tyrosine kinase stimulant": 7229,
    "Tyrosine phenol-lyase inhibitor": 7230,
    "Tyrosine transaminase inhibitor": 7231,
    "Tyrosine transaminase stimulant": 7232,
    "Tyrosine-ester sulfotransferase inhibitor": 7233,
    "Tyrosine-protein kinase ABL2 inhibitor": 7234,
    "Tyrosine-protein kinase BMX inhibitor": 7235,
    "Tyrosine-protein kinase BRK inhibitor": 7236,
    "Tyrosine-protein kinase EMT inhibitor": 7237,
    "Tyrosine-protein kinase FER inhibitor": 7238,
    "Tyrosine-protein kinase FES inhibitor": 7239,
    "Tyrosine-protein kinase FRK inhibitor": 7240,
    "Tyrosine-protein kinase TXK inhibitor": 7241,
    "Tyrosine-protein kinase TYRO 10 inhibitor": 7242,
    "Tyrosine-protein kinase receptor FLT3 inhibitor": 7243,
    "Tyrosine-protein kinase receptor TYRO3 inhibitor": 7244,
    "Tyrosine-protein kinase receptor antagonist": 7245,
    "Tyrosyl-DNA phosphodiesterase 2 inhibitor": 7246,
    "UAP1 expression inhibitor": 7247,
    "UBA52 expression inhibitor": 7248,
    "UBD expression enhancer": 7249,
    "UBE2C expression enhancer": 7250,
    "UBE2M expression inhibitor": 7251,
    "UBE2T expression enhancer": 7252,
    "UBL5 expression inhibitor": 7253,
    "UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitor": 7254,
    "UDP-Glucuronosyltransferase inhibitor": 7255,
    "UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor": 7256,
    "UDP-N-acetylglucosamine 2-epimerase inhibitor": 7257,
    "UDP-N-acetylglucosamine 4-epimerase inhibitor": 7258,
    "UDP-N-acetylglucosamine diphosphorylase inhibitor": 7259,
    "UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase inhibitor": 7260,
    "UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase inhibitor": 7261,
    "UDP-N-acetylmuramate dehydrogenase inhibitor": 7262,
    "UDP-N-acetylmuramate-L-alanine ligase inhibitor": 7263,
    "UDP-N-acetylmuramoylalanine-D-glutamate ligase inhibitor": 7264,
    "UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase inhibitor": 7265,
    "UDP-N-acetylmuramoylalanyl-D-glutamyllysine-D-alanyl-D-alanine ligase inhibitor": 7266,
    "UDP-glucose 4-epimerase inhibitor": 7267,
    "UDP-glucose 6-dehydrogenase inhibitor": 7268,
    "UDP-glucose-hexose-1-phosphate uridylyltransferase inhibitor": 7269,
    "UDP-glucuronate 4-epimerase inhibitor": 7270,
    "UDP-glucuronate 5'-epimerase inhibitor": 7271,
    "UDP-glucuronate decarboxylase inhibitor": 7272,
    "UDP-glucuronosyltransferase 2B7 inhibitor": 7273,
    "UDP-glucuronosyltransferase substrate": 7274,
    "UDP-sugar diphosphatase inhibitor": 7275,
    "UGCG expression enhancer": 7276,
    "UGCG expression inhibitor": 7277,
    "UGDH expression enhancer": 7278,
    "UGP2 expression enhancer": 7279,
    "UGT1A substrate": 7280,
    "UGT1A1 expression enhancer": 7281,
    "UGT1A1 expression inhibitor": 7282,
    "UGT1A1 substrate": 7283,
    "UGT1A10 expression enhancer": 7284,
    "UGT1A10 substrate": 7285,
    "UGT1A3 expression enhancer": 7286,
    "UGT1A3 expression inhibitor": 7287,
    "UGT1A3 substrate": 7288,
    "UGT1A4 substrate": 7289,
    "UGT1A5 substrate": 7290,
    "UGT1A6 expression enhancer": 7291,
    "UGT1A6 substrate": 7292,
    "UGT1A7 expression enhancer": 7293,
    "UGT1A7 substrate": 7294,
    "UGT1A8 substrate": 7295,
    "UGT1A9 substrate": 7296,
    "UGT2B substrate": 7297,
    "UGT2B1 substrate": 7298,
    "UGT2B10 substrate": 7299,
    "UGT2B11 substrate": 7300,
    "UGT2B12 substrate": 7301,
    "UGT2B15 expression enhancer": 7302,
    "UGT2B15 substrate": 7303,
    "UGT2B17 expression enhancer": 7304,
    "UGT2B17 substrate": 7305,
    "UGT2B18 substrate": 7306,
    "UGT2B19 substrate": 7307,
    "UGT2B20 substrate": 7308,
    "UGT2B23 substrate": 7309,
    "UGT2B28 substrate": 7310,
    "UGT2B3 substrate": 7311,
    "UGT2B30 substrate": 7312,
    "UGT2B33 substrate": 7313,
    "UGT2B4 substrate": 7314,
    "UGT2B4D substrate": 7315,
    "UGT2B4E substrate": 7316,
    "UGT2B7 substrate": 7317,
    "UGT2B7H substrate": 7318,
    "UGT2B7Y substrate": 7319,
    "UGT2B9 substrate": 7320,
    "UHRF1 expression enhancer": 7321,
    "UNG expression enhancer": 7322,
    "UNG expression inhibitor": 7323,
    "UPP1 expression enhancer": 7324,
    "UQCRC2 expression inhibitor": 7325,
    "UQCRH expression inhibitor": 7326,
    "USP1 expression inhibitor": 7327,
    "USP18 expression enhancer": 7328,
    "USP32 expression inhibitor": 7329,
    "USP47 expression inhibitor": 7330,
    "UTP-glucose-1-phosphate uridylyltransferase inhibitor": 7331,
    "UTRN expression inhibitor": 7332,
    "UVRAG expression inhibitor": 7333,
    "Ubiquitin thiolesterase inhibitor": 7334,
    "Ubiquitin-conjugating enzyme E2 N inhibitor": 7335,
    "Ubiquitin-protein ligase inhibitor": 7336,
    "Ulcer, aphthous": 7337,
    "Ulcer, gastric": 7338,
    "Ulcer, peptic": 7339,
    "Ulceration": 7340,
    "Ulcerative colitis treatment": 7341,
    "Undecaprenyl-diphosphatase inhibitor": 7342,
    "Undecaprenyl-phosphate galactose phosphotransferase inhibitor": 7343,
    "Undecaprenyl-phosphate mannosyltransferase inhibitor": 7344,
    "Undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase inhibitor": 7345,
    "Uracil phosphoribosyltransferase inhibitor": 7346,
    "Urate transporter 1 inhibitor": 7347,
    "Urate-ribonucleotide phosphorylase inhibitor": 7348,
    "Urease inhibitor": 7349,
    "Urethanase inhibitor": 7350,
    "Uric acid excretion stimulant": 7351,
    "Uridine kinase inhibitor": 7352,
    "Uridine nucleosidase inhibitor": 7353,
    "Uridine phosphorylase 1 inhibitor": 7354,
    "Uridine phosphorylase inhibitor": 7355,
    "Urinary incontinence treatment": 7356,
    "Urinary retention": 7357,
    "Urinary urge": 7358,
    "Urine discoloration": 7359,
    "Urocanate hydratase inhibitor": 7360,
    "Urokinase inhibitor": 7361,
    "Urolithiasis treatment": 7362,
    "Urologic disorders treatment": 7363,
    "Uroporphyrinogen decarboxylase inhibitor": 7364,
    "Uroporphyrinogen-III synthase inhibitor": 7365,
    "Urotensin II agonist": 7366,
    "Urotensin II antagonist": 7367,
    "Urticaria": 7368,
    "Urticaria treatment": 7369,
    "Uterine relaxant": 7370,
    "Uterine rupture": 7371,
    "Uterine stimulant": 7372,
    "Uveitis": 7373,
    "VAMP8 expression enhancer": 7374,
    "VAT1 expression enhancer": 7375,
    "VAV3 expression inhibitor": 7376,
    "VCAM antagonist": 7377,
    "VCAM-1 antagonist": 7378,
    "VCAM1 expression enhancer": 7379,
    "VCAM1 expression inhibitor": 7380,
    "VCAN expression inhibitor": 7381,
    "VDR expression enhancer": 7382,
    "VEGF expression enhancer": 7383,
    "VEGF expression inhibitor": 7384,
    "VEGFA expression enhancer": 7385,
    "VEGFA expression inhibitor": 7386,
    "VEGFC expression inhibitor": 7387,
    "VEGFR2 expression inhibitor": 7388,
    "VEZT expression inhibitor": 7389,
    "VIM expression inhibitor": 7390,
    "VIPR1 expression enhancer": 7391,
    "VLA-4 antagonist": 7392,
    "VSNL1 expression inhibitor": 7393,
    "VTCN1 expression enhancer": 7394,
    "VWCE expression enhancer": 7395,
    "Vacuolar ATP synthase subunit B, kidney isoform inhibitor": 7396,
    "Vacuolar H(+)-transporting ATPase 116 kDa subunit, a1 isoform inhibitor": 7397,
    "Vacuolar-type proton translocating pyrophosphatase 1 inhibitor": 7398,
    "Vaginitis": 7399,
    "Valine decarboxylase inhibitor": 7400,
    "Valine dehydrogenase (NADP+) inhibitor": 7401,
    "Valine-pyruvate transaminase inhibitor": 7402,
    "Valine-tRNA ligase inhibitor": 7403,
    "Vanilloid 1 agonist": 7404,
    "Vanilloid 1 antagonist": 7405,
    "Vanilloid 2 antagonist": 7406,
    "Vanilloid 3 antagonist": 7407,
    "Vanilloid 4 agonist": 7408,
    "Vanilloid 4 antagonist": 7409,
    "Vanilloid agonist": 7410,
    "Vanilloid antagonist": 7411,
    "Vanillyl-alcohol oxidase inhibitor": 7412,
    "Vascular (periferal) disease treatment": 7413,
    "Vascular adhesion protein 1 inhibitor": 7414,
    "Vascular dementia treatment": 7415,
    "Vascular endothelial growth factor 1 antagonist": 7416,
    "Vascular endothelial growth factor 2 antagonist": 7417,
    "Vascular endothelial growth factor 3 antagonist": 7418,
    "Vascular endothelial growth factor antagonist": 7419,
    "Vasculitis": 7420,
    "Vasculitis treatment": 7421,
    "Vasodilator": 7422,
    "Vasodilator, cerebral": 7423,
    "Vasodilator, coronary": 7424,
    "Vasodilator, peripheral": 7425,
    "Vasodilator, renal": 7426,
    "Vasopressin 1 agonist": 7427,
    "Vasopressin 1 antagonist": 7428,
    "Vasopressin 1A agonist": 7429,
    "Vasopressin 1A antagonist": 7430,
    "Vasopressin 1B agonist": 7431,
    "Vasopressin 1B antagonist": 7432,
    "Vasopressin 2 agonist": 7433,
    "Vasopressin 2 antagonist": 7434,
    "Vasopressor": 7435,
    "Vasoprotector": 7436,
    "Venom exonuclease inhibitor": 7437,
    "Venombin A inhibitor": 7438,
    "Venombin AB inhibitor": 7439,
    "Vertigo": 7440,
    "Vesicant": 7441,
    "Vesicle monoamine transporter 2 inhibitor": 7442,
    "Vesicle monoamine transporter inhibitor": 7443,
    "Vesicular acetylcholine transporter inhibitor": 7444,
    "Vesicular glutamate transport inhibitor": 7445,
    "Vestibular dysfunction": 7446,
    "Vibriolysin inhibitor": 7447,
    "Viral entry inhibitor": 7448,
    "Viral fusion inhibitor": 7449,
    "Vision disturbance": 7450,
    "Visual acuity impairment": 7451,
    "Vitamin": 7452,
    "Vitamin D receptor agonist": 7453,
    "Vitamin D receptor antagonist": 7454,
    "Vitamin D-like": 7455,
    "Vitamin D3 hydroxylase inhibitor": 7456,
    "Vitamin D3-like": 7457,
    "Vitamin K-dependent protein C inhibitor": 7458,
    "Vitamin K-like": 7459,
    "Vitamin-K-epoxide reductase (warfarin-insensitive) inhibitor": 7460,
    "Vitamin-K-epoxide reductase (warfarin-sensitive) inhibitor": 7461,
    "Vitiligo treatment": 7462,
    "Vitronectin receptor antagonist": 7463,
    "Vomilenine glucosyltransferase inhibitor": 7464,
    "WARS expression enhancer": 7465,
    "WAS expression enhancer": 7466,
    "WDR1 expression enhancer": 7467,
    "WDR4 expression inhibitor": 7468,
    "WFDC2 expression enhancer": 7469,
    "WHSC1 expression inhibitor": 7470,
    "WIPI1 expression enhancer": 7471,
    "WISP2 expression enhancer": 7472,
    "WISP2 expression inhibitor": 7473,
    "WNT10B expression enhancer": 7474,
    "WNT5A expression enhancer": 7475,
    "WNT7A expression inhibitor": 7476,
    "WWP2 expression inhibitor": 7477,
    "Weakness": 7478,
    "Weight gain": 7479,
    "Weight loss": 7480,
    "Wilson's disease treatment": 7481,
    "Withdrawal": 7482,
    "Wound healing agent": 7483,
    "X-His dipeptidase inhibitor": 7484,
    "X-Pro dipeptidase inhibitor": 7485,
    "X-Trp aminopeptidase inhibitor": 7486,
    "X-methyl-His dipeptidase inhibitor": 7487,
    "XBP1 expression enhancer": 7488,
    "XIAP expression inhibitor": 7489,
    "XPO1 expression inhibitor": 7490,
    "XPO5 expression inhibitor": 7491,
    "XRCC4 expression enhancer": 7492,
    "XRCC5 expression inhibitor": 7493,
    "Xaa-Pro aminopeptidase 2 inhibitor": 7494,
    "Xaa-Pro dipeptidyl-peptidase inhibitor": 7495,
    "Xanthine dehydrogenase inhibitor": 7496,
    "Xanthine oxidase inhibitor": 7497,
    "Xanthine oxidase substrate": 7498,
    "Xanthine phosphoribosyltransferase inhibitor": 7499,
    "Xanthine-like": 7500,
    "Xanthommatin reductase inhibitor": 7501,
    "Xenobiotic-transporting ATPase inhibitor": 7502,
    "Xerostomia": 7503,
    "Xylan 1,4-beta-xylosidase inhibitor": 7504,
    "Xylan endo-1,3-beta-xylosidase inhibitor": 7505,
    "Xylose isomerase inhibitor": 7506,
    "YAK3 inhibitor": 7507,
    "YBX1 expression inhibitor": 7508,
    "YPEL5 expression inhibitor": 7509,
    "YWHAE expression inhibitor": 7510,
    "YWHAZ expression inhibitor": 7511,
    "Yawning": 7512,
    "Yeast ribonuclease inhibitor": 7513,
    "Yersiniabactin siderophore biosynthetic protein inhibitor": 7514,
    "ZAK expression inhibitor": 7515,
    "ZAP-70 protein tyrosine kinase inhibitor": 7516,
    "ZBTB1 expression enhancer": 7517,
    "ZBTB10 expression inhibitor": 7518,
    "ZBTB43 expression inhibitor": 7519,
    "ZC3HAV1 expression enhancer": 7520,
    "ZCCHC2 expression enhancer": 7521,
    "ZCCHC2 expression inhibitor": 7522,
    "ZEB1 expression inhibitor": 7523,
    "ZFAND5 expression inhibitor": 7524,
    "ZFHX3 expression inhibitor": 7525,
    "ZFP36 expression enhancer": 7526,
    "ZFP36L1 expression inhibitor": 7527,
    "ZKSCAN2 expression enhancer": 7528,
    "ZKSCAN4 expression enhancer": 7529,
    "ZMYM2 expression enhancer": 7530,
    "ZMYM2 expression inhibitor": 7531,
    "ZMYM3 expression enhancer": 7532,
    "ZNF131 expression inhibitor": 7533,
    "ZNF652 expression inhibitor": 7534,
    "ZNF703 expression enhancer": 7535,
    "ZNF91 expression inhibitor": 7536,
    "ZWINT expression enhancer": 7537,
    "ZYG11B expression inhibitor": 7538,
    "Zinc deficiency": 7539,
    "Zinc finger protein GLI1 inhibitor": 7540,
    "Zinc finger protein GLI2 inhibitor": 7541,
    "[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)] kinase inhibitor": 7542,
    "[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase inhibitor": 7543,
    "[Isocitrate dehydrogenase (NADP+)] kinase inhibitor": 7544,
    "[Skp1-protein]-hydroxyproline N-acetylglucosaminyltransferase inhibitor": 7545,
    "[acetyl-CoA carboxylase] kinase inhibitor": 7546,
    "[acyl-carrier-protein] S-acetyltransferase inhibitor": 7547,
    "[acyl-carrier-protein] S-malonyltransferase inhibitor": 7548,
    "[citrate-(pro-3S)-lyase] thiolesterase inhibitor": 7549,
    "[glutamate-ammonia-ligase] adenylyltransferase inhibitor": 7550,
    "[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitor": 7551,
    "[hydroxymethylglutaryl-CoA reductase (NADPH)]-phosphatase inhibitor": 7552,
    "[myelin basic protein]-arginine N-methyltransferase inhibitor": 7553,
    "[phosphorylase] phosphatase inhibitor": 7554,
    "[protein-PII] uridylyltransferase inhibitor": 7555,
    "[pyruvate dehydrogenase (lipoamide)]-phosphatase inhibitor": 7556,
    "c-Jun N-terminal kinase inhibitor": 7557,
    "c-Src kinase inhibitor": 7558,
    "cAMP-dependent protein kinase alpha catalytic subunit inhibitor": 7559,
    "cAMP-dependent protein kinase beta catalytic subunit inhibitor": 7560,
    "cAMP-dependent protein kinase gamma catalytic subunit inhibitor": 7561,
    "cAMP-dependent protein kinase type I-alpha regulatory subunit inhibitor": 7562,
    "cAMP-dependent protein kinase type I-beta regulatory subunit inhibitor": 7563,
    "cAMP-dependent protein kinase type II-alpha regulatory subunit inhibitor": 7564,
    "cAMP-dependent protein kinase type II-beta regulatory subunit inhibitor": 7565,
    "cGMP-dependent protein kinase 1 alpha inhibitor": 7566,
    "cGMP-dependent protein kinase 1 beta inhibitor": 7567,
    "cGMP-dependent protein kinase 2 inhibitor": 7568,
    "cGMP-dependent protein kinase inhibitor": 7569,
    "dCMP deaminase inhibitor": 7570,
    "dCTP deaminase inhibitor": 7571,
    "dCTP diphosphatase inhibitor": 7572,
    "dTDP-4-dehydrorhamnose reductase inhibitor": 7573,
    "dTDP-glucose 4,6-dehydratase inhibitor": 7574,
    "dTMP kinase (Mycobacterium tuberculosis) inhibitor": 7575,
    "dTMP kinase inhibitor": 7576,
    "dUTP diphosphatase inhibitor": 7577,
    "dUTP pyrophosphatase inhibitor": 7578,
    "mRNA (guanine-N7-)-methyltransferase inhibitor": 7579,
    "mRNA (nucleoside-2'-O-)-methyltransferase inhibitor": 7580,
    "mTOR complex 1 inhibitor": 7581,
    "mTOR complex 2 inhibitor": 7582,
    "mTOR inhibitor": 7583,
    "p21 inhibitor": 7584,
    "p21-activated kinase 1 inhibitor": 7585,
    "p21-activated kinase 4 inhibitor": 7586,
    "p21-activated kinase inhibitor": 7587,
    "p38 MAP kinase inhibitor": 7588,
    "p53 inhibitor": 7589,
    "pFOX inhibitor": 7590,
    "rRNA (adenosine-2'-O-)-methyltransferase inhibitor": 7591,
    "sAPP-alpha secretion enhancer": 7592,
    "tRNA (adenine-N1-)-methyltransferase inhibitor": 7593,
    "tRNA (cytosine-5-)-methyltransferase inhibitor": 7594,
    "tRNA (guanine-N1-)-methyltransferase inhibitor": 7595,
    "tRNA (guanine-N2-)-methyltransferase inhibitor": 7596,
    "tRNA (guanine-N7-)-methyltransferase inhibitor": 7597,
    "tRNA (uracil-5-)-methyltransferase inhibitor": 7598,
    "tRNA adenylyltransferase inhibitor": 7599,
    "tRNA cytidylyltransferase inhibitor": 7600,
    "tRNA methyltransferase inhibitor": 7601,
    "tRNA nucleotidyltransferase inhibitor": 7602,
    "tRNA-pseudouridine synthase I inhibitor": 7603
}